{"46e6c155f1b7e6d93735e45da3f93b0f1ae63113": [["BackgroundClinical laboratory workers are subjected daily to occupational hazards that include infections from biological samples and contaminated equipment [1] .", [["infections", "DISEASE", 95, 105], ["infections", "PROBLEM", 95, 105]]], ["For example, literature showed that workers at clinical laboratory are at increased risk of acquiring viral infections such as hepatitis viruses (HBV and HCV), human immunodeficiency viruses (HIV), Middle East Respiratory Syndrome (MERS-CoV), and others [2, 3] .", [["viral infections", "DISEASE", 102, 118], ["hepatitis viruses", "DISEASE", 127, 144], ["HBV and HCV)", "DISEASE", 146, 158], ["human immunodeficiency viruses (HIV)", "DISEASE", 160, 196], ["Middle East Respiratory Syndrome", "DISEASE", 198, 230], ["hepatitis viruses", "ORGANISM", 127, 144], ["HBV", "ORGANISM", 146, 149], ["human immunodeficiency viruses", "ORGANISM", 160, 190], ["MERS-CoV", "ORGANISM", 232, 240], ["human immunodeficiency viruses", "SPECIES", 160, 190], ["hepatitis viruses", "SPECIES", 127, 144], ["HBV", "SPECIES", 146, 149], ["HCV", "SPECIES", 154, 157], ["human immunodeficiency viruses", "SPECIES", 160, 190], ["HIV", "SPECIES", 192, 195], ["Middle East Respiratory Syndrome (MERS-CoV", "SPECIES", 198, 240], ["acquiring viral infections", "PROBLEM", 92, 118], ["hepatitis viruses", "PROBLEM", 127, 144], ["HBV", "PROBLEM", 146, 149], ["HCV", "PROBLEM", 154, 157], ["human immunodeficiency viruses (HIV)", "PROBLEM", 160, 196], ["Middle East Respiratory Syndrome", "PROBLEM", 198, 230], ["viral infections", "OBSERVATION", 102, 118], ["hepatitis viruses", "OBSERVATION", 127, 144], ["immunodeficiency viruses", "OBSERVATION", 166, 190], ["Middle", "ANATOMY_MODIFIER", 198, 204], ["Respiratory Syndrome", "OBSERVATION", 210, 230]]], ["In addition, bacterial occupational infection has been shown to be high among clinical laboratory workers and other health care providers [4] [5] [6] .", [["occupational infection", "DISEASE", 23, 45], ["bacterial occupational infection", "PROBLEM", 13, 45], ["bacterial", "OBSERVATION_MODIFIER", 13, 22], ["occupational infection", "OBSERVATION", 23, 45]]], ["For example, in a study that was conducted in the United Kingdom, clinical laboratory workers were at about seven times higher risk of acquiring tuberculosis infection in reference to the general population [7] .BackgroundOne of the major sources of infection among health care professionals is needlestick injuries [8, 9] .", [["tuberculosis infection", "DISEASE", 145, 167], ["infection", "DISEASE", 250, 259], ["needlestick injuries", "DISEASE", 295, 315], ["a study", "TEST", 16, 23], ["acquiring tuberculosis infection", "PROBLEM", 135, 167], ["infection", "PROBLEM", 250, 259], ["needlestick injuries", "PROBLEM", 295, 315], ["tuberculosis", "OBSERVATION_MODIFIER", 145, 157], ["infection", "OBSERVATION", 158, 167], ["infection", "OBSERVATION", 250, 259]]], ["According to the literature, needlestick injury is responsible for the majority of hepatitis and HIV infections among health care professionals.", [["needlestick injury", "DISEASE", 29, 47], ["hepatitis", "DISEASE", 83, 92], ["HIV infections", "DISEASE", 97, 111], ["HIV", "SPECIES", 97, 100], ["HIV", "SPECIES", 97, 100], ["needlestick injury", "PROBLEM", 29, 47], ["hepatitis", "PROBLEM", 83, 92], ["HIV infections", "PROBLEM", 97, 111], ["hepatitis", "OBSERVATION", 83, 92]]], ["In addition, the majority of these infections occur in developing countries [10] .", [["infections", "DISEASE", 35, 45], ["these infections", "PROBLEM", 29, 45], ["infections", "OBSERVATION", 35, 45]]], ["Analysis of needlestick injuries showed that injuries could happen during all steps of needle use procedures [8] .", [["needlestick injuries", "DISEASE", 12, 32], ["injuries", "DISEASE", 45, 53], ["needlestick injuries", "PROBLEM", 12, 32], ["injuries", "PROBLEM", 45, 53], ["injuries", "OBSERVATION", 45, 53]]], ["However recapping of the needle, work load and lack of training, and not following safety precautions are among major risk factors [11] [12] [13] .", [["safety precautions", "TREATMENT", 83, 101]]], ["Requiring workers to follow procedures and practices related to infection control, injury prevention and the use of protective equipment can significantly reduce infections and needlestick injury [14, 15] .BackgroundThe aim of the current study is to investigate self-reported frequency of occupational infection and needlestick injury among the clinical laboratory workers in Al-Madinah.", [["infection", "DISEASE", 64, 73], ["infections", "DISEASE", 162, 172], ["needlestick injury", "DISEASE", 177, 195], ["infection", "DISEASE", 303, 312], ["needlestick injury", "DISEASE", 317, 335], ["practices", "TREATMENT", 43, 52], ["infection control", "TREATMENT", 64, 81], ["injury prevention", "TREATMENT", 83, 100], ["protective equipment", "TREATMENT", 116, 136], ["infections", "PROBLEM", 162, 172], ["needlestick injury", "PROBLEM", 177, 195], ["the current study", "TEST", 227, 244], ["occupational infection", "PROBLEM", 290, 312], ["needlestick injury", "PROBLEM", 317, 335], ["infection", "OBSERVATION", 64, 73], ["infection", "OBSERVATION", 303, 312]]], ["The considerable diversity of patients and heavy load highlight the importance of adopting good practices and safety protection measures to limit the spread of diseases in the city.", [["patients", "ORGANISM", 30, 38], ["patients", "SPECIES", 30, 38], ["safety protection measures", "TREATMENT", 110, 136], ["diseases", "PROBLEM", 160, 168], ["considerable", "OBSERVATION_MODIFIER", 4, 16], ["diversity", "OBSERVATION_MODIFIER", 17, 26]]], ["Therefore, this study was designed to examine the self-reported occurrence of needlestick injuries, safety practices (i.e. recapping), and occupational infection among laboratory workers in Al-Madinah.", [["needlestick injuries", "DISEASE", 78, 98], ["infection", "DISEASE", 152, 161], ["this study", "TEST", 11, 21], ["needlestick injuries", "PROBLEM", 78, 98], ["safety practices", "TREATMENT", 100, 116], ["infection", "OBSERVATION", 152, 161]]], ["The results of the current study can be used for interventions that target the enhancement of biosafety measures among Al-Madinah clinical laboratory workers.Study participantsA survey-based study design was adapted to investigate the incidence and factors associated with needlestick injury and occupational infection among clinical laboratory workers in Al-Madinah city.", [["Al", "CHEMICAL", 119, 121], ["needlestick injury", "DISEASE", 273, 291], ["infection", "DISEASE", 309, 318], ["participants", "SPECIES", 164, 176], ["the current study", "TEST", 15, 32], ["interventions", "TREATMENT", 49, 62], ["A survey-based study", "TEST", 176, 196], ["needlestick injury", "PROBLEM", 273, 291], ["occupational infection", "PROBLEM", 296, 318]]], ["Al-Madinah is the second holy city after Mecca in Saudi Arabia that host the Prophet's Mosque.", [["Al-Madinah", "CHEMICAL", 0, 10]]], ["The city receives more than 10 million pilgrims each year who came from most world countries.Study participantsClinical laboratory staff from the majority of Al-Madinah clinics (eight private and ten governmental) was invited to be part of the study.", [["participants", "SPECIES", 99, 111], ["the study", "TEST", 240, 249]]], ["Details about the purpose of the study and assurance of confidentiality were presented to participants as part of the recruitment procedure.", [["participants", "SPECIES", 90, 102], ["the study", "TEST", 29, 38], ["the recruitment procedure", "TREATMENT", 114, 139]]], ["About 405 participants were invited to fill out the questionnaire among which 234 agreed to participate (58%).", [["participants", "SPECIES", 10, 22]]], ["This anonymity was a requirement that ensured no possible risks for the participants.", [["participants", "SPECIES", 72, 84], ["no possible", "UNCERTAINTY", 46, 57]]], ["To ensure confidentiality, the research team has removed the IP addresses from the data spreadsheet after completion of the recruitment process.", [["the recruitment process", "TREATMENT", 120, 143], ["recruitment", "OBSERVATION", 124, 135]]], ["The study was approved by the Institutional Review Board of the Faculty of Applied Medical Sciences (ID number: MLT 2016-23).Study instrumentThe questionnaire was prepared from previous studies that examined needlestick injury, occupation safety and factors associated with their incidence [16] [17] [18] .", [["needlestick injury", "DISEASE", 208, 226], ["The study", "TEST", 0, 9], ["Study instrument", "TEST", 125, 141], ["previous studies", "TEST", 177, 193], ["needlestick injury", "PROBLEM", 208, 226]]], ["The instrument was subjected to several revisions after comments were received from colleagues at the Department of Medical Laboratory Sciences and a pilot study that involved 20 staff from diagnostic clinical labs.", [["a pilot study", "TEST", 148, 161], ["diagnostic clinical labs", "TEST", 190, 214]]], ["The first part gathered information about participants' age, gender, experience, prior training on biosafety, specialty, academic degree and place of work.", [["participants", "SPECIES", 42, 54]]], ["The second part focused on needlestick injury and related behaviors such as covering needle after use (re-sheathing or re-capping).", [["needlestick injury", "DISEASE", 27, 45], ["needlestick injury", "PROBLEM", 27, 45], ["injury", "OBSERVATION", 39, 45]]], ["In this part, the participants were asked if they have experienced a needlestick injury during their career period.", [["needlestick injury", "DISEASE", 69, 87], ["participants", "ORGANISM", 18, 30], ["participants", "SPECIES", 18, 30], ["a needlestick injury", "PROBLEM", 67, 87]]], ["In addition, the participant was asked about frequency of re-capping needles after use.", [["participant", "SPECIES", 17, 28], ["re-capping needles", "TREATMENT", 58, 76]]], ["The third part focused on occupational infection and knowledge about disinfection procedures and infection routes.", [["infection", "DISEASE", 39, 48], ["infection", "DISEASE", 97, 106], ["occupational infection", "PROBLEM", 26, 48], ["disinfection procedures", "TREATMENT", 69, 92], ["infection routes", "TREATMENT", 97, 113], ["infection", "OBSERVATION", 39, 48]]], ["Participants were asked if they have experienced an occupational infection, which was defined as acquiring bacterial or viral infection from work place during their career period.", [["infection", "DISEASE", 65, 74], ["infection", "DISEASE", 126, 135], ["Participants", "SPECIES", 0, 12], ["an occupational infection", "PROBLEM", 49, 74], ["viral infection", "PROBLEM", 120, 135], ["infection", "OBSERVATION", 65, 74], ["viral", "OBSERVATION_MODIFIER", 120, 125], ["infection", "OBSERVATION", 126, 135]]], ["Participants filled the questionnaire electronically using google forms.Statistical analysisThe SPSS software was used to analyze the data, which was presented as frequencies and number of participants in each category.", [["Participants", "SPECIES", 0, 12], ["participants", "SPECIES", 189, 201], ["Statistical analysis", "TEST", 72, 92], ["The SPSS software", "TEST", 92, 109]]], ["Chi square test, Fisher Exact test and odd ratios with 95% confidence intervals were used to correlate demographic variables with needlestick and occupational infection.", [["infection", "DISEASE", 159, 168], ["Chi square test", "TEST", 0, 15], ["Fisher Exact test", "TEST", 17, 34], ["needlestick", "PROBLEM", 130, 141], ["occupational infection", "PROBLEM", 146, 168], ["infection", "OBSERVATION", 159, 168]]], ["The P value of significance was set at 0.05 threshold.ResultsA total of 234 medical laboratory workers was recruited to participate in the study.", [["The P value", "TEST", 0, 11], ["the study", "TEST", 135, 144]]], ["The majority ( participants were vaccinated against HBV as this a requirement by health law in Saudi Arabia before employment in medical laboratories.ResultsThe results showed that about 24% of the sample had experienced a needlestick injury.", [["needlestick injury", "DISEASE", 223, 241], ["HBV", "ORGANISM", 52, 55], ["participants", "SPECIES", 15, 27], ["HBV", "SPECIES", 52, 55], ["HBV", "PROBLEM", 52, 55], ["a needlestick injury", "PROBLEM", 221, 241], ["needlestick injury", "OBSERVATION", 223, 241]]], ["The results showed that the needlestick injury was associated with private clinics (P < 0.05) and lack of training on biosafety ( Table 2 ).", [["needlestick injury", "DISEASE", 28, 46], ["the needlestick injury", "PROBLEM", 24, 46]]], ["The participants were asked about capping needle directly after use.", [["participants", "ORGANISM", 4, 16], ["participants", "SPECIES", 4, 16]]], ["Table 4 shows the incidence of occupational infection among participants.", [["infection", "DISEASE", 44, 53], ["participants", "SPECIES", 60, 72], ["occupational infection", "PROBLEM", 31, 53], ["occupational", "OBSERVATION_MODIFIER", 31, 43], ["infection", "OBSERVATION", 44, 53]]], ["Figure 1 shows the awareness of participants about disinfection procedures and infection routes.", [["infection", "DISEASE", 79, 88], ["participants", "SPECIES", 32, 44], ["disinfection procedures", "TREATMENT", 51, 74], ["infection routes", "TREATMENT", 79, 95]]], ["The results showed that the majority of participants reported excellent to very good awareness levels (> 80%).DiscussionsIn this study, the incidence of occupational infection and needlestick injury among clinical laboratory workers in Al-Madinah city was investigated.", [["infection", "DISEASE", 166, 175], ["needlestick injury", "DISEASE", 180, 198], ["participants", "ORGANISM", 40, 52], ["participants", "SPECIES", 40, 52], ["this study", "TEST", 124, 134], ["occupational infection", "PROBLEM", 153, 175], ["needlestick injury", "PROBLEM", 180, 198], ["infection", "OBSERVATION", 166, 175]]], ["With respect to the self-reported frequency of needlestick injury, approximately 24% of the sample had such experience during their career period.", [["needlestick injury", "DISEASE", 47, 65], ["needlestick injury", "PROBLEM", 47, 65]]], ["This rate is comparable to what was reported in some previous studies [16] [17] [18] .", [["[16] [17] [18]", "SIMPLE_CHEMICAL", 70, 84], ["some previous studies", "TEST", 48, 69]]], ["For example, an incidence rate of 22.4% sharp injuries over a period of 12 months was reported in a cross-sectional study that was conducted in Dominican Republic [16] .", [["injuries", "DISEASE", 46, 54], ["an incidence rate", "TEST", 13, 30], ["sharp injuries", "PROBLEM", 40, 54], ["a cross-sectional study", "TEST", 98, 121], ["sharp", "OBSERVATION_MODIFIER", 40, 45], ["injuries", "OBSERVATION", 46, 54]]], ["In an Egyptian cross-sectional interview-based study, about 36% of participants reported exposure to at least 1 needlestick injury during the past 3 months [18] .", [["needlestick injury", "DISEASE", 112, 130], ["participants", "ORGANISM", 67, 79], ["participants", "SPECIES", 67, 79], ["based study", "TEST", 41, 52], ["1 needlestick injury", "PROBLEM", 110, 130]]], ["However, higher frequencies (63-73%) were reported in cross-sectional survey-based studies that were conducted in Bosnia [19] and Afghanistan [20] and include the whole career period.DiscussionsNeedlestick injuries reported in this study could be due to what was reported by the participants that they always (49%) recap needle after use, whereas 15% reported doing that most of the times.", [["injuries", "DISEASE", 206, 214], ["participants", "SPECIES", 279, 291], ["cross-sectional survey", "TEST", 54, 76], ["Needlestick injuries", "PROBLEM", 194, 214], ["this study", "TEST", 227, 237], ["higher", "OBSERVATION_MODIFIER", 9, 15]]], ["In a Poland study, 64% of respondents occasionally recap needles after injections [21] .", [["a Poland study", "TEST", 3, 17]]], ["In a review that was conducted by De Carli and colleagues [8] , issues related to management of sharp disposals, needle recapping, and the transfer of sampled blood from syringes into tubes account for the majority of needlestick injuries.", [["blood", "ANATOMY", 159, 164], ["needlestick injuries", "DISEASE", 218, 238], ["blood", "ORGANISM_SUBSTANCE", 159, 164], ["sharp disposals", "PROBLEM", 96, 111], ["needle recapping", "TREATMENT", 113, 129], ["sampled blood from syringes into tubes", "TREATMENT", 151, 189], ["needlestick injuries", "PROBLEM", 218, 238]]], ["Thus, behavior of medical staff plays an important in sharp injuries [23] .", [["injuries", "DISEASE", 60, 68]]], ["Needlestick and sharp injuries can be prevented by applying educational and biosafety training programs and needle protective devices [24, 25] .", [["injuries", "DISEASE", 22, 30], ["Needlestick", "TREATMENT", 0, 11], ["sharp injuries", "PROBLEM", 16, 30], ["biosafety training programs", "TREATMENT", 76, 103], ["needle protective devices", "TREATMENT", 108, 133], ["sharp", "OBSERVATION_MODIFIER", 16, 21], ["injuries", "OBSERVATION", 22, 30]]], ["The finding of the present study that needlestick injuries were strongly associated with the lack of training on biosafety and private clinics confirmed the importance of education in reducing sharp injuries in medical laboratories.", [["needlestick injuries", "DISEASE", 38, 58], ["injuries", "DISEASE", 199, 207], ["the present study", "TEST", 15, 32], ["needlestick injuries", "PROBLEM", 38, 58], ["reducing sharp injuries", "PROBLEM", 184, 207]]], ["Finally, the results showed that needledstick injuries were less frequent in governmental clinics and recapping was performed more frequently.", [["needledstick injuries", "DISEASE", 33, 54], ["needledstick injuries", "PROBLEM", 33, 54]]], ["Thus, additional factors seem to contribute to needlestick injury, such as workloads and adherence to safety guidelines that are expected to differ in governmental and private clinics.", [["needlestick injury", "DISEASE", 47, 65], ["needlestick injury", "PROBLEM", 47, 65]]], ["More studies are required to determine the exact factors that contribute to the observed high frequency of needlestick injury among Al-Madinah clinical laboratory workers.", [["needlestick injury", "DISEASE", 107, 125], ["Al", "CHEMICAL", 132, 134], ["More studies", "TEST", 0, 12], ["needlestick injury", "PROBLEM", 107, 125]]], ["The results showed that approximately 33% of participants experienced occupational infection during their career period.", [["infection", "DISEASE", 83, 92], ["participants", "ORGANISM", 45, 57], ["participants", "SPECIES", 45, 57], ["occupational infection", "PROBLEM", 70, 92], ["infection", "OBSERVATION", 83, 92]]], ["Previous studies have shown increased risk of clinical laboratory workers to diverse types of infection from their work places [26] that include blood borne pathogens (HBV, HCV, HIV), respiratory illnesses (MERS-CoV, influenza viruses, Tuberculosis) [27] and skin infections [28] .", [["blood", "ANATOMY", 145, 150], ["skin", "ANATOMY", 259, 263], ["infection", "DISEASE", 94, 103], ["blood borne pathogens", "DISEASE", 145, 166], ["HBV, HCV, HIV)", "DISEASE", 168, 182], ["respiratory illnesses", "DISEASE", 184, 205], ["MERS-CoV, influenza viruses", "DISEASE", 207, 234], ["Tuberculosis", "DISEASE", 236, 248], ["skin infections", "DISEASE", 259, 274], ["blood", "ORGANISM_SUBSTANCE", 145, 150], ["HBV", "ORGANISM", 168, 171], ["HCV", "ORGANISM", 173, 176], ["MERS-CoV", "ORGANISM", 207, 215], ["influenza viruses", "ORGANISM", 217, 234], ["skin", "ORGAN", 259, 263], ["HIV", "SPECIES", 178, 181], ["HBV", "SPECIES", 168, 171], ["HCV", "SPECIES", 173, 176], ["HIV", "SPECIES", 178, 181], ["MERS-CoV", "SPECIES", 207, 215], ["Previous studies", "TEST", 0, 16], ["infection", "PROBLEM", 94, 103], ["blood borne pathogens", "PROBLEM", 145, 166], ["HBV", "PROBLEM", 168, 171], ["HCV", "PROBLEM", 173, 176], ["HIV", "PROBLEM", 178, 181], ["respiratory illnesses", "PROBLEM", 184, 205], ["influenza viruses", "PROBLEM", 217, 234], ["Tuberculosis", "PROBLEM", 236, 248], ["skin infections", "PROBLEM", 259, 274], ["increased", "OBSERVATION_MODIFIER", 28, 37], ["infection", "OBSERVATION", 94, 103], ["respiratory", "ANATOMY", 184, 195], ["skin", "ANATOMY", 259, 263], ["infections", "OBSERVATION", 264, 274]]], ["In a cross-sectional survey study that was conducted in clinics from 10 Moroccan cities, 58.9% of the subjects underwent at least one occupational blood exposure [22] .", [["blood", "ANATOMY", 147, 152], ["blood", "ORGANISM_SUBSTANCE", 147, 152], ["a cross-sectional survey study", "TEST", 3, 33]]], ["The results showed an association between occupational infection and college degree holders and training on biosafety.DiscussionsThe results showed that > 80% of the sample reported very-good to excellent knowledge regarding infection routes and disinfection procedures.", [["infection", "DISEASE", 55, 64], ["infection", "DISEASE", 225, 234], ["occupational infection", "PROBLEM", 42, 64], ["infection routes", "TREATMENT", 225, 241], ["disinfection procedures", "TREATMENT", 246, 269], ["infection", "OBSERVATION", 55, 64]]], ["Thus, other factors apart from education are likely to play a role in determining incorrect behaviors such as the adherence to infection control guidelines.", [["infection", "DISEASE", 127, 136], ["infection control guidelines", "TREATMENT", 127, 155]]], ["However, the association between needlestick injury and occupational infection with lack of training on biosafety highlights the importance of training in reducing such biohazards.", [["needlestick injury", "DISEASE", 33, 51], ["infection", "DISEASE", 69, 78], ["needlestick injury", "PROBLEM", 33, 51], ["occupational infection", "PROBLEM", 56, 78], ["biosafety", "TREATMENT", 104, 113], ["infection", "OBSERVATION", 69, 78]]], ["Previous studies have pointed to the effectiveness of the adherence to infection control guidelines, use of injury prevention devices and biosafety educational programs in the prevention of occupational infection and injury [29, 30] .DiscussionsIn this cross-sectional study, we asked the participants if they have ever experienced needlestick injury or occupational infection.", [["infection", "DISEASE", 71, 80], ["infection", "DISEASE", 203, 212], ["needlestick injury", "DISEASE", 332, 350], ["infection", "DISEASE", 367, 376], ["participants", "SPECIES", 289, 301], ["Previous studies", "TEST", 0, 16], ["infection control guidelines", "TREATMENT", 71, 99], ["injury prevention devices", "TREATMENT", 108, 133], ["biosafety educational programs", "TREATMENT", 138, 168], ["occupational infection", "PROBLEM", 190, 212], ["injury", "PROBLEM", 217, 223], ["this cross-sectional study", "TEST", 248, 274], ["needlestick injury", "PROBLEM", 332, 350], ["occupational infection", "PROBLEM", 354, 376], ["infection", "OBSERVATION", 71, 80], ["infection", "OBSERVATION", 203, 212], ["infection", "OBSERVATION", 367, 376]]], ["To have a better assessment of the current situation, conduction of a longitudinal study is strongly recommended where the incidence of such biohazards can be accurately measured.", [["a better assessment", "TEST", 8, 27], ["a longitudinal study", "TEST", 68, 88], ["such biohazards", "PROBLEM", 136, 151]]], ["Inclusion of more questions in the assessment such as how often the participants perform phlebotomy and whether they use needlestick prevention devices are strongly recommended.", [["participants", "SPECIES", 68, 80], ["the assessment", "TEST", 31, 45], ["phlebotomy", "TREATMENT", 89, 99], ["needlestick prevention devices", "TREATMENT", 121, 151]]], ["Other limitations include the validity of key measures such as recall bias and social desirability related to recapping practices, selection bias and the data were not adjusted for confounder factors.DiscussionsIn conclusion, the frequency occupational infection and needlestick injury among clinical laboratory workers in Al-Madinah was relatively high as self-reported by participants.", [["infection", "DISEASE", 253, 262], ["needlestick injury", "DISEASE", 267, 285], ["participants", "SPECIES", 374, 386], ["recapping practices", "TREATMENT", 110, 129], ["confounder factors", "PROBLEM", 181, 199], ["the frequency occupational infection", "PROBLEM", 226, 262], ["needlestick injury", "PROBLEM", 267, 285], ["infection", "OBSERVATION", 253, 262]]], ["Strict implementation of biohazard guidelines in the health care settings and the use of needlestick prevention devices are recommended to reduce the risk of occupational health infections.", [["infections", "DISEASE", 178, 188], ["biohazard guidelines", "TREATMENT", 25, 45], ["needlestick prevention devices", "TREATMENT", 89, 119], ["occupational health infections", "PROBLEM", 158, 188]]], ["Fig. 1 Awareness of participants about disinfection procedures and infection routes.", [["infection", "DISEASE", 67, 76], ["participants", "SPECIES", 20, 32], ["disinfection procedures", "TREATMENT", 39, 62], ["infection routes", "TREATMENT", 67, 83]]], ["A total of 234 participants were included in the study.", [["participants", "ORGANISM", 15, 27], ["participants", "SPECIES", 15, 27], ["the study", "TEST", 45, 54]]], ["More than 80% of study sample reported having excellent to very good awareness about disinfection procedures and infection routes", [["infection", "DISEASE", 113, 122], ["study sample", "TEST", 17, 29], ["disinfection procedures", "TREATMENT", 85, 108], ["infection routes", "PROBLEM", 113, 129]]]], "2e2c5aa98446adadfcf1e9748d38e853bbf1863a": [["telehealth, all forms of technology are included that support health care, public health, patient monitoring, and healthcare administration.", [["patient", "ORGANISM", 90, 97], ["patient", "SPECIES", 90, 97], ["patient monitoring", "TEST", 90, 108], ["healthcare administration", "TREATMENT", 114, 139]]], ["10 Terminology pertaining to telehealth is broad and in a constant state of flux.", [["broad", "OBSERVATION_MODIFIER", 43, 48]]]], "d25afe613478bcd25254e58ec076aa0df90ba10f": [["I. INTRODUCTIONA key strength of single-molecule localization microscopy (SMLM) is its ability to measure the full distribution of the phenomena under study and avoid ensemble averaging.", [["single-molecule localization microscopy", "TEST", 33, 72]]], ["Going beyond standard SMLM to measure SM position and orientation simultaneously is critical for understanding a variety of nanoscale biological and chemical processes, such as the motions of molecular motors [1] [2] [3] , the complex higher-order structures of DNA [4, 5] , and reaction kinetics within catalytic nanoparticles [6] .", [["DNA", "CELLULAR_COMPONENT", 262, 265], ["4, 5]", "SIMPLE_CHEMICAL", 267, 272], ["SMLM", "PROTEIN", 22, 26], ["SM", "PROTEIN", 38, 40]]], ["To perform these measurements, molecular position and orientation must be encoded within the shape of the image produced by a microscope [7] , i.e., its point-spread function (PSF).", [["these measurements", "TEST", 11, 29], ["a microscope", "TEST", 124, 136]]], ["However, balancing the need to resolve various orientations unambiguously with the need to detect SMs efficiently with high signal-to-background ratio (SBR) remains a challenge that limits the adoption of Single-Molecule Orientation Localization Microscopy (SMOLM) for biological and chemical applications; existing techniques either cannot discriminate between similar types of molecular motions or cannot detect weak fluorescent emitters.I. INTRODUCTIONIn order to design a PSF for measuring molecular orientation, one must have a figure of merit for comparison.", [["PSF", "DNA", 476, 479], ["high signal", "PROBLEM", 119, 130], ["biological and chemical applications", "TREATMENT", 269, 305], ["existing techniques", "TREATMENT", 307, 326], ["weak fluorescent emitters", "PROBLEM", 414, 439], ["a PSF", "TREATMENT", 474, 479]]], ["The Cram\u00e9r-Rao bound (CRB), which is the bestpossible precision achievable by an unbiased estimator, has been used extensively for evaluating [8] and optimizing [9, 10] SMLM techniques.", [["[9, 10] SMLM", "SIMPLE_CHEMICAL", 161, 173], ["Rao bound", "OBSERVATION_MODIFIER", 11, 20]]], ["However, since CRB quantifies measurement performance locally, in the sense that it yields an expected measurement sensitivity for * These authors contributed equally to this work \u2020 mdlew@wustl.edu one specific molecular orientation, it is computationally expensive to characterize or optimize a PSF for all possible molecular orientations.", [["CRB", "PROTEIN", 15, 18], ["PSF", "PROTEIN", 296, 299]]], ["We seek to develop an analytical framework for 1) quantifying the performance of any proposed method for measuring molecular orientation, 2) illuminating why a particular method performs well or poorly in a particular situation, and 3) comparing the sensitivity of various methods for measuring specific types of rotational motions.I. INTRODUCTIONIn this paper, we derive a performance metric, termed variance upper bound (VUB), that globally bounds the CRB to quickly evaluate any optical method for measuring molecular orientation.", [["CRB", "PROTEIN", 454, 457], ["various methods", "TEST", 265, 280]]], ["Our VUB analysis surprisingly shows that a microscope with two polarization detection channels, exhibiting a polarized (standard) PSF, provides superior measurement precision when molecules are near a refractive index interface, especially when they lie perpendicular to the optical axis, even under low SBR.", [["Our VUB analysis", "TEST", 0, 16], ["a microscope", "TEST", 41, 53], ["a polarized (standard) PSF", "TREATMENT", 107, 133], ["refractive index interface", "OBSERVATION", 201, 227], ["low SBR", "OBSERVATION", 300, 307]]], ["This conventional method of measuring molecular orientation has poor performance in index-matched samples unless a perturbation, such as defocus, is added to the optical system [11] .", [["a perturbation", "PROBLEM", 113, 127]]], ["To demonstrate, we use a form of SMLM termed transient amyloid binding (TAB) [12] and a maximum likelihood estimator that promotes sparsity [13, 14] to measure the position and orientation of fluorescent molecules transiently bound to amyloid fibrils.", [["amyloid fibrils", "GENE_OR_GENE_PRODUCT", 235, 250], ["SMLM", "PROTEIN", 33, 37], ["fluorescent molecules", "PROTEIN", 192, 213], ["amyloid fibrils", "PROTEIN", 235, 250], ["SMLM termed transient amyloid binding", "PROBLEM", 33, 70], ["fluorescent molecules", "PROBLEM", 192, 213], ["amyloid fibrils", "PROBLEM", 235, 250], ["amyloid binding", "OBSERVATION", 55, 70], ["amyloid fibrils", "OBSERVATION", 235, 250]]], ["For the first time to our knowledge, SMOLM reveals the orientation and rotational diffusion of Nile red (NR), a fluorescent molecule whose quantum yield increases when exposed to a nonpolar environment [15, 16] , when bound to fibrils at the single-molecule level.", [["Nile red", "CHEMICAL", 95, 103], ["Nile red", "SIMPLE_CHEMICAL", 95, 103], ["SMOLM", "PROTEIN", 37, 42], ["Nile red", "PROTEIN", 95, 103], ["NR", "PROTEIN", 105, 107], ["rotational diffusion of Nile red (NR)", "PROBLEM", 71, 108], ["a fluorescent molecule", "PROBLEM", 110, 132]]], ["We show that SMOLM probes structural heterogeneities between these amyloid aggregates that are not detectable by standard SMLM.II. ORIENTATION LOCALIZATION MICROSCOPY AND VARIANCE UPPER BOUNDTo begin, we model a fluorescent molecule as a dipolelike emitter [17] [18] [19] with an orientational unit vector \u00b5 = [\u00b5 x , \u00b5 y , \u00b5 z ] T , or equivalent angles (\u03c6, \u03b8) in spherical coordinates (Fig. S1 ).", [["II", "CHEMICAL", 127, 129], ["[17] [18] [19]", "SIMPLE_CHEMICAL", 257, 271], ["SMOLM", "PROTEIN", 13, 18], ["SMLM", "PROTEIN", 122, 126], ["SMOLM probes structural heterogeneities between these amyloid aggregates", "PROBLEM", 13, 85], ["a dipolelike emitter", "TREATMENT", 236, 256], ["an orientational unit vector", "TEST", 277, 305], ["heterogeneities", "OBSERVATION_MODIFIER", 37, 52], ["amyloid aggregates", "OBSERVATION", 67, 85], ["not detectable", "UNCERTAINTY", 95, 109], ["S1", "ANATOMY", 392, 394]]], ["Assuming that a molecule's rotational correlation time is faster than its excited state lifetime and the camera integration time [20] , its orientation trajectory can be modeled by a second-moment vector m = \u00b5 2II.", [["\u00b5 2II", "CELL_LINE", 208, 213]]], ["These orientational second moments contain information on both the orientation of a molecule and its \"wobble\" or rotational diffusion, represented by the solid angle \u2126, within a camera frame.", [["camera frame", "DNA", 178, 190], ["rotational diffusion", "PROBLEM", 113, 133], ["solid angle", "OBSERVATION", 154, 165]]], ["Fluorescence photons collected from such an emitter are projected to a microscope's image plane with an n-pixel intensity distribution that can be modeled as a linear superposition of six basis images weighted by m, i.e.,II.", [["Fluorescence photons", "TREATMENT", 0, 20], ["a microscope's image plane", "TEST", 69, 95], ["an n-pixel intensity distribution", "TREATMENT", 101, 134]]], ["ORIENTATION LOCALIZATION MICROSCOPY AND VARIANCE UPPER BOUNDwhere s is the number of photons collected by the detector and b is the number of background photons in each pixel.", [["LOCALIZATION MICROSCOPY", "TEST", 12, 35], ["background photons", "TREATMENT", 142, 160]]], ["Each so-called basis image B j \u2208 R n\u00d71 , corresponding to the response of the optical system to each orientational second-moment component m j , can be calculated by vectorial diffraction theory [21] [22] [23] [24] , and various optical elements, such as phase masks, polarizers, and waveplates, can be used to encode orientation information within B j more efficiently.", [["B j", "GENE_OR_GENE_PRODUCT", 349, 352], ["polarizers", "TREATMENT", 268, 278]]], ["A key feature of this forward imaging model is its linearity with respect to the orientation parameters m of interest; B is simply a linear operator or transformation from object space to image space, and the fundamental measurement sensitivity of the optical system is bounded by considering B directly.", [["B", "GENE_OR_GENE_PRODUCT", 293, 294], ["this forward imaging", "TEST", 17, 37], ["a linear operator", "PROBLEM", 131, 148], ["image space", "TEST", 188, 199], ["the fundamental measurement sensitivity", "TEST", 205, 244], ["linear", "OBSERVATION_MODIFIER", 133, 139]]], ["We next quantify the Fisher information (FI) contained in the basis images, i.e., the amount of information that the basis images contain about each of the orientational second moments.", [["the basis images", "TEST", 113, 129]]], ["A larger FI corresponds to a smaller CRB and higher sensitivity for measuring m.", [["A larger FI", "PROBLEM", 0, 11], ["a smaller CRB", "TREATMENT", 27, 40], ["larger", "OBSERVATION_MODIFIER", 2, 8], ["FI", "OBSERVATION", 9, 11], ["smaller", "OBSERVATION_MODIFIER", 29, 36], ["CRB", "OBSERVATION", 37, 40], ["higher sensitivity", "OBSERVATION_MODIFIER", 45, 63]]], ["Given our linear imaging model, the FI matrix J \u2208 R 6\u00d76 for the orientational second moments can be written asII.", [["R 6\u00d76", "DNA", 50, 55], ["asII", "PROTEIN", 108, 112], ["our linear imaging model", "TEST", 6, 30], ["the FI matrix J \u2208 R", "TREATMENT", 32, 51]]], ["ORIENTATION LOCALIZATION MICROSCOPY AND VARIANCE UPPER BOUNDwhere B i \u2208 R 1\u00d76 is the i th row of B. Here, we introduce A \u2208 R n\u00d76 , where each entry of A can be bounded by (Supplementary Material 1A) :II.", [["MICROSCOPY", "TEST", 25, 35], ["A \u2208 R n\u00d76", "TREATMENT", 119, 128]]], ["ORIENTATION LOCALIZATION MICROSCOPY AND VARIANCE UPPER BOUNDSince photon detection is a Poisson process, the entry A ij represents the square root of the expected signal-to-noise ratio of the j th orientational second moment measured by the i th camera pixel.", [["LOCALIZATION MICROSCOPY", "TEST", 12, 35], ["VARIANCE UPPER BOUNDSince photon detection", "TEST", 40, 82], ["A ij", "TREATMENT", 115, 119], ["ij", "ANATOMY", 117, 119]]], ["We now develop our VUB matrix \u0393 (Supplementary Material 1A) to bound the CRB matrix R = J \u22121 as,II.", [["our VUB matrix", "PROBLEM", 15, 29]]], ["ORIENTATION LOCALIZATION MICROSCOPY AND VARIANCE UPPER BOUNDwhere the subscript jj denotes the j th diagonal element.II. ORIENTATION LOCALIZATION MICROSCOPY AND VARIANCE UPPER BOUNDSince \u0393 is independent of m, i.e., it is only a function of the imaging system and not molecular orientation, VUB can be used to efficiently estimate the global performance of the imaging system and the precision of measuring each orientational second moment under various SBRs without expensive calculations of CRB.", [["II", "CHEMICAL", 117, 119], ["CRB", "GENE_OR_GENE_PRODUCT", 493, 496], ["subscript jj", "DNA", 70, 82], ["j th diagonal element", "DNA", 95, 116], ["CRB", "PROTEIN", 493, 496], ["LOCALIZATION MICROSCOPY", "TEST", 12, 35], ["the subscript jj", "TREATMENT", 66, 82], ["LOCALIZATION MICROSCOPY", "TEST", 133, 156], ["the imaging system", "TEST", 241, 259], ["the imaging system", "TEST", 357, 375], ["various SBRs", "TREATMENT", 446, 458], ["expensive calculations of CRB", "TREATMENT", 467, 496], ["j th", "OBSERVATION_MODIFIER", 95, 99], ["diagonal", "ANATOMY_MODIFIER", 100, 108], ["CRB", "OBSERVATION", 493, 496]]], ["We calculated the trace \u0393 \u03a3 of \u0393 as a summary measure of performance of seven orientation-sensing PSFs, namely unpolarized standard, polarized standard, bifocal microscope [25] , bisected [26] , double helix [27] , trispot [28] , and quadrated [29] , for a molecule emitting at a glass-water interface ( Fig. 1(a) ).", [["trispot [28]", "SIMPLE_CHEMICAL", 215, 227], ["\u0393 \u03a3", "PROTEIN", 24, 27], ["\u0393", "PROTEIN", 31, 32], ["bifocal microscope", "TEST", 153, 171], ["double helix", "TEST", 195, 207], ["trispot", "TEST", 215, 222], ["quadrated", "TEST", 234, 243], ["a molecule emitting", "PROBLEM", 255, 274]]], ["To quantify the accuracy of our VUB, we compared \u0393 \u03a3 to the minimum/average/maximum value of the trace R \u03a3 of all diagonal entries of the CRB matrix over all of orientation space ( Fig. 1(a) inset).", [["\u0393 \u03a3", "PROTEIN", 49, 52], ["trace R \u03a3", "PROTEIN", 97, 106], ["trace", "OBSERVATION_MODIFIER", 97, 102], ["diagonal", "ANATOMY_MODIFIER", 114, 122], ["CRB matrix", "OBSERVATION", 138, 148]]], ["Note that computing \u0393 \u03a3 is faster than calculating the average CRB over all of orientation space (2500 sampling points) by a factor of~1000.", [["\u0393 \u03a3", "PROTEIN", 20, 23], ["CRB", "PROTEIN", 63, 66]]], ["While the polarized standard PSF doesn't show the best variance \u0393 \u03a3 , its FI (in terms of \u0393 \u22121 jj ) is large for the first four second moments ( Fig. 1(b) ), implying its superior sensitivity to these rotational motions.", [["\u0393", "PROTEIN", 90, 91], ["large", "OBSERVATION", 103, 108], ["rotational motions", "OBSERVATION", 201, 219]]], ["Therefore, the polarized PSF can estimate the in-plane (xy) orientations of fluorescent molecules with excellent precision (Fig. S2) .II. ORIENTATION LOCALIZATION MICROSCOPY AND VARIANCE UPPER BOUNDTo explore the effect of refractive index (RI) mismatch, we evaluated \u0393 \u03a3 for sample media ranging from air (RI=1) to oil (RI=1.518).", [["II", "CHEMICAL", 134, 136], ["oil", "ORGANISM_SUBSTANCE", 316, 319], ["fluorescent molecules", "PROTEIN", 76, 97], ["S2", "PROTEIN", 129, 131], ["fluorescent molecules", "PROBLEM", 76, 97], ["LOCALIZATION MICROSCOPY", "TEST", 150, 173], ["refractive index (RI) mismatch", "PROBLEM", 223, 253], ["sample media", "TEST", 276, 288], ["air (RI", "TEST", 302, 309], ["RI", "TEST", 321, 323]]], ["When the RI is low, the polarized standard PSF and bifocal microscope surprisingly show superior measurement performance for the 3D second moments ( Fig. 1(c) ); these observations also hold for angular orientation parameters (\u03c6, \u03b8, \u2126) (Fig. S3 ).", [["RI", "PROTEIN", 9, 11], ["bifocal microscope", "TEST", 51, 69], ["these observations", "TEST", 162, 180], ["angular orientation parameters", "TEST", 195, 225], ["low", "OBSERVATION_MODIFIER", 15, 18], ["superior", "OBSERVATION_MODIFIER", 88, 96]]], ["This insight is confirmed by our observations that a molecule at an air-glass interface produces basis images B j with vastly superior contrast (energy) compared to one within matched media (Fig. S4) .", [["a molecule at an air-glass interface", "PROBLEM", 51, 87], ["air", "OBSERVATION", 68, 71], ["glass interface", "OBSERVATION", 72, 87]]], ["On the other hand, for samples with RI near that of oil, PSF engineering clearly provides increased orientation precision over other approaches.", [["samples", "ANATOMY", 23, 30], ["oil", "ANATOMY", 52, 55], ["oil", "ORGANISM_SUBSTANCE", 52, 55]]], ["We also quantified the error between VUB and the maximum trace of CRB for a range of RIs (Fig. S5 ).", [["CRB", "PROTEIN", 66, 69], ["VUB", "TEST", 37, 40], ["CRB", "TREATMENT", 66, 69], ["CRB", "OBSERVATION", 66, 69]]], ["Therefore, if VUB predicts that one method is superior to another in terms of measurement variance, then CRB confirms this finding.", [["CRB", "PROTEIN", 105, 108], ["measurement variance", "TEST", 78, 98], ["CRB", "TEST", 105, 108]]], ["In addition to high orientation measurement precision, PSFs must be easily detectable under low SBRs in order to be practical for SMOLM.", [["PSFs", "SIMPLE_CHEMICAL", 55, 59], ["low SBRs", "TREATMENT", 92, 100]]], ["Using the polarized standard PSF, a fixed molecule (\u03b8 = 90 \u2022 , \u03c6 = 45 \u2022 ) and an isotropic emitter can be distinguished from one another with only 380 photons detected (Figs.", [["PSF", "PROTEIN", 29, 32], ["a fixed molecule", "TEST", 34, 50], ["\u03c6", "TEST", 63, 64], ["an isotropic emitter", "PROBLEM", 78, 98]]], ["1(d,e) , S6).", [["S6", "PROTEIN", 9, 11]]], ["Note that distinguishing these two types of emitters is nearly impossible under matched RI conditions; it is the RI mismatch and the associated supercritical fluorescence collected from fluorophores near the interface (Fig. S7 ) that enables this remarkable sensitivity.", [["the RI mismatch", "PROBLEM", 109, 124], ["the associated supercritical fluorescence", "PROBLEM", 129, 170], ["supercritical fluorescence", "OBSERVATION", 144, 170]]], ["However, the tri-spot PSF, despite its superior VUB, cannot detect the same isotropic emitter due to the splitting of photons into three spots in each polarization channel ( Fig. 1(f) ).", [["tri-spot PSF", "PROTEIN", 13, 25], ["the tri-spot PSF", "TEST", 9, 25], ["the same isotropic emitter", "PROBLEM", 67, 93], ["the splitting of photons", "TREATMENT", 101, 125]]], ["These observations suggest that the polarized standard PSF should be practical for measuring the positions and orientations of single fluorescent molecules precisely and sensitively.III. RESOLVING STRUCTURAL HETEROGENEITIES BETWEEN AMYLOID FIBERSAmyloid aggregates are signatures of various neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, and small soluble oligomeric intermediates formed during amyloid fibrillation are typically associated with cytotoxicity [31, 32] .", [["neurodegenerative disorders", "DISEASE", 291, 318], ["Alzheimer's and Parkinson's diseases", "DISEASE", 327, 363], ["amyloid fibrillation", "DISEASE", 422, 442], ["the polarized standard PSF", "TREATMENT", 32, 58], ["single fluorescent molecules", "PROBLEM", 127, 155], ["STRUCTURAL HETEROGENEITIES BETWEEN AMYLOID FIBERSAmyloid aggregates", "PROBLEM", 197, 264], ["various neurodegenerative disorders", "PROBLEM", 283, 318], ["Alzheimer's", "PROBLEM", 327, 338], ["Parkinson's diseases", "PROBLEM", 343, 363], ["small soluble oligomeric intermediates", "PROBLEM", 369, 407], ["amyloid fibrillation", "PROBLEM", 422, 442], ["cytotoxicity", "PROBLEM", 473, 485], ["STRUCTURAL HETEROGENEITIES", "OBSERVATION", 197, 223], ["AMYLOID FIBERSAmyloid aggregates", "OBSERVATION", 232, 264], ["various", "OBSERVATION_MODIFIER", 283, 290], ["neurodegenerative disorders", "OBSERVATION", 291, 318], ["small", "OBSERVATION_MODIFIER", 369, 374], ["amyloid fibrillation", "OBSERVATION", 422, 442]]], ["Although many amyloid aggregates share a common cross-\u03b2 sheet structural motif that is an assembly of identical copies of amyloid peptides, oligomers and fibrils are highly heterogeneous in terms of their structure and size [33, 34] .", [["fibrils", "ANATOMY", 154, 161], ["amyloid peptides", "GENE_OR_GENE_PRODUCT", 122, 138], ["-\u03b2 sheet structural motif", "PROTEIN", 53, 78], ["many amyloid aggregates", "PROBLEM", 9, 32], ["amyloid peptides", "PROBLEM", 122, 138], ["fibrils", "PROBLEM", 154, 161], ["amyloid aggregates", "OBSERVATION", 14, 32], ["amyloid peptides", "OBSERVATION", 122, 138], ["fibrils", "OBSERVATION_MODIFIER", 154, 161], ["highly", "OBSERVATION_MODIFIER", 166, 172], ["heterogeneous", "OBSERVATION_MODIFIER", 173, 186], ["size", "OBSERVATION_MODIFIER", 219, 223]]], ["Here, we explore using SMOLM with the polarized standard PSF and Nile red (NR) for detecting the structural heterogeneity of amyloid fibrils.", [["amyloid fibrils", "GENE_OR_GENE_PRODUCT", 125, 140], ["PSF", "PROTEIN", 57, 60], ["Nile red", "PROTEIN", 65, 73], ["NR", "PROTEIN", 75, 77], ["Nile red (NR)", "TREATMENT", 65, 78], ["amyloid fibrils", "PROBLEM", 125, 140], ["amyloid fibrils", "OBSERVATION", 125, 140]]], ["NR has been used as a surface hydrophobicity sensor for individual protein aggregates by measuring its emission wavelength while transiently and spontaneously bound to fibrils and proto-fibrils [36, 37] .", [["surface", "ANATOMY", 22, 29], ["fibrils", "ANATOMY", 168, 175], ["NR", "PROTEIN", 0, 2], ["fibrils", "PROTEIN", 168, 175], ["a surface hydrophobicity sensor", "TREATMENT", 20, 51], ["individual protein aggregates", "PROBLEM", 56, 85], ["proto-fibrils", "TEST", 180, 193]]], ["In this paper, we characterize NR's binding orientation as a method of mapping the organization of \u03b2-sheets within amyloid aggregates.III. RESOLVING STRUCTURAL HETEROGENEITIES BETWEEN AMYLOID FIBERSWe prepared fibrils of amyloid-\u03b2 peptide (A\u03b242) adhered to cleaned glass-bottom imaging chambers as described previously [12] (Supplementary Material 2A).", [["amyloid-\u03b2 peptide", "CHEMICAL", 221, 238], ["A\u03b242", "CHEMICAL", 240, 244], ["amyloid-\u03b2 peptide", "SIMPLE_CHEMICAL", 221, 238], ["NR", "PROTEIN", 31, 33], ["STRUCTURAL HETEROGENEITIES", "PROBLEM", 149, 175], ["amyloid-\u03b2 peptide", "TREATMENT", 221, 238], ["bottom imaging chambers", "TREATMENT", 271, 294], ["amyloid aggregates", "OBSERVATION", 115, 133], ["STRUCTURAL HETEROGENEITIES", "OBSERVATION", 149, 175], ["AMYLOID FIBERSWe", "OBSERVATION", 184, 200]]], ["By adding 50 nM NR and illuminating with a circularly polarized 561-nm laser, we captured isolated fluorescence bursts corresponding to individual NR molecules transiently bound to the amyloid aggregates [12, 38] (Movie S1).", [["NR molecules", "PROTEIN", 147, 159], ["isolated fluorescence bursts", "PROBLEM", 90, 118], ["individual NR molecules", "PROBLEM", 136, 159], ["the amyloid aggregates", "TEST", 181, 203], ["fluorescence bursts", "OBSERVATION", 99, 118], ["NR molecules", "OBSERVATION", 147, 159]]], ["Note that the circularly polarized illumination preferentially pumps NR molecules lying mostly parallel to the coverslip-precisely those molecules for which the polarized PSF has the best sensitivity for measuring orientations and wobbling areas (Fig. S2) .", [["NR molecules", "PROTEIN", 69, 81], ["PSF", "PROTEIN", 171, 174], ["S2", "PROTEIN", 252, 254], ["the circularly polarized illumination preferentially pumps NR molecules", "PROBLEM", 10, 81], ["NR molecules", "OBSERVATION", 69, 81]]], ["The brightness (s), 2D position (x, y) and secondmoment vector (m) of individual NRs within each frame were jointly estimated by using a sparsity-promoting maximum-likelihood estimator [13, 14] , followed by a weighted least-square estimator for projecting the estimated second moments to angular coordinates (\u03c6, \u03b8, \u2126) (Supplementary Material 2D).", [["secondmoment vector", "DNA", 43, 62], ["NRs", "DNA", 81, 84], ["individual NRs", "PROBLEM", 70, 84], ["angular coordinates", "TEST", 289, 308]]], ["For simulated images of NR using the polarized PSF, the estimator shows good accuracy and precision for both localization and orientation measurements, especially for molecules approximately parallel to the coverslip (Fig. S8-S13) .III. RESOLVING STRUCTURAL HETEROGENEITIES BETWEEN AMYLOID FIBERSThe concentrated photon distribution of the polarized PSF enables our estimator to detect relatively dim molecules, providing > 1.4 localizations/nm on amyloid aggregates over~3 min measurement time (Table S1 , Dataset 1 [30] ).", [["S8-S13", "GENE_OR_GENE_PRODUCT", 223, 229], ["NR", "PROTEIN", 24, 26], ["PSF", "DNA", 47, 50], ["S8", "PROTEIN", 223, 225], ["S13", "PROTEIN", 226, 229], ["PSF", "PROTEIN", 350, 353], ["dim molecules", "PROTEIN", 397, 410], ["simulated images", "TEST", 4, 20], ["both localization and orientation measurements", "TEST", 104, 150], ["STRUCTURAL HETEROGENEITIES", "PROBLEM", 247, 273], ["relatively dim molecules", "PROBLEM", 386, 410], ["amyloid aggregates", "PROBLEM", 448, 466], ["good", "OBSERVATION_MODIFIER", 72, 76], ["STRUCTURAL HETEROGENEITIES", "OBSERVATION", 247, 273], ["AMYLOID", "OBSERVATION_MODIFIER", 282, 289]]], ["Fig. 2(a) shows a super-resolved fibril network.", [["fibril network", "MULTI-TISSUE_STRUCTURE", 33, 47], ["super-resolved fibril network", "PROTEIN", 18, 47], ["fibril network", "OBSERVATION", 33, 47]]], ["NR molecules exhibit strikingly different polarized PSFs depending on the long axis of the underlying fibrils (Fig. S15 ).", [["fibrils", "ANATOMY", 102, 109], ["PSFs", "GENE_OR_GENE_PRODUCT", 52, 56], ["NR molecules", "PROTEIN", 0, 12], ["PSFs", "PROTEIN", 52, 56], ["NR molecules", "PROBLEM", 0, 12], ["strikingly different polarized PSFs", "PROBLEM", 21, 56], ["the underlying fibrils", "PROBLEM", 87, 109], ["strikingly", "OBSERVATION_MODIFIER", 21, 31], ["different", "OBSERVATION_MODIFIER", 32, 41], ["polarized PSFs", "OBSERVATION", 42, 56], ["long axis", "OBSERVATION_MODIFIER", 74, 83], ["fibrils", "OBSERVATION", 102, 109]]], ["Our orientation measurements show mostly in-plane polar angles (\u03b8 \u2248 90 \u2022 , Fig. S16 ) and azimuthal orientations (\u03c6) aligned to the long axis of amyloid fibrils (Figs.", [["amyloid fibrils", "GENE_OR_GENE_PRODUCT", 145, 160], ["amyloid fibrils", "PROTEIN", 145, 160], ["Our orientation measurements", "TEST", 0, 28], ["amyloid fibrils", "PROBLEM", 145, 160], ["mostly", "OBSERVATION_MODIFIER", 34, 40], ["long axis", "OBSERVATION_MODIFIER", 132, 141], ["amyloid fibrils", "OBSERVATION", 145, 160]]], ["These observations confirm that NR molecules preferentially bind to surfaces of \u03b2-sheets with their transition dipoles parallel to the fibril backbones ( Fig. 2(b) inset), similar to the binding behavior of Thioflavin T [39, 40] .", [["Thioflavin T", "CHEMICAL", 207, 219], ["Thioflavin T", "CHEMICAL", 207, 219], ["NR molecules", "GENE_OR_GENE_PRODUCT", 32, 44], ["Thioflavin T", "GENE_OR_GENE_PRODUCT", 207, 219], ["NR molecules", "PROTEIN", 32, 44], ["These observations", "TEST", 0, 18], ["NR molecules", "PROBLEM", 32, 44], ["their transition dipoles", "PROBLEM", 94, 118]]], ["NR may bind transiently to grooves formed by adjacent amino acid side chains [41] .III. RESOLVING STRUCTURAL HETEROGENEITIES BETWEEN AMYLOID FIBERSAlthough we observed most NR orientations to be parallel to the fibril backbones, these orientations are not always aligned with one another, even in neighboring structures.", [["amino acid", "CHEMICAL", 54, 64], ["amino acid", "CHEMICAL", 54, 64], ["amino acid", "AMINO_ACID", 54, 64], ["NR", "PROTEIN", 0, 2], ["adjacent amino acid side chains", "TREATMENT", 45, 76], ["STRUCTURAL HETEROGENEITIES", "OBSERVATION", 98, 124], ["AMYLOID FIBERSAlthough", "OBSERVATION", 133, 155]]], ["For example, two small aggregation limbs shown in Fig. 2 (g) exhibit substantial differences in the standard deviation of azimuthal orientations (\u03c3 \u03c6 ) and median wobbling area (\u2126 med ), despite looking quite similar in the standard SMLM image.", [["limbs", "ANATOMY", 35, 40], ["two small aggregation limbs", "PROBLEM", 13, 40], ["substantial differences", "PROBLEM", 69, 92], ["median wobbling area", "PROBLEM", 156, 176], ["small", "OBSERVATION_MODIFIER", 17, 22], ["aggregation limbs", "OBSERVATION", 23, 40], ["substantial", "OBSERVATION_MODIFIER", 69, 80], ["differences", "OBSERVATION_MODIFIER", 81, 92], ["median", "OBSERVATION_MODIFIER", 156, 162]]], ["We speculate that this variation arises from structural dissimilarity between these regions, i.e., one of the limbs (Fig. 2(g)(i) ) could be a relatively new deposit with disordered binding sites (leading to diverse mean orientations and large wobble), while the other (Fig. 2(g)(ii) ) is a relatively well-ordered secondary nucleation of a new fibril branch [34, 42] .", [["limbs", "ANATOMY", 110, 115], ["limbs", "ORGANISM_SUBDIVISION", 110, 115], ["disordered binding sites", "PROTEIN", 171, 195], ["this variation", "PROBLEM", 18, 32], ["disordered binding sites", "PROBLEM", 171, 195], ["diverse mean orientations", "TREATMENT", 208, 233], ["large wobble)", "PROBLEM", 238, 251], ["structural dissimilarity", "OBSERVATION", 45, 69], ["regions", "ANATOMY_MODIFIER", 84, 91], ["limbs", "ANATOMY", 110, 115], ["relatively", "OBSERVATION_MODIFIER", 143, 153], ["new", "OBSERVATION_MODIFIER", 154, 157], ["deposit", "OBSERVATION", 158, 165], ["binding sites", "OBSERVATION", 182, 195], ["large wobble", "OBSERVATION", 238, 250], ["new", "OBSERVATION_MODIFIER", 341, 344], ["fibril", "OBSERVATION_MODIFIER", 345, 351], ["branch", "OBSERVATION_MODIFIER", 352, 358]]], ["These structural details of amyloid aggregates cannot be detected by standard SMLM.III. RESOLVING STRUCTURAL HETEROGENEITIES BETWEEN AMYLOID FIBERSTo further correlate the orientations of single-molecule probes with the structural organization of amyloid aggregates, we imaged an amyloid aggregate containing obvious fibril bundles (Fig. 3(a) , Dataset 1 [30] ).", [["fibril bundles", "ANATOMY", 317, 331], ["amyloid", "DISEASE", 280, 287], ["amyloid", "GENE_OR_GENE_PRODUCT", 28, 35], ["fibril bundles", "CELLULAR_COMPONENT", 317, 331], ["SMLM", "PROTEIN", 78, 82], ["amyloid aggregates", "PROBLEM", 28, 46], ["STRUCTURAL HETEROGENEITIES", "PROBLEM", 98, 124], ["single-molecule probes", "TREATMENT", 188, 210], ["amyloid aggregates", "PROBLEM", 247, 265], ["an amyloid aggregate", "PROBLEM", 277, 297], ["amyloid aggregates", "OBSERVATION", 28, 46], ["cannot be detected", "UNCERTAINTY", 47, 65], ["STRUCTURAL HETEROGENEITIES", "OBSERVATION", 98, 124], ["AMYLOID FIBERSTo", "OBSERVATION", 133, 149], ["amyloid aggregates", "OBSERVATION", 247, 265], ["amyloid aggregate", "OBSERVATION", 280, 297], ["obvious", "OBSERVATION_MODIFIER", 309, 316], ["fibril bundles", "OBSERVATION", 317, 331]]], ["The intertwined structures are evidenced by their branching architecture and their at least twice larger width (purple) compared to thinner structures (green) in the field of view (Fig. S19) .", [["branching", "OBSERVATION_MODIFIER", 50, 59], ["architecture", "OBSERVATION_MODIFIER", 60, 72], ["larger", "OBSERVATION_MODIFIER", 98, 104], ["width", "OBSERVATION_MODIFIER", 105, 110], ["purple", "OBSERVATION_MODIFIER", 112, 118], ["green", "OBSERVATION_MODIFIER", 152, 157]]], ["We observed NR to be mostly parallel to the backbone (Figs.", [["NR", "PROTEIN", 12, 14], ["NR", "PROBLEM", 12, 14], ["NR", "OBSERVATION", 12, 14]]], ["3(b)(i), 3(c)(i), and Movie S2) of the thin fibrils, whereas thicker bundles cause NR to bind with relatively disordered \u03c6 angles (Figs.", [["fibrils", "ANATOMY", 44, 51], ["NR", "PROTEIN", 83, 85], ["the thin fibrils", "PROBLEM", 35, 51]]], ["3(b) (ii), 3(c)(ii), and Movie S2).", [["3(c)(ii)", "SIMPLE_CHEMICAL", 11, 19]]], ["Since NR binds to specific grooves along the stacked \u03b2-sheet aggregate, these orientation measurements indicate highly aligned \u03b2-sheets within the thin fibrils.", [["fibrils", "ANATOMY", 152, 159], ["NR", "PROTEIN", 6, 8], ["these orientation measurements", "TEST", 72, 102], ["the thin fibrils", "PROBLEM", 143, 159], ["highly", "OBSERVATION_MODIFIER", 112, 118], ["aligned", "OBSERVATION", 119, 126], ["thin fibrils", "OBSERVATION", 147, 159]]], ["We consistently observed similarly disordered \u03c6 orientations of NR on thicker aggregates compared to thinner structures (Figs.", [["NR", "PROTEIN", 64, 66], ["thicker aggregates", "PROBLEM", 70, 88]]], ["S21 and S22) .", [["S21", "GENE_OR_GENE_PRODUCT", 0, 3], ["S21", "PROTEIN", 0, 3], ["S22", "PROTEIN", 8, 11]]], ["These disordered \u03c6 angles show that the \u03b2-sheets within bundles of amyloid fibrils exhibit a complex and heterogeneous architecture.III. RESOLVING STRUCTURAL HETEROGENEITIES BETWEEN AMYLOID FIBERSWe note that the wobbling area \u2126, which can indicate the binding strength between NR and the surrounding \u03b2-sheet grooves, also exhibits obvious differences between the two regions.", [["amyloid fibrils", "GENE_OR_GENE_PRODUCT", 67, 82], ["\u03b2-sheets", "PROTEIN", 40, 48], ["amyloid fibrils", "PROTEIN", 67, 82], ["NR", "PROTEIN", 278, 280], ["amyloid fibrils", "PROBLEM", 67, 82], ["a complex and heterogeneous architecture", "PROBLEM", 91, 131], ["obvious differences between the two regions", "PROBLEM", 332, 375], ["amyloid fibrils", "OBSERVATION", 67, 82], ["complex", "OBSERVATION_MODIFIER", 93, 100], ["heterogeneous", "OBSERVATION_MODIFIER", 105, 118], ["architecture", "OBSERVATION_MODIFIER", 119, 131], ["STRUCTURAL HETEROGENEITIES", "OBSERVATION", 147, 173], ["AMYLOID FIBERSWe", "OBSERVATION", 182, 198], ["binding strength", "OBSERVATION", 253, 269], ["obvious", "OBSERVATION_MODIFIER", 332, 339], ["differences", "OBSERVATION", 340, 351]]], ["We observed small \u2126 values on the thin fibril molecules to each local region, respectively.", [["thin fibril molecules", "PROTEIN", 34, 55], ["small \u2126 values", "PROBLEM", 12, 26], ["small", "OBSERVATION_MODIFIER", 12, 17], ["\u2126 values", "OBSERVATION_MODIFIER", 18, 26], ["thin fibril", "OBSERVATION_MODIFIER", 34, 45], ["local", "ANATOMY_MODIFIER", 64, 69], ["region", "ANATOMY_MODIFIER", 70, 76]]], ["From these measurements, we speculate that fibril bundling not only produces relatively disordered \u03b2-sheet orientations due to the entwining of multiple fibers but also increases dramatically the local density of binding sites for NR, thereby causing large NR wobbling during a single fluorescence burst.", [["fibril", "ANATOMY", 43, 49], ["fibril", "CELLULAR_COMPONENT", 43, 49], ["fibers", "CELLULAR_COMPONENT", 153, 159], ["binding sites", "PROTEIN", 213, 226], ["NR", "PROTEIN", 231, 233], ["these measurements", "TEST", 5, 23], ["fibril bundling", "PROBLEM", 43, 58], ["multiple fibers", "PROBLEM", 144, 159], ["large NR wobbling", "PROBLEM", 251, 268], ["a single fluorescence burst", "PROBLEM", 276, 303], ["fibril bundling", "OBSERVATION", 43, 58], ["multiple", "OBSERVATION_MODIFIER", 144, 152], ["fibers", "OBSERVATION", 153, 159], ["increases", "OBSERVATION_MODIFIER", 169, 178], ["dramatically", "OBSERVATION_MODIFIER", 179, 191], ["local", "OBSERVATION_MODIFIER", 196, 201], ["density", "OBSERVATION", 202, 209], ["binding sites", "OBSERVATION", 213, 226], ["large", "OBSERVATION_MODIFIER", 251, 256], ["NR wobbling", "OBSERVATION", 257, 268]]], ["Note that we did not observe significantly different burst times for NR on thin fibers (\u03c4 on = 13 ms in Fig. 3 (b)(i)) versus disordered fibrillar bundles (\u03c4 on = 11 ms in Fig. 3III.", [["thin fibers", "ANATOMY", 75, 86], ["fibrillar bundles", "ANATOMY", 137, 154], ["NR", "PROTEIN", 69, 71], ["NR on thin fibers", "TREATMENT", 69, 86], ["disordered fibrillar bundles", "PROBLEM", 126, 154], ["fibrillar bundles", "OBSERVATION", 137, 154]]], ["RESOLVING STRUCTURAL HETEROGENEITIES BETWEEN AMYLOID FIBERSInterestingly, the local structural heterogeneity in amyloid fibrils detected by SMOLM is not always associated with thicker fibrils in standard SMLM.", [["fibrils", "ANATOMY", 184, 191], ["amyloid", "DISEASE", 112, 119], ["amyloid fibrils", "GENE_OR_GENE_PRODUCT", 112, 127], ["amyloid fibrils", "PROTEIN", 112, 127], ["SMOLM", "PROTEIN", 140, 145], ["STRUCTURAL HETEROGENEITIES BETWEEN AMYLOID FIBERSInterestingly", "PROBLEM", 10, 72], ["amyloid fibrils", "PROBLEM", 112, 127], ["thicker fibrils in standard SMLM", "PROBLEM", 176, 208], ["STRUCTURAL HETEROGENEITIES", "OBSERVATION", 10, 36], ["AMYLOID FIBERSInterestingly", "OBSERVATION", 45, 72], ["local", "OBSERVATION_MODIFIER", 78, 83], ["structural", "OBSERVATION_MODIFIER", 84, 94], ["heterogeneity", "OBSERVATION_MODIFIER", 95, 108], ["amyloid fibrils", "OBSERVATION", 112, 127], ["not always associated with", "UNCERTAINTY", 149, 175], ["thicker", "OBSERVATION_MODIFIER", 176, 183], ["fibrils", "OBSERVATION", 184, 191]]], ["We observed similar disordered \u03c6 values and large \u2126 estimates from a fibril in another field of view (Fig 3(e) ).", [["similar disordered \u03c6 values", "PROBLEM", 12, 39], ["large \u2126 estimates", "PROBLEM", 44, 61], ["a fibril", "PROBLEM", 67, 75], ["large", "OBSERVATION_MODIFIER", 44, 49]]], ["Although the two fibril strands have similar thickness, the estimated \u03c6 and \u2126 distributions show noticeable differences (Fig. 3(f)-3(h) ).", [["the two fibril strands", "PROBLEM", 9, 31], ["the estimated \u03c6 and \u2126 distributions", "PROBLEM", 56, 91], ["two", "OBSERVATION_MODIFIER", 13, 16], ["fibril strands", "OBSERVATION", 17, 31], ["similar", "OBSERVATION_MODIFIER", 37, 44], ["thickness", "OBSERVATION_MODIFIER", 45, 54], ["noticeable", "OBSERVATION_MODIFIER", 97, 107]]], ["These measurements suggest the fibril in Fig. 3 (f)(ii) may consist of more disorganized assemblies of \u03b2-sheets compared to those of Fig. 3(f)(i) .", [["These measurements", "TEST", 0, 18], ["the fibril in Fig.", "PROBLEM", 27, 45], ["more disorganized assemblies of \u03b2-sheets", "PROBLEM", 71, 111], ["more disorganized", "OBSERVATION_MODIFIER", 71, 88]]], ["Similar to the small aggregates shown in Fig. 2(g) , the local heterogeneity cannot be resolved by conventional SMLM.IV. CONCLUSIONHere, we propose and characterize a new variance upper bound (VUB) for efficiently quantifying the sensitivity of any PSF for measuring the orientation and wobble of dipole-like emitters.", [["SMLM", "PROTEIN", 112, 116], ["PSF", "DNA", 249, 252], ["the local heterogeneity", "PROBLEM", 53, 76], ["IV", "TREATMENT", 117, 119], ["a new variance upper bound", "PROBLEM", 165, 191], ["any PSF", "TREATMENT", 245, 252], ["wobble of dipole-like emitters", "PROBLEM", 287, 317], ["small", "OBSERVATION_MODIFIER", 15, 20], ["aggregates", "OBSERVATION", 21, 31], ["local", "OBSERVATION_MODIFIER", 57, 62], ["heterogeneity", "OBSERVATION", 63, 76], ["cannot be", "UNCERTAINTY", 77, 86], ["new", "OBSERVATION_MODIFIER", 167, 170]]], ["Since the orientational second moment vector m is six dimensional, VUB greatly accelerates the comparison of various PSFs for any specific imaging scenario.", [["PSFs", "CANCER", 117, 121], ["any specific imaging scenario", "TEST", 126, 155]]], ["While VUB overestimates the mean variance of an orientation measurement by 37%, computing the VUB is~1000 times faster than evaluating the average CRB across orientation space with sufficient sampling.", [["VUB", "CANCER", 6, 9], ["VUB", "PROTEIN", 6, 9], ["VUB", "DNA", 94, 97], ["an orientation measurement", "TEST", 45, 71], ["the VUB", "TEST", 90, 97]]], ["We stress that this computational speedup of measuring global performance makes VUB a useful design and optimization tool, but CRB is still useful for quantitatively characterizing measurement performance for specific molecular orientations m.", [["CRB", "TEST", 127, 130]]], ["Using VUB, we discover that imaging dipoles near a refractive index interface enables the simple polarized standard PSF to robustly measure orientational dynamics, particularly within the xy plane, that cannot be detected in matched media.IV. CONCLUSIONUsing the polarized standard PSF, our SMOLM images of amyloid aggregates confirm that the main binding orientation of NR is mostly parallel to the long axis of the fibrils.", [["fibrils", "ANATOMY", 417, 424], ["fibrils", "CELLULAR_COMPONENT", 417, 424], ["PSF", "PROTEIN", 116, 119], ["NR", "PROTEIN", 371, 373], ["imaging dipoles", "TEST", 28, 43], ["a refractive index interface", "PROBLEM", 49, 77], ["our SMOLM images", "TEST", 287, 303], ["amyloid aggregates", "TEST", 307, 325], ["the fibrils", "PROBLEM", 413, 424], ["refractive index", "OBSERVATION", 51, 67], ["simple", "OBSERVATION_MODIFIER", 90, 96], ["polarized", "OBSERVATION_MODIFIER", 97, 106], ["standard PSF", "OBSERVATION", 107, 119], ["cannot be", "UNCERTAINTY", 203, 212], ["main", "OBSERVATION_MODIFIER", 343, 347], ["NR", "OBSERVATION", 371, 373], ["long axis", "OBSERVATION_MODIFIER", 400, 409]]], ["In cases where multiple fibrils are intertwined, TAB SMOLM detects heterogeneities in the stacking of \u03b2-sheets via larger variations in NR orientations and increased wobbling angles.", [["fibrils", "ANATOMY", 24, 31], ["TAB SMOLM", "PROTEIN", 49, 58], ["multiple fibrils", "PROBLEM", 15, 31], ["TAB SMOLM", "TEST", 49, 58], ["larger variations in NR orientations", "PROBLEM", 115, 151], ["increased wobbling angles", "PROBLEM", 156, 181], ["larger", "OBSERVATION_MODIFIER", 115, 121], ["variations", "OBSERVATION", 122, 132], ["NR orientations", "OBSERVATION", 136, 151], ["increased", "OBSERVATION_MODIFIER", 156, 165], ["wobbling angles", "OBSERVATION", 166, 181]]], ["In particular, SMOLM detects structural disorder along the fibrillar network which cannot be resolved by simple SMLM analysis of fibrillar width or NR binding time.IV. CONCLUSIONSimultaneous imaging of single-molecule positions and orientations in SMOLM allows scientists to quantify local structural features on a nanometer scale without ensemble averaging.", [["fibrillar network", "ANATOMY", 59, 76], ["disorder", "DISEASE", 40, 48], ["SMOLM", "PROTEIN", 15, 20], ["SMOLM", "CELL_LINE", 248, 253], ["structural disorder", "PROBLEM", 29, 48], ["fibrillar width", "PROBLEM", 129, 144], ["IV", "TREATMENT", 164, 166], ["CONCLUSIONSimultaneous imaging", "TEST", 168, 198], ["single-molecule positions", "TREATMENT", 202, 227], ["a nanometer scale", "TREATMENT", 313, 330], ["structural disorder", "OBSERVATION", 29, 48], ["fibrillar network", "OBSERVATION", 59, 76], ["cannot be", "UNCERTAINTY", 83, 92], ["fibrillar width", "OBSERVATION_MODIFIER", 129, 144], ["NR binding", "OBSERVATION", 148, 158]]], ["In particular, measuring the full spatial configuration (i.e., positions and orientations) of molecules provides unprecedented insight into the density and orientations of binding sites for NR on aggregate surfaces that aren't revealed with location information alone.", [["binding sites", "PROTEIN", 172, 185], ["NR", "PROTEIN", 190, 192], ["binding sites", "PROBLEM", 172, 185], ["full", "OBSERVATION_MODIFIER", 29, 33], ["spatial", "OBSERVATION_MODIFIER", 34, 41], ["configuration", "OBSERVATION_MODIFIER", 42, 55], ["density", "OBSERVATION", 144, 151]]], ["These distributions could be a signature of how the stacked \u03b2-sheets are organized within fibrils and other aggregate morphologies.", [["\u03b2-sheets", "ANATOMY", 60, 68], ["fibrils", "ANATOMY", 90, 97], ["fibrils", "CELLULAR_COMPONENT", 90, 97], ["aggregate morphologies", "OBSERVATION", 108, 130]]], ["Since our analysis shows that no single PSF measures all combinations of orientational second moments with optimal precision, the superior speed and sufficient accuracy of VUB may be useful for adaptively optimizing PSFs for a particular sample or field of view during a SMOLM experiment.", [["PSFs", "CANCER", 216, 220], ["PSF", "DNA", 40, 43], ["PSFs", "CELL_TYPE", 216, 220], ["our analysis", "TEST", 6, 18], ["single PSF measures", "TREATMENT", 33, 52]]], ["Such optimization would need to be performed in near real-time to obtain the best-possible measurement precision while minimizing photobleaching and photodamage within the specific sample of interest.IV. CONCLUSIONCurrently, no methodology can visualize the nanoscale structural configuration of amyloid aggregates as they organize over time at the single particle level [34] .", [["amyloid aggregates", "SIMPLE_CHEMICAL", 296, 314], ["photobleaching", "TREATMENT", 130, 144], ["photodamage", "PROBLEM", 149, 160], ["amyloid aggregates", "PROBLEM", 296, 314], ["amyloid aggregates", "OBSERVATION", 296, 314]]], ["In the future, SMOLM combined with transient binding of amyloid-sensitive fluorogenic molecules could become a powerful tool for understanding how structure affects various aggregation processes, such as \"stop-and-go\" and polarized aggregation [42] [43] [44] as well as the switching of aggregation modes [45] , with nanoscale resolution over periods of hours to days [12, 38] .", [["SMOLM", "CHEMICAL", 15, 20], ["SMOLM", "SIMPLE_CHEMICAL", 15, 20], ["SMOLM", "PROTEIN", 15, 20], ["transient binding of amyloid", "PROBLEM", 35, 63], ["sensitive fluorogenic molecules", "PROBLEM", 64, 95], ["various aggregation processes", "PROBLEM", 165, 194], ["amyloid", "OBSERVATION", 56, 63]]], ["Time-lapse SMOLM imaging of amyloidophilic dye-binding sites on aggregate surfaces could provide insight into amyloid assembly mechanisms [44, 46] by connecting the energy landscapes of these pathways to \u03b2-sheet organization over time.", [["amyloid", "GENE_OR_GENE_PRODUCT", 110, 117], ["amyloidophilic dye-binding sites", "DNA", 28, 60], ["imaging", "TEST", 17, 24], ["amyloidophilic dye-binding sites", "PROBLEM", 28, 60]]], ["Finally, TAB SMOLM imaging of amyloid aggregates on model membranes and neurons may provide links between aggregate structure and toxicity necessary for developing effective therapeutics against amyloidosis.Funding InformationNational Science Foundation (NSF) (ECCS-1653777); National Institute of General Medical Sciences of the National Institutes of Health (R35GM124858).", [["membranes", "ANATOMY", 58, 67], ["neurons", "ANATOMY", 72, 79], ["toxicity", "DISEASE", 130, 138], ["amyloidosis", "DISEASE", 195, 206], ["ECCS-1653777", "CHEMICAL", 261, 273], ["amyloid aggregates", "GENE_OR_GENE_PRODUCT", 30, 48], ["membranes", "CELLULAR_COMPONENT", 58, 67], ["neurons", "CELL", 72, 79], ["TAB SMOLM imaging", "TEST", 9, 26], ["amyloid aggregates", "PROBLEM", 30, 48], ["model membranes", "TREATMENT", 52, 67], ["amyloidosis", "PROBLEM", 195, 206], ["amyloid aggregates", "OBSERVATION", 30, 48]]]], "d64f3bf920566c9c30d0c3115c259c35103515aa": [["Transmission of highly infectious respiratory diseases, including SARS-CoV-2 are facilitated by the transport of tiny droplets and aerosols (harboring viruses, bacteria, etc.) that are breathed out by individuals and can remain suspended in air for extended periods of time in confined environments.", [["respiratory", "ANATOMY", 34, 45], ["infectious respiratory diseases", "DISEASE", 23, 54], ["SARS", "DISEASE", 66, 70], ["SARS-CoV-2", "ORGANISM", 66, 76], ["SARS-CoV", "SPECIES", 66, 74], ["highly infectious respiratory diseases", "PROBLEM", 16, 54], ["SARS", "PROBLEM", 66, 70], ["tiny droplets", "PROBLEM", 113, 126], ["aerosols (harboring viruses", "PROBLEM", 131, 158], ["bacteria", "PROBLEM", 160, 168], ["highly", "OBSERVATION_MODIFIER", 16, 22], ["infectious", "OBSERVATION_MODIFIER", 23, 33], ["respiratory diseases", "OBSERVATION", 34, 54], ["tiny", "OBSERVATION_MODIFIER", 113, 117], ["droplets", "OBSERVATION", 118, 126]]], ["A passenger car cabin represents one such situation in which there exists an elevated risk of pathogen transmission.", [["A passenger car cabin", "PROBLEM", 0, 21], ["an elevated risk of pathogen transmission", "PROBLEM", 74, 115], ["elevated", "OBSERVATION_MODIFIER", 77, 85], ["pathogen", "OBSERVATION", 94, 102]]], ["Here we present results from numerical simulations of the potential routes of airborne transmission within a model car geometry, for a variety of ventilation configurations representing different combinations of open and closed windows.", [["ventilation configurations", "TREATMENT", 146, 172], ["open and closed windows", "TREATMENT", 212, 235], ["ventilation configurations", "OBSERVATION", 146, 172], ["closed windows", "OBSERVATION", 221, 235]]], ["We estimate relative concentrations and residence times of a non-interacting, passive scalar -a proxy for infectious pathogenic particles -that are advected and diffused by the turbulent airflows inside the cabin.", [["infectious pathogenic particles", "PROBLEM", 106, 137], ["concentrations", "OBSERVATION_MODIFIER", 21, 35], ["diffused", "OBSERVATION_MODIFIER", 161, 169], ["turbulent", "OBSERVATION_MODIFIER", 177, 186], ["cabin", "ANATOMY", 207, 212]]], ["Our findings reveal that creating an airflow pattern that travels across the cabin, entering and existing farthest from the occupants can potentially reduce the transmission.Airborne transmission | Ventilation | Aerodynamics | COVID-19 |The COVID-19 pandemic is redefining a myriad of social and physical interactions as we seek to control the predominantly airborne transmission of the causative severe acute respiratory syndrome coronovirus 2 (SARS-CoV-2) (1-3).", [["acute respiratory syndrome coronovirus", "DISEASE", 404, 442], ["severe acute respiratory syndrome coronovirus", "SPECIES", 397, 442], ["SARS-CoV-2", "SPECIES", 446, 456], ["an airflow pattern", "PROBLEM", 34, 52], ["COVID", "TEST", 227, 232], ["the causative severe acute respiratory syndrome coronovirus", "PROBLEM", 383, 442], ["SARS-CoV", "TEST", 446, 454], ["airflow", "OBSERVATION", 37, 44], ["severe", "OBSERVATION_MODIFIER", 397, 403], ["acute", "OBSERVATION_MODIFIER", 404, 409], ["respiratory syndrome", "OBSERVATION", 410, 430]]], ["One common and critical social interaction that must be reconsidered is how people travel in passenger automobiles.", [["people", "ORGANISM", 76, 82], ["people", "SPECIES", 76, 82]]], ["For maximum social isolation, driving alone is clearly ideal but this is not widely practical or environmentally sustainable, and there are many situations in which two or more people need to drive together.", [["people", "ORGANISM", 177, 183], ["people", "SPECIES", 177, 183], ["maximum social isolation", "TREATMENT", 4, 28]]], ["Wearing face masks and using of barrier shields to separate occupants do offer an effective first step towards reducing infection rates (4) (5) (6) (7) (8) (9) .", [["infection", "DISEASE", 120, 129], ["face masks", "TREATMENT", 8, 18], ["barrier shields", "TREATMENT", 32, 47], ["reducing infection rates", "PROBLEM", 111, 135], ["infection", "OBSERVATION", 120, 129]]], ["However, aerosols can pass through all but the most high-performance filters (10) and virus emissions via micron-sized aerosols associated with breathing and talking, let alone coughing and sneezing, are practically unavoidable (11) (12) (13) (14) (15) .", [["virus emissions", "TREATMENT", 86, 101], ["micron-sized aerosols", "TREATMENT", 106, 127], ["coughing", "PROBLEM", 177, 185], ["sneezing", "PROBLEM", 190, 198], ["sized", "OBSERVATION_MODIFIER", 113, 118], ["aerosols", "OBSERVATION", 119, 127]]], ["Preliminary models indicate a build-up of the viral load inside a car cabin for drives as short as 15 minutes (16, 17) , with evidence of virus viability within aerosols of up to 3 hours (18, 19) .Airborne transmission | Ventilation | Aerodynamics | COVID-19 |To assess these risks, it is critical to understand the complex airflow patterns that exist inside the passenger cabin of an automobile, and furthermore, to quantify the air that might be exchanged between a driver and a passenger.", [["the viral load", "PROBLEM", 42, 56], ["virus viability", "PROBLEM", 138, 153], ["viral load", "OBSERVATION", 46, 56], ["evidence of", "UNCERTAINTY", 126, 137], ["virus viability", "OBSERVATION", 138, 153], ["aerosols", "OBSERVATION_MODIFIER", 161, 169], ["airflow", "OBSERVATION", 324, 331], ["air", "OBSERVATION", 430, 433]]], ["Although the danger of transmission while traveling in a car has been recognized (20) , published investigations of the detailed air flow inside the passenger cabin of an automobile are surprisingly sparse.", [["air flow", "OBSERVATION", 129, 137], ["automobile", "OBSERVATION", 171, 181], ["sparse", "OBSERVATION_MODIFIER", 199, 205]]], ["Several works have addressed the flow patterns inside automobile cabins, but only in the all-windows-closed configuration (21-23) -most commonly employed so as to reduce noise in the cabin.", [["cabin", "ANATOMY", 183, 188]]], ["At the same time, an intuitive means to minimize infection pathways is to drive with some or all of the windows open, presumably enhancing the fresh air circulating through the cabin.Airborne transmission | Ventilation | Aerodynamics | COVID-19 |Motivated by the influence of pollutants on the passengers, a few studies have evaluated the concentration of contaminants entering from outside the cabin (24) and the persistence of cigarette smoke inside the cabin subject to different ventilation scenarios (25, 26) .", [["infection", "DISEASE", 49, 58], ["cigarette", "ORGANISM", 429, 438], ["infection pathways", "PROBLEM", 49, 67], ["a few studies", "TEST", 306, 319], ["infection", "OBSERVATION", 49, 58], ["enhancing", "OBSERVATION_MODIFIER", 129, 138], ["fresh air", "OBSERVATION", 143, 152], ["cabin", "ANATOMY", 177, 182], ["cigarette smoke", "OBSERVATION", 429, 444], ["ventilation scenarios", "OBSERVATION", 483, 504]]], ["However, none of these studies have addressed the micro-climate of the passenger enclosure, and the transport of a contaminant from a specific person in the cabin (e.g. the driver) to another specific person (e.g. a passenger).", [["person", "SPECIES", 143, 149], ["person", "SPECIES", 201, 207], ["these studies", "TEST", 17, 30], ["passenger enclosure", "OBSERVATION", 71, 90]]], ["In addition to this being an important problem applicable to airborne pathogens in general, given that the COVID-19 pandemic is likely to present a public health risk for several months or years to come, the need for a quantitative assessment of such airflow patterns inside the passenger cabin of an automobile seems urgent.Airborne transmission | Ventilation | Aerodynamics | COVID-19 |The current work presents a quantitative approach to this problem.", [["COVID-19", "ORGANISM", 107, 115], ["the COVID", "TEST", 103, 112], ["a quantitative assessment", "TEST", 217, 242], ["such airflow patterns", "PROBLEM", 246, 267]]], ["While the range of car geometries and driving conditions is vast, we restrict our attention to that of two people driving in a car, which is close to the average occupancy in passenger cars in the United States (27) .", [["people", "ORGANISM", 107, 113], ["people", "SPECIES", 107, 113]]], ["We ask the question: what is the transport of air and potentially infectious aerosol droplets between the driver and the passenger, and how does that air exchange change for various combinations of openand closed windows.Airborne transmission | Ventilation | Aerodynamics | COVID-19 |To address this question, we conducted a series of representative Computational Fluid Dynamics (CFD) simulations forSignificance StatementOutbreaks of respiratory diseases, such as influenza, SARS, MERS and now the novel coronavirus (SARS-CoV-2), have taken a significant toll on human populations worldwide.", [["respiratory diseases", "DISEASE", 435, 455], ["influenza", "DISEASE", 465, 474], ["SARS", "DISEASE", 476, 480], ["SARS-CoV-2", "ORGANISM", 518, 528], ["human", "ORGANISM", 564, 569], ["human", "SPECIES", 564, 569], ["human", "SPECIES", 564, 569], ["infectious aerosol droplets", "TREATMENT", 66, 93], ["air exchange change", "TREATMENT", 150, 169], ["openand closed windows", "TREATMENT", 198, 220], ["representative Computational Fluid Dynamics (CFD)", "TREATMENT", 335, 384], ["respiratory diseases", "PROBLEM", 435, 455], ["influenza", "PROBLEM", 465, 474], ["SARS", "PROBLEM", 476, 480], ["MERS", "PROBLEM", 482, 486], ["the novel coronavirus", "PROBLEM", 495, 516], ["respiratory diseases", "OBSERVATION", 435, 455]]], ["With ever-increasing commutes performed by urban populations, driving in an enclosed car cabin with passengers presents a risk of airborne disease transmission.", [["airborne disease transmission", "DISEASE", 130, 159], ["airborne disease transmission", "PROBLEM", 130, 159], ["airborne disease", "OBSERVATION", 130, 146]]], ["Here we used numerical simulations to quantify the air flow patterns inside a model car geometry, for a variety of ventilation configurations.", [["numerical simulations", "TREATMENT", 13, 34], ["air flow", "OBSERVATION", 51, 59], ["model car geometry", "OBSERVATION", 78, 96], ["ventilation configurations", "OBSERVATION", 115, 141]]], ["Our findings reveal the complex fluid dynamics at play during everyday commutes in cars, and non-intuitive ways in which open windows can enhance or suppress airborne transmission pathways.Significance StatementKB and JB conceived the project.", [["fluid", "ANATOMY", 32, 37], ["the complex fluid dynamics", "PROBLEM", 20, 46], ["complex", "OBSERVATION_MODIFIER", 24, 31], ["fluid dynamics", "OBSERVATION", 32, 46]]], ["VM and KB designed the numerical simulations.", [["KB", "CELL_LINE", 7, 9], ["VM", "PROBLEM", 0, 2], ["the numerical simulations", "TEST", 19, 44]]], ["AD and VM performed the numerical simulations.", [["AD", "DISEASE", 0, 2], ["VM", "ANATOMY", 7, 9]]], ["KB conducted the field experiment.", [["KB", "CELL_LINE", 0, 2], ["field", "OBSERVATION_MODIFIER", 17, 22]]], ["1 VM and AD contributed equally to this work and are joint first authors.", [["AD", "DISEASE", 9, 11], ["AD", "PROBLEM", 9, 11], ["joint", "ANATOMY", 53, 58]]], ["2 We consider the case of two persons traveling in the car -the driver in the front left-hand seat (assuming a left-hand-drive vehicle) and the passenger sitting in the rear right-hand seat, thereby maximizing the physical distance (\u2248 1.5 m) between the occupants.", [["left-hand", "ANATOMY", 84, 93], ["left-hand", "ANATOMY", 111, 120], ["right-hand", "ANATOMY", 174, 184], ["persons", "ORGANISM", 30, 37], ["persons", "SPECIES", 30, 37], ["right", "ANATOMY_MODIFIER", 174, 179], ["hand seat", "ANATOMY", 180, 189]]], ["The intake air was modeled to be fresh (i.e. no re-circulation) with a relatively high inflow rate of 0.1 kg/s (29) .Significance StatementThe numerical simulations were performed using ANSYS-Fluent package, solving the three-dimensional, steady, Reynolds-Averaged Navier-Stokes (RANS) equations using a standard k \u2212 turbulence model (for details see Methods section).", [["a relatively high inflow rate", "TREATMENT", 69, 98], ["The numerical simulations", "TEST", 139, 164], ["ANSYS", "TEST", 186, 191], ["Reynolds", "TEST", 247, 255], ["a standard k \u2212 turbulence model", "TREATMENT", 302, 333]]], ["We simulated a single driving speed of v = 22 m/s (50 mph) and an air density, \u03c1a = 1.2 kg/m 3 .", [["an air density", "TEST", 63, 77], ["air density", "OBSERVATION", 66, 77]]], ["The flow patterns calculated for each configuration were used to estimate the air (and potential pathogen) transmission from the driver to the passenger, and conversely from the passenger to the driver.", [["The flow patterns", "TEST", 0, 17], ["flow patterns", "OBSERVATION", 4, 17], ["air", "OBSERVATION", 78, 81]]], ["These estimates were achieved by computing the concentration field of a passive tracer \"released\" from each of the occupants, and evaluating the amount of that tracer reaching the other occupant (see Methods section).Significance StatementIn this paper, we first describe the pressure distributions established by the car motion and the flow induced inside the passenger compartment.", [["a passive tracer", "TREATMENT", 70, 86], ["the pressure distributions", "TEST", 272, 298], ["pressure", "OBSERVATION", 276, 284], ["passenger compartment", "OBSERVATION", 361, 382]]], ["Following that we describe the passenger-to-driver and driver-to-passenger transmission results for each of the ventilation options, and finally conclude with insights based on the observed concentration fields, and general conclusions and implications of the results.Results and DiscussionOverall air flow patterns.", [["the ventilation options", "TREATMENT", 108, 131], ["DiscussionOverall air flow patterns", "TEST", 280, 315], ["air flow patterns", "OBSERVATION", 298, 315]]], ["The external airflow generates a pressure distribution over the car (Fig. 2) , forming a high-pressure stagnation region over the radiator grille and on the front of the windshield.", [["a high-pressure stagnation region", "PROBLEM", 87, 120], ["external", "OBSERVATION_MODIFIER", 4, 12], ["airflow", "OBSERVATION", 13, 20], ["pressure", "OBSERVATION_MODIFIER", 33, 41], ["distribution", "OBSERVATION_MODIFIER", 42, 54], ["high", "OBSERVATION_MODIFIER", 89, 93], ["pressure", "OBSERVATION_MODIFIER", 94, 102], ["stagnation", "OBSERVATION_MODIFIER", 103, 113], ["region", "OBSERVATION_MODIFIER", 114, 120], ["radiator grille", "ANATOMY", 130, 145], ["windshield", "OBSERVATION", 170, 180]]], ["The peak pressure here (301 Pa) is of the order of the dynamic pressure (0.5\u03c1av 2 = 290 Pa at 22 m/s).", [["The peak pressure", "TEST", 0, 17], ["the dynamic pressure", "TEST", 51, 71], ["peak", "OBSERVATION_MODIFIER", 4, 8], ["pressure", "OBSERVATION_MODIFIER", 9, 17]]], ["Conversely, as the airflow wraps over the top of the the car and around the sides, the high air speed is associated with a low pressure zone, with the local pressure well below atmospheric (zero gauge pressure in Fig 2) .", [["the airflow wraps", "TREATMENT", 15, 32], ["the high air speed", "PROBLEM", 83, 101], ["a low pressure zone", "PROBLEM", 121, 140], ["atmospheric (zero gauge pressure in Fig", "TREATMENT", 177, 216], ["top", "ANATOMY_MODIFIER", 42, 45], ["car", "ANATOMY", 57, 60], ["high", "OBSERVATION_MODIFIER", 87, 91], ["air speed", "OBSERVATION", 92, 101], ["low pressure", "OBSERVATION", 123, 135], ["local", "OBSERVATION_MODIFIER", 151, 156], ["pressure", "OBSERVATION_MODIFIER", 157, 165]]], ["This overall pressure map is consistent with other computations of flows over automobile bodies (30) (31) (32) and gives a physical preview to a key featurethat the areas near the front windows and roof of the car are associated with lower-than-atmospheric pressures, while the areas towards the rear of the passenger cabin are associated with neutral or higher-than-atmospheric pressures.Results and DiscussionA typical streamline (or pathline) pattern in the car interior is shown in Fig. 3 , where the rear-left and front-right windows are opened (Config.", [["rear-left and front-right windows", "DNA", 505, 538], ["This overall pressure map", "TEST", 0, 25], ["pressure map", "OBSERVATION", 13, 25], ["consistent with", "UNCERTAINTY", 29, 44], ["flows", "OBSERVATION_MODIFIER", 67, 72], ["roof", "ANATOMY_MODIFIER", 198, 202], ["car", "ANATOMY", 210, 213], ["atmospheric pressures", "OBSERVATION", 245, 266], ["passenger cabin", "OBSERVATION", 308, 323], ["higher", "OBSERVATION_MODIFIER", 355, 361], ["atmospheric pressures", "OBSERVATION", 367, 388], ["rear", "ANATOMY_MODIFIER", 505, 509], ["left", "ANATOMY_MODIFIER", 510, 514], ["front", "ANATOMY_MODIFIER", 519, 524], ["right", "ANATOMY_MODIFIER", 525, 530], ["windows", "OBSERVATION", 531, 538], ["opened", "OBSERVATION", 543, 549]]], ["The streamlines were initiated at the rear-left (RL) window which is the location of a strong inflow ( Fig. 3 -lower right),due to the high pressure zone established by the car's motion (Fig 2) .", [["the high pressure zone", "PROBLEM", 131, 153], ["streamlines", "OBSERVATION_MODIFIER", 4, 15], ["left", "ANATOMY_MODIFIER", 43, 47], ["strong", "OBSERVATION_MODIFIER", 87, 93], ["inflow", "OBSERVATION", 94, 100], ["right", "ANATOMY_MODIFIER", 117, 122], ["high pressure", "OBSERVATION", 135, 148]]], ["A strong air current (\u223c 10 m/s) enters the cabin from this region and travels along the back seat of the car, before flowing past the passenger sitting on the rear-right side of the cabin.", [["strong", "OBSERVATION_MODIFIER", 2, 8], ["air", "OBSERVATION", 9, 12], ["back", "ANATOMY", 88, 92], ["car", "ANATOMY", 105, 108], ["right", "ANATOMY_MODIFIER", 164, 169], ["cabin", "ANATOMY", 182, 187]]], ["The air current turns at the closed rear-right window, moves forward and the majority of the air exits the cabin at the open window on the front-right (FR) side of the vehicle, where the exterior pressure is lower than atmospheric (Fig 2) .", [["the exterior pressure", "TEST", 183, 204], ["air", "OBSERVATION", 4, 7], ["right", "ANATOMY_MODIFIER", 41, 46], ["window", "ANATOMY", 47, 53], ["air", "OBSERVATION", 93, 96], ["open", "OBSERVATION_MODIFIER", 120, 124], ["window", "OBSERVATION", 125, 131], ["right", "ANATOMY_MODIFIER", 145, 150], ["vehicle", "OBSERVATION", 168, 175], ["exterior", "OBSERVATION_MODIFIER", 187, 195], ["pressure", "OBSERVATION_MODIFIER", 196, 204], ["lower", "OBSERVATION_MODIFIER", 208, 213]]], ["There is a much weaker air current (\u223c 2 m/s) that, after turning around the passenger, continues to circulate within the cabin.", [["a much weaker air current", "PROBLEM", 9, 34], ["much", "OBSERVATION_MODIFIER", 11, 15], ["weaker", "OBSERVATION_MODIFIER", 16, 22], ["air", "OBSERVATION", 23, 26], ["cabin", "ANATOMY", 121, 126]]], ["A small fraction of this flow is seen to exit through the RL window.Results and DiscussionThe streamline arrows indicate that the predominant direction of the recirculation zone inside the cabin is counterclockwise (viewed from above).", [["A small fraction of this flow", "PROBLEM", 0, 29], ["small", "OBSERVATION_MODIFIER", 2, 7], ["fraction", "OBSERVATION_MODIFIER", 8, 16], ["flow", "OBSERVATION", 25, 29], ["RL window", "OBSERVATION", 58, 67], ["predominant", "OBSERVATION_MODIFIER", 130, 141], ["recirculation zone", "OBSERVATION", 159, 177], ["cabin", "ANATOMY", 189, 194]]], ["These streamlines, of course, represent possible paths of transmission, potentially transporting virus-laden droplets or aerosols throughout the cabin and, in particular, from the passenger to the driver.Results and DiscussionAs already indicated, for the particular ventilation option shown here, the overall air pattern -entering on the rear-left and leaving on the front-right -is consistent with the external pressure distributions (Fig 2) .", [["the particular ventilation option", "TREATMENT", 252, 285], ["air pattern", "OBSERVATION", 310, 321], ["left", "ANATOMY_MODIFIER", 344, 348], ["right", "ANATOMY_MODIFIER", 374, 379], ["consistent with", "UNCERTAINTY", 384, 399], ["external", "ANATOMY_MODIFIER", 404, 412], ["pressure distributions", "OBSERVATION", 413, 435]]], ["The elevated pressure towards the rear of the cabin and the suction pressure near the front of the cabin drive the cabin flow.", [["The elevated pressure", "PROBLEM", 0, 21], ["the suction pressure", "TREATMENT", 56, 76], ["elevated", "OBSERVATION_MODIFIER", 4, 12], ["pressure", "OBSERVATION_MODIFIER", 13, 21], ["suction pressure", "OBSERVATION", 60, 76], ["cabin drive", "OBSERVATION", 99, 110], ["cabin flow", "OBSERVATION", 115, 125]]], ["This particular airflow pattern was confirmed in a \"field test\" in which the windows of a An important consideration when evaluating different ventilation options in the confined cabin of a car is the rate at which the cabin air gets replenished with fresh air from the outside.", [["a \"field test", "TEST", 49, 62], ["different ventilation options", "TREATMENT", 133, 162], ["fresh air", "OBSERVATION", 251, 260]]], ["This was measured by Ott et al. (25) for a variety of cars, traveling at a range of speeds, and for a limited set of ventilation options.", [["ventilation options", "TREATMENT", 117, 136]]], ["In these measurements, a passive tracer (representing cigarette smoke) was released inside the cabin and the exponential decay of the tracer concentration measured.", [["cigarette", "ORGANISM_SUBDIVISION", 54, 63], ["a passive tracer", "PROBLEM", 23, 39], ["the tracer concentration", "TEST", 130, 154], ["tracer concentration", "OBSERVATION", 134, 154]]], ["Assuming the cabin air to be well-mixed (25) , they estimated the air-changes-per-hour (ACH) -a widely used metric in indoor ventilation designs.Results and DiscussionFrom the simulations, we can precisely compute the total flow of air entering (and leaving) the cabin and, knowing the cabin volume, we can compute the air-changes-per-hour directly.", [["cabin air", "OBSERVATION", 13, 22], ["indoor ventilation", "OBSERVATION", 118, 136], ["air", "OBSERVATION", 232, 235]]], ["Such a calculation yields a very high estimate of ACH (of the order of 1000, see Supplemental Fig. S-3 ), but this is misleading, since the assumption of well-mixed cabin air is an over-simplification.", [["ACH", "SIMPLE_CHEMICAL", 50, 53], ["S-3", "GENE_OR_GENE_PRODUCT", 99, 102], ["a calculation", "TEST", 5, 18], ["mixed cabin air", "PROBLEM", 159, 174], ["cabin air", "OBSERVATION", 165, 174]]], ["Instead, a more relevant quantification of the ACH was obtained using a residence time analysis (RTA) for a passive scalar released at multiple locations within the passenger cabin.", [["a residence time analysis", "TEST", 70, 95], ["a passive scalar", "TREATMENT", 106, 122]]], ["However, what is somewhat surprising is that the ACH for Config.", [["Config", "PROBLEM", 57, 63]]], ["2, in which the the windows adjacent to the driver and the passenger (FL and RR, respectively) are opened is only 89 -barely higher than the all-windows-closed configuration; the remaining three configurations (Configs.", [["RR", "TEST", 77, 79], ["higher", "OBSERVATION_MODIFIER", 125, 131], ["windows", "OBSERVATION", 145, 152], ["closed", "OBSERVATION", 153, 159], ["configuration", "OBSERVATION_MODIFIER", 160, 173], ["three", "OBSERVATION_MODIFIER", 189, 194], ["configurations", "OBSERVATION_MODIFIER", 195, 209]]], ["3, 4 & 5) with two or three open windows all show relatively high efficacy of about 150 ACH.", [["three open windows", "TEST", 22, 40], ["relatively", "OBSERVATION_MODIFIER", 50, 60], ["high", "OBSERVATION", 61, 65]]], ["The reason for these differences can be traced back to the overall streamline patterns and the pressure distributions that drive the cabin flow (Fig.2) .", [["the pressure distributions", "PROBLEM", 91, 117], ["the cabin flow", "TEST", 129, 143], ["pressure distributions", "OBSERVATION", 95, 117], ["cabin flow", "OBSERVATION", 133, 143]]], ["A well-ventilated space requires the availability of an entrance and an exit, and a favorable pressure gradient between the two.", [["A well-ventilated space", "PROBLEM", 0, 23], ["a favorable pressure gradient", "PROBLEM", 82, 111], ["well-", "OBSERVATION_MODIFIER", 2, 7], ["ventilated space", "OBSERVATION", 7, 23], ["favorable", "OBSERVATION_MODIFIER", 84, 93], ["pressure gradient", "OBSERVATION", 94, 111]]], ["Once such a cross-ventilation path is established (as in Config.", [["a cross-ventilation path", "TREATMENT", 10, 34]]], ["3 or Fig. 3) , opening a third window has little effect on the ACH.", [["opening a third window", "TREATMENT", 15, 37], ["little", "OBSERVATION_MODIFIER", 42, 48], ["effect", "OBSERVATION_MODIFIER", 49, 55]]], ["However, we will later show that the ACH gives only a partial picture and the spreading of a passive scalar can show marked variations between the configurations 3-5, despite their nearly constant ACH.Results and DiscussionDriver-to-Passenger transmission.", [["the ACH", "PROBLEM", 33, 40], ["a partial picture", "PROBLEM", 52, 69], ["partial", "OBSERVATION_MODIFIER", 54, 61], ["marked", "OBSERVATION_MODIFIER", 117, 123], ["variations", "OBSERVATION", 124, 134]]], ["The flows established through the cabin provide a path for air transmission between the two occupants, and hence a possible infection route.", [["infection", "DISEASE", 124, 133], ["air transmission", "TEST", 59, 75], ["infection route", "PROBLEM", 124, 139], ["flows", "OBSERVATION_MODIFIER", 4, 9], ["possible", "UNCERTAINTY", 115, 123], ["infection", "OBSERVATION", 124, 133]]], ["Our focus here is on transmission via aerosols, which are small enough (and non-inertial) that they can be regarded as faithful tracers of the fluid flow (34, 35) .Results and DiscussionWe begin by addressing the problem from the viewpoint of an infected driver releasing pathogen-laden aerosols and potentially infecting the passenger.", [["fluid", "ANATOMY", 143, 148], ["the fluid flow", "TEST", 139, 153], ["small", "OBSERVATION_MODIFIER", 58, 63], ["fluid flow", "OBSERVATION", 143, 153], ["infected", "OBSERVATION", 246, 254]]], ["To obtain a volumetric quantification, the average scalar concentration in a 0.1 m diameter spherical domain surrounding the passenger's face is also computed, as shown in Fig. 5(b) .Results and DiscussionThe all-windows-closed configuration fares the worst and results in over 10% of the scalar that leaves the driver reaching the passenger.", [["a volumetric quantification", "TEST", 10, 37], ["the average scalar concentration", "TREATMENT", 39, 71], ["a 0.1 m diameter spherical domain", "TREATMENT", 75, 108]]], ["An overall trend of decreasing transmission is observed when the number of open windows are increased.", [["decreasing transmission", "PROBLEM", 20, 43], ["open windows", "TEST", 75, 87], ["overall", "OBSERVATION_MODIFIER", 3, 10], ["trend", "OBSERVATION_MODIFIER", 11, 16], ["decreasing", "OBSERVATION_MODIFIER", 20, 30], ["increased", "OBSERVATION_MODIFIER", 92, 101]]], ["However, there is some variability between the different configurations, the reasons for which may not be clear until one looks at the overall flow patterns (e.g. Fig. 3 ).", [["some", "OBSERVATION_MODIFIER", 18, 22], ["variability", "OBSERVATION_MODIFIER", 23, 34], ["different", "OBSERVATION_MODIFIER", 47, 56], ["configurations", "OBSERVATION_MODIFIER", 57, 71], ["flow", "OBSERVATION", 143, 147]]], ["Figure 5 (c) shows the concentration field of the scalar in a horizontal plane A-B-C-D within the car cabin roughly at head height of the occupants (Fig. 5(a) ).", [["head", "ANATOMY", 119, 123], ["A-B-C-D", "CHEMICAL", 79, 86], ["A-B-C-D", "SIMPLE_CHEMICAL", 79, 86], ["head", "ORGANISM_SUBDIVISION", 119, 123], ["a horizontal plane A-B", "TEST", 60, 82]]], ["The scalar field concentration is the highest for Config.", [["scalar", "OBSERVATION_MODIFIER", 4, 10], ["field", "OBSERVATION_MODIFIER", 11, 16], ["concentration", "OBSERVATION_MODIFIER", 17, 30], ["highest", "OBSERVATION_MODIFIER", 38, 45]]], ["1, where all four windows are closed.", [["closed", "OBSERVATION", 30, 36]]], ["We note that this driving configuration might also represent the most widely preferred one in the United States (with some seasonal variations).", [["might also represent", "UNCERTAINTY", 40, 60], ["most widely", "OBSERVATION_MODIFIER", 65, 76]]], ["One might assume that this is a logical thing to do for avoiding infection from the other occupant.", [["infection", "DISEASE", 65, 74], ["infection", "PROBLEM", 65, 74]]], ["2 does not effectively dilute the tracer particles, and the passenger receives a fairly large contaminant load from the driver.", [["tracer particles", "OBSERVATION", 34, 50], ["large", "OBSERVATION_MODIFIER", 88, 93], ["contaminant", "OBSERVATION", 94, 105]]], ["To explain this result, we looked more closely at the air flow patterns.", [["air flow", "OBSERVATION", 54, 62]]], ["In analogy with the streamlines associated with Config 3 (Fig. 3) , Config 2 establishes a strong air current from the open rear window (RR) towards the open front window (FL), and a clockwise recirculating flow within the cabin (viewed from above).", [["a clockwise recirculating flow", "TREATMENT", 181, 211], ["flow", "OBSERVATION", 207, 211]]], ["Although this flow pattern is weak, it increases the transport of tracer from the driver to the passenger.", [["this flow pattern", "TEST", 9, 26], ["weak", "PROBLEM", 30, 34], ["flow", "OBSERVATION", 14, 18], ["weak", "OBSERVATION_MODIFIER", 30, 34]]], ["Moreover, the incoming air stream in Config.", [["the incoming air stream", "PROBLEM", 10, 33], ["air stream", "OBSERVATION", 23, 33]]], ["2 enters behind the passenger and is ineffective in flushing out potential contaminants emanating from the driver.Results and DiscussionAn improvement to this configuration can be achieved if two modifications are possible: i) a change in the direction of the internal circulation, and ii) a modified incoming air flow that impinges the passenger before leaving through the open window on the front.", [["a modified incoming air flow", "PROBLEM", 290, 318], ["ineffective", "OBSERVATION_MODIFIER", 37, 48], ["internal circulation", "ANATOMY", 260, 280], ["air flow", "OBSERVATION", 310, 318], ["open", "OBSERVATION_MODIFIER", 374, 378], ["window", "OBSERVATION", 379, 385]]], ["3 (Fig. 5(c) ), wherein the RL and FR windows are open (same as the configuration shown in Fig. 3) .", [["RL and FR windows", "DNA", 28, 45], ["the RL and FR windows", "TREATMENT", 24, 45], ["RL", "ANATOMY", 28, 30], ["open", "OBSERVATION", 50, 54]]], ["Now, the incoming clean air stream from the RL window partially impinges on the passenger (seated in the RR seat) as it turns around the corner.", [["clean", "OBSERVATION_MODIFIER", 18, 23], ["air stream", "OBSERVATION", 24, 34], ["RL window", "OBSERVATION", 44, 53]]], ["This stream of air might also act as a \"air curtain\" (36) , and hence the concentration of potentially contaminated air reaching the passenger is reduced.Results and DiscussionThe remaining configurations (Configs.", [["a \"air curtain\"", "PROBLEM", 37, 52], ["contaminated air", "PROBLEM", 103, 119], ["air", "OBSERVATION", 15, 18], ["contaminated air", "OBSERVATION", 103, 119], ["reduced", "OBSERVATION_MODIFIER", 146, 153]]], ["Since this represents opening an additional window (RR), it may be surprising to find a detrimental effect on the concentration field and the ACH (comparing Configs.", [["ACH", "CHEMICAL", 142, 145], ["ACH", "SIMPLE_CHEMICAL", 142, 145], ["RR", "TEST", 52, 54]]], ["The increase in the concentration can be linked to the modified air flow patterns that result from opening the third (RR) window.", [["the modified air flow patterns", "PROBLEM", 51, 81], ["increase", "OBSERVATION_MODIFIER", 4, 12], ["air flow", "OBSERVATION", 64, 72]]], ["Firstly, opening the RR window leads to a reduction in the flow turning at the rear-right end of cabin, since a fraction of the incoming air gets bled out of this window (Fig. S-1 ).", [["S-1", "GENE_OR_GENE_PRODUCT", 176, 179], ["opening the RR window", "TREATMENT", 9, 30], ["a reduction", "TREATMENT", 40, 51], ["the flow turning", "TREATMENT", 55, 71], ["reduction", "OBSERVATION_MODIFIER", 42, 51], ["flow", "OBSERVATION", 59, 63], ["right", "ANATOMY_MODIFIER", 84, 89], ["air", "OBSERVATION", 137, 140]]], ["Due to this diversion of the air flow, the region surrounding passenger is less effective as a barrier to the scalar released by the driver.", [["this diversion", "TREATMENT", 7, 21], ["the air flow", "PROBLEM", 25, 37], ["diversion", "OBSERVATION", 12, 21], ["air flow", "OBSERVATION", 29, 37], ["less", "OBSERVATION_MODIFIER", 75, 79], ["effective", "OBSERVATION_MODIFIER", 80, 89]]], ["Secondly, the modified flow also creates an entrainment current from the driver to the passenger, which further elevates the scalar transport.", [["flow", "OBSERVATION", 23, 27]]], ["5 presents the scenario where the third open window is the FL.", [["window", "OBSERVATION", 45, 51], ["FL", "OBSERVATION", 59, 61]]], ["This modification leads to an improvement, nearly halving the average concentration when compared to that in Config.", [["improvement", "OBSERVATION_MODIFIER", 30, 41]]], ["Now that the FL window near the driver is open, the relatively low pressure near the front of the car creates an outward flow that flushes out much of released species.", [["the FL window", "TREATMENT", 9, 22], ["released species", "PROBLEM", 151, 167], ["relatively", "OBSERVATION_MODIFIER", 52, 62], ["low", "OBSERVATION_MODIFIER", 63, 66], ["pressure", "OBSERVATION", 67, 75], ["car", "ANATOMY", 98, 101], ["outward", "OBSERVATION_MODIFIER", 113, 120], ["flow", "OBSERVATION", 121, 125], ["species", "OBSERVATION", 160, 167]]], ["With the substantially reduced initial concentration field near the driver, the fraction reaching the passenger is proportionately reduced.", [["substantially", "OBSERVATION_MODIFIER", 9, 22], ["reduced", "OBSERVATION_MODIFIER", 23, 30], ["proportionately", "OBSERVATION_MODIFIER", 115, 130], ["reduced", "OBSERVATION_MODIFIER", 131, 138]]], ["6), we can again use the exterior pressure distribution to predict the flow directions.", [["the exterior pressure distribution", "TREATMENT", 21, 55]]], ["The streamlines enter through the rear windows (RL and RR) and leave via the front windows (FL and FR).", [["RL and RR)", "TREATMENT", 48, 58]]], ["However, unlike the configuration with only two windows open (Fig. 3) , the overall flow pattern is substantially modified (Fig. S-2 ) and the streamlines obey left-right symmetry and, for the most part, do not cross the vertical mid-plane of the car.", [["the overall flow pattern", "TEST", 72, 96], ["two", "OBSERVATION_MODIFIER", 44, 47], ["windows", "OBSERVATION", 48, 55], ["overall", "OBSERVATION_MODIFIER", 76, 83], ["flow pattern", "OBSERVATION", 84, 96], ["left", "ANATOMY_MODIFIER", 160, 164], ["right", "ANATOMY_MODIFIER", 165, 170], ["symmetry", "OBSERVATION", 171, 179], ["car", "ANATOMY", 247, 250]]], ["In this configuration, the flow is largely partitioned into two zones creating two cross-ventilation paths in which the total air flow rate is nearly doubled when compared to the two and three window open configurations (Fig. S-3) .Results and DiscussionPassenger-to-Driver transmission.", [["S-3", "GENE_OR_GENE_PRODUCT", 226, 229], ["the total air flow rate", "TEST", 116, 139], ["flow", "OBSERVATION", 27, 31], ["two", "OBSERVATION_MODIFIER", 60, 63], ["zones", "OBSERVATION_MODIFIER", 64, 69], ["two", "OBSERVATION_MODIFIER", 79, 82], ["cross-ventilation paths", "OBSERVATION", 83, 106], ["total", "OBSERVATION_MODIFIER", 120, 125], ["air flow", "OBSERVATION", 126, 134], ["nearly", "OBSERVATION_MODIFIER", 143, 149], ["doubled", "OBSERVATION_MODIFIER", 150, 157]]], ["Fig. 6 shows a comparison of the spreading patterns of a passive scalar within the car cabin.Results and DiscussionThe general trend suggests a decreasing level of transmission as the number of open windows is increased, similar to the results found for the driver-to-passenger transmission.", [["a decreasing level of transmission", "PROBLEM", 142, 176], ["decreasing", "OBSERVATION_MODIFIER", 144, 154], ["increased", "OBSERVATION_MODIFIER", 210, 219]]], ["This value, however, is lower than the 11% reported for the inverse transport, i.e. from the driver to the passenger (Fig. 5(b) ), a difference that can be attributed to the fact that the air-conditioning creates a front-to-back mean flow.", [["This value", "TEST", 0, 10], ["the air-conditioning", "PROBLEM", 184, 204], ["lower", "OBSERVATION_MODIFIER", 24, 29]]], ["As before, the lowest level of scalar transport corresponds to Config.", [["scalar transport", "OBSERVATION", 31, 47]]], ["6 with all windows open, although we note that the concentration load here (about 2%), is noticeably higher than that for the driver-to-passenger transmission (about 0.2%).", [["the concentration load", "TEST", 47, 69], ["higher", "OBSERVATION_MODIFIER", 101, 107]]], ["The streamline patterns for this configuration (Supplemental Fig. S-2) show that the air enters through the rear windows,(RL and RR) and exits through the respective front windows (FL and FR).", [["S-2", "GENE_OR_GENE_PRODUCT", 66, 69], ["Supplemental Fig", "TREATMENT", 48, 64], ["air", "OBSERVATION", 85, 88], ["RL", "ANATOMY_MODIFIER", 122, 124]]], ["There is, therefore, an average rear-tofront flow in both the left and right halves of the cabin which enhances transmission from the passenger to the driver.Results and DiscussionAmong the remaining configurations (Configs.", [["left", "ANATOMY", 62, 66], ["right halves", "ANATOMY", 71, 83], ["average", "OBSERVATION_MODIFIER", 24, 31], ["rear", "OBSERVATION_MODIFIER", 32, 36], ["tofront flow", "OBSERVATION", 37, 49], ["both", "ANATOMY_MODIFIER", 53, 57], ["left", "ANATOMY_MODIFIER", 62, 66], ["right", "ANATOMY_MODIFIER", 71, 76], ["halves", "ANATOMY_MODIFIER", 77, 83], ["cabin", "ANATOMY", 91, 96]]], ["3 shows a slightly elevated level of average concentration.", [["a slightly elevated level of average concentration", "PROBLEM", 8, 58], ["slightly", "OBSERVATION_MODIFIER", 10, 18], ["elevated", "OBSERVATION", 19, 27]]], ["The counter-clockwise interior circulation pattern is at the heart of this transmission pattern.", [["heart", "ANATOMY", 61, 66], ["heart", "ORGAN", 61, 66], ["interior", "ANATOMY_MODIFIER", 22, 30], ["circulation pattern", "OBSERVATION", 31, 50], ["heart", "ANATOMY", 61, 66]]], ["A substantial reduction in the average concentration can be achieved by additionally opening the rear window adjacent to the passenger (Config.", [["A substantial reduction", "TREATMENT", 0, 23], ["substantial", "OBSERVATION_MODIFIER", 2, 13], ["reduction", "OBSERVATION_MODIFIER", 14, 23]]], ["This allows for much of the scalar released by the passenger to be immediately flushed out through the rear window, analogous to the way in which opening the driver-adjacent (FL) window helps to flush out the high concentration contaminants from the driver before they can circulate to the passenger (Fig. 5(c, #5) ).Concluding remarksIn summary, the flow patterns and the scalar concentration fields obtained from the CFD simulations demonstrate that establishing a dominant cross-ventilation flow within the car cabin is crucial to the minimization of particle transport between car occupants and to lessening the exchange of potentially infectious micro-particles.", [["adjacent (FL) window", "TREATMENT", 165, 185], ["the flow patterns", "TEST", 347, 364], ["the scalar concentration fields", "TEST", 369, 400], ["the CFD simulations", "TEST", 415, 434], ["a dominant cross-ventilation flow", "PROBLEM", 465, 498], ["potentially infectious micro-particles", "PROBLEM", 628, 666], ["dominant", "OBSERVATION_MODIFIER", 467, 475], ["cross-ventilation flow", "OBSERVATION", 476, 498], ["potentially", "OBSERVATION_MODIFIER", 628, 639], ["infectious", "OBSERVATION", 640, 650]]], ["With this flow pattern established, the relative positions of the driver and passenger determine the quantity of of air transmitted between the occupants.Concluding remarksIt is, perhaps, not surprising that the most effective way to minimize cross-contamination between the occupants is to have all of the windows open (Config.", [["this flow pattern", "TEST", 5, 22], ["air", "PROBLEM", 116, 119], ["flow", "OBSERVATION", 10, 14], ["air", "OBSERVATION", 116, 119], ["windows", "OBSERVATION", 307, 314]]], ["This establishes two distinct air flow paths within the car cabin which help to isolate the left and right sides, and maximizes the ACH in the passenger cabin.", [["left", "ANATOMY", 92, 96], ["right sides", "ANATOMY", 101, 112], ["ACH", "CHEMICAL", 132, 135], ["two", "OBSERVATION_MODIFIER", 17, 20], ["distinct", "OBSERVATION_MODIFIER", 21, 29], ["air flow paths", "OBSERVATION", 30, 44], ["left", "ANATOMY_MODIFIER", 92, 96], ["right", "ANATOMY_MODIFIER", 101, 106], ["passenger cabin", "OBSERVATION", 143, 158]]], ["Nevertheless, driving with all the windows open might not always be a viable or desirable option, and in these situations there are some non-intuitive results that are revealed by the calculations.Concluding remarksThe all-windows-closed scenario with air-conditioning on (Config.", [["closed", "OBSERVATION", 231, 237]]], ["1) appears to be the least effective option.", [["appears to be", "UNCERTAINTY", 3, 16], ["least", "OBSERVATION_MODIFIER", 21, 26], ["effective", "OBSERVATION_MODIFIER", 27, 36], ["option", "OBSERVATION", 37, 43]]], ["Perhaps most surprising is that an intuitive option -of opening the windows adjacent to each occupant (Config.", [["opening the windows", "TREATMENT", 56, 75]]], ["2) is effective, but not always the best amongst the partial ventilation options.", [["effective", "OBSERVATION_MODIFIER", 6, 15], ["partial", "OBSERVATION_MODIFIER", 53, 60], ["ventilation options", "OBSERVATION", 61, 80]]], ["The particular airflow patterns that the pressure distributions establish -channeling fresh air across the rear seat, and out the front-right windowhelp to minimize the interaction with the driver in the front left position.Concluding remarksThe role of car speed cannot be ignored when addressing the transport between the vehicle's occupants.", [["the pressure distributions", "TEST", 37, 63], ["airflow", "OBSERVATION", 15, 22], ["pressure", "OBSERVATION_MODIFIER", 41, 49], ["distributions", "OBSERVATION_MODIFIER", 50, 63], ["fresh air", "OBSERVATION", 86, 95], ["right", "ANATOMY_MODIFIER", 136, 141], ["interaction", "OBSERVATION", 169, 180], ["front", "ANATOMY_MODIFIER", 204, 209], ["left", "ANATOMY_MODIFIER", 210, 214], ["position", "ANATOMY_MODIFIER", 215, 223]]], ["Since the Reynolds number of the flow is high, the air flow patterns will be largely insensitive to how fast the car is driven.", [["the flow", "TEST", 29, 37], ["the air flow patterns", "PROBLEM", 47, 68], ["Reynolds", "OBSERVATION_MODIFIER", 10, 18], ["number", "OBSERVATION_MODIFIER", 19, 25], ["flow", "OBSERVATION_MODIFIER", 33, 37], ["high", "OBSERVATION_MODIFIER", 41, 45], ["air flow", "OBSERVATION", 51, 59]]], ["However, the airchanges-per-hour (ACH) is expected to depend linearly on the car speed (33) and consequently, the slower the car speed, the lower the ACH, the longer the residence time in the cabin, and hence the higher the opportunity for pathogenic infection.Concluding remarksThe findings reported here can be easily translated to righthand-drive vehicles, of relevance to countries like the UK and India.", [["infection", "DISEASE", 251, 260], ["pathogenic infection", "PROBLEM", 240, 260], ["infection", "OBSERVATION", 251, 260]]], ["In those situations similar, but mirrored, flow patterns can be expected.", [["flow patterns", "OBSERVATION", 43, 56]]], ["Furthermore, although the computations were performed for a particular vehicle design (loosely modeled on a Toyota Prius), the overall results are expected to be valid for many four-windowed passenger vehicles.", [["the computations", "TEST", 22, 38]]], ["One should expect, however, that trucks, minivans and cars with an open moonroof may well exhibit different airflow patterns and hence different scalar transport trends.Concluding remarksThere are, to be sure, uncertainties with our analyses and we must be clear that we do not make any definitive assessment of the health risks associated with riding in an automobile.Concluding remarksThe simulations solve for a steady turbulent flow, while the transmission of scalar particles that might represent pathogenic aerosols will be affected by large scale, unsteady, turbulent fluctuations that are not captured well in the current work.", [["an open moonroof", "TREATMENT", 64, 80], ["different airflow patterns", "PROBLEM", 98, 124], ["our analyses", "TEST", 229, 241], ["a steady turbulent flow", "PROBLEM", 413, 436], ["scalar particles", "PROBLEM", 464, 480], ["pathogenic aerosols", "PROBLEM", 502, 521], ["unsteady", "PROBLEM", 555, 563], ["turbulent fluctuations", "PROBLEM", 565, 587], ["airflow", "OBSERVATION", 108, 115], ["turbulent", "OBSERVATION_MODIFIER", 422, 431], ["flow", "OBSERVATION", 432, 436], ["scalar particles", "OBSERVATION", 464, 480], ["might represent", "UNCERTAINTY", 486, 501], ["pathogenic aerosols", "OBSERVATION", 502, 521], ["large", "OBSERVATION_MODIFIER", 542, 547], ["scale", "OBSERVATION_MODIFIER", 548, 553]]], ["These effects could change the amount of tracer emitted by one occupant that reaches the other occupant (37) .", [["amount", "OBSERVATION_MODIFIER", 31, 37], ["tracer emitted", "OBSERVATION", 41, 55]]], ["Although RANS simulations represent a widely-used model for scientific, industrial and automotive applications (38) , there are still known limitations to its predictive capabilities, and a more accurate assessment of the flow patterns and the turbulent dispersion requires a much more computationally intensive set of simulations, such as Large Eddy simulation (LES) or Direct Numerical Simulations (DNS) -an undertaking far beyond the aims and scope of this work.Concluding remarksNevertheless, despite these caveats, these results provide critical insight for the hundreds of millions of people who need to travel in a car during the COVID-19 pandemic, and establishes a starting point for an extended analysis of the micro-climate inside vehicle interiors which we hope will yield safer and lower-risk approaches to personal transportation.MethodsThe car geometry was chosen based on the basic exterior of a Toyota Prius.", [["people", "ORGANISM", 591, 597], ["people", "SPECIES", 591, 597], ["the flow patterns", "TEST", 218, 235], ["the turbulent dispersion", "PROBLEM", 240, 264], ["an extended analysis", "TEST", 693, 713], ["flow patterns", "OBSERVATION", 222, 235], ["turbulent", "OBSERVATION_MODIFIER", 244, 253], ["dispersion", "OBSERVATION_MODIFIER", 254, 264], ["Large", "OBSERVATION_MODIFIER", 340, 345], ["Eddy", "OBSERVATION", 346, 350]]], ["The interior was kept minimal, and comprised of two cylindrical bodies representing the driver and the passenger.", [["interior", "OBSERVATION_MODIFIER", 4, 12], ["minimal", "OBSERVATION_MODIFIER", 22, 29], ["cylindrical bodies", "OBSERVATION", 52, 70]]], ["The CAD model for the car geometry was prepared using SolidWorks, and subsequent operations including domain discretization (meshing) and case setup were carried out using the ANSYS-Fluent module.MethodsThe steady Reynolds-averaged Navier-Stokes (RANS) equations with a standard k \u2212 turbulence model was solved on an unstructured grid, made up of about 1 million tetrahedral grid cells.", [["cells", "ANATOMY", 380, 385], ["grid cells", "CELL", 375, 385], ["tetrahedral grid cells", "CELL_LINE", 363, 385], ["SolidWorks", "TREATMENT", 54, 64], ["subsequent operations", "TREATMENT", 70, 91], ["domain discretization (meshing) and case setup", "TREATMENT", 102, 148], ["the ANSYS", "TEST", 172, 181], ["Methods", "TEST", 196, 203], ["The steady Reynolds", "TEST", 203, 222], ["a standard k \u2212 turbulence model", "TREATMENT", 268, 299], ["Fluent module", "OBSERVATION", 182, 195]]], ["The domain size was 6h \u00d7 5h \u00d7 3h in the streamwise, normal, and spanwise directions, respectively, where h is the car height.", [["The domain size", "TEST", 0, 15], ["size", "OBSERVATION_MODIFIER", 11, 15], ["normal", "OBSERVATION", 52, 58]]], ["A single vehicle speed of U = 22 m/s (50 mph), which was set as the inflow condition upstream of the front of the car body.", [["body", "ANATOMY", 118, 122], ["body", "ORGANISM_SUBDIVISION", 118, 122], ["inflow", "OBSERVATION", 68, 74], ["front", "ANATOMY_MODIFIER", 101, 106], ["car", "ANATOMY", 114, 117], ["body", "ANATOMY_MODIFIER", 118, 122]]], ["A pressure outlet condition was applied at the exit.", [["A pressure outlet condition", "TREATMENT", 0, 27], ["pressure outlet", "OBSERVATION", 2, 17]]], ["The simulations were iterated until convergence was achieved for the continuity and momentum equations, and the turbulence dissipation rate, .", [["The simulations", "TREATMENT", 0, 15], ["the turbulence dissipation rate", "TEST", 108, 139]]], ["A grid-independence study was performed, which established that the resolution adopted was sufficient for the quantities reported in the present work.MethodsThe mixing and transport of a passive scalar were modeled by solving species transport equations describing an advectiondiffusion equation.", [["A grid-independence study", "TEST", 0, 25], ["a passive scalar", "TREATMENT", 185, 201], ["an advectiondiffusion equation", "PROBLEM", 265, 295]]], ["Separate simulations were performed for the scalar released near driver, and then for its release near the passenger's face.", [["Separate simulations", "TEST", 0, 20]]], ["The scalar was set to be a non-interacting material, i.e. with an exceedingly low mass diffusivity, which meant that only advection and turbulent diffusion contributed to its transport dynamics.", [["an exceedingly low mass diffusivity", "PROBLEM", 63, 98], ["turbulent diffusion", "PROBLEM", 136, 155], ["mass", "OBSERVATION", 82, 86], ["turbulent", "OBSERVATION_MODIFIER", 136, 145]]], ["This approach mimics the mixing of a high Schmidt number material, such as dye or smoke, which are commonly used as a tracers in turbulent fluid flows (39) .", [["fluid", "ANATOMY", 139, 144], ["a high Schmidt number material", "TREATMENT", 35, 65], ["a tracers in turbulent fluid flows", "TEST", 116, 150], ["turbulent", "OBSERVATION_MODIFIER", 129, 138], ["fluid flows", "OBSERVATION", 139, 150]]], ["The injection rate of the species was very low in order that it did not influence the air flow.", [["The injection rate", "TEST", 0, 18], ["the species", "TEST", 22, 33], ["air flow", "OBSERVATION", 86, 94]]], ["This was verified by comparing the concentration fields for various injection rates, which showed negligible variation.", [["various injection rates", "TEST", 60, 83], ["negligible variation", "PROBLEM", 98, 118], ["negligible variation", "OBSERVATION", 98, 118]]], ["This strategy was followed in order that the effects of turbulent diffusion effects were also captured in the analyses.", [["turbulent diffusion effects", "PROBLEM", 56, 83], ["turbulent", "OBSERVATION_MODIFIER", 56, 65], ["diffusion effects", "OBSERVATION", 66, 83]]]], "474e12e66c6210b9b692365e7bd439a421012fb6": [["slight excess of soluble antigens lead to the accumulation of immune complexes, not enough cleared from the circulation by the innate immune system [5] .", [["soluble antigens", "PROTEIN", 17, 33], ["immune complexes", "PROTEIN", 62, 78], ["slight excess of soluble antigens", "PROBLEM", 0, 33], ["immune complexes", "PROBLEM", 62, 78], ["excess", "OBSERVATION_MODIFIER", 7, 13], ["immune complexes", "OBSERVATION", 62, 78]]], ["These antigen-antibody complexes precipitate inside the tissues, in particular blood vessels, inducing a severe inflammatory state by the action of complement anaphylatoxins (C3a and C5a), which in turn stimulate the release of histamine from mast cells and the recruitment of phagocytes, in primis neutrophils, the main responsible for the tissue damage [5] .", [["tissues", "ANATOMY", 56, 63], ["blood vessels", "ANATOMY", 79, 92], ["mast cells", "ANATOMY", 243, 253], ["phagocytes", "ANATOMY", 277, 287], ["primis neutrophils", "ANATOMY", 292, 310], ["tissue", "ANATOMY", 341, 347], ["histamine", "CHEMICAL", 228, 237], ["histamine", "CHEMICAL", 228, 237], ["antigen-antibody", "GENE_OR_GENE_PRODUCT", 6, 22], ["tissues", "TISSUE", 56, 63], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 79, 92], ["complement", "GENE_OR_GENE_PRODUCT", 148, 158], ["anaphylatoxins", "GENE_OR_GENE_PRODUCT", 159, 173], ["C3a", "GENE_OR_GENE_PRODUCT", 175, 178], ["C5a", "GENE_OR_GENE_PRODUCT", 183, 186], ["histamine", "SIMPLE_CHEMICAL", 228, 237], ["mast cells", "CELL", 243, 253], ["phagocytes", "CELL", 277, 287], ["primis neutrophils", "CELL", 292, 310], ["tissue", "TISSUE", 341, 347], ["antigen-antibody complexes", "PROTEIN", 6, 32], ["complement anaphylatoxins", "PROTEIN", 148, 173], ["C3a", "PROTEIN", 175, 178], ["C5a", "PROTEIN", 183, 186], ["mast cells", "CELL_TYPE", 243, 253], ["phagocytes", "CELL_TYPE", 277, 287], ["primis neutrophils", "CELL_TYPE", 292, 310], ["These antigen-antibody complexes", "TEST", 0, 32], ["a severe inflammatory state", "PROBLEM", 103, 130], ["complement anaphylatoxins", "PROBLEM", 148, 173], ["C3a and C5a)", "TREATMENT", 175, 187], ["histamine from mast cells", "TREATMENT", 228, 253], ["the tissue damage", "PROBLEM", 337, 354], ["tissues", "ANATOMY", 56, 63], ["vessels", "ANATOMY", 85, 92], ["severe", "OBSERVATION_MODIFIER", 105, 111], ["inflammatory", "OBSERVATION", 112, 124], ["mast cells", "OBSERVATION", 243, 253]]], ["On histopathology, the result of this process inside the walls of blood vessels is depicted by an acute necrotizing vasculitis with neutrophilic infiltration, karyorrhexis and fibrinoid necrosis, the so called \u00ableukocytoclastic vasculitis\u00bb (LCV), also reported in the English medical literature by the term \u00abhypersensitivity vasculitis\u00bb [6] ; platelet aggregation correlates with hypercoagulability and thrombosis, disorders described in course of COVID-19, too [7] .", [["walls", "ANATOMY", 57, 62], ["blood vessels", "ANATOMY", 66, 79], ["neutrophilic", "ANATOMY", 132, 144], ["fibrinoid", "ANATOMY", 176, 185], ["platelet", "ANATOMY", 343, 351], ["vasculitis", "DISEASE", 116, 126], ["karyorrhexis", "DISEASE", 159, 171], ["necrosis", "DISEASE", 186, 194], ["\u00ableukocytoclastic vasculitis\u00bb", "DISEASE", 210, 239], ["vasculitis", "DISEASE", 325, 335], ["platelet aggregation", "DISEASE", 343, 363], ["hypercoagulability", "DISEASE", 380, 398], ["thrombosis", "DISEASE", 403, 413], ["COVID-19", "CHEMICAL", 448, 456], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 66, 79], ["platelet", "CELL", 343, 351], ["histopathology", "TEST", 3, 17], ["this process", "PROBLEM", 33, 45], ["an acute necrotizing vasculitis", "PROBLEM", 95, 126], ["neutrophilic infiltration", "PROBLEM", 132, 157], ["karyorrhexis", "PROBLEM", 159, 171], ["fibrinoid necrosis", "PROBLEM", 176, 194], ["\u00ableukocytoclastic vasculitis\u00bb", "PROBLEM", 210, 239], ["the term \u00abhypersensitivity vasculitis", "PROBLEM", 298, 335], ["platelet aggregation", "PROBLEM", 343, 363], ["hypercoagulability", "PROBLEM", 380, 398], ["thrombosis", "PROBLEM", 403, 413], ["disorders", "PROBLEM", 415, 424], ["COVID", "TEST", 448, 453], ["walls", "ANATOMY_MODIFIER", 57, 62], ["blood vessels", "ANATOMY", 66, 79], ["acute", "OBSERVATION_MODIFIER", 98, 103], ["necrotizing", "OBSERVATION_MODIFIER", 104, 115], ["vasculitis", "OBSERVATION", 116, 126], ["neutrophilic infiltration", "OBSERVATION", 132, 157], ["fibrinoid", "OBSERVATION_MODIFIER", 176, 185], ["necrosis", "OBSERVATION", 186, 194], ["thrombosis", "OBSERVATION", 403, 413]]], ["The just mentioned fibrinoid necrosis represents a specific pattern of tissue injury, which occurs once antigen-antibody complexes are deposited in the walls of blood vessels along with fibrin and complement anaphylatoxins; therefore, it can be considered a diagnostic clue of immune-mediated vasculitides from type 3 hypersensitivity [8] .", [["fibrinoid", "ANATOMY", 19, 28], ["tissue", "ANATOMY", 71, 77], ["walls", "ANATOMY", 152, 157], ["blood vessels", "ANATOMY", 161, 174], ["necrosis", "DISEASE", 29, 37], ["tissue injury", "DISEASE", 71, 84], ["vasculitides", "DISEASE", 293, 305], ["hypersensitivity", "DISEASE", 318, 334], ["fibrinoid", "TISSUE", 19, 28], ["tissue", "TISSUE", 71, 77], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 161, 174], ["fibrin", "GENE_OR_GENE_PRODUCT", 186, 192], ["anaphylatoxins", "GENE_OR_GENE_PRODUCT", 208, 222], ["antigen-antibody complexes", "PROTEIN", 104, 130], ["fibrin", "PROTEIN", 186, 192], ["fibrinoid necrosis", "PROBLEM", 19, 37], ["tissue injury", "PROBLEM", 71, 84], ["antigen-antibody complexes", "TEST", 104, 130], ["fibrin and complement anaphylatoxins", "PROBLEM", 186, 222], ["immune-mediated vasculitides", "PROBLEM", 277, 305], ["type 3 hypersensitivity", "PROBLEM", 311, 334], ["fibrinoid", "OBSERVATION_MODIFIER", 19, 28], ["necrosis", "OBSERVATION", 29, 37], ["tissue", "ANATOMY", 71, 77], ["injury", "OBSERVATION", 78, 84], ["walls", "ANATOMY_MODIFIER", 152, 157], ["blood vessels", "ANATOMY", 161, 174], ["fibrin", "OBSERVATION", 186, 192], ["anaphylatoxins", "OBSERVATION", 208, 222]]], ["LCV is preceded by a viral infection, such as hepatitis B, hepatitis C and HIV, in a relevant percentage of cases [6] .", [["viral infection", "DISEASE", 21, 36], ["hepatitis B", "DISEASE", 46, 57], ["hepatitis C", "DISEASE", 59, 70], ["HIV", "DISEASE", 75, 78], ["hepatitis B", "ORGANISM", 46, 57], ["hepatitis C", "ORGANISM", 59, 70], ["HIV", "ORGANISM", 75, 78], ["HIV", "SPECIES", 75, 78], ["hepatitis B", "SPECIES", 46, 57], ["HIV", "SPECIES", 75, 78], ["a viral infection", "PROBLEM", 19, 36], ["hepatitis B", "PROBLEM", 46, 57], ["hepatitis C", "PROBLEM", 59, 70], ["HIV", "PROBLEM", 75, 78], ["viral", "OBSERVATION_MODIFIER", 21, 26], ["infection", "OBSERVATION", 27, 36]]], ["The onset time of type 3 hypersensitivity varies from days to weeks depending on the presence or not of memory cells against the precipitating antigen; clinical features emerge approximately 10 days after initial antigenic challenge [8] .", [["memory cells", "ANATOMY", 104, 116], ["hypersensitivity", "DISEASE", 25, 41], ["memory cells", "CELL", 104, 116], ["memory cells", "CELL_TYPE", 104, 116], ["type 3 hypersensitivity varies", "PROBLEM", 18, 48], ["memory cells", "PROBLEM", 104, 116], ["the precipitating antigen", "PROBLEM", 125, 150], ["initial antigenic challenge", "TREATMENT", 205, 232]]], ["During the Severe Acute Respiratory Syndrome (SARS) outbreak in 2002-2003, caused by SARS-CoV-2 predecessor (SARS-CoV), it was observed that the acute respiratory distress syndrome, one the most serious complications of the disease, significantly overlapped with antiviral immunoglobulin G (IgG) seroconversion [9] ; besides, it was found that patients who developed more quickly the anti-spike neutralizing antibody showed a higher risk of dying from the disease [10] .", [["respiratory", "ANATOMY", 151, 162], ["Acute Respiratory Syndrome", "DISEASE", 18, 44], ["SARS", "DISEASE", 46, 50], ["respiratory distress syndrome", "DISEASE", 151, 180], ["CoV-2", "ORGANISM", 90, 95], ["SARS-CoV", "ORGANISM", 109, 117], ["immunoglobulin G", "GENE_OR_GENE_PRODUCT", 273, 289], ["IgG", "GENE_OR_GENE_PRODUCT", 291, 294], ["patients", "ORGANISM", 344, 352], ["antiviral immunoglobulin G", "PROTEIN", 263, 289], ["IgG", "PROTEIN", 291, 294], ["anti-spike neutralizing antibody", "PROTEIN", 384, 416], ["patients", "SPECIES", 344, 352], ["SARS-CoV", "SPECIES", 85, 93], ["SARS-CoV", "SPECIES", 109, 117], ["the Severe Acute Respiratory Syndrome", "PROBLEM", 7, 44], ["SARS", "PROBLEM", 85, 89], ["the acute respiratory distress syndrome", "PROBLEM", 141, 180], ["the disease", "PROBLEM", 220, 231], ["antiviral immunoglobulin G (IgG) seroconversion", "TREATMENT", 263, 310], ["the anti-spike neutralizing antibody", "TEST", 380, 416], ["the disease", "PROBLEM", 452, 463], ["Severe", "OBSERVATION_MODIFIER", 11, 17], ["Acute", "OBSERVATION_MODIFIER", 18, 23], ["Respiratory Syndrome", "OBSERVATION", 24, 44], ["acute", "OBSERVATION_MODIFIER", 145, 150], ["respiratory", "OBSERVATION", 151, 162], ["distress syndrome", "OBSERVATION", 163, 180], ["disease", "OBSERVATION", 224, 231]]], ["Translating our current findings on COVID-19, these alarming data can be now explained by a life-threatening escalation from T h 2 immune response to type 3 hypersensitivity with the subsequent deposition of antigen-antibody complexes, particularly inside the walls of blood vessels, to such an extent as to generate a systemic vasculitis in the context of an immune complex J o u r n a l P r e -p r o o f disease (Fig. 1) .", [["walls", "ANATOMY", 260, 265], ["blood vessels", "ANATOMY", 269, 282], ["hypersensitivity", "DISEASE", 157, 173], ["vasculitis", "DISEASE", 328, 338], ["COVID-19", "CELL", 36, 44], ["T h 2", "CELL", 125, 130], ["antigen-antibody complexes", "GENE_OR_GENE_PRODUCT", 208, 234], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 269, 282], ["antigen-antibody complexes", "PROTEIN", 208, 234], ["COVID", "TEST", 36, 41], ["type 3 hypersensitivity", "PROBLEM", 150, 173], ["the subsequent deposition of antigen-antibody complexes", "PROBLEM", 179, 234], ["a systemic vasculitis", "PROBLEM", 317, 338], ["disease", "PROBLEM", 406, 413], ["walls", "ANATOMY_MODIFIER", 260, 265], ["blood vessels", "ANATOMY", 269, 282], ["systemic", "OBSERVATION_MODIFIER", 319, 327], ["vasculitis", "OBSERVATION", 328, 338], ["disease", "OBSERVATION", 406, 413]]], ["Preexisting endothelial dysfunctions due to atherosclerosis could worsen the deposition process in elderly and middle-aged patients [11] ; since the smooth muscle cells in tunica media of blood vessels are able to produce interleukin-6 (IL-6) [12], a key myokine of inflammation and of the cytokine release syndrome, their inflammatory involvement can justify well the described \u00abcytokine storm\u00bb in COVID-19 critical patients, a dramatic phenomenon remained not fully elucidated up to date.", [["endothelial", "ANATOMY", 12, 23], ["smooth muscle cells", "ANATOMY", 149, 168], ["tunica media", "ANATOMY", 172, 184], ["blood vessels", "ANATOMY", 188, 201], ["endothelial dysfunctions", "DISEASE", 12, 36], ["atherosclerosis", "DISEASE", 44, 59], ["inflammation", "DISEASE", 266, 278], ["endothelial", "CELL", 12, 23], ["patients", "ORGANISM", 123, 131], ["smooth muscle cells", "CELL", 149, 168], ["tunica", "TISSUE", 172, 178], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 188, 201], ["interleukin-6", "GENE_OR_GENE_PRODUCT", 222, 235], ["IL-6) [12", "GENE_OR_GENE_PRODUCT", 237, 246], ["patients", "ORGANISM", 417, 425], ["smooth muscle cells", "CELL_TYPE", 149, 168], ["interleukin-6", "PROTEIN", 222, 235], ["cytokine", "PROTEIN", 290, 298], ["patients", "SPECIES", 123, 131], ["patients", "SPECIES", 417, 425], ["Preexisting endothelial dysfunctions", "PROBLEM", 0, 36], ["atherosclerosis", "PROBLEM", 44, 59], ["the deposition process", "PROBLEM", 73, 95], ["the smooth muscle cells", "PROBLEM", 145, 168], ["interleukin-6 (IL", "TEST", 222, 239], ["inflammation", "PROBLEM", 266, 278], ["the cytokine release syndrome", "PROBLEM", 286, 315], ["their inflammatory involvement", "PROBLEM", 317, 347], ["a dramatic phenomenon", "PROBLEM", 427, 448], ["endothelial dysfunctions", "OBSERVATION", 12, 36], ["atherosclerosis", "OBSERVATION", 44, 59], ["deposition", "OBSERVATION_MODIFIER", 77, 87], ["middle", "OBSERVATION_MODIFIER", 111, 117], ["smooth muscle", "ANATOMY", 149, 162], ["tunica", "ANATOMY_MODIFIER", 172, 178], ["blood vessels", "ANATOMY", 188, 201], ["inflammation", "OBSERVATION", 266, 278], ["inflammatory", "OBSERVATION_MODIFIER", 323, 335]]]], "PMC7473184": [], "PMC6945725": [["BackgroundHealthcare-associated infection (HAI) is a serious and persistent problem throughout the world.", [["infection", "DISEASE", 32, 41], ["HAI", "DISEASE", 43, 46], ["associated infection", "PROBLEM", 21, 41], ["a serious and persistent problem", "PROBLEM", 51, 83], ["infection", "OBSERVATION", 32, 41], ["persistent", "OBSERVATION_MODIFIER", 65, 75], ["problem", "OBSERVATION", 76, 83]]], ["HAIs are burdensome to patients, complicate treatment, prolong hospital length-of-stay, induce resistance of microorganisms to antimicrobials, raise healthcare costs, and can be life-threatening [1\u20135].", [["HAIs", "DISEASE", 0, 4], ["patients", "ORGANISM", 23, 31], ["patients", "SPECIES", 23, 31], ["treatment", "TREATMENT", 44, 53], ["microorganisms", "PROBLEM", 109, 123], ["antimicrobials", "TREATMENT", 127, 141]]], ["In 2011, the estimated prevalence of HAIs in European acute care hospitals was 5.7%, affecting approximately 3.2 million patients [6].", [["HAIs", "DISEASE", 37, 41], ["patients", "ORGANISM", 121, 129], ["patients", "SPECIES", 121, 129]]], ["The most commonly reported infection types were respiratory tract infections (23.5%), surgical site infections (19.6%), urinary tract infections (19%), bloodstream infections (10.7%), and gastro-intestinal infections (7.7%), of which 48% were Clostridioides difficile infection (CDI) [6].", [["respiratory tract", "ANATOMY", 48, 65], ["site", "ANATOMY", 95, 99], ["urinary tract", "ANATOMY", 120, 133], ["bloodstream", "ANATOMY", 152, 163], ["gastro-intestinal", "ANATOMY", 188, 205], ["infection", "DISEASE", 27, 36], ["respiratory tract infections", "DISEASE", 48, 76], ["surgical site infections", "DISEASE", 86, 110], ["urinary tract infections", "DISEASE", 120, 144], ["bloodstream infections", "DISEASE", 152, 174], ["gastro-intestinal infections", "DISEASE", 188, 216], ["Clostridioides difficile infection", "DISEASE", 243, 277], ["CDI", "DISEASE", 279, 282], ["tract", "ORGANISM_SUBDIVISION", 60, 65], ["urinary tract", "ORGANISM_SUBDIVISION", 120, 133], ["gastro-intestinal", "ORGAN", 188, 205], ["Clostridioides difficile", "ORGANISM", 243, 267], ["Clostridioides difficile", "SPECIES", 243, 267], ["Clostridioides difficile", "SPECIES", 243, 267], ["infection types", "PROBLEM", 27, 42], ["respiratory tract infections", "PROBLEM", 48, 76], ["surgical site infections", "PROBLEM", 86, 110], ["urinary tract infections", "PROBLEM", 120, 144], ["bloodstream infections", "PROBLEM", 152, 174], ["gastro-intestinal infections", "PROBLEM", 188, 216], ["Clostridioides difficile infection", "PROBLEM", 243, 277], ["most commonly", "OBSERVATION_MODIFIER", 4, 17], ["infection", "OBSERVATION", 27, 36], ["respiratory tract", "ANATOMY", 48, 65], ["infections", "OBSERVATION", 100, 110], ["urinary tract", "ANATOMY", 120, 133], ["bloodstream", "OBSERVATION_MODIFIER", 152, 163], ["infections", "OBSERVATION", 164, 174], ["gastro-intestinal", "ANATOMY", 188, 205], ["infections", "OBSERVATION", 206, 216], ["difficile", "OBSERVATION_MODIFIER", 258, 267], ["infection", "OBSERVATION", 268, 277]]], ["Hospital surveillance in the Netherlands showed a decreasing prevalence of HAIs from 7.2% in 2008 [7] to 5.0% in 2017 [8].", [["HAIs", "DISEASE", 75, 79], ["HAIs", "PROBLEM", 75, 79], ["decreasing", "OBSERVATION_MODIFIER", 50, 60], ["HAIs", "OBSERVATION_MODIFIER", 75, 79]]], ["Despite this decrease, point prevalence of HAIs varies considerably between Dutch hospitals, ranging from 1.5 to 6.5% [8].", [["HAIs", "DISEASE", 43, 47], ["HAIs", "PROBLEM", 43, 47], ["decrease", "OBSERVATION_MODIFIER", 13, 21], ["HAIs", "OBSERVATION", 43, 47]]], ["The distribution of hospitals, the severity of patient case mix or infection types did not seem to explain the differences between the hospitals [8].BackgroundMajor types of HAIs are device-associated, including catheter-associated urinary tract infection (CAUTI), central line-associated bloodstream infection (CLABSI), and ventilator-associated pneumonia (VAP) [9\u201311].", [["urinary", "ANATOMY", 232, 239], ["bloodstream", "ANATOMY", 289, 300], ["infection", "DISEASE", 67, 76], ["HAIs", "DISEASE", 174, 178], ["urinary tract infection", "DISEASE", 232, 255], ["CAUTI", "DISEASE", 257, 262], ["bloodstream infection", "DISEASE", 289, 310], ["CLABSI", "DISEASE", 312, 318], ["ventilator-associated pneumonia", "DISEASE", 325, 356], ["VAP", "DISEASE", 358, 361], ["patient", "ORGANISM", 47, 54], ["urinary tract", "ORGANISM_SUBDIVISION", 232, 245], ["patient", "SPECIES", 47, 54], ["infection", "PROBLEM", 67, 76], ["catheter", "TREATMENT", 212, 220], ["urinary tract infection", "PROBLEM", 232, 255], ["CAUTI)", "PROBLEM", 257, 263], ["central line-associated bloodstream infection", "PROBLEM", 265, 310], ["ventilator-associated pneumonia (VAP)", "PROBLEM", 325, 362], ["distribution", "OBSERVATION_MODIFIER", 4, 16], ["HAIs", "OBSERVATION", 174, 178], ["catheter", "OBSERVATION", 212, 220], ["urinary tract", "ANATOMY", 232, 245], ["infection", "OBSERVATION", 246, 255], ["CAUTI", "OBSERVATION", 257, 262], ["central line", "OBSERVATION", 265, 277], ["bloodstream", "OBSERVATION_MODIFIER", 289, 300], ["infection", "OBSERVATION", 301, 310], ["pneumonia", "OBSERVATION", 347, 356]]], ["The Dutch surveillance data of 2017 pointed out that 17% of the observed HAIs were symptomatic urinary tract infections - of which 62% were catheter-associated.", [["urinary tract", "ANATOMY", 95, 108], ["HAIs", "DISEASE", 73, 77], ["urinary tract infections", "DISEASE", 95, 119], ["urinary tract", "ORGANISM_SUBDIVISION", 95, 108], ["The Dutch surveillance data", "TEST", 0, 27], ["the observed HAIs", "PROBLEM", 60, 77], ["symptomatic urinary tract infections", "PROBLEM", 83, 119], ["catheter", "TREATMENT", 140, 148], ["symptomatic", "OBSERVATION_MODIFIER", 83, 94], ["urinary tract", "ANATOMY", 95, 108], ["catheter", "OBSERVATION", 140, 148]]], ["Primary bloodstream infections accounted for 0.8% of the observed HAIs of which 33% were central line-associated, and pneumonia accounted for 20% of the observed HAIs - of which 21% were ventilator-associated [8].BackgroundIt is estimated that 65% of CAUTIs, 55% of CLABSIs, and 55% of VAPs could be prevented by using certain evidence-based infection prevention strategies [12, 13].", [["bloodstream", "ANATOMY", 8, 19], ["Primary bloodstream infections", "DISEASE", 0, 30], ["HAIs", "DISEASE", 66, 70], ["pneumonia", "DISEASE", 118, 127], ["HAIs", "DISEASE", 162, 166], ["CAUTIs", "DISEASE", 251, 257], ["CLABSIs", "DISEASE", 266, 273], ["VAPs", "DISEASE", 286, 290], ["infection", "DISEASE", 342, 351], ["CAUTIs", "CANCER", 251, 257], ["Primary bloodstream infections", "PROBLEM", 0, 30], ["central line", "TREATMENT", 89, 101], ["pneumonia", "PROBLEM", 118, 127], ["ventilator", "TEST", 187, 197], ["CAUTIs", "TEST", 251, 257], ["CLABSIs", "TEST", 266, 273], ["VAPs", "PROBLEM", 286, 290], ["based infection prevention strategies", "PROBLEM", 336, 373], ["bloodstream", "OBSERVATION_MODIFIER", 8, 19], ["infections", "OBSERVATION", 20, 30], ["central line", "OBSERVATION", 89, 101], ["pneumonia", "OBSERVATION", 118, 127], ["infection", "OBSERVATION", 342, 351]]], ["Most strategies focus on a core set of recommended prevention practices, based on guidelines from numerous professional organizations and government agencies [14\u201317].", [["prevention practices", "TREATMENT", 51, 71]]], ["The extent to which these practices are adopted by Dutch hospitals is unknown.", [["extent", "OBSERVATION_MODIFIER", 4, 10]]], ["We thus conducted a nationwide cross-sectional survey to evaluate the use of currently recommended practices for preventing CAUTI, CLABSI, VAP, and CDI in the Netherlands.Study design and survey instrument ::: MethodsData for this cross-sectional study were collected using a survey instrument based on the \u2018Translating Healthcare-Associated Infection Prevention Research into Practice\u2019 (TRIP) questionnaire developed by Krein, Saint, and colleagues and previously distributed in the USA, Japan, and Thailand [18\u201324].", [["CAUTI", "DISEASE", 124, 129], ["CLABSI", "DISEASE", 131, 137], ["VAP", "DISEASE", 139, 142], ["CDI", "DISEASE", 148, 151], ["Infection", "DISEASE", 342, 351], ["CAUTI", "PROBLEM", 124, 129], ["CLABSI", "PROBLEM", 131, 137], ["VAP", "PROBLEM", 139, 142], ["CDI", "PROBLEM", 148, 151], ["MethodsData", "TREATMENT", 210, 221], ["this cross-sectional study", "TEST", 226, 252], ["a survey instrument", "TEST", 274, 293], ["CAUTI", "OBSERVATION", 124, 129], ["CLABSI", "OBSERVATION", 131, 137], ["VAP", "OBSERVATION", 139, 142], ["CDI", "OBSERVATION", 148, 151], ["Infection", "OBSERVATION", 342, 351]]], ["The instrument contained questions about general hospital characteristics (e.g. number of beds), general infection prevention policies (e.g. presence of guidelines and surveillance systems), staffing of the infection control program, and use of specific practices related to the prevention and monitoring of CAUTI, CLABSI, VAP, and CDI.", [["infection", "DISEASE", 105, 114], ["infection", "DISEASE", 207, 216], ["CAUTI", "DISEASE", 308, 313], ["CLABSI", "DISEASE", 315, 321], ["VAP", "DISEASE", 323, 326], ["CDI", "DISEASE", 332, 335], ["general infection prevention policies", "TREATMENT", 97, 134], ["surveillance systems", "TEST", 168, 188], ["the infection control program", "TREATMENT", 203, 232], ["specific practices", "TREATMENT", 245, 263], ["CAUTI", "PROBLEM", 308, 313], ["CLABSI", "PROBLEM", 315, 321], ["VAP", "PROBLEM", 323, 326], ["CDI", "PROBLEM", 332, 335], ["infection", "OBSERVATION", 105, 114], ["CAUTI", "OBSERVATION", 308, 313]]], ["The survey instrument was forward-backward translated into Dutch by the research team with support of a bilingual translator and digitalized afterwards with LimeSurvey.", [["The survey instrument", "TEST", 0, 21], ["LimeSurvey", "TREATMENT", 157, 167]]], ["As in the original survey instrument, respondents were asked to indicate the frequency of use for certain infection prevention practices on a scale from 1 (never use) to 5 (always use).", [["infection", "DISEASE", 106, 115], ["certain infection prevention practices", "TREATMENT", 98, 136], ["infection", "OBSERVATION", 106, 115]]], ["The survey instrument was pilot tested by five infection preventionists from five different hospitals, recruited via the Dutch Association for Hygiene & Infection Prevention in Healthcare, to ensure the validity, reliability, and acceptability of the survey.", [["infection", "DISEASE", 47, 56], ["Hygiene", "DISEASE", 143, 150], ["Infection", "DISEASE", 153, 162], ["The survey instrument", "TEST", 0, 21], ["the survey", "TEST", 247, 257]]], ["No changes were made after pilot testing (see Additional file 1).Data collection procedure ::: MethodsBetween July 18, 2017 and October 31, 2017, we approached 72 infection prevention teams, representing all acute care hospitals in the Netherlands, to participate in the survey.", [["infection", "DISEASE", 163, 172], ["pilot testing", "TEST", 27, 40], ["acute", "OBSERVATION_MODIFIER", 208, 213]]], ["We first contacted infection prevention teams by telephone to explore their willingness to participate.", [["infection", "DISEASE", 19, 28]]], ["An email invitation with log-in details was then sent to the infection prevention representative of the teams that agreed to participate.", [["infection", "DISEASE", 61, 70], ["the infection prevention", "TREATMENT", 57, 81], ["infection", "OBSERVATION", 61, 70]]], ["The survey responses were anonymized.Statistical analysis ::: MethodsDescriptive statistics, n (%) for categorical and mean \u00b1 standard deviation (SD) for continuous variables were examined for all hospital characteristics as well as specific infection prevention practices.", [["infection", "DISEASE", 242, 251], ["categorical", "TEST", 103, 114], ["continuous variables", "TEST", 154, 174], ["specific infection prevention practices", "TREATMENT", 233, 272], ["infection", "OBSERVATION", 242, 251]]], ["All statistical analyses were conducted in SAS V9.4 (Cary, NC).ResultsInfection prevention teams of 47 hospitals completed the questionnaire, yielding a response rate of 65% (47/72).", [["All statistical analyses", "TEST", 0, 24], ["a response rate", "TEST", 151, 166]]], ["Of these, three hospitals explicitly indicated that they had not implemented specific infection prevention measures with regard to CAUTI, CLABSI, VAP, and CDI.", [["infection", "DISEASE", 86, 95], ["VAP", "DISEASE", 146, 149], ["CDI", "DISEASE", 155, 158], ["specific infection prevention measures", "TREATMENT", 77, 115], ["CAUTI", "PROBLEM", 131, 136], ["CLABSI", "PROBLEM", 138, 144], ["VAP", "PROBLEM", 146, 149], ["CDI", "PROBLEM", 155, 158], ["infection", "OBSERVATION", 86, 95]]], ["There was an average of 4.8 infection prevention personnel, with an average of 3.9 Full-Time Equivalent (FTE) employees, at the hospitals.", [["infection", "DISEASE", 28, 37], ["average", "OBSERVATION_MODIFIER", 13, 20], ["infection", "OBSERVATION", 28, 37]]], ["All respondents indicated that their hospital had clear infection prevention guidelines present that support the clinical teams, and 91.5% indicated that all the resources and materials for appropriate application of the guidelines were available.", [["infection", "DISEASE", 56, 65], ["infection", "OBSERVATION", 56, 65]]], ["An antimicrobial stewardship program was present in 43 (91.5%) hospitals.", [["An antimicrobial stewardship program", "TREATMENT", 0, 36]]]], "PMC7152911": [["IntroductionPathogens are infectious agents that cause disease.", [["IntroductionPathogens", "TREATMENT", 0, 21], ["infectious agents", "TREATMENT", 26, 43], ["disease", "PROBLEM", 55, 62], ["infectious", "OBSERVATION", 26, 36]]], ["They include microorganisms, such as fungi, protozoans, and bacteria, and molecular-scale infectious agents, including viruses and prions.", [["microorganisms", "PROBLEM", 13, 27], ["fungi", "PROBLEM", 37, 42], ["protozoans", "PROBLEM", 44, 54], ["bacteria", "PROBLEM", 60, 68], ["molecular-scale infectious agents", "TREATMENT", 74, 107], ["viruses", "PROBLEM", 119, 126], ["microorganisms", "OBSERVATION", 13, 27]]], ["Foodborne, waterborne, and airborne pathogens enter the body through various modes of infection and are responsible for over 15 million deaths annually worldwide (Dye, 2014).", [["body", "ANATOMY", 56, 60], ["infection", "DISEASE", 86, 95], ["deaths", "DISEASE", 136, 142], ["body", "ORGANISM_SUBDIVISION", 56, 60], ["airborne pathogens", "PROBLEM", 27, 45], ["infection", "PROBLEM", 86, 95], ["infection", "OBSERVATION", 86, 95]]], ["Some of the most common pathogens include viruses, such as norovirus and influenza virus, and bacteria, such as E. coli and S. aureus.", [["norovirus and influenza virus", "DISEASE", 59, 88], ["influenza virus", "ORGANISM", 73, 88], ["E. coli", "ORGANISM", 112, 119], ["S. aureus", "ORGANISM", 124, 133], ["influenza virus", "SPECIES", 73, 88], ["E. coli", "SPECIES", 112, 119], ["S. aureus", "SPECIES", 124, 133], ["influenza virus", "SPECIES", 73, 88], ["E. coli", "SPECIES", 112, 119], ["S. aureus", "SPECIES", 124, 133], ["the most common pathogens", "PROBLEM", 8, 33], ["viruses", "PROBLEM", 42, 49], ["norovirus", "PROBLEM", 59, 68], ["influenza virus", "PROBLEM", 73, 88], ["bacteria", "PROBLEM", 94, 102], ["E. coli", "PROBLEM", 112, 119], ["S. aureus", "PROBLEM", 124, 133], ["most common", "OBSERVATION_MODIFIER", 12, 23], ["viruses", "OBSERVATION", 42, 49], ["E. coli", "OBSERVATION", 112, 119], ["aureus", "OBSERVATION", 127, 133]]], ["Pathogens vary in many regards, such as virulence, contagiousness, mode of transmission, and infectious dose.", [["contagiousness", "DISEASE", 51, 65], ["Pathogens", "PROBLEM", 0, 9]]], ["For example, the world is currently facing a global pandemic associated with the COVID-19 virus, for which virulence and infectious dose data are still emerging.", [["COVID-19 virus", "ORGANISM", 81, 95], ["COVID-19 virus", "SPECIES", 81, 95], ["a global pandemic", "PROBLEM", 43, 60], ["the COVID-19 virus", "PROBLEM", 77, 95], ["infectious dose data", "TEST", 121, 141], ["global", "OBSERVATION_MODIFIER", 45, 51], ["pandemic", "OBSERVATION", 52, 60]]], ["Techniques for sensitive and rapid detection of pathogens in complex matrices, such as body fluids and aerosols, and on surfaces are critical to the treatment of infectious diseases and controlling the spread of disease.IntroductionThe techniques used to identify and quantify pathogens can be broadly distinguished as immunoassays or DNA-based assays.", [["body fluids", "ANATOMY", 87, 98], ["infectious diseases", "DISEASE", 162, 181], ["body", "ORGANISM_SUBDIVISION", 87, 91], ["DNA", "CELLULAR_COMPONENT", 335, 338], ["pathogens in complex matrices", "PROBLEM", 48, 77], ["body fluids", "TREATMENT", 87, 98], ["aerosols", "TREATMENT", 103, 111], ["infectious diseases", "PROBLEM", 162, 181], ["disease", "PROBLEM", 212, 219], ["The techniques", "TREATMENT", 232, 246], ["pathogens", "PROBLEM", 277, 286], ["immunoassays", "TEST", 319, 331], ["DNA-based assays", "TEST", 335, 351], ["infectious", "OBSERVATION", 162, 172], ["spread", "OBSERVATION_MODIFIER", 202, 208]]], ["The use of immunoassays versus DNA-based assays depends on various factors, including the stage of an infection and the availability of antibodies and DNA sequence data, such as viral DNA, toxin-producing genes, as well as species- and strain-selective genes.", [["infection", "DISEASE", 102, 111], ["DNA", "CELLULAR_COMPONENT", 31, 34], ["DNA", "CELLULAR_COMPONENT", 151, 154], ["DNA", "CELLULAR_COMPONENT", 184, 187], ["toxin", "GENE_OR_GENE_PRODUCT", 189, 194], ["antibodies", "PROTEIN", 136, 146], ["viral DNA", "DNA", 178, 187], ["toxin-producing genes", "DNA", 189, 210], ["species- and strain-selective genes", "DNA", 223, 258], ["immunoassays", "TEST", 11, 23], ["DNA-based assays", "TEST", 31, 47], ["an infection", "PROBLEM", 99, 111], ["antibodies", "TEST", 136, 146], ["DNA sequence data", "TEST", 151, 168], ["viral DNA", "TEST", 178, 187], ["toxin", "TEST", 189, 194], ["species", "TEST", 223, 230], ["infection", "OBSERVATION", 102, 111]]], ["Immunoassays are ubiquitous across medical diagnostics and food safety applications.", [["Immunoassays", "TEST", 0, 12]]], ["Pathogens can be identified through the presence of generated antibodies in an organism, which may be present both during and after an infection (i.e., after the pathogen is no longer present).", [["infection", "DISEASE", 135, 144], ["antibodies", "PROTEIN", 62, 72], ["Pathogens", "PROBLEM", 0, 9], ["generated antibodies", "PROBLEM", 52, 72], ["an organism", "PROBLEM", 76, 87], ["an infection", "PROBLEM", 132, 144], ["the pathogen", "PROBLEM", 158, 170], ["antibodies", "OBSERVATION", 62, 72], ["may be", "UNCERTAINTY", 95, 101], ["infection", "OBSERVATION", 135, 144], ["no longer", "UNCERTAINTY", 174, 183]]], ["In such assays, both the biorecognition element and the target are antibodies.", [["biorecognition element", "DNA", 25, 47], ["antibodies", "PROTEIN", 67, 77]]], ["If antibodies are available for the pathogen (e.g., anti-E. coli O157:H7), one can also directly detect the pathogen using immunoassays.", [["anti-E. coli", "ORGANISM", 52, 64], ["O157:H7", "ORGANISM", 65, 72], ["antibodies", "PROTEIN", 3, 13], ["anti-E. coli O157", "SPECIES", 52, 69], ["anti-E. coli O157:H7", "SPECIES", 52, 72], ["antibodies", "PROBLEM", 3, 13], ["the pathogen", "PROBLEM", 32, 44], ["immunoassays", "TEST", 123, 135]]], ["The ability to indirectly and directly detect pathogens via generated antibodies and pathogen epitopes, respectively, makes immunoassays flexible techniques for pathogen detection.", [["antibodies", "PROTEIN", 70, 80], ["pathogen epitopes", "PROTEIN", 85, 102], ["pathogens via generated antibodies and pathogen epitopes", "PROBLEM", 46, 102], ["immunoassays flexible techniques", "TEST", 124, 156], ["pathogen detection", "TEST", 161, 179]]], ["In cases of limited antibody availability, need for highly sensitive results, or infections that do not generate a significant level of antibody production in the organism although the pathogen is present, DNA-based assays are commonly employed.", [["infections", "DISEASE", 81, 91], ["antibody", "GENE_OR_GENE_PRODUCT", 136, 144], ["DNA", "CELLULAR_COMPONENT", 206, 209], ["limited antibody availability", "PROBLEM", 12, 41], ["infections", "PROBLEM", 81, 91], ["antibody production", "PROBLEM", 136, 155], ["the organism", "PROBLEM", 159, 171], ["the pathogen", "PROBLEM", 181, 193], ["antibody production", "OBSERVATION", 136, 155]]], ["DNA-based assays require the pathogen to be present in the sample or to have been recently present.", [["sample", "ANATOMY", 59, 65], ["DNA", "CELLULAR_COMPONENT", 0, 3], ["DNA", "TEST", 0, 3], ["the pathogen", "PROBLEM", 25, 37]]], ["In addition to detection of pathogens using antibodies or toxin-producing genes, pathogens can also be detected based on their expression of toxins.", [["antibodies", "PROTEIN", 44, 54], ["toxin", "PROTEIN", 58, 63], ["pathogens", "PROBLEM", 28, 37], ["antibodies", "TEST", 44, 54], ["toxin", "PROBLEM", 58, 63], ["pathogens", "PROBLEM", 81, 90], ["toxins", "PROBLEM", 141, 147]]], ["Thus, targets associated with pathogen detection include toxins, nucleic acids, viruses, cells, and oocysts.", [["cells", "ANATOMY", 89, 94], ["oocysts", "ANATOMY", 100, 107], ["nucleic acids", "CHEMICAL", 65, 78], ["nucleic acids", "SIMPLE_CHEMICAL", 65, 78], ["cells", "CELL", 89, 94], ["pathogen detection", "TEST", 30, 48], ["toxins", "PROBLEM", 57, 63], ["nucleic acids", "TEST", 65, 78], ["viruses", "PROBLEM", 80, 87], ["oocysts", "PROBLEM", 100, 107], ["oocysts", "OBSERVATION", 100, 107]]], ["As a result, biorecognition elements widely vary, including antibodies, aptamers, and imprinted polymers.", [["biorecognition elements", "DNA", 13, 36], ["antibodies", "PROTEIN", 60, 70], ["antibodies", "TEST", 60, 70], ["aptamers", "TREATMENT", 72, 80]]], ["Several comprehensive reviews have been written on pathogen detection using high-throughput, well plate-based bioanalytical techniques (Alahi and Mukhopadhyay, 2017; Lazcka et al. 2007; Zourob et al. 2008), such as enzyme-linked immunosorbent assay (ELISA) (Law et al. 2015) and polymerase chain reaction (PCR) (Klein, 2002; Malorny et al. 2003), which remain the gold standards for pathogen detection.", [["pathogen detection", "TEST", 51, 69], ["enzyme", "TEST", 215, 221], ["immunosorbent assay", "TEST", 229, 248], ["polymerase chain reaction", "PROBLEM", 279, 304], ["PCR", "TEST", 306, 309], ["pathogen detection", "TEST", 383, 401]]], ["Few reviews, however, have focused on emerging label-free biosensors for pathogen detection, which provide useful characteristics for applications in process monitoring (e.g., of biomanufacturing processes), environmental monitoring, and precision agriculture.IntroductionBioanalytical techniques utilize a selective biorecognition element, often called a molecular probe, in combination with an analytical system, such as a plate reader or PCR analyzer, to quantify one or more components of a sample.", [["biorecognition element", "DNA", 317, 339], ["pathogen detection", "TEST", 73, 91], ["process monitoring", "TEST", 150, 168], ["environmental monitoring", "TEST", 208, 232], ["a selective biorecognition element", "TREATMENT", 305, 339], ["a molecular probe", "TREATMENT", 354, 371], ["PCR analyzer", "TEST", 441, 453], ["a sample", "TEST", 493, 501]]], ["While capable of being highly sensitive and robust, they are destructive testing methods and require the addition of reagents to the sample and extensive sample preparation steps, which increase the time-to-results (TTR).", [["sample", "ANATOMY", 154, 160], ["destructive testing methods", "PROBLEM", 61, 88], ["extensive sample preparation steps", "TREATMENT", 144, 178]]], ["Bioanalytical techniques, such as PCR, may also encounter inhibition effects caused by background species in the sample (Justino et al. 2017; Scognamiglio et al. 2016; Sin et al. 2014), which introduce measurement bias and increase measurement uncertainty (Clark et al. 2016; Silverman et al. 2019).", [["Bioanalytical techniques", "TREATMENT", 0, 24], ["PCR", "TEST", 34, 37], ["background species", "PROBLEM", 87, 105], ["increase", "OBSERVATION_MODIFIER", 223, 231]]], ["Considering such limitations of traditional plate-based bioanalytical techniques and the need for real-time continuous monitoring capabilities among various applications, there is a need to examine alternative bioanalytical techniques.IntroductionOver the past twenty-five years, biosensors have emerged to complement PCR and ELISA for pathogen detection.", [["traditional plate", "TREATMENT", 32, 49], ["bioanalytical techniques", "TREATMENT", 56, 80], ["alternative bioanalytical techniques", "TREATMENT", 198, 234], ["complement PCR", "TEST", 307, 321], ["ELISA", "TEST", 326, 331], ["pathogen detection", "TEST", 336, 354]]], ["Biosensors are based on the direct integration of a selective biorecognition element and a sensitive transducer element and provide complementary platforms to PCR and ELISA for pathogen identification and quantification.", [["biorecognition element", "DNA", 62, 84], ["sensitive transducer element", "DNA", 91, 119], ["a selective biorecognition element", "TREATMENT", 50, 84], ["a sensitive transducer element", "TREATMENT", 89, 119], ["PCR", "TEST", 159, 162], ["ELISA", "TEST", 167, 172], ["pathogen identification", "TEST", 177, 200], ["quantification", "TEST", 205, 219]]], ["According to the International Union of Pure and Applied Chemistry (IUPAC), a biosensor must contain a biorecognition element in direct spatial contact with a transduction element (Th\u00e9venot et al. 2001).", [["biorecognition element", "DNA", 103, 125], ["a biosensor", "TEST", 76, 87], ["a transduction element", "TREATMENT", 157, 179], ["biorecognition element", "OBSERVATION", 103, 125]]], ["In addition, a biosensor should provide quantitative or semi-quantitative analytical information and measurement without the requirement of additional processing steps or reagents.", [["additional processing steps", "TREATMENT", 140, 167]]], ["While a biosensor should also be a self-contained, integrated device, the measurement approach can vary from droplet formats to continuous flow formats that require associated fluid handling systems.", [["fluid", "ANATOMY", 176, 181], ["integrated device", "TREATMENT", 51, 68], ["the measurement approach", "TEST", 70, 94], ["continuous flow formats", "TEST", 128, 151], ["associated fluid handling systems", "PROBLEM", 165, 198], ["fluid handling", "OBSERVATION", 176, 190]]], ["Biosensors have achieved sensitive and selective real-time detection of pathogens in various environments without the need for sample preparation.", [["sample", "ANATOMY", 127, 133], ["Biosensors", "TEST", 0, 10], ["pathogens", "PROBLEM", 72, 81], ["sample preparation", "TREATMENT", 127, 145]]], ["For example, biosensors have enabled the detection of an abundance of pathogens in various matrices and environments, including foods, body fluids, and object surfaces.", [["body fluids", "ANATOMY", 135, 146], ["body", "ORGANISM_SUBDIVISION", 135, 139], ["the detection", "TEST", 37, 50], ["body fluids", "TREATMENT", 135, 146], ["pathogens", "OBSERVATION", 70, 79]]], ["In addition to sample preparation-free protocols, biosensors are compatible with label-free protocols (Daniels and Pourmand, 2007; Rapp et al. 2010; Sang et al. 2016; Vestergaard et al. 2007).", [["sample preparation", "TEST", 15, 33], ["biosensors", "TEST", 50, 60]]], ["Labels, often referred to as reporters, are molecular species, such as organic dyes or quantum dots (Resch-Genger et al. 2008), that are attached to the target, either directly or through a biorecognition element, using a series of sample preparation steps or secondary binding steps to facilitate detection through the properties of the label.", [["organic dyes", "SIMPLE_CHEMICAL", 71, 83], ["biorecognition element", "DNA", 190, 212], ["molecular species", "PROBLEM", 44, 61], ["organic dyes", "TREATMENT", 71, 83], ["a series of sample preparation steps", "TREATMENT", 220, 256]]], ["Thus, label-free biosensors avoid the use of a reporter species to detect the target species (Cooper, 2009; Syahir et al. 2015).", [["a reporter species", "PROBLEM", 45, 63]]], ["Label-free assays often have fewer sample preparation steps due to the elimination of procedures associated with target labeling and lower cost than label-based assays, which are important considerations for applications in which preparation facilities or trained personnel are either limited or unavailable (Cooper, 2009; Syahir et al. 2015).IntroductionWhile various types of transducers have been investigated for pathogen biosensing (Lazcka et al. 2007; Singh et al. 2014; Yoo and Lee, 2016), including mechanical and optical transducers, such as cantilever biosensors or surface plasmon resonance (SPR)-based biosensors, electrochemical biosensors have been extensively applied to pathogen detection (Felix and Angnes, 2018; Pereira da Silva Neves et al. 2018; Saucedo et al. 2019).", [["Label-free assays", "TEST", 0, 17], ["procedures", "TREATMENT", 86, 96], ["transducers", "TREATMENT", 378, 389], ["mechanical and optical transducers", "TREATMENT", 507, 541], ["cantilever biosensors", "TREATMENT", 551, 572], ["surface plasmon resonance (SPR)", "TREATMENT", 576, 607], ["based biosensors", "TREATMENT", 608, 624], ["electrochemical biosensors", "TREATMENT", 626, 652]]], ["Electrochemical biosensors for pathogen detection utilize conducting and semiconducting materials as the transducer, which is commonly referred to as an electrode.", [["Electrochemical biosensors", "TEST", 0, 26], ["pathogen detection", "TEST", 31, 49], ["conducting and semiconducting materials", "TREATMENT", 58, 97]]], ["The chemical energy associated with binding between target pathogens and electrode-immobilized biorecognition elements is converted into electrical energy through an electrochemical method that involves the electrode and a pathogen-containing electrolyte solution.", [["electrode-immobilized biorecognition elements", "DNA", 73, 118], ["The chemical energy", "PROBLEM", 0, 19], ["binding between target pathogens", "PROBLEM", 36, 68], ["electrode-immobilized biorecognition elements", "TREATMENT", 73, 118], ["an electrochemical method", "TREATMENT", 163, 188], ["electrolyte solution", "TREATMENT", 243, 263], ["chemical energy", "OBSERVATION", 4, 19]]], ["To date, electrochemical biosensors have enabled sample preparation-free detection of pathogens in various matrices, in situ detection of pathogens on surfaces, rapid pathogen detection using low-cost platforms, multiplexed detection of pathogens in practical matrices, and detection of pathogens via wireless actuation and data acquisition formats.", [["sample", "ANATOMY", 49, 55], ["electrochemical biosensors", "TEST", 9, 35], ["pathogens in various matrices", "PROBLEM", 86, 115], ["pathogens", "PROBLEM", 138, 147], ["rapid pathogen detection", "TEST", 161, 185], ["pathogens", "PROBLEM", 237, 246], ["pathogens", "PROBLEM", 287, 296], ["wireless actuation and data acquisition formats", "TEST", 301, 348], ["pathogens", "OBSERVATION", 86, 95], ["pathogens", "OBSERVATION", 138, 147]]], ["As a result, electrochemical biosensors for pathogen detection have been widely examined for food and water safety, medical diagnostic, environmental monitoring, and bio-threat applications (Amiri et al. 2018; Duffy and Moore, 2017; Felix and Angnes, 2018; Furst and Francis, 2019; Mishra et al. 2018; Monz\u00f3 et al. 2015; Rastogi and Singh, 2019).IntroductionHere, we critically review electrochemical biosensors for pathogen detection.", [["electrochemical biosensors", "TEST", 13, 39], ["pathogen detection", "TEST", 44, 62], ["environmental monitoring", "TEST", 136, 160], ["pathogen detection", "TEST", 416, 434]]], ["To gain insight into the trajectory of the field, electrochemical biosensors for pathogen detection reported since 2005 are critically reviewed and classified with respect to IUPAC-recommended definitions and classifications (Th\u00e9venot et al. 2001).", [["pathogen detection", "TEST", 81, 99]]], ["Applications of electrochemical biosensors for pathogen detection are critically reviewed with respect to the target pathogen, sample matrix, biosensor design, fabrication method, measurement format, and biosensor performance.", [["electrochemical biosensors", "TEST", 16, 42], ["pathogen detection", "TEST", 47, 65], ["fabrication method", "TEST", 160, 178], ["measurement format", "TEST", 180, 198]]], ["We also discuss future directions of electrochemical biosensors for pathogen detection, which includes a discussion of present technological and methodological challenges and emerging application areas.Metal electrodes ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionMetal electrodes, such as Au and platinum (Pt), have been commonly used for pathogen detection.", [["Au", "CHEMICAL", 331, 333], ["platinum", "CHEMICAL", 338, 346], ["Pt", "CHEMICAL", 348, 350], ["Au", "CHEMICAL", 331, 333], ["platinum", "CHEMICAL", 338, 346], ["Pt", "CHEMICAL", 348, 350], ["Au", "SIMPLE_CHEMICAL", 331, 333], ["platinum (Pt", "SIMPLE_CHEMICAL", 338, 350], ["Transduction elements", "DNA", 223, 244], ["electrochemical biosensors", "TEST", 37, 63], ["pathogen detection", "TEST", 68, 86], ["methodological challenges", "TREATMENT", 145, 170], ["emerging application areas", "TREATMENT", 175, 201], ["Electrochemical biosensor designs", "TREATMENT", 249, 282], ["pathogen detectionMetal electrodes", "TREATMENT", 287, 321], ["Au and platinum (Pt)", "TREATMENT", 331, 351], ["pathogen detection", "TEST", 381, 399]]], ["Thick metal electrodes are commonly fabricated from bulk structures via cutting processes.", [["Thick metal electrodes", "TREATMENT", 0, 22], ["metal electrodes", "OBSERVATION", 6, 22], ["bulk structures", "OBSERVATION", 52, 67], ["cutting processes", "OBSERVATION", 72, 89]]], ["Thin-film metal electrodes are often fabricated by deposition of metals on insulating substrates through traditional microfabrication approaches, including physical vapor deposition (Hierlemann et al. 2003) and screen printing (Taleat et al. 2014).", [["Thin-film metal electrodes", "TREATMENT", 0, 26], ["insulating substrates", "TREATMENT", 75, 96], ["traditional microfabrication approaches", "TREATMENT", 105, 144], ["physical vapor deposition", "TREATMENT", 156, 181], ["metal electrodes", "OBSERVATION", 10, 26], ["deposition", "OBSERVATION_MODIFIER", 51, 61], ["metals", "OBSERVATION", 65, 71], ["vapor deposition", "OBSERVATION", 165, 181]]], ["Resultant conductive components are often embedded in insulating polymer or ceramic substrates, including Teflon, polyetherkeytone (PEK), and glass, to complete fabrication of the transducer element.", [["polyetherkeytone", "CHEMICAL", 114, 130], ["PEK", "CHEMICAL", 132, 135], ["Teflon", "CHEMICAL", 106, 112], ["polyetherkeytone", "CHEMICAL", 114, 130], ["polyetherkeytone", "SIMPLE_CHEMICAL", 114, 130], ["PEK", "SIMPLE_CHEMICAL", 132, 135], ["transducer element", "DNA", 180, 198], ["Resultant conductive components", "PROBLEM", 0, 31], ["insulating polymer or ceramic substrates", "TREATMENT", 54, 94], ["Teflon, polyetherkeytone (PEK)", "TREATMENT", 106, 136], ["the transducer element", "TREATMENT", 176, 198], ["conductive components", "OBSERVATION", 10, 31], ["insulating polymer", "OBSERVATION", 54, 72], ["ceramic substrates", "OBSERVATION", 76, 94]]], ["While not yet applied to pathogen detection applications, three-dimensional (3D) printing processes, including inkjet printing (Bhat et al. 2018; Medina-S\u00e1nchez et al. 2014; Pavinatto et al. 2015), selective laser melting (Ambrosi et al. 2016; Loo et al. 2017), and microextrusion printing (Foo et al. 2018), have also been used for the fabrication of electrochemical sensors and electrodes using a variety of metals.", [["selective laser melting", "TREATMENT", 198, 221], ["the fabrication of electrochemical sensors and electrodes", "TREATMENT", 333, 390], ["a variety of metals", "TREATMENT", 397, 416]]], ["As shown in Table 1, unstructured metal electrodes exhibit a range of detection limits.", [["unstructured metal electrodes", "TREATMENT", 21, 50]]], ["For example, the detection limits of electrochemical biosensors for bacteria that employ unstructured metal electrodes range from 1 to 104 CFU/mL (see Table 1).Ceramic electrodes ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionConducting and semiconducting ceramics, including indium tin oxide (ITO), polysilicon, and titanium dioxide (TiO2) have also been examined for pathogen detection.", [["indium tin oxide", "CHEMICAL", 315, 331], ["ITO", "CHEMICAL", 333, 336], ["polysilicon", "CHEMICAL", 339, 350], ["titanium dioxide", "CHEMICAL", 356, 372], ["TiO2", "CHEMICAL", 374, 378], ["indium tin oxide", "CHEMICAL", 315, 331], ["ITO", "CHEMICAL", 333, 336], ["polysilicon", "CHEMICAL", 339, 350], ["titanium dioxide", "CHEMICAL", 356, 372], ["TiO2", "CHEMICAL", 374, 378], ["indium tin oxide", "SIMPLE_CHEMICAL", 315, 331], ["ITO", "SIMPLE_CHEMICAL", 333, 336], ["polysilicon", "SIMPLE_CHEMICAL", 339, 350], ["titanium dioxide", "SIMPLE_CHEMICAL", 356, 372], ["TiO2", "SIMPLE_CHEMICAL", 374, 378], ["Transduction elements", "DNA", 183, 204], ["electrochemical biosensors", "TEST", 37, 63], ["bacteria", "PROBLEM", 68, 76], ["Electrochemical biosensor designs", "PROBLEM", 209, 242], ["pathogen detection", "TEST", 247, 265], ["semiconducting ceramics", "TREATMENT", 280, 303], ["indium tin oxide (ITO)", "TREATMENT", 315, 337], ["polysilicon", "TREATMENT", 339, 350], ["titanium dioxide (TiO2", "TREATMENT", 356, 378], ["pathogen detection", "TEST", 408, 426]]], ["For example, Das et al. used a silicon electrode for Salmonella typhimurium (S. typhimurium) detection (Das et al. 2009).", [["silicon", "CHEMICAL", 31, 38], ["Salmonella typhimurium", "ORGANISM", 53, 75], ["S. typhimurium", "ORGANISM", 77, 91], ["Salmonella typhimurium", "SPECIES", 53, 75], ["S. typhimurium", "SPECIES", 77, 91], ["Salmonella typhimurium", "SPECIES", 53, 75], ["S. typhimurium", "SPECIES", 77, 91], ["a silicon electrode", "TREATMENT", 29, 48], ["Salmonella typhimurium", "PROBLEM", 53, 75]]], ["Barreiros dos Santos et al. developed an antibody-functionalized ITO electrode for the detection of E. coliwith a dynamic range of 10\u2013106 CFU/mL (Barreiros dos Santos et al. 2015).", [["ITO", "CHEMICAL", 65, 68], ["ITO", "CHEMICAL", 65, 68], ["E. coliwith", "SPECIES", 100, 111], ["an antibody-functionalized ITO electrode", "TREATMENT", 38, 78]]], ["In addition to high conductivity, ITO is transparent, which presents various measurement advantages, including the ability to accurately correlate biosensor response with pathogen surface coverage (Ayd\u0131n and Sezgint\u00fcrk, 2017; Yang and Li, 2005).", [["surface", "ANATOMY", 180, 187], ["ITO", "CHEMICAL", 34, 37], ["ITO", "CHEMICAL", 34, 37], ["high conductivity", "PROBLEM", 15, 32], ["pathogen surface coverage", "TREATMENT", 171, 196], ["high conductivity", "OBSERVATION_MODIFIER", 15, 32], ["transparent", "OBSERVATION_MODIFIER", 41, 52]]], ["Transparent electrodes also enable in situ verification of target binding via microscopic techniques and offer compatibility with optical approaches, such as those based on optical stimulation (Wenzel et al. 2018).", [["Transparent electrodes", "TREATMENT", 0, 22], ["microscopic techniques", "TEST", 78, 100], ["optical approaches", "TREATMENT", 130, 148], ["electrodes", "OBSERVATION_MODIFIER", 12, 22]]], ["Carbon electrodes based on various allotropes of carbon, such as graphite and glass-like carbon, can also be classified as ceramic materials due to their mechanical properties (e.g., brittleness).Polymer electrodes ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionPolymers have also been investigated as electrodes for pathogen detection.", [["carbon", "CHEMICAL", 49, 55], ["Carbon", "CHEMICAL", 0, 6], ["carbon", "CHEMICAL", 49, 55], ["graphite", "CHEMICAL", 65, 73], ["carbon", "CHEMICAL", 89, 95], ["carbon", "SIMPLE_CHEMICAL", 49, 55], ["graphite", "SIMPLE_CHEMICAL", 65, 73], ["Transduction elements", "DNA", 219, 240], ["Carbon electrodes", "TREATMENT", 0, 17], ["various allotropes of carbon", "TREATMENT", 27, 55], ["graphite and glass-like carbon", "TREATMENT", 65, 95], ["ceramic materials", "TREATMENT", 123, 140], ["Electrochemical biosensor designs", "PROBLEM", 245, 278], ["pathogen detectionPolymers", "TREATMENT", 283, 309], ["pathogen detection", "TEST", 356, 374]]], ["Polymers have various advantages, including tunable electrical conductivity, biocompatiblity, and environmentally stability.", [["Polymers", "TREATMENT", 0, 8], ["tunable electrical conductivity", "TREATMENT", 44, 75], ["biocompatiblity", "PROBLEM", 77, 92], ["environmentally stability", "OBSERVATION", 98, 123]]], ["Polymer electrodes are also compatible with a range of biorecognition element immobilization techniques (Arshak et al. 2009; Guimard et al. 2007).", [["Polymer electrodes", "TREATMENT", 0, 18], ["biorecognition element immobilization techniques", "TREATMENT", 55, 103], ["compatible with", "UNCERTAINTY", 28, 43]]], ["Polymers also exhibit mechanical properties that enable electrode-tissue mechanical matching, an important consideration in the design of implantable and wearable biosensors.", [["tissue", "ANATOMY", 66, 72], ["tissue", "TISSUE", 66, 72], ["Polymers", "TREATMENT", 0, 8], ["mechanical properties", "TREATMENT", 22, 43], ["electrode-tissue mechanical matching", "TREATMENT", 56, 92], ["implantable and wearable biosensors", "TREATMENT", 138, 173], ["mechanical properties", "OBSERVATION", 22, 43], ["mechanical matching", "OBSERVATION", 73, 92]]], ["Polymer electrodes can be broadly classified as (1) conjugated polymer or (2) polymer composite.Polymer electrodes ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionPolyaniline and polypyrrole have been the most commonly used conjugated polymers for pathogen detection due to their high conductivity in the doped state (Kaur et al. 2015).", [["Polyaniline", "CHEMICAL", 201, 212], ["polypyrrole", "CHEMICAL", 217, 228], ["Polyaniline", "CHEMICAL", 201, 212], ["polypyrrole", "CHEMICAL", 217, 228], ["(1) conjugated polymer", "SIMPLE_CHEMICAL", 48, 70], ["(2) polymer composite", "SIMPLE_CHEMICAL", 74, 95], ["Polyaniline", "SIMPLE_CHEMICAL", 201, 212], ["polypyrrole", "SIMPLE_CHEMICAL", 217, 228], ["Transduction elements", "DNA", 119, 140], ["Polymer electrodes", "TREATMENT", 0, 18], ["conjugated polymer or (2) polymer composite", "TREATMENT", 52, 95], ["Electrochemical biosensor designs", "TREATMENT", 145, 178], ["pathogen detectionPolyaniline and polypyrrole", "TREATMENT", 183, 228], ["conjugated polymers", "TREATMENT", 262, 281], ["pathogen detection", "TEST", 286, 304], ["high conductivity", "OBSERVATION_MODIFIER", 318, 335]]], ["Moreover, polypyrrole has been shown to be biocompatible and exhibit affinity for methylated nucleic acids (Arshak et al. 2009).", [["polypyrrole", "CHEMICAL", 10, 21], ["nucleic acids", "CHEMICAL", 93, 106], ["polypyrrole", "CHEMICAL", 10, 21], ["polypyrrole", "SIMPLE_CHEMICAL", 10, 21], ["nucleic acids", "SIMPLE_CHEMICAL", 93, 106], ["methylated nucleic acids", "PROBLEM", 82, 106]]], ["However, polyaniline films lose electrochemical activity in solutions of pH greater than 4, which presents a measurement challenge when considering samples of varying pH (Wan, 2008).", [["polyaniline", "CHEMICAL", 9, 20], ["polyaniline", "CHEMICAL", 9, 20], ["polyaniline films", "SIMPLE_CHEMICAL", 9, 26], ["polyaniline films", "TEST", 9, 26], ["pH", "TEST", 73, 75], ["a measurement challenge", "TEST", 107, 130], ["varying pH", "PROBLEM", 159, 169]]], ["Conjugated polymer electrodes commonly exhibit thin-film form factors and are deposited onto insulating substrates via layer-by-layer approaches, spin coating, or electrochemical polymerization (Xia et al. 2010).", [["thin-film form factors", "PROTEIN", 47, 69], ["Conjugated polymer electrodes", "TREATMENT", 0, 29], ["thin-film form factors", "PROBLEM", 47, 69], ["spin coating", "TREATMENT", 146, 158]]], ["For example, Chowdhury et al. used a polyaniline electrode for detection of E. coli over a dynamic range of 102 to 107 CFU/mL (Chowdhury et al. 2012).", [["polyaniline", "CHEMICAL", 37, 48], ["polyaniline", "CHEMICAL", 37, 48], ["polyaniline", "SIMPLE_CHEMICAL", 37, 48], ["E. coli", "ORGANISM", 76, 83], ["E. coli", "SPECIES", 76, 83], ["E. coli", "SPECIES", 76, 83], ["a polyaniline electrode", "TREATMENT", 35, 58], ["E. coli", "PROBLEM", 76, 83], ["E. coli", "OBSERVATION", 76, 83]]], ["Hai et al. and He et al. used organic transistors based on spin-coated poly(3,4-ethylenedioxythiophene):polystyrene sulfonate (PEDOT:PSS) films for detection of human influenza A virus (H1N1) and E. coli, respectively (Hai et al. 2018; He et al. 2012).Polymer electrodes ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionPolymer composite electrodes are often composed of a non-conducting polymer mixed with a conducting or semiconducting dispersed phase.", [["poly(3,4-ethylenedioxythiophene", "CHEMICAL", 71, 102], ["polystyrene sulfonate", "CHEMICAL", 104, 125], ["PEDOT", "CHEMICAL", 127, 132], ["influenza A virus", "DISEASE", 167, 184], ["poly(3,4-ethylenedioxythiophene)", "CHEMICAL", 71, 103], ["polystyrene sulfonate", "CHEMICAL", 104, 125], ["PEDOT", "CHEMICAL", 127, 132], ["PSS", "CHEMICAL", 133, 136], ["poly(3,4-ethylenedioxythiophene):polystyrene sulfonate", "SIMPLE_CHEMICAL", 71, 125], ["PEDOT:PSS", "SIMPLE_CHEMICAL", 127, 136], ["human", "ORGANISM", 161, 166], ["influenza A virus", "ORGANISM", 167, 184], ["H1N1", "ORGANISM", 186, 190], ["E. coli", "ORGANISM", 196, 203], ["Transduction elements", "DNA", 275, 296], ["human", "SPECIES", 161, 166], ["influenza A virus", "SPECIES", 167, 184], ["E. coli", "SPECIES", 196, 203], ["human influenza A virus", "SPECIES", 161, 184], ["E. coli", "SPECIES", 196, 203], ["organic transistors", "TREATMENT", 30, 49], ["spin-coated poly(3,4-ethylenedioxythiophene)", "TREATMENT", 59, 103], ["polystyrene sulfonate (PEDOT:PSS) films", "TREATMENT", 104, 143], ["human influenza A virus (H1N1", "PROBLEM", 161, 190], ["E. coli", "PROBLEM", 196, 203], ["Electrochemical biosensor designs", "TREATMENT", 301, 334], ["pathogen detectionPolymer composite electrodes", "TREATMENT", 339, 385]]], ["Micro-particles and nanomaterials, such as graphite, Au nanoparticles (AuNPs), graphene, and carbon nanotubes (CNTs), have been commonly used as the dispersed phase (Dong et al. 2013; Lee et al. 2011; Lee and Jun 2016; Li et al. 2012; Viswanathan et al. 2012) in combination with various polymers, including chitosan (G\u00fcner et al. 2017), polyethylenimine (PEI) (Lee and Jun 2016), and polyallyamine (Viswanathan et al. 2012).", [["Au nanoparticles", "CHEMICAL", 53, 69], ["AuNPs", "CHEMICAL", 71, 76], ["graphene", "CHEMICAL", 79, 87], ["carbon nanotubes", "CHEMICAL", 93, 109], ["CNTs", "CHEMICAL", 111, 115], ["chitosan", "CHEMICAL", 308, 316], ["polyethylenimine", "CHEMICAL", 338, 354], ["PEI", "CHEMICAL", 356, 359], ["polyallyamine", "CHEMICAL", 385, 398], ["graphite", "CHEMICAL", 43, 51], ["Au", "CHEMICAL", 53, 55], ["graphene", "CHEMICAL", 79, 87], ["carbon", "CHEMICAL", 93, 99], ["polyethylenimine", "CHEMICAL", 338, 354], ["PEI", "CHEMICAL", 356, 359], ["polyallyamine", "CHEMICAL", 385, 398], ["graphite", "SIMPLE_CHEMICAL", 43, 51], ["Au nanoparticles", "SIMPLE_CHEMICAL", 53, 69], ["AuNPs", "SIMPLE_CHEMICAL", 71, 76], ["graphene", "SIMPLE_CHEMICAL", 79, 87], ["carbon nanotubes", "SIMPLE_CHEMICAL", 93, 109], ["CNTs", "SIMPLE_CHEMICAL", 111, 115], ["chitosan", "SIMPLE_CHEMICAL", 308, 316], ["polyethylenimine", "SIMPLE_CHEMICAL", 338, 354], ["PEI", "SIMPLE_CHEMICAL", 356, 359], ["polyallyamine", "SIMPLE_CHEMICAL", 385, 398], ["Micro-particles", "TEST", 0, 15], ["nanomaterials", "PROBLEM", 20, 33], ["graphite, Au nanoparticles (AuNPs)", "TREATMENT", 43, 77], ["graphene", "TREATMENT", 79, 87], ["carbon nanotubes (CNTs", "TREATMENT", 93, 115], ["various polymers", "TREATMENT", 280, 296], ["chitosan", "TREATMENT", 308, 316], ["polyethylenimine (PEI)", "TREATMENT", 338, 360], ["polyallyamine", "TREATMENT", 385, 398], ["carbon nanotubes", "OBSERVATION", 93, 109]]], ["For example, Viswanathan et al. developed a polyallylamine/CNT polymer composite electrode for the detection of E. coli, S. typhimurium, and Campylobacter via anodic stripping voltammetry over the dynamic range of 103 to 105 cells/mL (Viswanathan et al. 2012).", [["cells", "ANATOMY", 225, 230], ["polyallylamine", "CHEMICAL", 44, 58], ["polyallylamine", "CHEMICAL", 44, 58], ["polyallylamine", "SIMPLE_CHEMICAL", 44, 58], ["E. coli", "ORGANISM", 112, 119], ["S. typhimurium", "ORGANISM", 121, 135], ["cells", "CELL", 225, 230], ["E. coli", "SPECIES", 112, 119], ["S. typhimurium", "SPECIES", 121, 135], ["E. coli", "SPECIES", 112, 119], ["S. typhimurium", "SPECIES", 121, 135], ["a polyallylamine/CNT polymer composite electrode", "TREATMENT", 42, 90], ["E. coli", "PROBLEM", 112, 119], ["S. typhimurium", "PROBLEM", 121, 135], ["Campylobacter", "PROBLEM", 141, 154], ["anodic stripping voltammetry", "TEST", 159, 187], ["E. coli", "OBSERVATION", 112, 119]]], ["A multicomponent polymer composite electrode of poly(amidoamine), CNTs, and chitosan layered with AuNPs enabled the detection of S. typhimurium (Dong et al. 2013).", [["poly(amidoamine", "CHEMICAL", 48, 63], ["CNTs", "CHEMICAL", 66, 70], ["chitosan", "CHEMICAL", 76, 84], ["AuNPs", "CHEMICAL", 98, 103], ["poly(amidoamine)", "CHEMICAL", 48, 64], ["poly(amidoamine)", "SIMPLE_CHEMICAL", 48, 64], ["CNTs", "SIMPLE_CHEMICAL", 66, 70], ["chitosan", "SIMPLE_CHEMICAL", 76, 84], ["AuNPs", "SIMPLE_CHEMICAL", 98, 103], ["S. typhimurium", "ORGANISM", 129, 143], ["S. typhimurium", "SPECIES", 129, 143], ["S. typhimurium", "SPECIES", 129, 143], ["A multicomponent polymer composite electrode of poly(amidoamine)", "TREATMENT", 0, 64], ["CNTs, and chitosan layered", "TREATMENT", 66, 92], ["AuNPs", "TREATMENT", 98, 103], ["S. typhimurium", "PROBLEM", 129, 143]]], ["The detection limits associated with polymer composite electrodes are comparable to metallic and polymer electrodes and range from 1 to 103 CFU/mL (see Table 1).", [["polymer composite electrodes", "TREATMENT", 37, 65], ["metallic and polymer electrodes", "TREATMENT", 84, 115], ["composite electrodes", "OBSERVATION", 45, 65]]], ["While polymer composite electrodes often contain nanomaterials, they are dispersed throughout the bulk of polymer, which is in contrast to the electrode nanostructuring techniques that occur at the electrode surface and are discussed in the following sections.Polymer electrodes ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionPolymer electrode development has been, in part, driven by the need for flexible biosensors.", [["sections", "ANATOMY", 251, 259], ["Transduction elements", "DNA", 283, 304], ["polymer composite electrodes", "TREATMENT", 6, 34], ["the electrode nanostructuring techniques", "TREATMENT", 139, 179], ["Electrochemical biosensor designs", "TREATMENT", 309, 342], ["pathogen detectionPolymer electrode development", "TREATMENT", 347, 394], ["flexible biosensors", "TREATMENT", 437, 456], ["nanomaterials", "OBSERVATION", 49, 62], ["dispersed", "OBSERVATION_MODIFIER", 73, 82], ["bulk", "OBSERVATION_MODIFIER", 98, 102]]], ["For example, free-standing film electrodes and polymer electrodes on flexible substrates, such as paper, are now being examined for biosensing applications (Xu et al. 2019).", [["free-standing film electrodes and polymer electrodes on flexible substrates", "TREATMENT", 13, 88], ["polymer electrodes", "OBSERVATION", 47, 65]]], ["Given conjugated polymers and polymer composites are compatible with 3D printing processes (Kong et al. 2014), polymer electrodes are also emerging as attractive candidates for wearable conformal (i.e., form-fitting) biosensors.", [["conjugated polymers", "SIMPLE_CHEMICAL", 6, 25], ["conjugated polymers and polymer composites", "TREATMENT", 6, 48], ["polymer electrodes", "TREATMENT", 111, 129], ["compatible with", "UNCERTAINTY", 53, 68]]], ["While polymer electrodes typically exhibit planar form factors, such as thin films, they can also be constructed as nanowires and nanofibers, as discussed in the following section.", [["planar form factors", "PROTEIN", 43, 62], ["planar form factors", "PROBLEM", 43, 62], ["thin films", "TEST", 72, 82], ["nanowires and nanofibers", "TREATMENT", 116, 140]]], ["A comprehensive discussion of biosensor LOD and dynamic range for all electrode materials is provided in Table 1, Table 2.Electrode form factor and patterning ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionAs shown in Table 1, Au electrodes of various size and form factor have been used for pathogen detection.", [["Au", "CHEMICAL", 266, 268], ["Au", "CHEMICAL", 266, 268], ["Electrode form factor", "PROTEIN", 122, 143], ["Transduction elements", "DNA", 163, 184], ["biosensor LOD", "TEST", 30, 43], ["all electrode materials", "TREATMENT", 66, 89], ["Electrochemical biosensor designs", "PROBLEM", 189, 222], ["pathogen detection", "TEST", 227, 245], ["Au electrodes of various size", "TREATMENT", 266, 295], ["pathogen detection", "TEST", 331, 349], ["various", "OBSERVATION_MODIFIER", 283, 290], ["size", "OBSERVATION_MODIFIER", 291, 295]]], ["The use of complex masks and programmable tool paths with lithographic and 3D printing processes, respectively, also enable the fabrication of complex electrode geometries (Cesewski et al. 2018; Xu et al. 2017).", [["complex masks", "TREATMENT", 11, 24], ["lithographic and 3D printing processes", "TREATMENT", 58, 96], ["the fabrication of complex electrode geometries", "TREATMENT", 124, 171]]], ["In addition to complex form factor, lithographic processes, 3D printing processes, and assembly operations also enable the fabrication of electrode arrays through electrode patterning (Hintsche et al. 1994).", [["complex form factor", "PROTEIN", 15, 34], ["lithographic processes", "PROBLEM", 36, 58], ["3D printing processes", "TREATMENT", 60, 81], ["the fabrication of electrode arrays through electrode patterning", "TREATMENT", 119, 183]]], ["Electrode arrays, including interdigitated microelectrodes and other patterned electrodes, have been developed in an attempt to enhance the sensitivity and multiplexing capability of biosensors.", [["Electrode arrays", "TREATMENT", 0, 16], ["interdigitated microelectrodes and other patterned electrodes", "TREATMENT", 28, 89], ["the sensitivity", "TEST", 136, 151], ["patterned electrodes", "OBSERVATION", 69, 89]]], ["Interdigitated array microelectrodes (IDAMs) consist of alternating, parallel-electrode fingers organized in an interdigitated pattern.", [["Interdigitated array microelectrodes", "TREATMENT", 0, 36], ["parallel-electrode fingers", "TREATMENT", 69, 95], ["interdigitated pattern", "OBSERVATION", 112, 134]]], ["IDAMs have been shown to exhibit rapid response and high signal-to-noise ratio (Varshney and Li, 2009).", [["IDAMs", "SIMPLE_CHEMICAL", 0, 5], ["IDAMs", "PROTEIN", 0, 5], ["rapid response", "PROBLEM", 33, 47], ["rapid", "OBSERVATION_MODIFIER", 33, 38]]], ["As shown in Table 1, Au interdigitated microelectrode arrays are one of the most common electrode configurations for pathogen detection.", [["Au", "CHEMICAL", 21, 23], ["Au", "CHEMICAL", 21, 23], ["Au interdigitated microelectrode arrays", "TREATMENT", 21, 60], ["pathogen detection", "TEST", 117, 135], ["pathogen", "OBSERVATION", 117, 125]]], ["For example, Dastider et al. usedinterdigitated Au microelectrode arrays for detection of S. typhimurium via EIS (see Fig. 4a) (Dastider et al. 2015).", [["Au", "CHEMICAL", 48, 50], ["S. typhimurium", "ORGANISM", 90, 104], ["S. typhimurium", "SPECIES", 90, 104], ["S. typhimurium", "SPECIES", 90, 104], ["Au microelectrode arrays", "TREATMENT", 48, 72], ["S. typhimurium", "PROBLEM", 90, 104]]], ["Ceramic electrodes, such as ITO, with interdigitated array designs have also been examined for the detection of S. typhimurium (Yang and Li, 2006).", [["ITO", "CHEMICAL", 28, 31], ["S. typhimurium", "ORGANISM", 112, 126], ["S. typhimurium", "SPECIES", 112, 126], ["S. typhimurium", "SPECIES", 112, 126], ["Ceramic electrodes", "TREATMENT", 0, 18], ["S. typhimurium", "PROBLEM", 112, 126], ["electrodes", "OBSERVATION_MODIFIER", 8, 18]]], ["Mannoor et al. also examined interdigitated carbon-based electrodes for pathogen detection (Mannoor et al. 2012).", [["carbon", "CHEMICAL", 44, 50], ["carbon", "SIMPLE_CHEMICAL", 44, 50], ["pathogen detection", "TEST", 72, 90]]], ["The aforementioned emerging manufacturing processes are also used to construct electrode arrays that exhibit geometries other than interdigitated designs for electrochemical sensing applications.", [["electrode arrays", "TREATMENT", 79, 95], ["electrochemical sensing applications", "TREATMENT", 158, 194]]], ["For example, Yang et al. used aerosol jet additive manufacturing to fabricate silver (Ag) microelectrode arrays (Yang et al. 2016a).Electrode nanostructuring ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionTransducers with physical dimensions comparable to the target species have been widely investigated as a means of creating sensitive biosensors (Gupta et al. 2004; Pumera et al. 2007; Singh et al. 2010; Wei et al. 2009).", [["silver (Ag", "CHEMICAL", 78, 88], ["silver", "CHEMICAL", 78, 84], ["Ag", "CHEMICAL", 86, 88], ["silver (Ag", "SIMPLE_CHEMICAL", 78, 88], ["Transduction elements", "DNA", 162, 183], ["aerosol jet additive manufacturing to fabricate silver (Ag) microelectrode arrays", "TREATMENT", 30, 111], ["Electrochemical biosensor designs", "TREATMENT", 188, 221], ["pathogen detectionTransducers", "TEST", 226, 255]]], ["Thus, electrodes ranging from micrometers to nanometers have been investigated for pathogen detection.", [["electrodes ranging from micrometers to nanometers", "TREATMENT", 6, 55], ["pathogen detection", "TEST", 83, 101]]], ["While nanoscale planar electrodes are among the most commonly examined for pathogen detection (Hong et al. 2015; Peh and Li, 2013), the fabrication of nanoscale structures of conducting and semiconducting materials using a wide range of bottom-up and top-down nanomanufacturing processes, such as nanowires, has led to the investigation of nanostructured electrodes for pathogen detection (Patolsky and Lieber, 2005).", [["nanoscale planar electrodes", "TREATMENT", 6, 33], ["pathogen detection", "TEST", 75, 93], ["the fabrication of nanoscale structures of conducting and semiconducting materials", "TREATMENT", 132, 214], ["a wide range of bottom", "TREATMENT", 221, 243], ["top-down nanomanufacturing processes", "TREATMENT", 251, 287], ["pathogen detection", "TEST", 370, 388], ["semiconducting materials", "OBSERVATION", 190, 214]]], ["Nanostructuring can be performed simultaneously with bottom-up electrode fabrication processes or as a post-processing step with top-down electrode fabrication processes.Electrode nanostructuring ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionNanowire-based electrodes have been fabricated using a variety of engineering materials using both bottom-up and top-down nanomanufacturing processes (Hu et al. 1999; Yogeswaran and Chen, 2008).", [["Transduction elements", "DNA", 200, 221], ["bottom-up electrode fabrication processes", "TREATMENT", 53, 94], ["top-down electrode fabrication processes", "TREATMENT", 129, 169], ["Electrochemical biosensor designs", "TREATMENT", 226, 259], ["pathogen detectionNanowire-based electrodes", "TREATMENT", 264, 307], ["a variety of engineering materials", "TREATMENT", 335, 369]]], ["A detailed review of nanomanufacturing processes for nanowire fabrication can be found elsewhere (Hu et al. 1999).", [["nanomanufacturing processes", "TREATMENT", 21, 48], ["nanowire fabrication", "TREATMENT", 53, 73]]], ["Nanowires can exhibit circular, hexagonal, and even triangular cross-sections.", [["cross-sections", "ANATOMY", 63, 77], ["circular", "OBSERVATION_MODIFIER", 22, 30], ["hexagonal", "OBSERVATION_MODIFIER", 32, 41], ["triangular", "OBSERVATION_MODIFIER", 52, 62]]], ["The nanowire aspect ratio, defined as the ratio of the length to width, often ranges from 1 to greater than 10 (Hu et al. 1999; Vaseashta and Dimova-Malinovska, 2005; Wanekaya et al. 2006).Electrode nanostructuring ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionAs shown in Table 1, metallic and ceramic microwire- and nanowire-based electrodes have been examined for pathogen detection.", [["Transduction elements", "DNA", 219, 240], ["The nanowire aspect ratio", "TEST", 0, 25], ["width", "TEST", 65, 70], ["Vaseashta", "TEST", 128, 137], ["Electrochemical biosensor designs", "PROBLEM", 245, 278], ["pathogen detection", "TEST", 283, 301], ["metallic and ceramic microwire- and nanowire-based electrodes", "TREATMENT", 322, 383], ["pathogen detection", "TEST", 407, 425], ["nanowire", "OBSERVATION_MODIFIER", 4, 12], ["length", "OBSERVATION_MODIFIER", 55, 61], ["width", "OBSERVATION_MODIFIER", 65, 70], ["ceramic microwire", "OBSERVATION", 335, 352]]], ["For example, Wang et al. used nanowire-bundled TiO2 electrodes synthesized using a bottom-up wet chemistry process for the detection of Listeria monocytogenes (L. monocytogenes) (Wang et al. 2008).", [["TiO2", "CHEMICAL", 47, 51], ["TiO2", "CHEMICAL", 47, 51], ["TiO2 electrodes", "SIMPLE_CHEMICAL", 47, 62], ["Listeria monocytogenes", "ORGANISM", 136, 158], ["L. monocytogenes", "ORGANISM", 160, 176], ["Listeria monocytogenes", "SPECIES", 136, 158], ["L. monocytogenes", "SPECIES", 160, 176], ["Listeria monocytogenes", "SPECIES", 136, 158], ["L. monocytogenes", "SPECIES", 160, 176], ["nanowire-bundled TiO2 electrodes", "TREATMENT", 30, 62], ["a bottom", "TREATMENT", 81, 89], ["Listeria monocytogenes", "PROBLEM", 136, 158], ["Listeria monocytogenes", "OBSERVATION", 136, 158]]], ["Shen et al. fabricated silicon nanowire-based electrodes using a chemical vapor deposition process for the rapid detection of human influenza A virus in an array-based format (Shen et al. 2012).Electrode nanostructuring ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionAlthough polymer nanowires have been relatively more applied to the detection of non-pathogenic species (Travas-Sejdic et al. 2014), there appears to be potential for their application to pathogen detection.", [["silicon", "CHEMICAL", 23, 30], ["silicon", "CHEMICAL", 23, 30], ["human", "ORGANISM", 126, 131], ["influenza A virus", "ORGANISM", 132, 149], ["Transduction elements", "DNA", 224, 245], ["human", "SPECIES", 126, 131], ["influenza A virus", "SPECIES", 132, 149], ["human influenza A virus", "SPECIES", 126, 149], ["fabricated silicon nanowire-based electrodes", "TREATMENT", 12, 56], ["a chemical vapor deposition process", "TREATMENT", 63, 98], ["the rapid detection", "TEST", 103, 122], ["human influenza A virus", "PROBLEM", 126, 149], ["Electrochemical biosensor designs", "PROBLEM", 250, 283], ["pathogen detection", "TEST", 288, 306], ["polymer nanowires", "TREATMENT", 315, 332], ["non-pathogenic species", "PROBLEM", 387, 409], ["pathogen detection", "TEST", 494, 512], ["silicon nanowire", "OBSERVATION", 23, 39], ["appears to be", "UNCERTAINTY", 445, 458]]], ["Polymer nanowires are also synthesized via bottom-up and top-down nanomanufacturing processes, including hard template methods, soft template methods, or physical approaches, but efficient, large-scale synthesis remains a challenge (Xia et al. 2010).", [["Polymer nanowires", "SIMPLE_CHEMICAL", 0, 17], ["Polymer nanowires", "TREATMENT", 0, 17], ["nanomanufacturing processes", "TREATMENT", 66, 93], ["hard template methods", "TREATMENT", 105, 126], ["large-scale synthesis", "TREATMENT", 190, 211]]], ["A comprehensive summary of studies using micro- and nano-wire electrodes for pathogen detection is shown in Table 1.", [["studies", "TEST", 27, 34], ["micro- and nano-wire electrodes", "TREATMENT", 41, 72], ["pathogen detection", "TEST", 77, 95]]], ["For example, Chartuprayoon et al. used Au microelectrode arrays modified with polypyrrole nanoribbons to detect cucumber mosaic virus (Chartuprayoon et al. 2013).Electrode nanostructuring ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionThe topographical modification of electrode surfaces with micro- and nano-structured features beyond wire-like structures has also been investigated for pathogen detection.", [["Au", "CHEMICAL", 39, 41], ["polypyrrole nanoribbons", "CHEMICAL", 78, 101], ["Au", "CHEMICAL", 39, 41], ["polypyrrole", "CHEMICAL", 78, 89], ["polypyrrole nanoribbons", "SIMPLE_CHEMICAL", 78, 101], ["cucumber mosaic virus", "ORGANISM", 112, 133], ["Transduction elements", "DNA", 192, 213], ["cucumber mosaic virus", "SPECIES", 112, 133], ["cucumber mosaic virus", "SPECIES", 112, 133], ["Au microelectrode arrays", "TREATMENT", 39, 63], ["polypyrrole nanoribbons", "TREATMENT", 78, 101], ["cucumber mosaic virus", "PROBLEM", 112, 133], ["Electrochemical biosensor designs", "PROBLEM", 218, 251], ["pathogen detection", "TEST", 256, 274], ["micro", "TEST", 332, 337], ["pathogen detection", "TEST", 427, 445], ["cucumber mosaic virus", "OBSERVATION", 112, 133], ["electrode", "OBSERVATION_MODIFIER", 308, 317], ["surfaces", "OBSERVATION_MODIFIER", 318, 326]]], ["Electrode nanostructuring increases the electrode surface area without significantly increasing the electrode volume, thereby increasing the ratio of electrode surface area to fluid volume analyzed (Soleymani et al. 2009).", [["surface area", "ANATOMY", 50, 62], ["surface", "ANATOMY", 160, 167], ["fluid", "ANATOMY", 176, 181], ["Electrode nanostructuring", "TREATMENT", 0, 25], ["the electrode surface area", "TREATMENT", 36, 62], ["significantly increasing the electrode volume", "PROBLEM", 71, 116], ["fluid volume", "TEST", 176, 188], ["nanostructuring", "OBSERVATION_MODIFIER", 10, 25], ["increases", "OBSERVATION_MODIFIER", 26, 35], ["electrode", "OBSERVATION_MODIFIER", 40, 49], ["surface", "OBSERVATION_MODIFIER", 50, 57], ["area", "OBSERVATION_MODIFIER", 58, 62], ["without", "UNCERTAINTY", 63, 70], ["significantly", "OBSERVATION_MODIFIER", 71, 84], ["increasing", "OBSERVATION_MODIFIER", 85, 95], ["electrode volume", "OBSERVATION", 100, 116], ["increasing", "OBSERVATION_MODIFIER", 126, 136], ["ratio", "OBSERVATION_MODIFIER", 141, 146], ["electrode", "OBSERVATION_MODIFIER", 150, 159], ["surface", "OBSERVATION_MODIFIER", 160, 167], ["fluid volume", "OBSERVATION", 176, 188]]], ["Topographical modification of electrodes can also affect their mechanical and electrical properties.", [["Topographical modification of electrodes", "TREATMENT", 0, 40]]], ["For example, electrochemical deposition of PEDOT on silicon electrodes reduces the electrode electrical impedance across a wide frequency range, which offers measurement advantages for neural monitoring and recording applications (Ludwig et al. 2006).Electrode nanostructuring ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionElectrode nanostructuring for pathogen detection beyond the fabrication of nanowire-based electrodes has been accomplished primarily using bottom-up wet chemistry approaches and electrochemical methods.", [["neural", "ANATOMY", 185, 191], ["PEDOT", "CHEMICAL", 43, 48], ["PEDOT", "CHEMICAL", 43, 48], ["silicon", "CHEMICAL", 52, 59], ["PEDOT", "SIMPLE_CHEMICAL", 43, 48], ["Transduction elements", "DNA", 281, 302], ["electrochemical deposition of PEDOT on silicon electrodes", "TREATMENT", 13, 70], ["the electrode electrical impedance", "TREATMENT", 79, 113], ["neural monitoring", "TEST", 185, 202], ["Electrochemical biosensor designs", "TREATMENT", 307, 340], ["pathogen detectionElectrode nanostructuring", "TREATMENT", 345, 388], ["pathogen detection", "TEST", 393, 411], ["the fabrication of nanowire-based electrodes", "TREATMENT", 419, 463], ["electrochemical", "OBSERVATION_MODIFIER", 13, 28], ["deposition", "OBSERVATION_MODIFIER", 29, 39], ["PEDOT", "OBSERVATION_MODIFIER", 43, 48], ["silicon electrodes", "OBSERVATION", 52, 70], ["wide", "OBSERVATION_MODIFIER", 123, 127]]], ["Among the wet chemistry approaches for electrode nanostructuring (Eftekhari et al. 2008), nanostructured electrodes are often fabricated by the deposition or coupling of nanoparticles to planar electrodes.", [["the wet chemistry approaches", "TREATMENT", 6, 34], ["electrode nanostructuring", "TREATMENT", 39, 64], ["nanostructured electrodes", "TREATMENT", 90, 115], ["coupling of nanoparticles to planar electrodes", "TREATMENT", 158, 204]]], ["For example, AuNPs are commonly deposited on planar electrodes to provide a nanostructured surface for biorecognition element immobilization.", [["surface", "ANATOMY", 91, 98], ["AuNPs", "CHEMICAL", 13, 18], ["AuNPs", "SIMPLE_CHEMICAL", 13, 18], ["planar electrodes", "TREATMENT", 45, 62], ["a nanostructured surface", "TREATMENT", 74, 98], ["biorecognition element immobilization", "TREATMENT", 103, 140], ["AuNPs", "OBSERVATION_MODIFIER", 13, 18], ["element immobilization", "OBSERVATION", 118, 140]]], ["In such studies, the particles are bound to the planar electrode via physical adsorption processes (Attar et al. 2016) or chemical methods (Wang et al. 2013).", [["such studies", "TEST", 3, 15]]], ["In addition to AuNPs, CNTs have also been extensively investigated as potentially useful nanomaterials for electrode nanostructuring (see Table 1).Electrode nanostructuring ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionDe Luna et al. found that high-curvature nanostructured Au microelectrodes exhibited a reduced extent of biorecognition element aggregation relative to that found on planar electrodes in DNA sensing studies using a combination of experimental studies and molecular dynamics simulations (see Fig. 3a) (De Luna et al. 2017; Mahshid et al. 2016).", [["AuNPs", "CHEMICAL", 15, 20], ["CNTs", "CHEMICAL", 22, 26], ["Au", "CHEMICAL", 315, 317], ["Au", "CHEMICAL", 315, 317], ["AuNPs", "SIMPLE_CHEMICAL", 15, 20], ["CNTs", "SIMPLE_CHEMICAL", 22, 26], ["DNA", "CELLULAR_COMPONENT", 446, 449], ["Transduction elements", "DNA", 177, 198], ["AuNPs", "TREATMENT", 15, 20], ["CNTs", "TREATMENT", 22, 26], ["electrode nanostructuring", "TREATMENT", 107, 132], ["Electrochemical biosensor designs", "TREATMENT", 203, 236], ["pathogen", "PROBLEM", 241, 249], ["high-curvature nanostructured Au microelectrodes", "PROBLEM", 285, 333], ["biorecognition element aggregation", "PROBLEM", 364, 398], ["planar electrodes", "TREATMENT", 425, 442], ["DNA sensing studies", "TEST", 446, 465], ["experimental studies", "TEST", 489, 509], ["high", "OBSERVATION_MODIFIER", 285, 289], ["curvature", "OBSERVATION_MODIFIER", 290, 299], ["reduced", "OBSERVATION_MODIFIER", 346, 353], ["extent", "OBSERVATION_MODIFIER", 354, 360], ["biorecognition element aggregation", "OBSERVATION", 364, 398]]], ["A study by Chin et al. found that nanostructuring of carbon electrodes with carbon nanoparticles enhanced the electron transfer kinetics and current intensity of the electrode by 63% for the detection of Japanese encephalitis virus (Chin et al. 2017).Electrode nanostructuring ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionIn addition to fabricating nanostructured electrodes by coupling already processed nanomaterials to planar electrodes, electrochemical methods are also commonly used for bottom-up electrode nanostructuring processes and have been leveraged to fabricate nanostructured electrodes for pathogen detection.", [["carbon nanoparticles", "CHEMICAL", 76, 96], ["Japanese encephalitis", "DISEASE", 204, 225], ["carbon", "CHEMICAL", 53, 59], ["carbon", "CHEMICAL", 76, 82], ["carbon nanoparticles", "SIMPLE_CHEMICAL", 76, 96], ["electron", "SIMPLE_CHEMICAL", 110, 118], ["Japanese encephalitis virus", "ORGANISM", 204, 231], ["Transduction elements", "DNA", 281, 302], ["Japanese encephalitis virus", "SPECIES", 204, 231], ["Japanese encephalitis virus", "SPECIES", 204, 231], ["A study", "TEST", 0, 7], ["carbon electrodes", "TREATMENT", 53, 70], ["carbon nanoparticles", "TREATMENT", 76, 96], ["the electrode", "TEST", 162, 175], ["Japanese encephalitis virus", "PROBLEM", 204, 231], ["Electrochemical biosensor designs", "PROBLEM", 307, 340], ["pathogen detection", "TEST", 345, 363], ["fabricating nanostructured electrodes", "TREATMENT", 378, 415], ["electrochemical methods", "TREATMENT", 482, 505], ["bottom-up electrode nanostructuring processes", "TREATMENT", 533, 578], ["pathogen detection", "TEST", 646, 664], ["nanostructuring", "OBSERVATION_MODIFIER", 34, 49], ["carbon electrodes", "OBSERVATION", 53, 70], ["nanostructured electrodes", "OBSERVATION", 390, 415]]], ["For example, Hong et al. fabricated a nanostructured Au electrode via electrochemical deposition of gold (III) chloride hydrates for the detection of norovirus in lettuce extracts (Hong et al. 2015).", [["extracts", "ANATOMY", 171, 179], ["Au", "CHEMICAL", 53, 55], ["gold (III) chloride", "CHEMICAL", 100, 119], ["norovirus", "DISEASE", 150, 159], ["Au", "CHEMICAL", 53, 55], ["gold (III) chloride", "CHEMICAL", 100, 119], ["gold (III) chloride hydrates", "SIMPLE_CHEMICAL", 100, 128], ["norovirus", "ORGANISM", 150, 159], ["lettuce", "ORGANISM", 163, 170], ["extracts", "ORGANISM_SUBSTANCE", 171, 179], ["lettuce", "SPECIES", 163, 170], ["a nanostructured Au electrode via electrochemical deposition of gold (III) chloride hydrates", "TREATMENT", 36, 128], ["norovirus", "PROBLEM", 150, 159], ["norovirus", "OBSERVATION", 150, 159]]], ["While the physical or chemical deposition of materials on planar electrodes provides a useful nanostructuring approach, introducing porosity to the electrode, such as nanoporosity, also enables electrode nanostructuring.", [["planar electrodes", "TREATMENT", 58, 75], ["a useful nanostructuring approach", "TREATMENT", 85, 118], ["introducing porosity to the electrode", "TREATMENT", 120, 157], ["electrode nanostructuring", "OBSERVATION", 194, 219]]], ["For example, Nguyen et al. utilized nanoporous alumina-coated Pt microwires for the detection of West Nile virus (Nguyen et al. 2009).Electrode nanostructuring ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionWhile studies have reported improved biosensor performance using electrode nanostructuring, such as improved sensitivity and LOD, it is prudent to consider the effect of nanostructuring on biorecognition element immobilization and target binding.", [["Pt", "CHEMICAL", 62, 64], ["Pt", "CHEMICAL", 62, 64], ["West Nile virus", "ORGANISM", 97, 112], ["Transduction elements", "DNA", 164, 185], ["Nile virus", "SPECIES", 102, 112], ["West Nile virus", "SPECIES", 97, 112], ["nanoporous alumina-coated Pt microwires", "TREATMENT", 36, 75], ["the detection", "TEST", 80, 93], ["West Nile virus", "PROBLEM", 97, 112], ["pathogen detectionWhile studies", "TEST", 228, 259], ["electrode nanostructuring", "TREATMENT", 311, 336], ["biorecognition element immobilization", "TREATMENT", 435, 472], ["target binding", "PROBLEM", 477, 491]]], ["For example, nanostructured electrodes that exhibit high-aspect-ratio structures and other three-dimensional structures have also been shown to enhance biomolecular steric hindrance effects, which may have implications for pathogen detection applications (Hong et al. 2015; Lam et al. 2012; Mahshid et al. 2017).", [["nanostructured electrodes", "TREATMENT", 13, 38], ["high-aspect-ratio structures", "PROBLEM", 52, 80], ["biomolecular steric hindrance effects", "PROBLEM", 152, 189], ["nanostructured electrodes", "OBSERVATION", 13, 38], ["high", "OBSERVATION_MODIFIER", 52, 56], ["steric hindrance", "OBSERVATION", 165, 181]]], ["There also remains a need to understand device-to-device and batch-to-batch variation in electrode nanostructuring quality.", [["device-to-device", "TREATMENT", 40, 56], ["batch", "TREATMENT", 61, 66]]], ["For example, it is presently unclear how the structure (e.g., topography, crystal structure) and material properties (e.g., electrical properties) of nanostructured surfaces vary among mass-produced electrodes.", [["mass", "PROBLEM", 185, 189], ["nanostructured", "OBSERVATION_MODIFIER", 150, 164], ["surfaces", "OBSERVATION_MODIFIER", 165, 173], ["mass", "OBSERVATION", 185, 189], ["electrodes", "OBSERVATION_MODIFIER", 199, 209]]], ["It is also unclear how such variance in nanostructuring quality affects the repeatability of biosensor performance.Integration of complementary transduction elements ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionGiven the need for rapid and reliable measurements, biosensors that contain integrated electrodes and complementary transducers have also been examined for pathogen detection applications.", [["complementary transduction elements", "DNA", 130, 165], ["Transduction elements", "DNA", 170, 191], ["Electrochemical biosensor designs", "PROBLEM", 196, 229], ["pathogen", "PROBLEM", 234, 242], ["biosensors", "TREATMENT", 304, 314], ["integrated electrodes", "TREATMENT", 328, 349], ["complementary transducers", "TREATMENT", 354, 379]]], ["For example, electrodes have been integrated with transducers that enable simultaneous fluid mixing and monitoring of molecular binding events (Choi et al. 2011).", [["fluid", "ANATOMY", 87, 92], ["transducers", "TREATMENT", 50, 61], ["simultaneous fluid mixing", "TREATMENT", 74, 99], ["molecular binding events", "PROBLEM", 118, 142], ["fluid mixing", "OBSERVATION", 87, 99]]], ["Biosensors composed of multiple transducers, referred to as hybrid biosensors, also offer unique opportunities for in situ verification of target binding as well as complementary analytical measurements (i.e., dual detection).Integration of complementary transduction elements ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionHybrid electrochemical biosensors for pathogen detection have been developed by integrating electrodes with optical and mechanical transducers.", [["complementary transduction elements", "DNA", 241, 276], ["Transduction elements", "DNA", 281, 302], ["complementary analytical measurements", "TEST", 165, 202], ["Electrochemical biosensor designs", "PROBLEM", 307, 340], ["pathogen detection", "TEST", 345, 363], ["pathogen detection", "PROBLEM", 401, 419], ["optical and mechanical transducers", "TREATMENT", 471, 505], ["mechanical transducers", "OBSERVATION", 483, 505]]], ["Electrochemical-optical waveguide light mode spectroscopy (EC-OWLS) combines evanescent-field optical sensing with electrochemical sensing (Bearinger et al. 2003).", [["optical waveguide light mode spectroscopy", "TEST", 16, 57]]], ["EC-OWLS optically monitors changes and growth at the electrode surface to provide complementary information on surface reactions.", [["surface", "ANATOMY", 111, 118], ["EC", "CELL", 0, 2], ["EC", "CELL_TYPE", 0, 2], ["surface reactions", "PROBLEM", 111, 128]]], ["EC-OWLS has been used to monitor the growth of bacteria (Nemeth et al. 2007) and could potentially be applied to selective detection of pathogens.", [["EC", "ANATOMY", 0, 2], ["EC", "CELL", 0, 2], ["EC", "CELL_TYPE", 0, 2], ["bacteria", "PROBLEM", 47, 55], ["pathogens", "PROBLEM", 136, 145], ["pathogens", "OBSERVATION", 136, 145]]], ["Electrochemical-surface plasmon resonance (EC-SPR) combines SPR sensing capability based on binding-induced refractive index changes at the electrode-electrolyte interface with electrochemical sensing capability on the same electrode (Hu et al. 2008).", [["Electrochemical-surface plasmon resonance", "TEST", 0, 41], ["EC", "TEST", 43, 45], ["SPR sensing capability", "PROBLEM", 60, 82], ["refractive index changes", "PROBLEM", 108, 132], ["electrochemical sensing capability", "PROBLEM", 177, 211], ["refractive index", "OBSERVATION", 108, 124], ["electrolyte interface", "OBSERVATION", 150, 171]]], ["This approach has been used for monitoring molecular binding events (Juan-Colas et al. 2017) and could potentially be applied to selective detection of pathogens.Integration of complementary transduction elements ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionIn addition to their combination with optical transducers, hybrid electrochemical biosensors have also been combined with mechanical transducers.", [["complementary transduction elements", "DNA", 177, 212], ["Transduction elements", "DNA", 217, 238], ["pathogens", "PROBLEM", 152, 161], ["Electrochemical biosensor designs", "PROBLEM", 243, 276], ["pathogen detection", "TEST", 281, 299], ["optical transducers", "TREATMENT", 337, 356], ["hybrid electrochemical biosensors", "TREATMENT", 358, 391], ["mechanical transducers", "TREATMENT", 421, 443], ["pathogens", "OBSERVATION", 152, 161]]], ["Mechanical transducers have included shear-mode resonators, such as the quartz crystal microbalance (QCM) and cantilever biosensors.", [["quartz", "CHEMICAL", 72, 78], ["Mechanical transducers", "TREATMENT", 0, 22], ["shear-mode resonators", "TREATMENT", 37, 58], ["the quartz crystal microbalance (QCM)", "TREATMENT", 68, 105], ["cantilever biosensors", "TREATMENT", 110, 131]]], ["Electrochemical-QCMs (E-QCMs) integrate mass-change and electrochemical sensing capabilities into a single platform.", [["Electrochemical", "TEST", 0, 15], ["QCMs (E-QCMs)", "TREATMENT", 16, 29], ["mass", "PROBLEM", 40, 44], ["electrochemical sensing capabilities", "TREATMENT", 56, 92], ["mass", "OBSERVATION", 40, 44]]], ["For example, Li et al. used an antibody-functionalized E-QCM for the detection of E. coli, which provided complementary cyclic voltammetry, EIS, and capacitive sensing measurements associated with the detection response (Li et al. 2011).", [["Li", "CHEMICAL", 13, 15], ["E-QCM", "SIMPLE_CHEMICAL", 55, 60], ["E. coli", "ORGANISM", 82, 89], ["E. coli", "SPECIES", 82, 89], ["E. coli", "SPECIES", 82, 89], ["an antibody", "TEST", 28, 39], ["E. coli", "PROBLEM", 82, 89], ["EIS", "TEST", 140, 143], ["capacitive sensing measurements", "TEST", 149, 180], ["E. coli", "OBSERVATION", 82, 89]]], ["Serra et al. used a lectin-modified E-QCM to detect E. coli using the biosensor's mass-change response (Serra et al. 2008).Integration of complementary transduction elements ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionBesides providing complementary responses for verification of binding events (Johnson and Mutharasan, 2012, 2013a), hybrid biosensors for pathogen detection can also generate fluid and particle mixing at the electrode-electrolyte interface and in the bulk solution via acoustic streaming or primary radiation effects of mechanical transducers (Cesewski et al. 2018).", [["E. coli", "ORGANISM", 52, 59], ["lectin", "PROTEIN", 20, 26], ["complementary transduction elements", "DNA", 138, 173], ["Transduction elements", "DNA", 178, 199], ["E. coli", "SPECIES", 52, 59], ["E. coli", "SPECIES", 52, 59], ["a lectin-modified E-QCM", "TREATMENT", 18, 41], ["E. coli", "PROBLEM", 52, 59], ["the biosensor's mass", "PROBLEM", 66, 86], ["Electrochemical biosensor designs", "PROBLEM", 204, 237], ["pathogen", "PROBLEM", 242, 250], ["hybrid biosensors", "TREATMENT", 376, 393], ["pathogen detection", "PROBLEM", 398, 416], ["the bulk solution", "TREATMENT", 507, 524], ["acoustic streaming", "PROBLEM", 529, 547], ["primary radiation effects of mechanical transducers", "TREATMENT", 551, 602], ["fluid", "OBSERVATION", 435, 440], ["primary radiation", "OBSERVATION", 551, 568]]], ["Thus, secondary transducers can apply force to bound species, such as nonspecifically adsorbed background species or captured target species.", [["secondary transducers", "TREATMENT", 6, 27], ["force to bound species", "PROBLEM", 38, 60], ["nonspecifically adsorbed background species", "PROBLEM", 70, 113]]], ["For example, various studies have reported the removal of surface-bound biomolecules using mechanical transducers, such as shear-mode resonators or cantilever biosensors (Johnson and Mutharasan, 2014; Yeh et al. 2007).", [["surface", "ANATOMY", 58, 65], ["various studies", "TEST", 13, 28], ["the removal of surface-bound biomolecules", "TREATMENT", 43, 84], ["mechanical transducers", "TREATMENT", 91, 113], ["shear-mode resonators", "TREATMENT", 123, 144]]], ["While the impediment or removal of nonspecifically adsorbed background species is a vital biosensor characteristic in pathogen detection applications that involve complex matrices, the regeneration of biosensor surfaces that contain specifically bound target species is essential for applications involving high-throughput characterization or process monitoring (e.g., bioprocesses or biomanufacturing processes) (Goode et al. 2015).", [["removal", "TREATMENT", 24, 31], ["nonspecifically adsorbed background species", "PROBLEM", 35, 78], ["complex matrices", "PROBLEM", 163, 179], ["the regeneration of biosensor surfaces", "PROBLEM", 181, 219], ["bound target species", "PROBLEM", 246, 266], ["process monitoring", "TEST", 343, 361]]], ["Hybrid designs may also be useful for electrodes that exhibit a high extent of biofouling.Integration of complementary transduction elements ::: Transduction elements ::: Electrochemical biosensor designs for pathogen detectionIn addition to hybrid biosensor designs composed of combinations of electrodes with other transducers, hybrid biosensor-based assays for pathogen detection based on the combination of an electrochemical biosensor with a traditional bioanalytical technique have also been utilized.", [["biofouling", "DISEASE", 79, 89], ["complementary transduction elements", "DNA", 105, 140], ["Transduction elements", "DNA", 145, 166], ["Hybrid designs", "PROBLEM", 0, 14], ["biofouling", "PROBLEM", 79, 89], ["Electrochemical biosensor designs", "PROBLEM", 171, 204], ["pathogen detection", "TEST", 209, 227], ["hybrid biosensor designs", "TREATMENT", 242, 266], ["other transducers", "TREATMENT", 311, 328], ["hybrid biosensor", "TEST", 330, 346], ["pathogen detection", "TEST", 364, 382], ["an electrochemical biosensor", "TREATMENT", 411, 439], ["a traditional bioanalytical technique", "TREATMENT", 445, 482], ["may also be", "UNCERTAINTY", 15, 26], ["high extent", "OBSERVATION_MODIFIER", 64, 75], ["biofouling", "OBSERVATION", 79, 89]]], ["For example, electrochemical-colorimetric (EC-C) biosensing combines an electrochemical method and a colorimetric, fluorescent, or luminescent detection method.", [["EC-C", "CHEMICAL", 43, 47], ["EC-C", "SIMPLE_CHEMICAL", 43, 47], ["electrochemical", "TEST", 13, 28], ["a colorimetric, fluorescent", "TEST", 99, 126], ["luminescent detection method", "TEST", 131, 159]]], ["The electrode detects the presence of a target species, while the colorimetric transduction pathway enables quantification of the products associated with the reaction between the target and an active species (Hou et al. 2018).", [["The electrode", "TEST", 0, 13], ["a target species", "PROBLEM", 38, 54], ["the colorimetric transduction pathway", "TEST", 62, 99], ["the products", "PROBLEM", 126, 138], ["the reaction", "PROBLEM", 155, 167], ["an active species", "PROBLEM", 191, 208], ["target species", "OBSERVATION", 40, 54], ["active", "OBSERVATION_MODIFIER", 194, 200], ["species", "OBSERVATION_MODIFIER", 201, 208]]], ["For example, Hou et al. used an EC-C approach based on a monoclonal antibody-functionalized AuNP-modified ITO electrode and dual-labeled magnetic beads for the detection of human enterovirus 71 (Hou et al. 2018).", [["AuNP", "CHEMICAL", 92, 96], ["ITO", "CHEMICAL", 106, 109], ["ITO", "CHEMICAL", 106, 109], ["EC-C", "CELL", 32, 36], ["AuNP", "SIMPLE_CHEMICAL", 92, 96], ["ITO electrode", "SIMPLE_CHEMICAL", 106, 119], ["human", "ORGANISM", 173, 178], ["enterovirus 71", "ORGANISM", 179, 193], ["monoclonal antibody", "PROTEIN", 57, 76], ["human", "SPECIES", 173, 178], ["human enterovirus 71", "SPECIES", 173, 193], ["an EC-C approach", "TREATMENT", 29, 45], ["a monoclonal antibody", "TEST", 55, 76], ["modified ITO electrode", "TREATMENT", 97, 119], ["dual-labeled magnetic beads", "TREATMENT", 124, 151], ["human enterovirus", "PROBLEM", 173, 190]]], ["In that study, antibody- and horseradish peroxidase (HRP)-labeled magnetic nanobeads were introduced as a secondary binding step following exposure of the electrode to enterovirus-containing samples.", [["samples", "ANATOMY", 191, 198], ["horseradish peroxidase", "SIMPLE_CHEMICAL", 29, 51], ["HRP", "SIMPLE_CHEMICAL", 53, 56], ["magnetic nanobeads", "SIMPLE_CHEMICAL", 66, 84], ["enterovirus", "ORGANISM", 168, 179], ["HRP", "PROTEIN", 53, 56], ["horseradish", "SPECIES", 29, 40], ["that study", "TEST", 3, 13], ["antibody", "TEST", 15, 23], ["horseradish peroxidase", "TEST", 29, 51], ["the electrode", "TREATMENT", 151, 164], ["enterovirus", "PROBLEM", 168, 179]]], ["Following the secondary binding step, the HRP-nanobead conjugates enabled colorimetric detection via monitoring of oxidative products produced by HRP-catalyzed redox reactions, while the functionalized electrode enabled electrochemical detection via chronoamperometry.", [["HRP-nanobead conjugates", "SIMPLE_CHEMICAL", 42, 65], ["HRP", "SIMPLE_CHEMICAL", 146, 149], ["HRP", "PROTEIN", 42, 45], ["oxidative products", "PROTEIN", 115, 133], ["HRP", "PROTEIN", 146, 149], ["the HRP", "TEST", 38, 45], ["colorimetric detection", "TEST", 74, 96], ["oxidative products", "TREATMENT", 115, 133], ["the functionalized electrode", "TREATMENT", 183, 211]]], ["Various techniques often rely on the use of optically-active labels for colorimetric, fluorescent, or luminescent sensing.", [["Various techniques", "TREATMENT", 0, 18]]], ["The optical labels used in pathogen detection applications commonly include biological fluorophores, such as green fluorescent protein, non-protein organic fluorophores, such as fluorescein and rhodamine, and nanoparticles, such as quantum dots, including CdS, CdSe, and GaAs, among others (Mungroo and Neethirajan 2016; Pires et al. 2014).", [["fluorescein", "CHEMICAL", 178, 189], ["rhodamine", "CHEMICAL", 194, 203], ["CdS", "CHEMICAL", 256, 259], ["fluorescein", "CHEMICAL", 178, 189], ["rhodamine", "CHEMICAL", 194, 203], ["CdS", "CHEMICAL", 256, 259], ["CdSe", "CHEMICAL", 261, 265], ["GaAs", "CHEMICAL", 271, 275], ["green fluorescent protein", "GENE_OR_GENE_PRODUCT", 109, 134], ["non-protein organic fluorophores", "SIMPLE_CHEMICAL", 136, 168], ["fluorescein", "SIMPLE_CHEMICAL", 178, 189], ["rhodamine", "SIMPLE_CHEMICAL", 194, 203], ["nanoparticles", "SIMPLE_CHEMICAL", 209, 222], ["CdS", "SIMPLE_CHEMICAL", 256, 259], ["CdSe", "SIMPLE_CHEMICAL", 261, 265], ["GaAs", "SIMPLE_CHEMICAL", 271, 275], ["green fluorescent protein", "PROTEIN", 109, 134], ["pathogen detection applications", "TREATMENT", 27, 58], ["biological fluorophores", "TREATMENT", 76, 99], ["green fluorescent protein", "TEST", 109, 134], ["non-protein organic fluorophores", "TREATMENT", 136, 168], ["fluorescein and rhodamine", "TREATMENT", 178, 203], ["nanoparticles", "TREATMENT", 209, 222]]], ["The use of such additional reagents to detect the target species is discussed further in the following sections.Antibodies and antibody fragments ::: Biorecognition elements ::: Electrochemical biosensor designs for pathogen detectionAntibodies and antibody fragments are among the most commonly utilized biorecognition elements for pathogen detection using electrochemical biosensors.", [["sections", "ANATOMY", 103, 111], ["antibody fragments", "PROTEIN", 127, 145], ["Biorecognition elements", "DNA", 150, 173], ["biorecognition elements", "DNA", 305, 328], ["such additional reagents", "TREATMENT", 11, 35], ["the target species", "PROBLEM", 46, 64], ["Antibodies", "TEST", 112, 122], ["Electrochemical biosensor designs", "TEST", 178, 211], ["pathogen detectionAntibodies", "TEST", 216, 244], ["antibody fragments", "PROBLEM", 249, 267], ["pathogen detection", "TEST", 333, 351], ["electrochemical biosensors", "TREATMENT", 358, 384], ["antibody fragments", "OBSERVATION", 127, 145]]], ["Biosensors employing antibody-based biorecognition elements are commonly referred to as immunosensors.", [["antibody-based biorecognition elements", "DNA", 21, 59], ["Biosensors employing antibody", "TEST", 0, 29]]], ["Given antibodies exhibit high selectivity and binding affinity for target species and can be generated for a wide range of infectious agents, antibodies are the gold-standard biorecognition element for pathogen detection.", [["antibodies", "PROTEIN", 6, 16], ["antibodies", "PROTEIN", 142, 152], ["antibodies", "PROBLEM", 6, 16], ["high selectivity", "PROBLEM", 25, 41], ["binding affinity", "PROBLEM", 46, 62], ["target species", "PROBLEM", 67, 81], ["infectious agents", "TREATMENT", 123, 140], ["pathogen detection", "TEST", 202, 220], ["high selectivity", "OBSERVATION", 25, 41]]], ["Antibodies contain recognition sites that selectively bind to antigens through a specific region of the antigen, referred to as an epitope (Patris et al. 2016).", [["antigens", "PROTEIN", 62, 70], ["Antibodies", "TREATMENT", 0, 10], ["recognition sites", "PROBLEM", 19, 36]]], ["Antibodies can be labeled with fluorescent or enzymatic tags, which leads to the designation of the approach as label-based.", [["fluorescent or enzymatic tags", "PROBLEM", 31, 60]]], ["While label-based approaches present measurement constraints associated with the use of additional reagents and processing steps (Cooper, 2009; Sang et al. 2016), antibody labeling may also alter the binding affinity to the antigen, which could affect the biosensor's selectivity.", [["additional reagents", "TREATMENT", 88, 107], ["antibody labeling", "TEST", 163, 180], ["the binding affinity", "PROBLEM", 196, 216]]], ["A detailed discussion of label-based biosensing approaches for pathogen detection has been reported elsewhere (Ahmed et al. 2014; Alahi and Mukhopadhyay, 2017; Bozal-Palabiyik et al. 2018; Leonard et al. 2003).", [["pathogen detection", "TEST", 63, 81]]], ["A list of recent label-based approaches for pathogen detection using electrochemical biosensors, however, is provided in Table 2.Antibodies and antibody fragments ::: Biorecognition elements ::: Electrochemical biosensor designs for pathogen detectionWhile both monoclonal and polyclonal antibodies enable the selective detection of pathogens (Patris et al. 2016), they vary in terms of production method, selectivity, and binding affinity.", [["antibody fragments", "PROTEIN", 144, 162], ["Biorecognition elements", "DNA", 167, 190], ["monoclonal and polyclonal antibodies", "PROTEIN", 262, 298], ["pathogen detection", "TEST", 44, 62], ["electrochemical biosensors", "TEST", 69, 95], ["Antibodies", "TEST", 129, 139], ["Electrochemical biosensor designs", "PROBLEM", 195, 228], ["pathogen", "PROBLEM", 233, 241], ["polyclonal antibodies", "TEST", 277, 298], ["pathogens", "PROBLEM", 333, 342], ["antibody fragments", "OBSERVATION", 144, 162]]], ["Monoclonal antibodies are produced by hybridoma technology (Birch and Racher, 2006; James and Bell, 1987).", [["Monoclonal antibodies", "PROTEIN", 0, 21], ["Monoclonal antibodies", "TEST", 0, 21]]], ["Thus, monoclonal antibodies are highly selective and bind to a single epitope, making them less vulnerable to cross-reactivity.", [["monoclonal antibodies", "PROTEIN", 6, 27], ["monoclonal antibodies", "TEST", 6, 27], ["a single epitope", "TREATMENT", 61, 77]]], ["While monoclonal antibodies tend to have a higher degree of selectivity, they are more expensive and take longer to develop than polyclonal antibodies.", [["monoclonal antibodies", "PROTEIN", 6, 27], ["polyclonal antibodies", "PROTEIN", 129, 150], ["monoclonal antibodies", "TEST", 6, 27], ["polyclonal antibodies", "TEST", 129, 150], ["higher degree", "OBSERVATION_MODIFIER", 43, 56]]], ["Polyclonal antibodies are produced by separation of immunoglobulin proteins from the blood of an infected host (Birch and Racher, 2006).", [["blood", "ANATOMY", 85, 90], ["immunoglobulin", "GENE_OR_GENE_PRODUCT", 52, 66], ["blood", "ORGANISM_SUBSTANCE", 85, 90], ["Polyclonal antibodies", "PROTEIN", 0, 21], ["immunoglobulin proteins", "PROTEIN", 52, 75], ["Polyclonal antibodies", "TEST", 0, 21], ["immunoglobulin proteins", "PROBLEM", 52, 75], ["the blood", "TEST", 81, 90], ["infected", "OBSERVATION", 97, 105]]], ["Polyclonal antibodies target different epitopes on a single antigen.", [["Polyclonal antibodies", "PROTEIN", 0, 21], ["epitopes", "PROTEIN", 39, 47], ["Polyclonal antibodies", "TEST", 0, 21]]], ["While polyclonal antibodies exhibit increased variability between batches, they are relatively less expensive to produce than monoclonal antibodies and facilitate robust measurements in various settings (Byrne et al. 2009).", [["polyclonal antibodies", "PROTEIN", 6, 27], ["monoclonal antibodies", "PROTEIN", 126, 147], ["polyclonal antibodies", "TEST", 6, 27], ["increased variability between batches", "PROBLEM", 36, 73], ["monoclonal antibodies", "TEST", 126, 147], ["increased", "OBSERVATION_MODIFIER", 36, 45], ["variability", "OBSERVATION_MODIFIER", 46, 57]]], ["Drawbacks to antibody use include high cost and stability challenges, such as the need for low-temperature storage.", [["high cost and stability challenges", "TREATMENT", 34, 68], ["low-temperature storage", "TREATMENT", 91, 114]]], ["As shown in Table 1, Table 2, both monoclonal and polyclonal antibodies are used as biorecognition elements for pathogen detection.", [["monoclonal and polyclonal antibodies", "PROTEIN", 35, 71], ["biorecognition elements", "DNA", 84, 107], ["both monoclonal and polyclonal antibodies", "TREATMENT", 30, 71], ["pathogen detection", "TEST", 112, 130]]], ["For assays involving secondary binding steps, monoclonal antibodies typically serve as the primary biorecognition element and are immobilized on the electrode, while polyclonal antibodies serve as the secondary biorecognition element and often facilitate target labeling.", [["monoclonal antibodies", "PROTEIN", 46, 67], ["biorecognition element", "DNA", 99, 121], ["polyclonal antibodies", "PROTEIN", 166, 187], ["biorecognition element", "DNA", 211, 233], ["assays", "TEST", 4, 10], ["secondary binding steps", "PROBLEM", 21, 44], ["monoclonal antibodies", "PROBLEM", 46, 67], ["the electrode", "TREATMENT", 145, 158], ["polyclonal antibodies", "TREATMENT", 166, 187]]], ["For assays that do not require secondary binding steps, polyclonal antibodies are also commonly used as immobilized biorecognition elements for pathogen detection.", [["polyclonal antibodies", "PROTEIN", 56, 77], ["biorecognition elements", "DNA", 116, 139], ["assays", "TEST", 4, 10], ["secondary binding steps", "PROBLEM", 31, 54], ["polyclonal antibodies", "TEST", 56, 77], ["pathogen detection", "TEST", 144, 162]]], ["For example, Pandey et al. immobilized monoclonal anti-E. coli on a composite nanostructured electrode to detect E. coli across a wide dynamic range of 10 to 108 CFU/mL with a LOD of 3.8 CFU/mL (Pandey et al. 2017).", [["anti-E. coli", "ORGANISM", 50, 62], ["E. coli", "ORGANISM", 113, 120], ["anti-E. coli", "SPECIES", 50, 62], ["E. coli", "SPECIES", 113, 120], ["anti-E. coli", "SPECIES", 50, 62], ["E. coli", "SPECIES", 113, 120], ["immobilized monoclonal anti-E. coli", "TREATMENT", 27, 62], ["a composite nanostructured electrode", "TREATMENT", 66, 102], ["E. coli", "PROBLEM", 113, 120], ["a LOD", "TEST", 174, 179], ["E. coli", "OBSERVATION", 113, 120], ["wide", "OBSERVATION_MODIFIER", 130, 134]]], ["Wu et al. used polyclonal anti-E. coli for detection of E. coli via amperometry that exhibited a LOD of 5 \u00d7 103 CFU/mL (Wu et al. 2016).", [["anti-E. coli", "ORGANISM", 26, 38], ["E. coli", "ORGANISM", 56, 63], ["anti-E. coli", "SPECIES", 26, 38], ["E. coli", "SPECIES", 56, 63], ["anti-E. coli", "SPECIES", 26, 38], ["E. coli", "SPECIES", 56, 63], ["polyclonal anti-E. coli", "TREATMENT", 15, 38], ["E. coli", "PROBLEM", 56, 63], ["a LOD", "TEST", 95, 100], ["E. coli", "OBSERVATION", 56, 63]]], ["Lin et al. used monoclonal antibodies for detection of avian influenza virus H5N1 in chicken swabs across a dynamic range of 2-1 to 24 hemagglutination units (HAU)/50 \u03bcL using EIS and the ferri/ferrocyanide (Fe(CN)63-/4-) couple as a redox probe (Lin et al. 2015).", [["swabs", "ANATOMY", 93, 98], ["influenza virus H5N1", "DISEASE", 61, 81], ["ferrocyanide", "CHEMICAL", 194, 206], ["Fe", "CHEMICAL", 208, 210], ["ferrocyanide", "CHEMICAL", 194, 206], ["Fe(CN)63-/4-)", "CHEMICAL", 208, 221], ["avian influenza virus H5N1", "ORGANISM", 55, 81], ["chicken", "ORGANISM", 85, 92], ["ferri", "SIMPLE_CHEMICAL", 188, 193], ["ferrocyanide", "SIMPLE_CHEMICAL", 194, 206], ["Fe(CN)", "SIMPLE_CHEMICAL", 208, 214], ["monoclonal antibodies", "PROTEIN", 16, 37], ["avian influenza virus H5N1", "SPECIES", 55, 81], ["chicken", "SPECIES", 85, 92], ["avian influenza virus H5N1", "SPECIES", 55, 81], ["chicken", "SPECIES", 85, 92], ["monoclonal antibodies", "TREATMENT", 16, 37], ["avian influenza virus H5N1", "TREATMENT", 55, 81], ["EIS", "TEST", 176, 179], ["the ferri/ferrocyanide (Fe(CN)", "TREATMENT", 184, 214], ["et al", "OBSERVATION", 4, 9]]], ["Luka et al. detected Cryptosporidium parvum (C. parvum) with a LOD of 40 cells/mm2 via capacitive sensing and Fe(CN)63-/4- (Luka et al. 2019).Antibodies and antibody fragments ::: Biorecognition elements ::: Electrochemical biosensor designs for pathogen detectionAntibody fragments, such as single-chain variable fragments (scFvs), offer selectivity similar to antibodies, but they have the advantage of achieving relatively higher packing densities on electrode surfaces due to their relatively smaller size.", [["cells", "ANATOMY", 73, 78], ["Cryptosporidium parvum", "DISEASE", 21, 43], ["Fe", "CHEMICAL", 110, 112], ["Fe(CN)", "CHEMICAL", 110, 116], ["Cryptosporidium parvum", "ORGANISM", 21, 43], ["C. parvum", "ORGANISM", 45, 54], ["antibody fragments", "PROTEIN", 157, 175], ["Biorecognition elements", "DNA", 180, 203], ["single-chain variable fragments", "PROTEIN", 292, 323], ["scFvs", "PROTEIN", 325, 330], ["antibodies", "PROTEIN", 362, 372], ["Cryptosporidium parvum", "SPECIES", 21, 43], ["C. parvum", "SPECIES", 45, 54], ["Cryptosporidium parvum", "SPECIES", 21, 43], ["C. parvum", "SPECIES", 45, 54], ["Cryptosporidium parvum (C. parvum", "PROBLEM", 21, 54], ["a LOD", "TEST", 61, 66], ["capacitive sensing", "TEST", 87, 105], ["Fe", "TEST", 110, 112], ["CN", "TEST", 113, 115], ["Antibodies", "TEST", 142, 152], ["Electrochemical biosensor designs", "PROBLEM", 208, 241], ["pathogen detectionAntibody fragments", "PROBLEM", 246, 282], ["single-chain variable fragments (scFvs", "PROBLEM", 292, 330], ["relatively higher packing densities on electrode surfaces", "PROBLEM", 415, 472], ["Cryptosporidium parvum", "OBSERVATION", 21, 43], ["parvum", "OBSERVATION_MODIFIER", 48, 54], ["antibody fragments", "OBSERVATION", 157, 175], ["Antibody fragments", "OBSERVATION", 264, 282], ["higher", "OBSERVATION_MODIFIER", 426, 432], ["packing densities", "OBSERVATION", 433, 450], ["relatively", "OBSERVATION_MODIFIER", 486, 496], ["smaller", "OBSERVATION_MODIFIER", 497, 504], ["size", "OBSERVATION_MODIFIER", 505, 509]]], ["For example, half-antibody fragments have been shown to improve biosensor sensitivity without the loss of selectivity, which warrants further investigation of reduced antibodies as biorecognition elements for pathogen detection applications (Sharma and Mutharasan, 2013).", [["reduced antibodies", "PROTEIN", 159, 177], ["biorecognition elements", "DNA", 181, 204], ["half-antibody fragments", "PROBLEM", 13, 36], ["biosensor sensitivity", "TEST", 64, 85], ["the loss of selectivity", "PROBLEM", 94, 117], ["further investigation", "TEST", 134, 155], ["reduced antibodies", "PROBLEM", 159, 177], ["antibody fragments", "OBSERVATION", 18, 36]]], ["In addition to scFvs, Fabs, re-engineered IgGs, and dimers can also potentially be used as biorecognition elements for pathogen detection (Byrne et al. 2009).Carbohydrate-binding proteins ::: Biorecognition elements ::: Electrochemical biosensor designs for pathogen detectionCarbohydrate-binding proteins, such as lectins, also provide selective biorecognition elements for pathogen detection based on their ability to selectively bind ligands on target species.", [["Carbohydrate", "CHEMICAL", 158, 170], ["Carbohydrate", "CHEMICAL", 276, 288], ["scFvs", "GENE_OR_GENE_PRODUCT", 15, 20], ["Fabs", "GENE_OR_GENE_PRODUCT", 22, 26], ["IgGs", "GENE_OR_GENE_PRODUCT", 42, 46], ["Carbohydrate-binding proteins", "GENE_OR_GENE_PRODUCT", 158, 187], ["scFvs", "PROTEIN", 15, 20], ["Fabs", "PROTEIN", 22, 26], ["re-engineered IgGs", "PROTEIN", 28, 46], ["biorecognition elements", "DNA", 91, 114], ["Carbohydrate-binding proteins", "PROTEIN", 158, 187], ["Biorecognition elements", "DNA", 192, 215], ["Carbohydrate-binding proteins", "PROTEIN", 276, 305], ["lectins", "PROTEIN", 315, 322], ["scFvs", "TEST", 15, 20], ["Fabs", "TEST", 22, 26], ["pathogen detection", "TEST", 119, 137], ["Electrochemical biosensor designs", "PROBLEM", 220, 253], ["pathogen", "PROBLEM", 258, 266], ["Carbohydrate-binding proteins", "TREATMENT", 276, 305], ["selective biorecognition elements", "TREATMENT", 337, 370], ["pathogen detection", "TEST", 375, 393]]], ["Peptide-based biorecognition elements are relatively low-cost, can be produced with high yield automated synthesis processes, and are modifiable (Pavan and Berti, 2012).", [["biorecognition elements", "DNA", 14, 37], ["Peptide-based biorecognition elements", "PROBLEM", 0, 37], ["high yield automated synthesis processes", "PROBLEM", 84, 124], ["biorecognition elements", "OBSERVATION", 14, 37], ["relatively", "OBSERVATION_MODIFIER", 42, 52], ["low", "OBSERVATION_MODIFIER", 53, 56]]], ["For example, lectins have been investigated as biorecognition elements for pathogen detection through their ability to selectively bind glycosylated proteins on the surfaces of viruses and cells (Reina et al. 2008).", [["cells", "ANATOMY", 189, 194], ["lectins", "GENE_OR_GENE_PRODUCT", 13, 20], ["cells", "CELL", 189, 194], ["lectins", "PROTEIN", 13, 20], ["biorecognition elements", "DNA", 47, 70], ["glycosylated proteins", "PROTEIN", 136, 157], ["pathogen detection", "TEST", 75, 93], ["viruses", "OBSERVATION", 177, 184]]], ["Concanavalin A (ConA) lectin has been extensively investigated for E. coli detection (see Table 1) (Jantra et al. 2011; Saucedo et al. 2019; Xi et al. 2011; Yang et al. 2016b).", [["Concanavalin A", "CHEMICAL", 0, 14], ["Concanavalin A", "GENE_OR_GENE_PRODUCT", 0, 14], ["ConA) lectin", "GENE_OR_GENE_PRODUCT", 16, 28], ["E. coli", "ORGANISM", 67, 74], ["Concanavalin A (ConA) lectin", "PROTEIN", 0, 28], ["E. coli", "SPECIES", 67, 74], ["E. coli", "SPECIES", 67, 74], ["Concanavalin A (ConA) lectin", "TREATMENT", 0, 28], ["E. coli detection", "PROBLEM", 67, 84]]], ["While not yet widely investigated for pathogen detection using electrochemical biosensors, Etayash et al. recently showed that oligopeptides also provide attractive biorecognition elements for real-time biosensor-based detection of breast cancer cells (Etayash et al. 2015).Oligosaccharides ::: Biorecognition elements ::: Electrochemical biosensor designs for pathogen detectionTrisaccharides are carbohydrates that can selectively bind carbohydrate-specific receptors on pathogens.", [["breast cancer cells", "ANATOMY", 232, 251], ["breast cancer", "DISEASE", 232, 245], ["Trisaccharides", "CHEMICAL", 379, 393], ["Oligosaccharides", "CHEMICAL", 274, 290], ["carbohydrates", "CHEMICAL", 398, 411], ["carbohydrate", "CHEMICAL", 438, 450], ["breast cancer cells", "CELL", 232, 251], ["Oligosaccharides", "SIMPLE_CHEMICAL", 274, 290], ["Trisaccharides", "SIMPLE_CHEMICAL", 379, 393], ["biorecognition elements", "DNA", 165, 188], ["breast cancer cells", "CELL_TYPE", 232, 251], ["Biorecognition elements", "DNA", 295, 318], ["carbohydrate-specific receptors", "PROTEIN", 438, 469], ["pathogen detection", "TEST", 38, 56], ["electrochemical biosensors", "TREATMENT", 63, 89], ["attractive biorecognition elements", "TREATMENT", 154, 188], ["breast cancer cells", "PROBLEM", 232, 251], ["Electrochemical biosensor designs", "TREATMENT", 323, 356], ["pathogen detectionTrisaccharides", "TREATMENT", 361, 393], ["carbohydrates", "TREATMENT", 398, 411], ["pathogens", "PROBLEM", 473, 482], ["breast", "ANATOMY", 232, 238], ["cancer", "OBSERVATION", 239, 245]]], ["Thus, trisaccharide ligands have been used as biorecognition elements for pathogen detection using electrochemical biosensors.", [["trisaccharide", "CHEMICAL", 6, 19], ["trisaccharide ligands", "SIMPLE_CHEMICAL", 6, 27], ["biorecognition elements", "DNA", 46, 69], ["trisaccharide ligands", "TREATMENT", 6, 27], ["pathogen detection", "TEST", 74, 92], ["electrochemical biosensors", "TREATMENT", 99, 125]]], ["For example, Hai et al. used a hybrid E-QCM biosensor coated with hemagglutinin-specific trisaccharide ligands for the detection of human influenza A virus (H1N1) (Hai et al. 2017).", [["influenza A virus", "DISEASE", 138, 155], ["human", "ORGANISM", 132, 137], ["influenza A virus", "ORGANISM", 138, 155], ["H1N1", "ORGANISM", 157, 161], ["hemagglutinin", "PROTEIN", 66, 79], ["human", "SPECIES", 132, 137], ["influenza A virus", "SPECIES", 138, 155], ["human influenza A virus", "SPECIES", 132, 155], ["a hybrid E-QCM biosensor", "TREATMENT", 29, 53], ["hemagglutinin-specific trisaccharide ligands", "TREATMENT", 66, 110], ["human influenza A virus", "PROBLEM", 132, 155]]], ["The use of carbohydrates as biorecognition elements is limited in part due to the weak affinity of carbohydrate-protein interactions and low selectivity, which are currently mitigated through secondary interactions (Zeng et al. 2012).Oligonucleotides ::: Biorecognition elements ::: Electrochemical biosensor designs for pathogen detectionSingle-stranded DNA (ssDNA) is a useful biorecognition element for the detection of pathogens.", [["carbohydrates", "CHEMICAL", 11, 24], ["carbohydrate", "CHEMICAL", 99, 111], ["carbohydrates", "SIMPLE_CHEMICAL", 11, 24], ["DNA", "CELLULAR_COMPONENT", 355, 358], ["ssDNA", "CELLULAR_COMPONENT", 360, 365], ["biorecognition elements", "DNA", 28, 51], ["Biorecognition elements", "DNA", 255, 278], ["pathogen detectionSingle-stranded DNA", "DNA", 321, 358], ["ssDNA", "DNA", 360, 365], ["biorecognition element", "DNA", 379, 401], ["carbohydrates", "TREATMENT", 11, 24], ["Electrochemical biosensor designs", "TEST", 283, 316], ["pathogen detectionSingle", "TEST", 321, 345], ["stranded DNA (ssDNA", "PROBLEM", 346, 365], ["pathogens", "PROBLEM", 423, 432], ["low selectivity", "OBSERVATION_MODIFIER", 137, 152], ["pathogens", "OBSERVATION", 423, 432]]], ["While ssDNA is commonly used as a biorecognition element for DNA-based assays, ssDNA aptamers are commonly used for pathogen detection using electrochemical biosensors.", [["ssDNA", "CELLULAR_COMPONENT", 6, 11], ["DNA", "CELLULAR_COMPONENT", 61, 64], ["ssDNA", "CELLULAR_COMPONENT", 79, 84], ["biorecognition element", "DNA", 34, 56], ["a biorecognition element", "TREATMENT", 32, 56], ["DNA-based assays", "TEST", 61, 77], ["ssDNA aptamers", "TREATMENT", 79, 93], ["pathogen detection", "TEST", 116, 134], ["electrochemical biosensors", "TREATMENT", 141, 167]]], ["Aptamers are single-stranded oligonucleotides capable of binding various molecules with high affinity and selectivity (Lakhin et al. 2013; Reverdatto et al. 2015).", [["Aptamers", "TREATMENT", 0, 8], ["single-stranded oligonucleotides", "TREATMENT", 13, 45], ["high affinity", "OBSERVATION_MODIFIER", 88, 101]]], ["Aptamers are isolated from a large random sequence pool through a selection process that utilizes systematic evolution of ligands by exponential enrichment, also known as SELEX (Stoltenburg et al. 2007).", [["a large random sequence pool", "PROBLEM", 27, 55], ["a selection process", "TREATMENT", 64, 83], ["systematic evolution of ligands", "PROBLEM", 98, 129], ["exponential", "OBSERVATION_MODIFIER", 133, 144], ["enrichment", "OBSERVATION", 145, 155]]], ["Suitable binding sequences can be isolated from a large random oligonucleotide sequence pool and subsequently amplified for use.", [["Suitable binding sequences", "TEST", 0, 26], ["a large random oligonucleotide sequence pool", "TREATMENT", 48, 92]]], ["Aptamers can also be produced at a lower cost than alternative biorecognition elements, such as antibodies.", [["biorecognition elements", "DNA", 63, 86], ["antibodies", "PROTEIN", 96, 106]]], ["Giamberardino et al. used SELEX to discover an aptamer for norovirus detection, which showed a million-fold higher binding affinity for the target than a random DNA strand that served as a negative control (Giamberardino et al. 2013).", [["DNA", "CELLULAR_COMPONENT", 161, 164], ["SELEX", "TREATMENT", 26, 31], ["norovirus detection", "TEST", 59, 78], ["a million-fold higher binding affinity", "PROBLEM", 93, 131], ["a random DNA strand", "TREATMENT", 152, 171]]], ["Iqbal et al. performed 10 rounds of SELEX to discover 14 aptamer clones with high affinities for C. parvum for detection in fruit samples (Iqbal et al. 2015).", [["fruit samples", "ANATOMY", 124, 137], ["C. parvum", "ORGANISM", 97, 106], ["C. parvum", "SPECIES", 97, 106], ["C. parvum", "SPECIES", 97, 106], ["SELEX", "TREATMENT", 36, 41], ["high affinities", "PROBLEM", 77, 92], ["C. parvum", "PROBLEM", 97, 106], ["et al", "OBSERVATION", 6, 11]]], ["However, the use of aptamers as biorecognition elements has not yet replaced traditional biorecognition elements, such as antibodies, because of several challenges, such as aptamer stability, degradation, cross-reactivity, and reproducibility using alternative processing approaches (Lakhin et al. 2013).Phages ::: Biorecognition elements ::: Electrochemical biosensor designs for pathogen detectionPhages, also referred to as bacteriophages, are viruses that infect and replicate in bacteria through selective binding via tail-spike proteins (Haq et al. 2012).", [["biorecognition elements", "DNA", 32, 55], ["biorecognition elements", "DNA", 89, 112], ["antibodies", "PROTEIN", 122, 132], ["Biorecognition elements", "DNA", 315, 338], ["tail-spike proteins", "PROTEIN", 523, 542], ["aptamers", "TREATMENT", 20, 28], ["Electrochemical biosensor designs", "PROBLEM", 343, 376], ["pathogen detectionPhages", "PROBLEM", 381, 405], ["viruses", "PROBLEM", 447, 454], ["spike proteins", "PROBLEM", 528, 542]]], ["Thus, they have been examined as biorecognition elements for pathogen detection using electrochemical biosensors (Kutter and Sulakvelidze, 2004).", [["biorecognition elements", "DNA", 33, 56], ["pathogen detection", "TEST", 61, 79], ["electrochemical biosensors", "TEST", 86, 112]]], ["Bacteriophages exhibit varying morphologies and are thus classified by selectivity and structure.", [["Bacteriophages", "PROBLEM", 0, 14], ["varying morphologies", "OBSERVATION_MODIFIER", 23, 43]]], ["A variety of bacteriophage-based electrochemical biosensors for pathogen detection can be found in Table 1.", [["bacteriophage", "TREATMENT", 13, 26], ["pathogen detection", "TEST", 64, 82], ["bacteriophage", "OBSERVATION", 13, 26]]], ["For example, Shabani et al. used E. coli-specific T4 bacteriophages for selective impedimetric detection studies (Shabani et al. 2008).", [["E. coli-specific T4 bacteriophages", "TREATMENT", 33, 67], ["selective impedimetric detection studies", "TEST", 72, 112]]], ["Mejri et al. compared the use of bacteriophages to antibodies as biorecognition elements for E. coli detection (Mejri et al. 2010).", [["E. coli", "ORGANISM", 93, 100], ["antibodies", "PROTEIN", 51, 61], ["biorecognition elements", "DNA", 65, 88], ["E. coli", "SPECIES", 93, 100], ["E. coli", "SPECIES", 93, 100], ["bacteriophages to antibodies", "TREATMENT", 33, 61], ["E. coli detection", "TEST", 93, 110]]], ["In that study, they found that bacteriophages improved the water stability of the biosensor and increased the sensitivity by approximately a factor of four relative to the response obtained with antibodies based on EIS measurements (Mejri et al. 2010).", [["antibodies", "PROTEIN", 195, 205], ["that study", "TEST", 3, 13], ["bacteriophages", "PROBLEM", 31, 45], ["the biosensor", "TEST", 78, 91], ["antibodies", "TREATMENT", 195, 205], ["EIS measurements", "TEST", 215, 231], ["bacteriophages", "OBSERVATION", 31, 45], ["water stability", "OBSERVATION_MODIFIER", 59, 74]]], ["In another study, Tolba et al. utilized immobilized bacteriophage-encoded peptidoglycan hydrolases on Au screen-printed electrodes for detection of L. innocua in pure milk with a LOD of 105 CFU/mL (Tolba et al. 2012).", [["milk", "ANATOMY", 167, 171], ["Au", "CHEMICAL", 102, 104], ["Au", "CHEMICAL", 102, 104], ["L. innocua", "ORGANISM", 148, 158], ["milk", "ORGANISM_SUBSTANCE", 167, 171], ["immobilized bacteriophage-encoded peptidoglycan hydrolases", "PROTEIN", 40, 98], ["L. innocua", "SPECIES", 148, 158], ["L. innocua", "SPECIES", 148, 158], ["another study", "TEST", 3, 16], ["immobilized bacteriophage", "TREATMENT", 40, 65], ["Au screen", "TEST", 102, 111]]], ["These results suggest that bacteriophages are potentially attractive biorecognition elements for water safety and environmental monitoring applications that require chronic monitoring of liquids.Cell- and molecularly-imprinted polymers ::: Biorecognition elements ::: Electrochemical biosensor designs for pathogen detectionGiven traditional biorecognition elements used in biosensing exhibit stability concerns, such as antibodies or aptamers, as discussed in Sections 2.2.1\u20132.2.4, there have been efforts to create engineered molecular biorecognition elements, such as scFvs.", [["Cell", "ANATOMY", 195, 199], ["Cell", "CELL", 195, 199], ["scFvs", "GENE_OR_GENE_PRODUCT", 571, 576], ["Biorecognition elements", "DNA", 240, 263], ["biorecognition elements", "DNA", 342, 365], ["antibodies", "PROTEIN", 421, 431], ["biorecognition elements", "DNA", 538, 561], ["scFvs", "PROTEIN", 571, 576], ["bacteriophages", "PROBLEM", 27, 41], ["water safety", "TREATMENT", 97, 109], ["environmental monitoring applications", "TREATMENT", 114, 151], ["chronic monitoring of liquids", "TREATMENT", 165, 194], ["Cell", "TEST", 195, 199], ["Electrochemical biosensor designs", "TREATMENT", 268, 301], ["pathogen", "PROBLEM", 306, 314], ["traditional biorecognition elements", "TREATMENT", 330, 365], ["bacteriophages", "OBSERVATION", 27, 41], ["biorecognition elements", "OBSERVATION", 538, 561]]], ["In contrast, materials-based biorecognition elements exploit the principle of target-specific morphology for selective capture (Pan et al. 2018; Zhou et al. 2019).", [["biorecognition elements", "DNA", 29, 52]]], ["The most common approach in materials-based biorecognition is based on cell- and molecularly-imprinted polymers (CIPs and MIPs, respectively) (Gui et al. 2018).", [["cell", "ANATOMY", 71, 75], ["cell", "CELL", 71, 75], ["CIPs", "SIMPLE_CHEMICAL", 113, 117], ["cell", "TEST", 71, 75], ["most common", "OBSERVATION_MODIFIER", 4, 15]]], ["CIPs and MIPs have been created using various processes, including bacteria-mediated lithography, micro-contact stamping, and colloid imprints (Chen et al. 2016a; Pan et al. 2018).Cell- and molecularly-imprinted polymers ::: Biorecognition elements ::: Electrochemical biosensor designs for pathogen detectionAs shown in Fig. 3b, Jafari et al. used imprinted organosilica sol-gel films of tetraethoxysilane and (3-mercaptopropyl)trimethoxysilane (MPTS) for selective detection of E. coli using an impedimetric method (Jafari et al. 2019).", [["Cell", "ANATOMY", 180, 184], ["organosilica sol-gel", "CHEMICAL", 359, 379], ["tetraethoxysilane", "CHEMICAL", 389, 406], ["3-mercaptopropyl)trimethoxysilane", "CHEMICAL", 412, 445], ["MPTS", "CHEMICAL", 447, 451], ["tetraethoxysilane", "CHEMICAL", 389, 406], ["(3-mercaptopropyl)trimethoxysilane", "CHEMICAL", 411, 445], ["MPTS", "CHEMICAL", 447, 451], ["CIPs", "SIMPLE_CHEMICAL", 0, 4], ["Cell", "CELL", 180, 184], ["tetraethoxysilane", "SIMPLE_CHEMICAL", 389, 406], ["(3-mercaptopropyl)trimethoxysilane", "SIMPLE_CHEMICAL", 411, 445], ["MPTS", "SIMPLE_CHEMICAL", 447, 451], ["E. coli", "ORGANISM", 480, 487], ["Biorecognition elements", "DNA", 225, 248], ["E. coli", "SPECIES", 480, 487], ["E. coli", "SPECIES", 480, 487], ["CIPs", "TEST", 0, 4], ["MIPs", "TEST", 9, 13], ["bacteria-mediated lithography", "TREATMENT", 67, 96], ["Cell", "TEST", 180, 184], ["Electrochemical biosensor designs", "PROBLEM", 253, 286], ["pathogen detectionAs", "PROBLEM", 291, 311], ["imprinted organosilica sol", "TREATMENT", 349, 375], ["tetraethoxysilane", "TREATMENT", 389, 406], ["3-mercaptopropyl)trimethoxysilane (MPTS)", "TREATMENT", 412, 452], ["E. coli", "PROBLEM", 480, 487], ["an impedimetric method", "TREATMENT", 494, 516], ["E. coli", "OBSERVATION", 480, 487]]], ["Similarly, Golabi et al. used imprinted poly(3-aminophenylboronic acid) films for detection of Staphylococcus epidermidis (S. epidermidis) (Golabi et al. 2017).", [["poly(3-aminophenylboronic acid", "CHEMICAL", 40, 70], ["Staphylococcus epidermidis", "DISEASE", 95, 121], ["poly(3-aminophenylboronic acid)", "CHEMICAL", 40, 71], ["poly(3-aminophenylboronic acid", "SIMPLE_CHEMICAL", 40, 70], ["Staphylococcus epidermidis", "ORGANISM", 95, 121], ["S. epidermidis", "ORGANISM", 123, 137], ["Staphylococcus epidermidis", "SPECIES", 95, 121], ["S. epidermidis", "SPECIES", 123, 137], ["Staphylococcus epidermidis", "SPECIES", 95, 121], ["S. epidermidis", "SPECIES", 123, 137], ["imprinted poly(3-aminophenylboronic acid) films", "TREATMENT", 30, 77], ["Staphylococcus epidermidis", "PROBLEM", 95, 121], ["S. epidermidis", "PROBLEM", 123, 137], ["Staphylococcus epidermidis", "OBSERVATION", 95, 121]]], ["Despite the absence of a highly selective molecular biorecognition element, CIPs and MIPs exhibit selectivity when exposed to samples that contain multiple analytes (i.e., non-target species) (Golabi et al. 2017; Jafari et al. 2019; Qi et al. 2013).", [["samples", "ANATOMY", 126, 133], ["CIPs", "SIMPLE_CHEMICAL", 76, 80], ["biorecognition element", "DNA", 52, 74], ["CIPs", "DNA", 76, 80], ["multiple analytes", "TEST", 147, 164], ["biorecognition element", "OBSERVATION", 52, 74], ["multiple", "OBSERVATION_MODIFIER", 147, 155]]], ["MIPs and CIPs are also of interest with regard to opportunities in biosensor regeneration.", [["CIPs", "SIMPLE_CHEMICAL", 9, 13], ["biosensor regeneration", "PROBLEM", 67, 89], ["biosensor regeneration", "OBSERVATION", 67, 89]]], ["Common adverse effects of regeneration on biosensors that employ molecular biorecognition elements, such as irreversible changes in structure, are less likely to affect MIPs and CIPs.", [["CIPs", "GENE_OR_GENE_PRODUCT", 178, 182], ["regeneration on biosensors", "PROBLEM", 26, 52], ["irreversible changes in structure", "PROBLEM", 108, 141], ["regeneration", "OBSERVATION", 26, 38], ["biorecognition elements", "OBSERVATION", 75, 98], ["irreversible", "OBSERVATION_MODIFIER", 108, 120], ["less likely", "UNCERTAINTY", 147, 158]]], ["However, it is generally accepted that current CIPs and MIPs exhibit lower selectivity to target species than antibodies and aptamers due to reduction of available chemical selectivity (Cheong et al. 2013; Kryscio and Peppas, 2012; Y\u00e1\u00f1ez-Sede\u00f1o et al. 2017).Immobilization and surface passivation ::: Electrochemical biosensor designs for pathogen detectionGiven biosensors are self-contained devices composed of integrated transducer-biorecognition elements, the immobilization of biorecognition elements on electrodes is central to the design, fabrication, and performance of electrochemical biosensors for pathogen detection.", [["surface", "ANATOMY", 277, 284], ["CIPs", "SIMPLE_CHEMICAL", 47, 51], ["antibodies", "PROTEIN", 110, 120], ["transducer-biorecognition elements", "DNA", 424, 458], ["biorecognition elements", "DNA", 482, 505], ["current CIPs", "TEST", 39, 51], ["antibodies", "TEST", 110, 120], ["Electrochemical biosensor designs", "PROBLEM", 301, 334], ["pathogen detection", "TEST", 339, 357], ["biosensors", "TREATMENT", 363, 373], ["self-contained devices", "TREATMENT", 378, 400], ["integrated transducer-biorecognition elements", "TREATMENT", 413, 458], ["the immobilization of biorecognition elements on electrodes", "TREATMENT", 460, 519], ["fabrication", "TREATMENT", 546, 557], ["electrochemical biosensors", "TEST", 578, 604], ["pathogen detection", "TEST", 609, 627]]], ["The goal of immobilization is to achieve a stable, irreversible bond between the biorecognition element and the electrode with suitable packing density and orientation that maintains high accessibility and binding affinity to target species.", [["biorecognition element", "DNA", 81, 103], ["immobilization", "TREATMENT", 12, 26], ["a stable, irreversible bond between the biorecognition element", "PROBLEM", 41, 103], ["the electrode", "TREATMENT", 108, 121], ["suitable packing density", "TREATMENT", 127, 151], ["stable", "OBSERVATION", 43, 49], ["irreversible bond", "OBSERVATION", 51, 68], ["biorecognition element", "OBSERVATION", 81, 103], ["packing density", "OBSERVATION", 136, 151], ["high accessibility", "OBSERVATION", 183, 201]]], ["Electrochemical biosensors for pathogen detection have typically used established techniques for preparation of the biorecognition layer.", [["Electrochemical biosensors", "TEST", 0, 26], ["pathogen detection", "TEST", 31, 49], ["the biorecognition layer", "TREATMENT", 112, 136]]], ["A detailed discussion of immobilization and surface passivation techniques is provided in Supporting Information.Thermodynamics of pathogen-biorecognition element binding reactions ::: Electrochemical biosensor designs for pathogen detectionWhile the rate of biosensor response is typically governed by a mass transfer-limited heterogeneous reaction between the immobilized biorecognition element and target species, the net change in the biosensor response is dependent on the reaction thermodynamics.", [["surface", "ANATOMY", 44, 51], ["biorecognition element", "DNA", 374, 396], ["immobilization and surface passivation techniques", "TREATMENT", 25, 74], ["Electrochemical biosensor designs", "PROBLEM", 185, 218], ["pathogen", "PROBLEM", 223, 231], ["a mass transfer", "PROBLEM", 303, 318], ["limited heterogeneous reaction", "PROBLEM", 319, 349], ["the immobilized biorecognition element", "PROBLEM", 358, 396], ["target species", "PROBLEM", 401, 415], ["the net change", "PROBLEM", 417, 431], ["the reaction thermodynamics", "PROBLEM", 474, 501], ["mass", "OBSERVATION", 305, 309], ["heterogeneous", "OBSERVATION_MODIFIER", 327, 340], ["reaction", "OBSERVATION", 341, 349]]], ["The binding affinity between a biorecognition element and target species, such as an antibody and antigen, is often reported in terms of a dissociation constant (KD), which has units of M. While the value of KD, solution = 1 nM provides a reasonable estimate for biosensor design considerations, such as understanding the mass transfer limitations associated with biosensor response (Squires et al. 2008), the binding affinity of antibodies can vary by orders of magnitude depending on the pathogen of interest and the clonality of the antibody.", [["biorecognition element", "DNA", 31, 53], ["antibodies", "PROTEIN", 430, 440], ["The binding affinity", "PROBLEM", 0, 20], ["a biorecognition element", "PROBLEM", 29, 53], ["target species", "PROBLEM", 58, 72], ["an antibody and antigen", "TEST", 82, 105], ["the mass transfer limitations", "PROBLEM", 318, 347], ["the binding affinity of antibodies", "PROBLEM", 406, 440]]], ["One important consideration when immobilizing biorecognition elements is potential effects of immobilization on binding affinity to the target.", [["biorecognition elements", "DNA", 46, 69], ["immobilizing biorecognition elements", "PROBLEM", 33, 69], ["immobilization on binding affinity", "TREATMENT", 94, 128]]], ["Traditionally, KD is obtained from a kinetic or thermodynamic analysis.", [["a kinetic or thermodynamic analysis", "TEST", 35, 70]]], ["Kinetic analyses measure association and dissociation rate constants (ka and kd, respectively) and enable calculation of KD as kd/ka.", [["Kinetic analyses", "TEST", 0, 16], ["dissociation rate constants", "PROBLEM", 41, 68]]], ["Thermodynamic analyses, such as calorimetric techniques, measure the binding enthalpy and entropy, which in turn provides the standard Gibbs free energy of the reaction (\u0394G\u00b0), and thus, KA = KD\u22121 though the expression KA = exp(-\u0394G\u00b0/RT), where R is the gas constant and T is the temperature.", [["Thermodynamic analyses", "TEST", 0, 22], ["calorimetric techniques", "TEST", 32, 55], ["the binding enthalpy", "TREATMENT", 65, 85], ["the reaction", "PROBLEM", 156, 168], ["the expression KA", "TEST", 203, 220], ["\u0394G\u00b0/RT", "TREATMENT", 228, 234], ["the gas constant", "PROBLEM", 248, 264], ["gas", "OBSERVATION", 252, 255]]], ["A detailed discussion of the kinetics and thermodynamics of biorecognition element-target binding reactions for solution- and surface-based biosensors is provided in Supporting Information.Sample filtration ::: Sample preparation: Filtration and pre-concentration ::: Measurement formats for pathogen detectionGenerally, sample filtration relies on the principle of size discrepancy between the target pathogen and background species.", [["biorecognition element", "DNA", 60, 82], ["biorecognition element", "PROBLEM", 60, 82], ["target binding reactions", "PROBLEM", 83, 107], ["solution", "TREATMENT", 112, 120], ["Measurement formats", "TEST", 268, 287], ["pathogen detection", "TEST", 292, 310], ["sample filtration", "TEST", 321, 338], ["size discrepancy", "PROBLEM", 366, 382], ["background species", "PROBLEM", 415, 433], ["size", "OBSERVATION_MODIFIER", 366, 370], ["target", "OBSERVATION_MODIFIER", 395, 401], ["pathogen", "OBSERVATION", 402, 410], ["background species", "OBSERVATION", 415, 433]]], ["Membranes, fibers, and channels have been used in size-selective sample filtration processes for biosensing applications.", [["Membranes", "ANATOMY", 0, 9], ["fibers", "ANATOMY", 11, 17], ["fibers", "CELLULAR_COMPONENT", 11, 17], ["selective sample filtration processes", "TREATMENT", 55, 92], ["biosensing applications", "TREATMENT", 97, 120], ["size", "OBSERVATION_MODIFIER", 50, 54]]], ["Biorecognition elements are commonly used to assist the separation process when the target species exhibits similar properties to background species or the matrix.", [["matrix", "ANATOMY", 156, 162], ["matrix", "CELLULAR_COMPONENT", 156, 162], ["Biorecognition elements", "DNA", 0, 23], ["the target species", "PROBLEM", 80, 98]]], ["For example, biorecognition elements that exhibit affinity to a broad group of pathogens, such as lectins, have been used in pre-concentration steps for pathogen detection (Zourob et al. 2008).", [["lectins", "GENE_OR_GENE_PRODUCT", 98, 105], ["biorecognition elements", "DNA", 13, 36], ["lectins", "PROTEIN", 98, 105], ["pathogens", "PROBLEM", 79, 88], ["pathogen detection", "TEST", 153, 171]]], ["Bacteria typically exhibit a net negative charge at physiological pH (7.4) because of an abundance of lipopolysaccharides or teichoic acids on the cell membrane (Gram-negative bacteria and Gram-positive bacteria, respectively) (Silhavy et al. 2010).", [["cell membrane", "ANATOMY", 147, 160], ["teichoic acids", "CHEMICAL", 125, 139], ["teichoic acids", "CHEMICAL", 125, 139], ["lipopolysaccharides", "SIMPLE_CHEMICAL", 102, 121], ["teichoic acids", "SIMPLE_CHEMICAL", 125, 139], ["cell membrane", "CELLULAR_COMPONENT", 147, 160], ["Gram-negative bacteria", "GENE_OR_GENE_PRODUCT", 162, 184], ["Gram-positive", "GENE_OR_GENE_PRODUCT", 189, 202], ["Bacteria", "PROBLEM", 0, 8], ["a net negative charge", "PROBLEM", 27, 48], ["physiological pH", "TEST", 52, 68], ["lipopolysaccharides", "PROBLEM", 102, 121], ["teichoic acids", "PROBLEM", 125, 139], ["the cell membrane", "TEST", 143, 160], ["Gram-negative bacteria", "PROBLEM", 162, 184], ["Gram-positive bacteria", "PROBLEM", 189, 211], ["net", "OBSERVATION_MODIFIER", 29, 32], ["negative charge", "OBSERVATION_MODIFIER", 33, 48]]], ["This physical property of cell-based pathogens is leveraged in biofiltration processes, for example, using electropositive filters (Altintas et al. 2015).", [["cell", "ANATOMY", 26, 30], ["cell", "CELL", 26, 30], ["cell-based pathogens", "PROBLEM", 26, 46], ["electropositive filters", "TREATMENT", 107, 130], ["pathogens", "OBSERVATION", 37, 46], ["biofiltration", "OBSERVATION", 63, 76]]], ["While the majority of the aforementioned separation processes involve manual handling steps, sample filtration processes are now being integrated with microfluidic-based biosensing platforms (Song et al. 2013).", [["manual handling steps", "TREATMENT", 70, 91], ["sample filtration processes", "TREATMENT", 93, 120]]], ["For example, Chand and Neethirajan incorporated an integrated sample filtration technique using silica microbeads for the detection of norovirus in spiked blood samples (Chand and Neethirajan 2017).Centrifugal separation ::: Sample preparation: Filtration and pre-concentration ::: Measurement formats for pathogen detectionCentrifugation can be used as a density gradient-based separation principle for concentrating target pathogens within a sample.", [["blood samples", "ANATOMY", 155, 168], ["silica", "CHEMICAL", 96, 102], ["norovirus", "DISEASE", 135, 144], ["silica", "CHEMICAL", 96, 102], ["norovirus", "ORGANISM", 135, 144], ["blood samples", "ORGANISM_SUBSTANCE", 155, 168], ["norovirus", "SPECIES", 135, 144], ["an integrated sample filtration technique", "TREATMENT", 48, 89], ["silica microbeads", "TREATMENT", 96, 113], ["norovirus", "PROBLEM", 135, 144], ["blood samples", "TEST", 155, 168], ["Measurement formats", "TEST", 282, 301], ["pathogen detectionCentrifugation", "TREATMENT", 306, 338], ["a density gradient-based separation principle", "TREATMENT", 354, 399], ["concentrating target pathogens", "PROBLEM", 404, 434], ["norovirus", "OBSERVATION", 135, 144]]], ["In cases where the target species exhibits similar density to background species, the approach is often implemented with antibody-functionalized beads.", [["the target species", "PROBLEM", 15, 33], ["background species", "PROBLEM", 62, 80], ["antibody-functionalized beads", "TREATMENT", 121, 150], ["similar", "OBSERVATION_MODIFIER", 43, 50], ["density", "OBSERVATION", 51, 58], ["background species", "OBSERVATION", 62, 80], ["functionalized beads", "OBSERVATION", 130, 150]]], ["This technique is commonly employed in applications requiring pathogen detection in complex matrices (e.g., body fluids).", [["body fluids", "ANATOMY", 108, 119], ["body", "ORGANISM_SUBDIVISION", 108, 112], ["This technique", "TREATMENT", 0, 14], ["pathogen detection in complex matrices (e.g., body fluids", "TREATMENT", 62, 119]]], ["Centrifugation-based separation techniques can also potentially be applied to microfluidic-based biosensing platforms.", [["Centrifugation-based separation techniques", "TREATMENT", 0, 42]]], ["For example, Lee et al. utilized centrifugal microfluidics to process a whole blood sample for subsequent analysis using ELISA (Lee et al. 2009), suggesting that this approach could be extended to electrochemical biosensor-based assays for pathogen detection.Broth enrichment ::: Sample preparation: Filtration and pre-concentration ::: Measurement formats for pathogen detectionBroth enrichment is a technique used to increase the concentration of target species in the sample through growth or replication of target species prior to measurement, thereby increasing the number present for detection.", [["blood sample", "ANATOMY", 78, 90], ["sample", "ANATOMY", 471, 477], ["blood", "ORGANISM_SUBSTANCE", 78, 83], ["centrifugal microfluidics", "TREATMENT", 33, 58], ["a whole blood sample", "TEST", 70, 90], ["subsequent analysis", "TEST", 95, 114], ["ELISA", "TEST", 121, 126], ["electrochemical biosensor", "TEST", 197, 222], ["pathogen detection", "TEST", 240, 258], ["Measurement formats", "TEST", 337, 356], ["pathogen detection", "TEST", 361, 379], ["a technique", "TREATMENT", 399, 410], ["target species", "PROBLEM", 449, 463], ["target species", "PROBLEM", 511, 525]]], ["The technique is commonly used in food safety applications.", [["The technique", "TREATMENT", 0, 13]]], ["For example, Liebana et al. enriched S. typhimurium-spiked milk samples in Luria broth (LB) for 8 h to improve the assay LOD from 7.5 \u00d7 103 CFU/mL for the 50-min enriched sample to 0.108 CFU/mL (Liebana et al. 2009).", [["milk samples", "ANATOMY", 59, 71], ["sample", "ANATOMY", 171, 177], ["S. typhimurium", "ORGANISM", 37, 51], ["milk samples", "ORGANISM_SUBSTANCE", 59, 71], ["S. typhimurium", "SPECIES", 37, 51], ["milk", "SPECIES", 59, 63], ["S. typhimurium", "SPECIES", 37, 51], ["the assay LOD", "TEST", 111, 124], ["typhimurium", "OBSERVATION_MODIFIER", 40, 51]]], ["Salam et al. enriched fresh chicken samples in enrichment buffer peptone for 18\u201324 h to recover injured S. typhimurium cells for detection via chronoamperometry (Salam and Tothill, 2009).", [["samples", "ANATOMY", 36, 43], ["cells", "ANATOMY", 119, 124], ["peptone", "CHEMICAL", 65, 72], ["chicken", "ORGANISM", 28, 35], ["samples", "ORGANISM_SUBSTANCE", 36, 43], ["S. typhimurium cells", "CELL", 104, 124], ["injured S. typhimurium cells", "CELL_LINE", 96, 124], ["chicken", "SPECIES", 28, 35], ["S. typhimurium", "SPECIES", 104, 118], ["chicken", "SPECIES", 28, 35], ["S. typhimurium", "SPECIES", 104, 118], ["enrichment buffer peptone", "TREATMENT", 47, 72], ["fresh chicken", "OBSERVATION", 22, 35]]], ["While enrichment can be a useful sample preparation step when the target concentration is below the biosensor's LOD, it is inherently limited to viable and cultural organisms.", [["a useful sample preparation step", "TREATMENT", 24, 56], ["the biosensor's LOD", "TEST", 96, 115], ["viable and cultural organisms", "PROBLEM", 145, 174]]], ["Further, analysis of the results obtained from multiple samples should consider potential differences in the growth rate of bacteria across different samples.", [["samples", "ANATOMY", 150, 157], ["multiple samples", "TEST", 47, 63], ["the growth rate", "TEST", 105, 120], ["bacteria", "PROBLEM", 124, 132]]], ["It is important to note that the need for sample enrichment significantly increases the TTR and impedes rapid and real-time detection.Magnetic separation ::: Sample preparation: Filtration and pre-concentration ::: Measurement formats for pathogen detectionThe separation of the target species from a sample using magnetic beads has become a commonly used sample preparation approach in pathogen detection applications.", [["sample", "ANATOMY", 301, 307], ["sample", "ANATOMY", 356, 362], ["TTR", "PROTEIN", 88, 91], ["sample enrichment", "TEST", 42, 59], ["the TTR", "TEST", 84, 91], ["Measurement formats", "TEST", 215, 234], ["pathogen detection", "TEST", 239, 257], ["the target species", "PROBLEM", 275, 293], ["a sample using magnetic beads", "TREATMENT", 299, 328], ["separation", "OBSERVATION_MODIFIER", 261, 271], ["target", "OBSERVATION_MODIFIER", 279, 285], ["species", "OBSERVATION", 286, 293]]], ["Target pre-concentration via magnetic bead-based separation processes typically involves the binding of antibody-functionalized magnetic beads to the target species.", [["antibody", "PROTEIN", 104, 112], ["Target pre-concentration via magnetic bead-based separation processes", "TREATMENT", 0, 69], ["magnetic bead", "OBSERVATION_MODIFIER", 29, 42], ["target species", "OBSERVATION", 150, 164]]], ["The bead-target complexes are subsequently separated from the solution by externally-applied magnetic fields.", [["bead-target complexes", "PROTEIN", 4, 25], ["The bead-target complexes", "TREATMENT", 0, 25], ["bead", "OBSERVATION_MODIFIER", 4, 8], ["target complexes", "OBSERVATION", 9, 25]]], ["Magnetic-assisted separation processes are useful when the target species exhibits similar properties to other analytes or background species in the sample, such as those with similar size, density, or chemical properties (Chen et al. 2017).", [["sample", "ANATOMY", 149, 155], ["Magnetic-assisted separation processes", "TREATMENT", 0, 38], ["the target species", "PROBLEM", 55, 73], ["background species", "PROBLEM", 123, 141], ["similar", "OBSERVATION_MODIFIER", 176, 183], ["size", "OBSERVATION_MODIFIER", 184, 188], ["density", "OBSERVATION", 190, 197]]], ["The bead-target complexes are then introduced directly to the biosensor to enable quantification of the target pathogen that was present in the initial sample.", [["sample", "ANATOMY", 152, 158], ["bead-target complexes", "PROTEIN", 4, 25], ["The bead-target complexes", "TREATMENT", 0, 25], ["the target pathogen", "PROBLEM", 100, 119], ["bead", "OBSERVATION_MODIFIER", 4, 8], ["target", "OBSERVATION_MODIFIER", 104, 110], ["pathogen", "OBSERVATION", 111, 119]]], ["As shown in Table 2, magnetic bead-based separation processes have been extensively used for pathogen detection as well as general substrates for traditional immunoassays.", [["magnetic bead-based separation processes", "TREATMENT", 21, 61], ["pathogen detection", "TEST", 93, 111], ["traditional immunoassays", "TEST", 146, 170], ["separation", "OBSERVATION", 41, 51]]], ["Such assays have been used to detect a variety of pathogens, including bacteria, such as E. coli (Chan et al. 2013) and Bacillus anthracis (B. anthracis) (Pal and Alocilja, 2009), and viruses, such as bovine viral diarrhea virus (Luo et al. 2010) and human influenza A virus (Shen et al. 2012).", [["bovine viral diarrhea virus", "DISEASE", 201, 228], ["influenza A", "DISEASE", 257, 268], ["E. coli", "ORGANISM", 89, 96], ["Chan et al. 2013", "ORGANISM", 98, 114], ["Bacillus anthracis", "ORGANISM", 120, 138], ["B. anthracis", "ORGANISM", 140, 152], ["bovine viral diarrhea virus", "ORGANISM", 201, 228], ["human influenza A virus", "ORGANISM", 251, 274], ["E. coli", "SPECIES", 89, 96], ["Bacillus anthracis", "SPECIES", 120, 138], ["B. anthracis", "SPECIES", 140, 152], ["bovine", "SPECIES", 201, 207], ["viral diarrhea virus", "SPECIES", 208, 228], ["human", "SPECIES", 251, 256], ["influenza A virus", "SPECIES", 257, 274], ["E. coli", "SPECIES", 89, 96], ["Bacillus anthracis", "SPECIES", 120, 138], ["B. anthracis", "SPECIES", 140, 152], ["bovine viral diarrhea virus", "SPECIES", 201, 228], ["human influenza A virus", "SPECIES", 251, 274], ["Such assays", "TEST", 0, 11], ["pathogens", "PROBLEM", 50, 59], ["bacteria", "PROBLEM", 71, 79], ["E. coli", "PROBLEM", 89, 96], ["Bacillus anthracis (B. anthracis", "PROBLEM", 120, 152], ["Pal and Alocilja", "TEST", 155, 171], ["viruses", "PROBLEM", 184, 191], ["bovine viral diarrhea virus", "PROBLEM", 201, 228], ["human influenza A virus", "PROBLEM", 251, 274], ["viruses", "OBSERVATION", 184, 191]]], ["In addition to serving as a separation agent, magnetic beads also serve as labels.Sample handling formats ::: Measurement formats for pathogen detectionThe sample handling format is highly influenced by the biosensor application.", [["sample", "ANATOMY", 156, 162], ["a separation agent", "TREATMENT", 26, 44], ["magnetic beads", "TREATMENT", 46, 60], ["Measurement formats", "TEST", 110, 129], ["pathogen detection", "TEST", 134, 152], ["The sample handling format", "TEST", 152, 178], ["the biosensor application", "TREATMENT", 203, 228]]], ["As discussed in further detail in the following sections, pathogens are present in liquid and solid matrices and on surfaces (e.g., of biomedical devices).", [["sections", "ANATOMY", 48, 56], ["pathogens", "PROBLEM", 58, 67], ["liquid and solid matrices", "TREATMENT", 83, 108], ["biomedical devices", "TREATMENT", 135, 153]]], ["In addition, pathogens can be aerosolized, which is a significant mode of disease transmission associated with viral pathogens (e.g., influenza and COVID-19).", [["influenza", "DISEASE", 134, 143], ["pathogens", "PROBLEM", 13, 22], ["disease transmission", "PROBLEM", 74, 94], ["viral pathogens", "PROBLEM", 111, 126], ["influenza", "PROBLEM", 134, 143], ["COVID", "TEST", 148, 153], ["aerosolized", "OBSERVATION", 30, 41], ["significant", "OBSERVATION_MODIFIER", 54, 65], ["disease", "OBSERVATION", 74, 81], ["viral pathogens", "OBSERVATION", 111, 126]]], ["Sample handling formats can be generally classified as droplet-, flow-, or surface-based.Sample handling formats ::: Measurement formats for pathogen detectionDroplet formats involve sampling from a larger volume of potentially pathogen-containing material or fluid.", [["Sample handling formats", "TEST", 0, 23], ["droplet", "TEST", 55, 62], ["Measurement formats", "TEST", 117, 136], ["pathogen detectionDroplet formats", "TEST", 141, 174], ["fluid", "PROBLEM", 260, 265], ["larger", "OBSERVATION_MODIFIER", 199, 205], ["volume", "OBSERVATION_MODIFIER", 206, 212], ["potentially", "OBSERVATION_MODIFIER", 216, 227], ["pathogen", "OBSERVATION", 228, 236], ["fluid", "OBSERVATION", 260, 265]]], ["The sample droplet is subsequently analyzed by deposition on a functionalized transducer or transferred to a fluidic delivery system.", [["sample droplet", "ANATOMY", 4, 18], ["The sample droplet", "TEST", 0, 18], ["a functionalized transducer", "TREATMENT", 61, 88], ["a fluidic delivery system", "TREATMENT", 107, 132]]], ["For example, Cheng et al. created an electrochemical biosensor based on a nanoporous alumina electrode tip capable of analyzing 5 \u03bcL of dengue virus-containing solutions (Cheng et al. 2012).", [["dengue", "DISEASE", 136, 142], ["alumina", "CHEMICAL", 85, 92], ["dengue virus", "SPECIES", 136, 148], ["an electrochemical biosensor", "TEST", 34, 62], ["a nanoporous alumina electrode tip", "TREATMENT", 72, 106], ["dengue virus", "PROBLEM", 136, 148], ["alumina electrode", "OBSERVATION", 85, 102]]], ["Droplet formats are simplistic sample handling formats and have the advantage of being performed by unskilled users.", [["Droplet formats", "TEST", 0, 15]]], ["While dropletformats have been extensively used with colorimetric biosensors, they have also been adapted for electrochemical biosensors.", [["dropletformats", "SIMPLE_CHEMICAL", 6, 20], ["colorimetric biosensors", "TEST", 53, 76], ["electrochemical biosensors", "TREATMENT", 110, 136]]], ["For example, commercially-available blood glucose meters use a droplet format (Vashist et al. 2011).", [["blood", "ANATOMY", 36, 41], ["glucose", "CHEMICAL", 42, 49], ["glucose", "CHEMICAL", 42, 49], ["blood", "ORGANISM_SUBSTANCE", 36, 41], ["glucose", "SIMPLE_CHEMICAL", 42, 49]]], ["Examples of low-cost, paper-based, or disposable electrochemical biosensors for pathogen detection that utilize droplet formats are provided in Table 1.", [["disposable electrochemical biosensors", "TEST", 38, 75], ["pathogen detection", "TEST", 80, 98], ["droplet formats", "TREATMENT", 112, 127]]], ["For example, Zhao et al. created a screen-printed graphite-based electrode for electrochemical detection of Vibrio parahaemolyticus (V. parahaemolyticus) based on 5 \u03bcL samples (Zhao et al. 2007).", [["graphite", "CHEMICAL", 50, 58], ["graphite", "CHEMICAL", 50, 58], ["Vibrio parahaemolyticus", "ORGANISM", 108, 131], ["V. parahaemolyticus", "ORGANISM", 133, 152], ["Vibrio parahaemolyticus", "SPECIES", 108, 131], ["V. parahaemolyticus", "SPECIES", 133, 152], ["Vibrio parahaemolyticus", "SPECIES", 108, 131], ["V. parahaemolyticus", "SPECIES", 133, 152], ["a screen", "TEST", 33, 41], ["electrochemical detection", "TEST", 79, 104], ["Vibrio parahaemolyticus", "PROBLEM", 108, 131]]], ["However, while droplet formats minimize the technical and methodological barriers to measurement, such as eliminating the need for physical systems associated with biosensor housing and sample handling, they can exhibit measurement challenges associated with mass transport and target sampling limitations.Sample handling formats ::: Measurement formats for pathogen detectionOne of the most critical considerations associated with application of droplet formats to pathogen detection is sampling, specifically if sufficient sampling has been performed on the system for which bioanalytical information is desired (e.g., a human, a food source, or source of drinking water).", [["human", "ORGANISM", 623, 628], ["human", "SPECIES", 623, 628], ["human", "SPECIES", 623, 628], ["physical systems", "TREATMENT", 131, 147], ["biosensor housing", "TREATMENT", 164, 181], ["mass transport", "PROBLEM", 259, 273], ["Measurement formats", "TEST", 334, 353], ["pathogen", "PROBLEM", 358, 366], ["pathogen detection", "TEST", 466, 484]]], ["For example, the rationale that the bioanalytical characteristics of a droplet represent that of the bulk system is sound only in a well-mixed system, specifically, a system that exhibits a uniform spatial distribution of species (i.e., concentration profile).", [["droplet", "OBSERVATION", 71, 78], ["sound", "OBSERVATION_MODIFIER", 116, 121], ["uniform", "OBSERVATION_MODIFIER", 190, 197], ["spatial", "OBSERVATION_MODIFIER", 198, 205], ["distribution", "OBSERVATION_MODIFIER", 206, 218], ["species", "OBSERVATION", 222, 229]]], ["We note that while this is typically the case for samples acquired from closed, convective systems, such as body fluids, it should be challenged when considering open systems that exhibit complex flow profiles or regions of static fluid.", [["samples", "ANATOMY", 50, 57], ["body fluids", "ANATOMY", 108, 119], ["body", "ORGANISM_SUBDIVISION", 108, 112], ["closed, convective systems", "TREATMENT", 72, 98], ["body fluids", "TREATMENT", 108, 119], ["open systems", "TEST", 162, 174], ["complex flow profiles", "PROBLEM", 188, 209], ["static fluid", "PROBLEM", 224, 236], ["complex", "OBSERVATION_MODIFIER", 188, 195], ["flow", "OBSERVATION", 196, 200], ["static fluid", "OBSERVATION", 224, 236]]], ["For example, groundwater systems (e.g., aquifers), rivers, and lakes have been reported to have complex flow profiles (Ji, 2017; Zhang et al. 1996).", [["complex flow profiles", "PROBLEM", 96, 117]]], ["Thus, the sampling approach should be considered when examining droplet formats for food and water safety applications.", [["the sampling approach", "TREATMENT", 6, 27]]], ["In addition to a consideration of system mixing, one should also consider the potential measurement pitfalls when analyzing samples that contain dilute levels of highly infectious pathogens, such as the potential for false-negative results.Sample handling formats ::: Measurement formats for pathogen detectionFlow formats involve the detection of target species in the presence of flow fields.", [["samples", "ANATOMY", 124, 131], ["system mixing", "TREATMENT", 34, 47], ["analyzing samples", "TEST", 114, 131], ["dilute levels", "TEST", 145, 158], ["highly infectious pathogens", "PROBLEM", 162, 189], ["Measurement formats", "TEST", 268, 287], ["pathogen detection", "TEST", 292, 310], ["Flow formats", "TEST", 310, 322], ["target species", "PROBLEM", 348, 362], ["highly", "OBSERVATION_MODIFIER", 162, 168], ["infectious", "OBSERVATION", 169, 179], ["flow fields", "OBSERVATION", 382, 393]]], ["Flow formats include continuously-stirred systems (e.g., continuously-stirred tank bioreactors), flow cells, and microfluidics.", [["cells", "ANATOMY", 102, 107], ["cells", "CELL", 102, 107], ["flow cells", "CELL_TYPE", 97, 107], ["Flow formats", "TEST", 0, 12], ["continuously-stirred systems", "PROBLEM", 21, 49], ["stirred tank bioreactors", "TREATMENT", 70, 94], ["flow cells", "TREATMENT", 97, 107], ["microfluidics", "TEST", 113, 126], ["flow cells", "OBSERVATION", 97, 107]]], ["Flow formats have the advantage of exposing the biosensor to target-containing samples in a controlled and repeatable fashion and the benefit of driving exposure of the functionalized biosensor to target species via convective mass transfer mechanisms.", [["samples", "ANATOMY", 79, 86], ["Flow formats", "TEST", 0, 12], ["the functionalized biosensor", "TREATMENT", 165, 193], ["convective mass transfer mechanisms", "PROBLEM", 216, 251], ["mass", "OBSERVATION", 227, 231]]], ["Flow formatsare also typically compatible with large sample volumes (liters).", [["sample", "ANATOMY", 53, 59], ["Flow formatsare", "TEST", 0, 15], ["large sample volumes", "PROBLEM", 47, 67], ["large", "OBSERVATION_MODIFIER", 47, 52], ["sample", "OBSERVATION_MODIFIER", 53, 59], ["volumes", "OBSERVATION_MODIFIER", 60, 67]]], ["Flow cells are typically fabricated via milling and extrusion processes using materials such as Teflon or Plexiglas.", [["cells", "ANATOMY", 5, 10], ["Teflon", "CHEMICAL", 96, 102], ["Flow cells", "CELL", 0, 10], ["Flow cells", "PROBLEM", 0, 10], ["extrusion processes using materials", "TREATMENT", 52, 87], ["Teflon or Plexiglas", "TREATMENT", 96, 115], ["extrusion processes", "OBSERVATION", 52, 71]]], ["They have the advantage of accommodating a variety of biosensor form factors, such as rigid three-dimensional biosensors.", [["biosensor form factors", "PROTEIN", 54, 76], ["rigid three-dimensional biosensors", "TREATMENT", 86, 120]]], ["In addition to flow cells, flow formats are commonly achieved using microfluidic devices.", [["cells", "ANATOMY", 20, 25], ["cells", "CELL", 20, 25], ["flow cells", "CELL_TYPE", 15, 25], ["flow cells", "TEST", 15, 25], ["flow formats", "TEST", 27, 39], ["microfluidic devices", "TREATMENT", 68, 88], ["flow cells", "OBSERVATION", 15, 25], ["microfluidic devices", "OBSERVATION", 68, 88]]], ["While microfluidic devices are typically used with biosensors that exhibit thin two-dimensional form factors, such as planar electrodes, they offer various measurement advantages.", [["microfluidic devices", "TREATMENT", 6, 26], ["biosensors", "TREATMENT", 51, 61], ["thin two-dimensional form factors", "PROBLEM", 75, 108], ["planar electrodes", "TREATMENT", 118, 135], ["various measurement advantages", "TREATMENT", 148, 178], ["microfluidic devices", "OBSERVATION", 6, 26]]], ["Unlike flow cells, which are typically fabricated from machinable polymers, microfluidics are typically fabricated using polydimethylsiloxane (PDMS) and polymethyl methacrylate (PMMA) given their low cost and compatibility with microfabrication approaches.", [["flow cells", "ANATOMY", 7, 17], ["polydimethylsiloxane", "CHEMICAL", 121, 141], ["polymethyl methacrylate", "CHEMICAL", 153, 176], ["PMMA", "CHEMICAL", 178, 182], ["polydimethylsiloxane", "CHEMICAL", 121, 141], ["PDMS", "CHEMICAL", 143, 147], ["polymethyl methacrylate", "CHEMICAL", 153, 176], ["PMMA", "CHEMICAL", 178, 182], ["cells", "CELL", 12, 17], ["polydimethylsiloxane", "SIMPLE_CHEMICAL", 121, 141], ["polymethyl methacrylate", "SIMPLE_CHEMICAL", 153, 176], ["PMMA", "SIMPLE_CHEMICAL", 178, 182], ["flow cells", "CELL_TYPE", 7, 17], ["Unlike flow cells", "PROBLEM", 0, 17], ["machinable polymers", "TREATMENT", 55, 74], ["microfluidics", "TREATMENT", 76, 89], ["polydimethylsiloxane (PDMS)", "TREATMENT", 121, 148], ["polymethyl methacrylate (PMMA", "TREATMENT", 153, 182], ["microfabrication approaches", "TREATMENT", 228, 255], ["flow cells", "OBSERVATION", 7, 17], ["polymethyl methacrylate", "OBSERVATION", 153, 176]]], ["One advantage of microfluidic devices is their ability to perform integrated sample preparation steps, which eliminates the need for additional steps in the sample-to-result process (Sin et al. 2014).", [["sample", "ANATOMY", 77, 83], ["microfluidic devices", "TREATMENT", 17, 37], ["integrated sample preparation steps", "TREATMENT", 66, 101], ["the sample", "TEST", 153, 163], ["microfluidic devices", "OBSERVATION", 17, 37]]], ["For example, microfluidic formats for pathogen detection using electrochemical biosensors have demonstrated fluid pumping, valving, and mixing of small sample volumes (Rivet et al. 2011).", [["fluid", "ANATOMY", 108, 113], ["sample", "ANATOMY", 152, 158], ["microfluidic formats", "TEST", 13, 33], ["pathogen detection", "TEST", 38, 56], ["electrochemical biosensors", "TEST", 63, 89], ["fluid pumping", "TREATMENT", 108, 121], ["valving", "TREATMENT", 123, 130], ["fluid pumping", "OBSERVATION", 108, 121], ["small", "OBSERVATION_MODIFIER", 146, 151]]], ["An example of a microfluidic format created by Dastider et al. for detection of S. typhimurium is shown in Fig. 4a (Dastider et al. 2015).Sample handling formats ::: Measurement formats for pathogen detectionDetection in the presence of flow fields requires high stability of immobilized biorecognition elements (Bard and Faulkner, 2000).", [["S. typhimurium", "ORGANISM", 80, 94], ["biorecognition elements", "DNA", 288, 311], ["S. typhimurium", "SPECIES", 80, 94], ["S. typhimurium", "SPECIES", 80, 94], ["a microfluidic format", "TEST", 14, 35], ["S. typhimurium", "PROBLEM", 80, 94], ["Measurement formats", "TEST", 166, 185], ["pathogen detectionDetection", "TEST", 190, 217], ["flow fields", "PROBLEM", 237, 248], ["flow", "OBSERVATION", 237, 241]]], ["The effect of flow characteristics on biosensor collection rates is an important consideration, especially when considering micro- and nano-scale transducers with microfluidic formats (Squires et al. 2008).", [["biosensor collection rates", "TEST", 38, 64], ["micro", "TEST", 124, 129], ["nano-scale transducers", "TREATMENT", 135, 157], ["flow", "OBSERVATION_MODIFIER", 14, 18]]], ["For example, emerging nanostructured electrodes, such as functionalized nanoporous membranes, have been shown to achieve high stability in microfluidic devices (Joung et al. 2013; Tan et al. 2011).", [["membranes", "ANATOMY", 83, 92], ["emerging nanostructured electrodes", "TREATMENT", 13, 47], ["functionalized nanoporous membranes", "TREATMENT", 57, 92], ["microfluidic devices", "TREATMENT", 139, 159], ["nanostructured electrodes", "OBSERVATION", 22, 47], ["nanoporous membranes", "OBSERVATION", 72, 92], ["microfluidic devices", "OBSERVATION", 139, 159]]], ["It is paramount for interpreting biosensor response that users understand the interplay between mass transport of target molecules (both diffusive and convective mechanisms) and reaction at the biosensor surface (i.e., binding of target species to immobilized biorecognition elements).", [["target molecules", "PROTEIN", 114, 130], ["immobilized biorecognition elements", "DNA", 248, 283], ["target molecules", "PROBLEM", 114, 130], ["both diffusive and convective mechanisms", "PROBLEM", 132, 172], ["reaction at the biosensor surface", "PROBLEM", 178, 211]]], ["Such fundamental understanding can also be employed in biosensor and experiment design to create improved assay outcomes, such as reducing TTR or improving measurement confidence.Sample handling formats ::: Measurement formats for pathogen detectionWhile the presence of pathogens on the surfaces of objects can be analyzed using droplet- and flow-based sample handling formats using material transfer processes, such as swabbing, in situ pathogen detection on the object surfaces is a vital measurement capability for medical diagnostic, infection control, and food safety applications.", [["sample", "ANATOMY", 354, 360], ["infection", "DISEASE", 539, 548], ["TTR", "GENE_OR_GENE_PRODUCT", 139, 142], ["TTR", "PROTEIN", 139, 142], ["Measurement formats", "TEST", 207, 226], ["pathogen", "PROBLEM", 231, 239], ["pathogens", "PROBLEM", 271, 280], ["droplet", "TEST", 330, 337], ["material transfer processes", "TREATMENT", 384, 411], ["swabbing", "TREATMENT", 421, 429], ["a vital measurement capability", "TEST", 484, 514], ["medical diagnostic", "TEST", 519, 537], ["infection control", "TREATMENT", 539, 556], ["pathogens", "OBSERVATION", 271, 280]]], ["Surface-based measurement formats typically require biosensors with flexible or conforming (i.e., form-fitting) form factors.", [["form-fitting) form factors", "PROTEIN", 98, 124], ["Surface-based measurement formats", "TEST", 0, 33], ["biosensors with flexible", "TREATMENT", 52, 76]]], ["For example, Mannoor et al. detected the presence of pathogenic species directly on teeth using a flexible graphene-based biosensor (Mannoor et al. 2012).", [["teeth", "ANATOMY", 84, 89], ["graphene", "CHEMICAL", 107, 115], ["graphene", "CHEMICAL", 107, 115], ["teeth", "ORGAN", 84, 89], ["pathogenic species", "PROBLEM", 53, 71], ["a flexible graphene", "TREATMENT", 96, 115], ["pathogenic", "OBSERVATION_MODIFIER", 53, 63], ["species", "OBSERVATION", 64, 71]]], ["Further discussion of surface-based pathogen detection applications are provided in the following sections.Sample handling formats ::: Measurement formats for pathogen detectionThe sample handling format often provides insight into the biosensor's reusability.", [["surface", "ANATOMY", 22, 29], ["sections", "ANATOMY", 98, 106], ["sample", "ANATOMY", 181, 187], ["surface-based pathogen detection applications", "TREATMENT", 22, 67], ["Measurement formats", "TEST", 135, 154], ["pathogen detection", "TEST", 159, 177], ["the biosensor's reusability", "TREATMENT", 232, 259]]], ["Biosensors within the aforementioned measurement formats can be broadly classified as single- or multi-use biosensors.", [["Biosensors", "TEST", 0, 10]]], ["Single-use biosensors are unable to monitor the analyte concentration continuously or upon regeneration, while multiple-use biosensors can be repeatedly recalibrated (Th\u00e9venot et al. 2001).", [["biosensors", "TREATMENT", 124, 134]]], ["For example, droplet-based low-cost, disposable biosensors for water safety are typically single-use, while biosensors for process monitoring applications can be recalibrated to characterize multiple samples and facilitate continuous monitoring.", [["samples", "ANATOMY", 200, 207], ["droplet", "TEST", 13, 20], ["disposable biosensors", "TREATMENT", 37, 58], ["water safety", "TREATMENT", 63, 75], ["process monitoring applications", "TREATMENT", 123, 154], ["multiple samples", "TEST", 191, 207], ["continuous monitoring", "TEST", 223, 244], ["droplet", "OBSERVATION_MODIFIER", 13, 20], ["low", "OBSERVATION_MODIFIER", 27, 30]]], ["The ability to regenerate biosensor surfaces following pathogen detection (i.e., remove selectively-bound pathogens) is a significant technical barrier limiting progress in multiple-use biosensors, and industrial applications thereof, and is discussed further in the following sections.Potentiometry ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionPotentiometric methods, also referred to as controlled-current methods, are those in which an electrical potential is measured in response to an applied current (Bard and Faulkner, 2000).", [["sections", "ANATOMY", 277, 285], ["pathogen detection", "TEST", 55, 73], ["bound pathogens", "PROBLEM", 100, 115], ["biosensors", "TREATMENT", 186, 196], ["pathogen detection", "TEST", 332, 350], ["Measurement formats", "TEST", 388, 407], ["pathogen detection", "TEST", 412, 430], ["significant", "OBSERVATION_MODIFIER", 122, 133]]], ["The applied current is typically low amplitude.", [["typically low amplitude", "PROBLEM", 23, 46], ["low amplitude", "OBSERVATION_MODIFIER", 33, 46]]], ["An advantage of controlled-current methods is the ability to use low-cost measurement instrumentation relative to that required for controlled-potential methods.Potentiometry ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionHai et al. used potentiometry with a conductive polymer-based biosensor to detect human influenza A virus (H1N1) at a LOD of 0.013 HAU (Hai et al. 2017).", [["influenza A virus", "DISEASE", 393, 410], ["human", "ORGANISM", 387, 392], ["influenza A virus", "ORGANISM", 393, 410], ["H1N1", "ORGANISM", 412, 416], ["human", "SPECIES", 387, 392], ["influenza A virus", "SPECIES", 393, 410], ["human influenza A virus", "SPECIES", 387, 410], ["low-cost measurement instrumentation", "TREATMENT", 65, 101], ["pathogen detection", "TEST", 207, 225], ["Measurement formats", "TEST", 263, 282], ["pathogen detection", "TEST", 287, 305], ["potentiometry", "TREATMENT", 321, 334], ["a conductive polymer", "TREATMENT", 340, 360], ["human influenza A virus (H1N1", "PROBLEM", 387, 416]]], ["Hernandez et al. used potentiometry with a carbon-rod modified electrode that contained reduced graphene oxide to detect S. aureus at a single CFU/mL (Hernandez et al. 2014).", [["graphene oxide", "CHEMICAL", 96, 110], ["carbon", "CHEMICAL", 43, 49], ["graphene oxide", "CHEMICAL", 96, 110], ["graphene oxide", "SIMPLE_CHEMICAL", 96, 110], ["S. aureus", "ORGANISM", 121, 130], ["S. aureus", "SPECIES", 121, 130], ["S. aureus", "SPECIES", 121, 130], ["potentiometry", "TREATMENT", 22, 35], ["a carbon-rod modified electrode", "TREATMENT", 41, 72], ["reduced graphene oxide", "TREATMENT", 88, 110], ["S. aureus", "PROBLEM", 121, 130], ["aureus", "OBSERVATION", 124, 130]]], ["Boehm et al. detected E. coli via potentiometry utilizing a Pt wire electrode (Boehm et al. 2007).", [["Pt", "CHEMICAL", 60, 62], ["E. coli", "ORGANISM", 22, 29], ["E. coli", "SPECIES", 22, 29], ["E. coli", "SPECIES", 22, 29], ["E. coli", "PROBLEM", 22, 29], ["a Pt wire electrode", "TREATMENT", 58, 77], ["coli", "OBSERVATION", 25, 29]]], ["Further studies utilizing potentiometric sensing approaches are listed in Table 1, Table 2.Linear sweep and cyclic voltammetry ::: Voltammetry ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionLinear sweep voltammetry (LSV) methods are those in which a current is measured in response to an applied electrical potential that is swept at a constant rate across a range of electrical potentials (Bard and Faulkner, 2000).", [["Further studies", "TEST", 0, 15], ["potentiometric sensing approaches", "TREATMENT", 26, 59], ["pathogen detection", "TEST", 175, 193], ["Measurement formats", "TEST", 231, 250], ["pathogen detectionLinear sweep voltammetry", "PROBLEM", 255, 297]]], ["Cyclic voltammetry (CV) is a commonly used linear-sweep method in which the electrical potential is swept in both the forward and reverse directions in partial cycles, full cycles, or a series of cycles.", [["Cyclic voltammetry", "TEST", 0, 18], ["linear-sweep method", "TREATMENT", 43, 62], ["a series of cycles", "TREATMENT", 184, 202], ["partial cycles", "OBSERVATION", 152, 166]]], ["CV is one of the most widely used voltammetric methods for pathogen detection.Linear sweep and cyclic voltammetry ::: Voltammetry ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionHong et al. used sweep voltammetry to detect norovirus in a sample solution with Fe(CN)63-/4- extracted from lettuce (Hong et al. 2015).", [["sample", "ANATOMY", 320, 326], ["norovirus", "DISEASE", 305, 314], ["Fe", "CHEMICAL", 341, 343], ["Fe(CN)", "CHEMICAL", 341, 347], ["norovirus", "ORGANISM", 305, 314], ["Fe(CN)63-/4", "SIMPLE_CHEMICAL", 341, 352], ["lettuce", "ORGANISM", 369, 376], ["lettuce", "SPECIES", 369, 376], ["pathogen detection", "TEST", 59, 77], ["pathogen detection", "TEST", 162, 180], ["Measurement formats", "TEST", 218, 237], ["pathogen detection", "TEST", 242, 260], ["sweep voltammetry", "TEST", 277, 294], ["norovirus", "PROBLEM", 305, 314], ["Fe(CN)", "TEST", 341, 347]]], ["A typical CV response using Fe(CN)63-/4- associated with pathogen detection is shown in Fig. 5a for various concentrations of E. coli binding to a polymer composite electrode (G\u00fcner et al. 2017).", [["Fe", "CHEMICAL", 28, 30], ["Fe(CN)63", "CHEMICAL", 28, 36], ["E. coli", "ORGANISM", 126, 133], ["E. coli", "SPECIES", 126, 133], ["E. coli", "SPECIES", 126, 133], ["A typical CV response", "PROBLEM", 0, 21], ["Fe(CN)", "TEST", 28, 34], ["pathogen detection", "TEST", 57, 75], ["E. coli binding", "PROBLEM", 126, 141], ["a polymer composite electrode", "TREATMENT", 145, 174], ["CV response", "OBSERVATION", 10, 21], ["E. coli", "OBSERVATION", 126, 133]]], ["A detailed overview of pathogen detection studies based on CV is provided in Table 1, Table 2.Pulse voltammetry ::: Voltammetry ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionPulse voltammetry is a type of voltammetry in which the electrical potential is applied in pulses.", [["pathogen detection studies", "TEST", 23, 49], ["CV", "TEST", 59, 61], ["Pulse voltammetry", "TEST", 94, 111], ["pathogen detection", "TEST", 160, 178], ["Measurement formats", "TEST", 216, 235], ["pathogen detection", "TEST", 240, 258], ["Pulse voltammetry", "TEST", 258, 275], ["a type of voltammetry", "PROBLEM", 279, 300]]], ["Square wave voltammetry (SWV) is a type of staircase voltammetry that applies a symmetric square-wave pulse superimposed on a staircase potential waveform.", [["Square wave voltammetry", "TEST", 0, 23], ["staircase voltammetry", "TREATMENT", 43, 64], ["a symmetric square-wave pulse", "PROBLEM", 78, 107], ["symmetric", "OBSERVATION_MODIFIER", 80, 89], ["square", "OBSERVATION_MODIFIER", 90, 96]]], ["The forward pulse of the waveform coincides with the staircase step.", [["waveform", "OBSERVATION_MODIFIER", 25, 33]]], ["In differential pulse voltammetry (DPV), the electrical potential is scanned with a series of fixed amplitude pulses and superimposed on a changing base potential.", [["fixed amplitude pulses", "PROBLEM", 94, 116], ["fixed amplitude", "OBSERVATION", 94, 109]]], ["The current is measured before the pulse application and again at the end of the pulse, which allows for the decay of the nonfaradaic current (Scott, 2016).Pulse voltammetry ::: Voltammetry ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionFor example, Iqbal et al. used SWV with AuNP-modified carbon electrodes for detection of C. parvum in samples taken from fruit (Iqbal et al. 2015).", [["samples", "ANATOMY", 422, 429], ["AuNP", "CHEMICAL", 360, 364], ["carbon", "CHEMICAL", 374, 380], ["AuNP", "SIMPLE_CHEMICAL", 360, 364], ["C. parvum", "ORGANISM", 409, 418], ["C. parvum", "SPECIES", 409, 418], ["C. parvum", "SPECIES", 409, 418], ["the pulse application", "TREATMENT", 31, 52], ["the pulse", "TEST", 77, 86], ["Pulse voltammetry", "TEST", 156, 173], ["pathogen detection", "TEST", 222, 240], ["Measurement formats", "TEST", 278, 297], ["pathogen detection", "TEST", 302, 320], ["AuNP-modified carbon electrodes", "TREATMENT", 360, 391], ["C. parvum", "PROBLEM", 409, 418]]], ["Kitajima et al. also used SWV with Au microelectrodes to detect norovirus at a LOD of 10 PFU/mL (Kitajima et al. 2016).", [["Au", "CHEMICAL", 35, 37], ["norovirus", "DISEASE", 64, 73], ["Au", "CHEMICAL", 35, 37], ["norovirus", "ORGANISM", 64, 73], ["SWV with Au microelectrodes", "TREATMENT", 26, 53], ["norovirus", "PROBLEM", 64, 73]]], ["Cheng et al. used DPV and a nanostructured alumina electrode for detection of dengue type 2 virus with a LOD of 1 PFU/mL (Cheng et al. 2012).", [["dengue", "DISEASE", 78, 84], ["alumina", "CHEMICAL", 43, 50], ["dengue type 2 virus", "ORGANISM", 78, 97], ["dengue type 2 virus", "SPECIES", 78, 97], ["DPV", "TREATMENT", 18, 21], ["a nanostructured alumina electrode", "TREATMENT", 26, 60], ["dengue type 2 virus", "PROBLEM", 78, 97]]], ["As shown in Fig. 5b, Bhardwaj et al. used DPV with a carbon-based electrode to detect S. aureus (Bhardwaj et al. 2017).", [["carbon", "CHEMICAL", 53, 59], ["S. aureus", "ORGANISM", 86, 95], ["S. aureus", "SPECIES", 86, 95], ["S. aureus", "SPECIES", 86, 95], ["DPV", "TREATMENT", 42, 45], ["a carbon-based electrode", "TREATMENT", 51, 75], ["S. aureus", "PROBLEM", 86, 95], ["aureus", "OBSERVATION", 89, 95]]], ["Additional studies that utilize pulse voltammetry methods forpathogen detection are listed in Table 1, Table 2.Stripping voltammetry ::: Voltammetry ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionMany of the previously described voltammetric methods can be modified to include a step that pre-concentrates the target on the electrode surface.", [["surface", "CELLULAR_COMPONENT", 417, 424], ["Additional studies", "TEST", 0, 18], ["pulse voltammetry methods forpathogen detection", "TEST", 32, 79], ["Stripping voltammetry", "TEST", 111, 132], ["pathogen detection", "TEST", 181, 199], ["Measurement formats", "TEST", 237, 256], ["pathogen", "PROBLEM", 261, 269], ["the previously described voltammetric methods", "PROBLEM", 287, 332]]], ["Subsequently, the pre-concentrated target is stripped from the surface by application of an electrical potential.", [["surface", "ANATOMY", 63, 70], ["surface", "CELLULAR_COMPONENT", 63, 70], ["stripped", "OBSERVATION", 45, 53], ["surface", "OBSERVATION_MODIFIER", 63, 70]]], ["In anodic stripping voltammetry (ASV), a negative potential is used to pre-concentrate metal ions onto the electrode surface.", [["anodic stripping voltammetry (ASV", "TREATMENT", 3, 36]]], ["These ions are then stripped from the surface by applied positive potentials.", [["surface", "ANATOMY", 38, 45], ["surface", "CELLULAR_COMPONENT", 38, 45], ["ions", "OBSERVATION", 6, 10], ["surface", "OBSERVATION_MODIFIER", 38, 45], ["positive potentials", "OBSERVATION", 57, 76]]], ["Although most commonly used to detect trace amounts of metals, this method has been adapted for pathogen detection by electrocatalytically coating metallic labels on bound targets for oxidative stripping and subsequently measuring the current response (Abbaspour et al. 2015).Stripping voltammetry ::: Voltammetry ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionChen et al. used stripping voltammetry with a polymer-CNT composite-based electrode to detect E. coli at a LOD of 13 CFU/mL (Chen et al. 2014).", [["polymer-CNT", "CHEMICAL", 490, 501], ["metals", "SIMPLE_CHEMICAL", 55, 61], ["E. coli", "ORGANISM", 538, 545], ["E. coli", "SPECIES", 538, 545], ["E. coli", "SPECIES", 538, 545], ["trace amounts of metals", "PROBLEM", 38, 61], ["pathogen detection", "TEST", 96, 114], ["oxidative stripping", "TREATMENT", 184, 203], ["Stripping voltammetry", "TEST", 276, 297], ["pathogen detection", "TEST", 346, 364], ["Measurement formats", "TEST", 402, 421], ["pathogen detection", "TEST", 426, 444], ["stripping voltammetry", "TREATMENT", 461, 482], ["a polymer-CNT composite-based electrode", "TREATMENT", 488, 527], ["E. coli", "PROBLEM", 538, 545], ["E. coli", "OBSERVATION", 538, 545]]], ["In that study, the biosensor was first incubated with E. coli.", [["E. coli", "ORGANISM", 54, 61], ["E. coli", "SPECIES", 54, 61], ["E. coli", "SPECIES", 54, 61], ["that study", "TEST", 3, 13], ["the biosensor", "TEST", 15, 28], ["E. coli", "PROBLEM", 54, 61], ["E. coli", "OBSERVATION", 54, 61]]], ["Silica-coated Ag nanoparticles conjugated with anti-E.coli were subsequently introduced to the system, inducing a binding reaction between the bacteria and the nanoparticles.", [["Silica", "CHEMICAL", 0, 6], ["Ag", "CHEMICAL", 14, 16], ["Silica", "CHEMICAL", 0, 6], ["Ag", "CHEMICAL", 14, 16], ["Silica", "SIMPLE_CHEMICAL", 0, 6], ["Ag nanoparticles", "SIMPLE_CHEMICAL", 14, 30], ["anti-E.coli", "SIMPLE_CHEMICAL", 47, 58], ["anti-E.coli", "TREATMENT", 47, 58], ["a binding reaction", "PROBLEM", 112, 130], ["the bacteria and the nanoparticles", "PROBLEM", 139, 173], ["nanoparticles", "OBSERVATION_MODIFIER", 17, 30], ["conjugated", "OBSERVATION_MODIFIER", 31, 41]]], ["After rinsing non-specifically bound particles, acid was introduced to dissolve Ag(s), and the resulting Ag+-rich solution was characterized using DPV.", [["Ag", "CHEMICAL", 80, 82], ["Ag", "CHEMICAL", 105, 107], ["Ag", "CHEMICAL", 80, 82], ["Ag", "CHEMICAL", 105, 107], ["Ag+", "SIMPLE_CHEMICAL", 105, 108], ["Ag", "PROTEIN", 105, 107], ["rinsing non-specifically bound particles", "TREATMENT", 6, 46], ["acid", "TREATMENT", 48, 52], ["the resulting Ag+-rich solution", "TREATMENT", 91, 122]]], ["Viswanathan et al. used ASV with screen-printed composite electrodes for multiplexed detection of Campylobacter, S. typhimurium, and E. coli with a LOD of 400 cells/mL, 400 cells/mL, and 800 cells/mL, respectively (Viswanathan et al. 2012).", [["cells", "ANATOMY", 159, 164], ["cells", "ANATOMY", 173, 178], ["cells", "ANATOMY", 191, 196], ["Campylobacter", "ORGANISM", 98, 111], ["S. typhimurium", "ORGANISM", 113, 127], ["E. coli", "ORGANISM", 133, 140], ["cells", "CELL", 173, 178], ["cells", "CELL", 191, 196], ["S. typhimurium", "SPECIES", 113, 127], ["E. coli", "SPECIES", 133, 140], ["S. typhimurium", "SPECIES", 113, 127], ["E. coli", "SPECIES", 133, 140], ["ASV", "TREATMENT", 24, 27], ["screen", "TEST", 33, 39], ["multiplexed detection", "TEST", 73, 94], ["Campylobacter", "PROBLEM", 98, 111], ["S. typhimurium", "PROBLEM", 113, 127], ["E. coli", "PROBLEM", 133, 140], ["a LOD", "TEST", 146, 151]]], ["In that study, antibody-functionalized nanocrystalline bioconjugates were first introduced to biosensor-bound bacteria, the specifically bound particles were dissolved with acid, and the ions were then stripped using a square-wave voltammetric waveform.", [["nanocrystalline bioconjugates", "SIMPLE_CHEMICAL", 39, 68], ["ions", "SIMPLE_CHEMICAL", 187, 191], ["that study", "TEST", 3, 13], ["antibody-functionalized nanocrystalline bioconjugates", "TREATMENT", 15, 68], ["acid", "TREATMENT", 173, 177], ["the ions", "TREATMENT", 183, 191]]], ["Additional studies using stripping voltammetry for electrochemical detection of pathogens can be found in Table 1, Table 2.Electrochemical impedance spectroscopy ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionThe aforementioned electrochemical methods involved responses based on step changes or continuous sweeps in the applied current or voltage that drove the electrode to a condition far from equilibrium.", [["Additional studies", "TEST", 0, 18], ["stripping voltammetry", "TEST", 25, 46], ["electrochemical detection", "TEST", 51, 76], ["pathogens", "PROBLEM", 80, 89], ["Electrochemical impedance spectroscopy", "TEST", 123, 161], ["pathogen detection", "TEST", 194, 212], ["Measurement formats", "TEST", 250, 269], ["pathogen detection", "TEST", 274, 292], ["step changes", "PROBLEM", 363, 375], ["continuous sweeps", "TREATMENT", 379, 396]]], ["Alternatively, frequency response methods, often referred to as impedance-based or impedimetric methods, are based on frequency response analysis (i.e., the response of the system to periodic applied current or potential waveforms at either a fixed frequency or over a range of frequencies) (Bard and Faulkner, 2000).", [["impedimetric methods", "TEST", 83, 103], ["frequency response analysis", "TEST", 118, 145]]], ["We next discuss impedance-based electrochemical methods for detection of pathogens using electrochemical biosensors.Electrochemical impedance spectroscopy ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionIn EIS the impedance and phase angle of the system are measured as a function of the frequency of the applied electrical potential.", [["pathogens", "PROBLEM", 73, 82], ["electrochemical biosensors", "TREATMENT", 89, 115], ["Electrochemical impedance spectroscopy", "TEST", 116, 154], ["pathogen detection", "TEST", 187, 205], ["Measurement formats", "TEST", 243, 262], ["pathogen", "PROBLEM", 267, 275]]], ["EIS is a diverse electrochemical method, which can be done as a faradaic or non-faradaic process, and enables the study of intrinsic material properties, experiment-specific processes, or biorecognition events at the electrode surface.", [["electrode surface", "CELLULAR_COMPONENT", 217, 234], ["a diverse electrochemical method", "PROBLEM", 7, 39], ["a faradaic or non-faradaic process", "PROBLEM", 62, 96], ["the study", "TEST", 110, 119], ["biorecognition events at the electrode surface", "PROBLEM", 188, 234], ["diverse", "OBSERVATION_MODIFIER", 9, 16], ["electrochemical method", "OBSERVATION", 17, 39]]], ["Equivalent circuit models are commonly fit to experimental impedance and phase angle data to interpret the electrochemical process in terms of passive circuit elements, such as resistors and capacitors.", [["Equivalent circuit models", "TREATMENT", 0, 25], ["experimental impedance and phase angle data", "TEST", 46, 89], ["passive circuit elements", "TREATMENT", 143, 167], ["resistors and capacitors", "TREATMENT", 177, 201], ["passive circuit", "OBSERVATION", 143, 158]]], ["For example, the electric double layer is typically modeled as a capacitive element, while the resistance to faradaic charge transfer at the electrode-electrolyte interface is represented as a resistor, often referred to as the charge transfer resistance.", [["the electric double layer", "PROBLEM", 13, 38], ["a capacitive element", "TREATMENT", 63, 83], ["electric", "OBSERVATION_MODIFIER", 17, 25], ["double", "OBSERVATION_MODIFIER", 26, 32], ["layer", "OBSERVATION_MODIFIER", 33, 38], ["capacitive element", "OBSERVATION", 65, 83], ["electrolyte interface", "OBSERVATION", 151, 172]]], ["Additional circuit elements, such as constant-phase or Warburg elements, can also be included to represent other features of the electrochemical cell and process, such transport characteristics of the species at the electrode-electrolyte interface.", [["cell", "ANATOMY", 145, 149], ["cell", "CELL", 145, 149], ["circuit elements", "DNA", 11, 27], ["constant-phase or Warburg elements", "DNA", 37, 71], ["Additional circuit elements", "TREATMENT", 0, 27], ["Warburg elements", "PROBLEM", 55, 71], ["the electrochemical cell and process", "PROBLEM", 125, 161], ["circuit elements", "OBSERVATION", 11, 27], ["electrochemical cell", "OBSERVATION", 129, 149], ["electrolyte interface", "OBSERVATION", 226, 247]]], ["The Randles model is a commonly used equivalent circuit for interpretation of biosensor EIS data.", [["biosensor EIS data", "TEST", 78, 96]]], ["The circuit consists of an electrolyte resistance in series with a parallel combination of the double-layer capacitance with the charge transfer resistance and the Warburg impedance element (Randles, 1947).", [["an electrolyte resistance in series", "PROBLEM", 24, 59], ["the double-layer capacitance", "TREATMENT", 91, 119], ["the charge transfer resistance", "TREATMENT", 125, 155], ["the Warburg impedance element", "PROBLEM", 160, 189], ["electrolyte resistance", "OBSERVATION", 27, 49]]], ["Variations of this model have been formulated for a variety of biosensing studies.", [["biosensing studies", "TEST", 63, 81]]], ["For example, the equivalent circuit model and associated Nyquist plot for electrochemical detection of S. typhimurium using EIS with a poly(pyrrole-co-3-carboxyl-pyrrole) copolymer supported aptamer can be found in Fig. 5c (Sheikhzadeh et al. 2016).", [["poly(pyrrole-co-3-carboxyl-pyrrole", "CHEMICAL", 135, 169], ["poly(pyrrole-co-3-carboxyl-pyrrole)", "CHEMICAL", 135, 170], ["S. typhimurium", "ORGANISM", 103, 117], ["poly(pyrrole-co-3-carboxyl-pyrrole) copolymer", "SIMPLE_CHEMICAL", 135, 180], ["S. typhimurium", "SPECIES", 103, 117], ["S. typhimurium", "SPECIES", 103, 117], ["Nyquist plot", "TEST", 57, 69], ["electrochemical detection", "TEST", 74, 99], ["S. typhimurium", "PROBLEM", 103, 117], ["a poly(pyrrole-co-3-carboxyl-pyrrole) copolymer supported aptamer", "TREATMENT", 133, 198]]], ["The equivalent circuit model consists of the solution resistance, charge transfer resistance at the copolymer-aptamer/electrolyte interface, and constant phase element for the charge capacitance at the copolymer-aptamer/electrolyte interface (Sheikhzadeh et al. 2016).Electrochemical impedance spectroscopy ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionWhile the impedance can be measured across a range of frequencies and interpreted using equivalent circuit models that describe impedance response over a wide frequency range, fixed-frequency measurements are also useful for biosensing applications.", [["the solution resistance", "TREATMENT", 41, 64], ["the copolymer-aptamer/electrolyte interface", "TREATMENT", 96, 139], ["the charge capacitance", "TREATMENT", 172, 194], ["the copolymer-aptamer/electrolyte interface", "TREATMENT", 198, 241], ["Electrochemical impedance spectroscopy", "TEST", 268, 306], ["pathogen detection", "TEST", 339, 357], ["Measurement formats", "TEST", 395, 414], ["pathogen detectionWhile the impedance", "TEST", 419, 456], ["equivalent circuit models", "TREATMENT", 525, 550], ["biosensing applications", "TREATMENT", 662, 685], ["equivalent circuit", "OBSERVATION", 4, 22]]], ["Fixed-frequency measurements are typically based on the identification of single frequencies or small frequency ranges in the impedance spectra that are most sensitive to molecular binding events.", [["Fixed-frequency measurements", "TEST", 0, 28], ["single frequencies", "PROBLEM", 74, 92], ["small frequency ranges", "PROBLEM", 96, 118], ["the impedance spectra", "TEST", 122, 143], ["small", "OBSERVATION_MODIFIER", 96, 101]]], ["Fixed-frequency approaches have the advantage of increasing the sampling frequency of the biosensor.", [["increasing", "OBSERVATION_MODIFIER", 49, 59]]], ["As a result, impedance-based electrochemical methods generate biosensor responses in terms of changes in the measured physical quantities (e.g., changes in impedance) or calculated equivalent circuit elements (e.g., double-layer capacitance or charge-transfer resistance).Electrochemical impedance spectroscopy ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionAs shown in Table 1, Table 2, EIS is one of the most commonly used methods for electrochemical detection of pathogens.", [["changes in the measured physical quantities", "PROBLEM", 94, 137], ["calculated equivalent circuit elements", "PROBLEM", 170, 208], ["double-layer capacitance", "TREATMENT", 216, 240], ["Electrochemical impedance spectroscopy", "TEST", 272, 310], ["pathogen detection", "TEST", 343, 361], ["Measurement formats", "TEST", 399, 418], ["pathogen detection", "TEST", 423, 441], ["pathogens", "PROBLEM", 549, 558], ["equivalent circuit", "OBSERVATION", 181, 199], ["pathogens", "OBSERVATION", 549, 558]]], ["For example, Zarei et al. used EIS with an Au nanoparticle-modified carbon-based electrode for detection of Shigella dysenteriae (S. dysenteriae) at a LOD of 1 CFU/mL (Zarei et al. 2018).", [["Au nanoparticle", "CHEMICAL", 43, 58], ["Au", "CHEMICAL", 43, 45], ["carbon", "CHEMICAL", 68, 74], ["Au nanoparticle", "SIMPLE_CHEMICAL", 43, 58], ["Shigella dysenteriae", "ORGANISM", 108, 128], ["S. dysenteriae", "ORGANISM", 130, 144], ["Shigella dysenteriae", "SPECIES", 108, 128], ["S. dysenteriae", "SPECIES", 130, 144], ["Shigella dysenteriae", "SPECIES", 108, 128], ["S. dysenteriae", "SPECIES", 130, 144], ["an Au nanoparticle-modified carbon-based electrode", "TREATMENT", 40, 90], ["Shigella dysenteriae", "PROBLEM", 108, 128], ["S. dysenteriae", "PROBLEM", 130, 144], ["Shigella dysenteriae", "OBSERVATION", 108, 128]]], ["Primiceri et al. used EIS with Au interdigitated microelectrode arrays and Fe(CN)63-/4- to detect L. monocytogenes at a LOD of 5 CFU/mL (Primiceri et al. 2016).", [["Au", "CHEMICAL", 31, 33], ["Fe", "CHEMICAL", 75, 77], ["Au", "CHEMICAL", 31, 33], ["Fe(CN)63", "CHEMICAL", 75, 83], ["Fe(CN)63", "SIMPLE_CHEMICAL", 75, 83], ["L. monocytogenes", "ORGANISM", 98, 114], ["L. monocytogenes", "SPECIES", 98, 114], ["L. monocytogenes", "SPECIES", 98, 114], ["EIS with Au interdigitated microelectrode arrays", "TREATMENT", 22, 70], ["Fe(CN)", "TEST", 75, 81]]], ["Andrade et al. used EIS with a CNT-based electrode for multiplexed detection of E. coli, B. subtilis, and Enterococcus faecalis (Andrade et al. 2015).Electrochemical impedance spectroscopy ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionRedox reactions at the electrode-electrolyte interface are typically established using a redox probe.", [["CNT", "CHEMICAL", 31, 34], ["E. coli", "ORGANISM", 80, 87], ["B. subtilis", "ORGANISM", 89, 100], ["Enterococcus faecalis", "ORGANISM", 106, 127], ["E. coli", "SPECIES", 80, 87], ["B. subtilis", "SPECIES", 89, 100], ["Enterococcus faecalis", "SPECIES", 106, 127], ["E. coli", "SPECIES", 80, 87], ["B. subtilis", "SPECIES", 89, 100], ["Enterococcus faecalis", "SPECIES", 106, 127], ["a CNT-based electrode", "TREATMENT", 29, 50], ["E. coli", "PROBLEM", 80, 87], ["B. subtilis", "PROBLEM", 89, 100], ["Enterococcus faecalis", "PROBLEM", 106, 127], ["Electrochemical impedance spectroscopy", "TEST", 150, 188], ["pathogen detection", "TEST", 221, 239], ["Measurement formats", "TEST", 277, 296], ["pathogen detectionRedox reactions", "PROBLEM", 301, 334], ["a redox probe", "TREATMENT", 406, 419], ["E. coli", "OBSERVATION", 80, 87], ["Enterococcus faecalis", "OBSERVATION", 106, 127]]], ["Owing to its high reversibility, the Fe(CN)63-/4- redox couple has been widely investigated as an electrochemical probe for biosensing applications and is regarded as a standard model for highly reversible electrochemical reactions (Daum and Enke, 1969).", [["Fe", "CHEMICAL", 37, 39], ["Fe(CN)63", "CHEMICAL", 37, 45], ["Fe(CN)", "SIMPLE_CHEMICAL", 37, 43], ["the Fe(CN)", "TEST", 33, 43], ["an electrochemical probe", "TREATMENT", 95, 119], ["highly reversible electrochemical reactions", "PROBLEM", 188, 231], ["high reversibility", "OBSERVATION", 13, 31]]], ["While useful electrochemical probes, redox reactions may also affect the electrode and immobilized biorecognition elements.", [["immobilized biorecognition elements", "DNA", 87, 122], ["redox reactions", "PROBLEM", 37, 52]]], ["For example, redox reactions associated with the Fe(CN)63-/4- probe can cause etching of Au electrodes due to the presence of CN\u2212 ions when using the redox couple for EIS measurements (Vogt et al. 2016).", [["Fe", "CHEMICAL", 49, 51], ["Au", "CHEMICAL", 89, 91], ["Fe(CN)63", "CHEMICAL", 49, 57], ["Au", "CHEMICAL", 89, 91], ["CN", "CHEMICAL", 126, 128], ["Fe(CN)", "SIMPLE_CHEMICAL", 49, 55], ["Au electrodes", "SIMPLE_CHEMICAL", 89, 102], ["CN\u2212 ions", "SIMPLE_CHEMICAL", 126, 134], ["CN", "PROTEIN", 126, 128], ["redox reactions", "PROBLEM", 13, 28], ["the Fe(CN)", "TEST", 45, 55], ["etching of Au electrodes", "TREATMENT", 78, 102], ["EIS measurements", "TEST", 167, 183], ["Au electrodes", "OBSERVATION", 89, 102]]], ["This observation warrants further investigation, particularly in the context of establishing the effects on biosensor repeatability and reusability.", [["This observation", "TEST", 0, 16], ["further investigation", "TEST", 26, 47], ["biosensor repeatability", "TEST", 108, 131]]], ["The use of alternative redox probes or electrode materials may mitigate such effects.", [["alternative redox probes", "TREATMENT", 11, 35], ["electrode materials", "TREATMENT", 39, 58]]], ["For example, ferrocene and ferrocenemethanol have also been used as redox probes for pathogen detection.", [["ferrocene", "CHEMICAL", 13, 22], ["ferrocenemethanol", "CHEMICAL", 27, 44], ["ferrocene", "CHEMICAL", 13, 22], ["ferrocenemethanol", "CHEMICAL", 27, 44], ["ferrocene", "SIMPLE_CHEMICAL", 13, 22], ["ferrocenemethanol", "SIMPLE_CHEMICAL", 27, 44], ["ferrocene", "TREATMENT", 13, 22], ["ferrocenemethanol", "TREATMENT", 27, 44], ["pathogen detection", "TEST", 85, 103]]], ["Ruthenium(III)/ruthenium(II) (Schrattenecker et al. 2019) and immobilized quinone pairs (Piro et al. 2013) are also potentially useful alternatives.Electrochemical impedance spectroscopy ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionBiosensors that use impedance-based methods and whose impedance response can be modeled using equivalent circuit models can be used to calculate the capacitance of the electric double layer.", [["Ruthenium", "CHEMICAL", 0, 9], ["ruthenium", "CHEMICAL", 15, 24], ["II", "CHEMICAL", 25, 27], ["quinone", "CHEMICAL", 74, 81], ["Ruthenium(III)", "CHEMICAL", 0, 14], ["ruthenium(II)", "CHEMICAL", 15, 28], ["quinone", "CHEMICAL", 74, 81], ["Ruthenium(III)", "SIMPLE_CHEMICAL", 0, 14], ["ruthenium(II)", "SIMPLE_CHEMICAL", 15, 28], ["quinone", "SIMPLE_CHEMICAL", 74, 81], ["Electrochemical impedance spectroscopy", "TEST", 148, 186], ["pathogen detection", "TEST", 219, 237], ["Measurement formats", "TEST", 275, 294], ["pathogen detectionBiosensors", "TEST", 299, 327], ["impedance-based methods", "TREATMENT", 337, 360], ["equivalent circuit models", "TREATMENT", 411, 436], ["the electric double layer", "TREATMENT", 481, 506]]], ["The double-layer capacitance is recognized to be sensitive to the structure of the electrode, the characteristics and concentration of analytes at the electrode surface and in the electrolyte, and the characteristics of the electrolyte (Lisdat and Sch\u00e4fer, 2008).", [["The double-layer capacitance", "TREATMENT", 0, 28], ["the electrolyte", "TEST", 176, 191], ["double", "OBSERVATION_MODIFIER", 4, 10], ["layer capacitance", "OBSERVATION", 11, 28]]], ["As a capacitor, the double-layer is not only dependent on the dielectric material but also the thickness of the dielectric layer.", [["a capacitor", "TREATMENT", 3, 14], ["the double-layer", "TREATMENT", 16, 32], ["not only", "UNCERTAINTY", 36, 44], ["dependent", "OBSERVATION_MODIFIER", 45, 54], ["dielectric material", "OBSERVATION", 62, 81], ["thickness", "OBSERVATION_MODIFIER", 95, 104], ["dielectric", "OBSERVATION_MODIFIER", 112, 122], ["layer", "OBSERVATION_MODIFIER", 123, 128]]], ["Importantly, both characteristics could be affected by molecular binding events on an electrode.", [["molecular binding events", "PROBLEM", 55, 79], ["an electrode", "TREATMENT", 83, 95]]], ["For example, when a target analyte binds to an immobilized biorecognition element, counter ions around the electrode surface are displaced, leading to a change in the capacitance (Berggren et al. 2001).", [["electrode surface", "ANATOMY", 107, 124], ["biorecognition element", "DNA", 59, 81], ["a target analyte binds", "PROBLEM", 18, 40], ["an immobilized biorecognition element", "TREATMENT", 44, 81], ["counter ions around the electrode surface", "TREATMENT", 83, 124], ["a change in the capacitance", "PROBLEM", 151, 178], ["displaced", "OBSERVATION", 129, 138], ["change", "OBSERVATION_MODIFIER", 153, 159]]], ["The capacitance can be determined from the reactive component of the impedance or by fitting of an equivalent circuit model (Barsoukov and Macdonald, 2018).Electrochemical impedance spectroscopy ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionIdil et al. used the capacitive response of a MIP electrode for the detection of E. coli (Idil et al. 2017).", [["E. coli", "ORGANISM", 406, 413], ["E. coli", "SPECIES", 406, 413], ["E. coli", "SPECIES", 406, 413], ["The capacitance", "TREATMENT", 0, 15], ["Electrochemical impedance spectroscopy", "TEST", 156, 194], ["pathogen detection", "TEST", 227, 245], ["Measurement formats", "TEST", 283, 302], ["pathogen", "PROBLEM", 307, 315], ["a MIP electrode", "TREATMENT", 369, 384], ["E. coli", "PROBLEM", 406, 413], ["reactive", "OBSERVATION_MODIFIER", 43, 51], ["component", "OBSERVATION_MODIFIER", 52, 61], ["E. coli", "OBSERVATION", 406, 413]]], ["Jantra et al. similarly used the capacitive response of an Au rod electrode for the detection of E. coli (Jantra et al. 2011).", [["Au", "CHEMICAL", 59, 61], ["Au", "CHEMICAL", 59, 61], ["E. coli", "ORGANISM", 97, 104], ["E. coli", "SPECIES", 97, 104], ["E. coli", "SPECIES", 97, 104], ["an Au rod electrode", "TREATMENT", 56, 75], ["E. coli", "PROBLEM", 97, 104], ["E. coli", "OBSERVATION", 97, 104]]], ["Luka et al. used the capacitive response of an Au interdigitated microelectrode array based on equivalent circuit analysis for the detection of C. parvum (Luka et al. 2019).", [["Au", "CHEMICAL", 47, 49], ["Au", "CHEMICAL", 47, 49], ["C. parvum", "ORGANISM", 144, 153], ["C. parvum", "SPECIES", 144, 153], ["C. parvum", "SPECIES", 144, 153], ["an Au interdigitated microelectrode array", "TREATMENT", 44, 85], ["equivalent circuit analysis", "TEST", 95, 122], ["the detection", "TEST", 127, 140], ["C. parvum", "PROBLEM", 144, 153]]], ["See Table 1, Table 2 for a detailed list of studies that have used the capacitive response of an electrochemical biosensor for pathogen detection.Conductometry ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionConductometry methods are those in which the conductivity of the sample solution is monitored using a low-amplitude alternating electrical potential (Dzyadevych and Jaffrezic-Renault, 2014).", [["studies", "TEST", 44, 51], ["pathogen detection", "TEST", 127, 145], ["pathogen detection", "TEST", 192, 210], ["Measurement formats", "TEST", 248, 267], ["pathogen detection", "TEST", 272, 290]]], ["The principle relies on conductivity change in the sample via the production or consumption of charged species.", [["sample", "ANATOMY", 51, 57], ["conductivity change", "PROBLEM", 24, 43], ["charged species", "PROBLEM", 95, 110], ["charged species", "OBSERVATION", 95, 110]]], ["The measurement has the advantage of not requiring a reference electrode and can be used to detect both electroactive and electroinactive analytes (Jaffrezic-Renault and Dzyadevych, 2008; Narayan, 2016).", [["a reference electrode", "TREATMENT", 51, 72], ["both electroactive and electroinactive analytes", "PROBLEM", 99, 146]]], ["Given the method can be performed using a two-electrode configuration, conductometric biosensors can be easily miniaturized.", [["a two-electrode configuration", "TREATMENT", 40, 69], ["conductometric biosensors", "TREATMENT", 71, 96]]], ["In addition, they are less vulnerable to many types of interference due to their differential measurement mode (Jaffrezic-Renault and Dzyadevych, 2008).Conductometry ::: Electrochemical methods for pathogen detection using electrochemical biosensors ::: Measurement formats for pathogen detectionAs shown in Fig. 5d, Yoo et al. used a conductometric biosensor with CNT-based electrodes for the detection of B. subtilis (Yoo et al. 2017).", [["CNT", "CHEMICAL", 365, 368], ["B. subtilis", "ORGANISM", 407, 418], ["B. subtilis", "SPECIES", 407, 418], ["B. subtilis", "SPECIES", 407, 418], ["pathogen detection", "TEST", 198, 216], ["Measurement formats", "TEST", 254, 273], ["pathogen detectionAs", "PROBLEM", 278, 298], ["a conductometric biosensor", "TREATMENT", 333, 359], ["CNT-based electrodes", "TREATMENT", 365, 385], ["B. subtilis", "PROBLEM", 407, 418]]], ["Mannoor et al. used a previously described conductometric biosensor to detect S. aureus and Helicobacter pylori on tooth enamel (Mannoor et al. 2012).", [["tooth enamel", "ANATOMY", 115, 127], ["S. aureus", "ORGANISM", 78, 87], ["Helicobacter pylori", "ORGANISM", 92, 111], ["tooth enamel", "MULTI-TISSUE_STRUCTURE", 115, 127], ["S. aureus", "SPECIES", 78, 87], ["Helicobacter pylori", "SPECIES", 92, 111], ["S. aureus", "SPECIES", 78, 87], ["Helicobacter pylori", "SPECIES", 92, 111], ["a previously described conductometric biosensor", "PROBLEM", 20, 67], ["S. aureus", "PROBLEM", 78, 87], ["Helicobacter pylori on tooth enamel", "PROBLEM", 92, 127], ["aureus", "OBSERVATION", 81, 87], ["Helicobacter pylori", "OBSERVATION", 92, 111]]], ["Shen et al. detected two strains of human influenza A virus (H1N1 and H3N2) using conductometry with a silicon nanowire array at a LOD of 29 viruses/\u03bcL (Shen et al. 2012).", [["influenza A virus", "DISEASE", 42, 59], ["silicon", "CHEMICAL", 103, 110], ["human", "ORGANISM", 36, 41], ["influenza A virus", "ORGANISM", 42, 59], ["human", "SPECIES", 36, 41], ["influenza A virus", "SPECIES", 42, 59], ["human influenza A virus", "SPECIES", 36, 59], ["human influenza A virus", "PROBLEM", 36, 59], ["H1N1", "PROBLEM", 61, 65], ["H3N2", "PROBLEM", 70, 74], ["conductometry", "TREATMENT", 82, 95], ["a silicon nanowire array", "TREATMENT", 101, 125]]], ["Additional studies that have examined the use of conductometric biosensors for pathogen detection can be found in Table 1, Table 2.Secondary binding approaches ::: Measurement formats for pathogen detectionElectrochemical biosensors would ideally produce sensitive and selective results using label-free protocols.", [["Additional studies", "TEST", 0, 18], ["conductometric biosensors", "TEST", 49, 74], ["pathogen detection", "TEST", 79, 97], ["Measurement formats", "TEST", 164, 183], ["pathogen detection", "TEST", 188, 206], ["Electrochemical biosensors", "TEST", 206, 232], ["label-free protocols", "TREATMENT", 293, 313]]], ["However, secondary binding reactions are sometimes required to facilitate the robust detection of pathogens that lack initial labels depending on the biosensor characteristics and measurement demands.", [["secondary binding reactions", "PROBLEM", 9, 36], ["pathogens", "PROBLEM", 98, 107]]], ["Secondary binding steps can facilitate target labeling, biosensor signal amplification, and verification of target binding.", [["Secondary binding steps", "PROBLEM", 0, 23], ["biosensor signal amplification", "TEST", 56, 86], ["target binding", "PROBLEM", 108, 122]]], ["Secondary binding steps provide useful in situ controls and can increase sensitivity, LOD, dynamic range, and measurement confidence (e.g., verification of target binding).", [["Secondary binding steps", "PROBLEM", 0, 23]]], ["Secondary binding steps also provide opportunities for acquiring additional bioanalytical information about the target species.Secondary binding approaches ::: Measurement formats for pathogen detectionHere, we classify assays that use secondary binding steps as labeled approaches in Table 1, Table 2 regardless of if the primary binding step produced a response.", [["Secondary binding steps", "PROBLEM", 0, 23], ["Measurement formats", "TEST", 160, 179], ["pathogen detection", "TEST", 184, 202]]], ["There is, however, a more subtle distinction if binding of the secondary species is used for amplification or verification purposes as previously discussed.", [["the secondary species", "PROBLEM", 59, 80], ["verification purposes", "TEST", 110, 131], ["secondary species", "OBSERVATION", 63, 80]]], ["Labels often include a biorecognition element-enzyme or -nanoparticle conjugate.", [["-nanoparticle conjugate", "SIMPLE_CHEMICAL", 56, 79], ["biorecognition element", "DNA", 23, 45], ["enzyme", "PROTEIN", 46, 52], ["a biorecognition element", "TEST", 21, 45], ["enzyme", "TEST", 46, 52]]], ["In electrochemical biosensing applications, such labels often serve the purpose of altering the material properties or transport processes of the electrode-electrolyte interface, often by inducing a secondary reaction.", [["electrochemical biosensing applications", "TREATMENT", 3, 42], ["a secondary reaction", "PROBLEM", 197, 217], ["secondary reaction", "OBSERVATION", 199, 217]]], ["Secondary binding of optically-active nanomaterials to captured targets can also enable the use of optical transducers for simultaneous detection or bioanalysis.", [["Secondary binding of optically-active nanomaterials", "PROBLEM", 0, 51], ["optical transducers", "TEST", 99, 118], ["simultaneous detection", "TEST", 123, 145], ["active", "OBSERVATION_MODIFIER", 31, 37], ["nanomaterials", "OBSERVATION", 38, 51]]], ["Enzymes are among the most commonly used secondary binding species for label-based pathogen detection.", [["Enzymes", "TEST", 0, 7], ["secondary binding species", "PROBLEM", 41, 66], ["label-based pathogen detection", "PROBLEM", 71, 101], ["binding species", "OBSERVATION", 51, 66], ["pathogen", "OBSERVATION", 83, 91]]], ["As shown in Table 2, electrochemical biosensors for pathogen detection that employ enzymes are commonly performed as a sandwich assay format.", [["enzymes", "PROTEIN", 83, 90], ["electrochemical biosensors", "TEST", 21, 47], ["pathogen detection", "TEST", 52, 70], ["employ enzymes", "TEST", 76, 90], ["a sandwich assay format", "TEST", 117, 140]]], ["A schematic of secondary binding steps for biosensor amplification based on the binding of HRP-antibody conjugates is shown in Fig. 6a (Kokkinos et al. 2016).", [["HRP", "GENE_OR_GENE_PRODUCT", 91, 94], ["HRP", "PROTEIN", 91, 94], ["secondary binding steps", "PROBLEM", 15, 38], ["biosensor amplification", "TREATMENT", 43, 66], ["HRP-antibody conjugates", "TEST", 91, 114]]], ["Hong et al. used HRP-labeled secondary antibodies to amplify the CV and EIS responses of a concanavalin A-functionalized nanostructured Au electrode to detect norovirus (Hong et al. 2015).", [["Au", "CHEMICAL", 136, 138], ["norovirus", "DISEASE", 159, 168], ["Au", "CHEMICAL", 136, 138], ["HRP", "SIMPLE_CHEMICAL", 17, 20], ["concanavalin", "SIMPLE_CHEMICAL", 91, 103], ["norovirus", "ORGANISM", 159, 168], ["HRP-labeled secondary antibodies", "PROTEIN", 17, 49], ["HRP", "TEST", 17, 20], ["secondary antibodies", "PROBLEM", 29, 49], ["the CV", "TEST", 61, 67], ["a concanavalin A-functionalized nanostructured Au electrode", "TREATMENT", 89, 148], ["norovirus", "PROBLEM", 159, 168], ["norovirus", "OBSERVATION", 159, 168]]], ["Gayathri et al. used an HRP-antibody conjugate to induce an enzyme-assisted reduction reaction with an immobilized thionine-antibody receptor in an H2O2 system for detection of E. coli down to 50 CFU/mL using a sandwich assay format (Gayathri et al. 2016).", [["thionine", "CHEMICAL", 115, 123], ["H2O2", "CHEMICAL", 148, 152], ["thionine", "CHEMICAL", 115, 123], ["H2O2", "CHEMICAL", 148, 152], ["HRP", "SIMPLE_CHEMICAL", 24, 27], ["thionine", "SIMPLE_CHEMICAL", 115, 123], ["H2O2", "SIMPLE_CHEMICAL", 148, 152], ["E. coli", "ORGANISM", 177, 184], ["HRP-antibody conjugate", "PROTEIN", 24, 46], ["immobilized thionine-antibody receptor", "PROTEIN", 103, 141], ["E. coli", "SPECIES", 177, 184], ["E. coli", "SPECIES", 177, 184], ["an HRP", "TEST", 21, 27], ["an enzyme", "TEST", 57, 66], ["assisted reduction reaction", "PROBLEM", 67, 94], ["an immobilized thionine-antibody receptor", "TREATMENT", 100, 141], ["an H2O2 system", "TEST", 145, 159], ["E. coli", "PROBLEM", 177, 184], ["a sandwich assay", "TEST", 209, 225]]], ["Xu et al. used glucose oxidase and monoclonal anti-S. typhimurium to functionalize magnetic bead labels for separation and detection of S. typhimurium on an Au IDAM using EIS and glucose to catalyze the reaction that exhibited a linear working range of 102 to 106 CFU/mL (Xu et al. 2016b).Secondary binding approaches ::: Measurement formats for pathogen detectionIn addition to enzymes, secondary binding of nanoparticles has also been used for pathogen detection.", [["glucose", "CHEMICAL", 15, 22], ["Au", "CHEMICAL", 157, 159], ["glucose", "CHEMICAL", 179, 186], ["glucose", "CHEMICAL", 15, 22], ["Au", "CHEMICAL", 157, 159], ["glucose", "CHEMICAL", 179, 186], ["glucose", "SIMPLE_CHEMICAL", 15, 22], ["oxidase", "GENE_OR_GENE_PRODUCT", 23, 30], ["anti-S. typhimurium", "ORGANISM", 46, 65], ["S. typhimurium", "ORGANISM", 136, 150], ["Au IDAM", "SIMPLE_CHEMICAL", 157, 164], ["glucose", "SIMPLE_CHEMICAL", 179, 186], ["glucose oxidase", "PROTEIN", 15, 30], ["enzymes", "PROTEIN", 379, 386], ["anti-S. typhimurium", "SPECIES", 46, 65], ["S. typhimurium", "SPECIES", 136, 150], ["anti-S. typhimurium", "SPECIES", 46, 65], ["S. typhimurium", "SPECIES", 136, 150], ["glucose oxidase", "TREATMENT", 15, 30], ["monoclonal anti-S. typhimurium", "TREATMENT", 35, 65], ["S. typhimurium", "PROBLEM", 136, 150], ["EIS and glucose", "TREATMENT", 171, 186], ["the reaction", "PROBLEM", 199, 211], ["Measurement formats", "TEST", 322, 341], ["enzymes", "TEST", 379, 386], ["secondary binding of nanoparticles", "PROBLEM", 388, 422], ["pathogen detection", "TEST", 446, 464]]], ["As shown in Fig. 6b, Wan et al. utilized non-functionalized AuNPs to amplify the EIS response of an antibody-immobilized planar Au electrode to E. coli detection (Wan et al. 2016).", [["AuNPs", "CHEMICAL", 60, 65], ["Au", "CHEMICAL", 128, 130], ["Au", "CHEMICAL", 128, 130], ["AuNPs", "SIMPLE_CHEMICAL", 60, 65], ["E. coli", "ORGANISM", 144, 151], ["E. coli", "SPECIES", 144, 151], ["E. coli", "SPECIES", 144, 151], ["non-functionalized AuNPs", "TREATMENT", 41, 65], ["an antibody", "TEST", 97, 108], ["immobilized planar Au electrode", "TREATMENT", 109, 140], ["E. coli detection", "TEST", 144, 161]]], ["A detailed overview of studies that employ enzymes and nanoparticles is provided in Table 2.", [["enzymes", "PROTEIN", 43, 50], ["employ enzymes", "TEST", 36, 50], ["nanoparticles", "TREATMENT", 55, 68]]], ["We remind the reader that while secondary binding steps are useful techniques, assays that avoid secondary binding steps have advantages for bioprocess monitoring and control applications, as they avoid the addition of reagents to a process that may compromise product quality).Food and water safety applications ::: Applications to pathogen detectionDetection of foodborne and waterborne pathogens is an essential aspect of public healthcare.", [["foodborne and waterborne pathogens", "DISEASE", 364, 398], ["secondary binding steps", "PROBLEM", 97, 120], ["bioprocess monitoring", "TEST", 141, 162], ["foodborne", "PROBLEM", 364, 373], ["waterborne pathogens", "PROBLEM", 378, 398]]], ["Foodborne and waterborne pathogens originate from a variety of sources and matrices and typically infect humans through the consumption of contaminated food and water.", [["humans", "ORGANISM", 105, 111], ["food", "ORGANISM_SUBDIVISION", 152, 156], ["humans", "SPECIES", 105, 111], ["humans", "SPECIES", 105, 111], ["waterborne pathogens", "PROBLEM", 14, 34], ["waterborne", "OBSERVATION_MODIFIER", 14, 24], ["pathogens", "OBSERVATION", 25, 34]]], ["Waterborne pathogens are responsible for about 2.2 million deaths annually worldwide (Pandey et al. 2014), and contaminated food-related deaths amount to around 420,000 annually (WHO, 2015).", [["deaths", "DISEASE", 59, 65], ["deaths", "DISEASE", 137, 143], ["Waterborne pathogens", "PROBLEM", 0, 20], ["pathogens", "OBSERVATION", 11, 20]]], ["In 2019, the United States suffered an outbreak of multidrug-resistant S. typhimurium in turkey products caused 358 infections across 42 states, demonstrating the importance of detecting pathogens in food sources (CDC, 2019).Food and water safety applications ::: Applications to pathogen detectionWhile biosensors for pathogen detection are critical to water and food safety in developed regions, biosensors are particularly important aspects of public healthcare in remote and under-developed regions due to relatively reduced infrastructure and resources for food and water quality analysis.", [["infections", "DISEASE", 116, 126], ["multidrug", "ORGANISM", 51, 60], ["S. typhimurium", "ORGANISM", 71, 85], ["turkey", "ORGANISM", 89, 95], ["S. typhimurium", "SPECIES", 71, 85], ["turkey", "SPECIES", 89, 95], ["S. typhimurium", "SPECIES", 71, 85], ["turkey", "SPECIES", 89, 95], ["pathogen detectionWhile biosensors", "TREATMENT", 280, 314], ["pathogen detection", "PROBLEM", 319, 337], ["water quality analysis", "TEST", 571, 593]]], ["For example, in 2014, a cholera outbreak linked to V. cholerae in Ghana, which has been associated with poor environmental water management and sanitation issues, infected over 20,000 individuals (Ohene-Adjei et al. 2017).", [["cholera", "DISEASE", 24, 31], ["V. cholerae", "ORGANISM", 51, 62], ["V. cholerae", "SPECIES", 51, 62], ["V. cholerae", "SPECIES", 51, 62], ["a cholera outbreak", "PROBLEM", 22, 40], ["poor environmental water management", "TREATMENT", 104, 139], ["associated with", "UNCERTAINTY", 88, 103], ["poor", "OBSERVATION_MODIFIER", 104, 108], ["environmental", "OBSERVATION_MODIFIER", 109, 122], ["water management", "OBSERVATION", 123, 139]]], ["The selective detection of pathogens in food and water remains a global healthcare challenge.", [["pathogens", "PROBLEM", 27, 36], ["a global healthcare challenge", "TREATMENT", 63, 92], ["selective", "OBSERVATION_MODIFIER", 4, 13], ["pathogens", "OBSERVATION", 27, 36]]], ["Here, we describe the most common foodborne and waterborne pathogens.", [["foodborne and waterborne pathogens", "DISEASE", 34, 68], ["waterborne pathogens", "PROBLEM", 48, 68], ["waterborne pathogens", "OBSERVATION", 48, 68]]], ["Common foodborne and waterborne pathogens include protozoa, such as C. parvum and G. lamblia, bacteria, such as E. coli, L. monocytogenes, S. typhimurium, S. aureus, and Campylobacter, and viruses, such as norovirus and rotavirus (Beuchat et al. 2013; Cabral, 2010).Food and water safety applications ::: Applications to pathogen detectionThe infectious dose of foodborne and waterborne pathogens can vary by 4\u20136 orders of magnitude, from a single cell or oocyst to greater than one million cells.", [["cell", "ANATOMY", 448, 452], ["oocyst", "ANATOMY", 456, 462], ["cells", "ANATOMY", 491, 496], ["foodborne and waterborne pathogens", "DISEASE", 7, 41], ["C. parvum and G. lamblia", "DISEASE", 68, 92], ["norovirus and rotavirus", "DISEASE", 206, 229], ["foodborne and waterborne pathogens", "DISEASE", 362, 396], ["C. parvum", "ORGANISM", 68, 77], ["G. lamblia", "ORGANISM", 82, 92], ["E. coli", "ORGANISM", 112, 119], ["L. monocytogenes", "ORGANISM", 121, 137], ["S. typhimurium", "ORGANISM", 139, 153], ["S. aureus", "ORGANISM", 155, 164], ["norovirus", "ORGANISM", 206, 215], ["rotavirus", "ORGANISM", 220, 229], ["cell", "CELL", 448, 452], ["oocyst", "ORGANISM_SUBSTANCE", 456, 462], ["cells", "CELL", 491, 496], ["C. parvum", "SPECIES", 68, 77], ["G. lamblia", "SPECIES", 82, 92], ["E. coli", "SPECIES", 112, 119], ["L. monocytogenes", "SPECIES", 121, 137], ["S. typhimurium", "SPECIES", 139, 153], ["S. aureus", "SPECIES", 155, 164], ["C. parvum", "SPECIES", 68, 77], ["G. lamblia", "SPECIES", 82, 92], ["E. coli", "SPECIES", 112, 119], ["L. monocytogenes", "SPECIES", 121, 137], ["S. typhimurium", "SPECIES", 139, 153], ["S. aureus", "SPECIES", 155, 164], ["rotavirus", "SPECIES", 220, 229], ["Common foodborne and waterborne pathogens", "PROBLEM", 0, 41], ["protozoa", "PROBLEM", 50, 58], ["C. parvum and G. lamblia", "PROBLEM", 68, 92], ["bacteria", "PROBLEM", 94, 102], ["E. coli", "PROBLEM", 112, 119], ["L. monocytogenes", "PROBLEM", 121, 137], ["S. typhimurium", "PROBLEM", 139, 153], ["S. aureus", "PROBLEM", 155, 164], ["Campylobacter", "PROBLEM", 170, 183], ["viruses", "PROBLEM", 189, 196], ["norovirus", "PROBLEM", 206, 215], ["rotavirus", "PROBLEM", 220, 229], ["pathogen detection", "TEST", 321, 339], ["waterborne pathogens", "PROBLEM", 376, 396], ["a single cell or oocyst", "PROBLEM", 439, 462], ["L. monocytogenes", "OBSERVATION", 121, 137], ["aureus", "OBSERVATION", 158, 164], ["Campylobacter", "OBSERVATION", 170, 183], ["viruses", "OBSERVATION", 189, 196], ["norovirus", "OBSERVATION", 206, 215], ["infectious", "OBSERVATION_MODIFIER", 343, 353], ["oocyst", "OBSERVATION", 456, 462]]], ["For example, the infectious dose of S. dysenteriae is 200 CFU (Greig and Todd, 2010), while that of S. aureus is 100,000 CFU (Schmid-Hempel and Frank, 2007).", [["S. dysenteriae", "ORGANISM", 36, 50], ["S. aureus", "ORGANISM", 100, 109], ["S. dysenteriae", "SPECIES", 36, 50], ["S. aureus", "SPECIES", 100, 109], ["S. dysenteriae", "SPECIES", 36, 50], ["S. aureus", "SPECIES", 100, 109], ["S. dysenteriae", "PROBLEM", 36, 50], ["S. aureus", "PROBLEM", 100, 109], ["Schmid", "TEST", 126, 132], ["infectious", "OBSERVATION_MODIFIER", 17, 27], ["aureus", "OBSERVATION", 103, 109]]], ["Given the extensive use of immunoassays in food and water safety, such as ELISA, it is possible to obtain commercially-available monoclonal and polyclonal antibodies for a large number of foodborne and waterborne pathogens.Food and water safety applications ::: Applications to pathogen detectionBiosensor applications associated with process monitoring applications may require biosensor designs and measurement formats that facilitate high-throughput analysis, continuous monitoring capability, and biosensor reusability.", [["foodborne and waterborne pathogens", "DISEASE", 188, 222], ["monoclonal and polyclonal antibodies", "PROTEIN", 129, 165], ["immunoassays", "TEST", 27, 39], ["monoclonal and polyclonal antibodies", "TREATMENT", 129, 165], ["waterborne pathogens", "PROBLEM", 202, 222], ["pathogen detectionBiosensor applications", "TREATMENT", 278, 318], ["process monitoring applications", "TREATMENT", 335, 366], ["biosensor designs", "TREATMENT", 379, 396], ["measurement formats", "TEST", 401, 420], ["continuous monitoring capability", "TEST", 463, 495], ["large", "OBSERVATION_MODIFIER", 172, 177]]], ["Alternatively, those for water safety applications in under-developed regions may require biosensor designs and measurement formats that facilitate field use, such as sample preparation-free protocols.", [["sample", "ANATOMY", 167, 173], ["water safety applications", "TREATMENT", 25, 50], ["biosensor designs", "TREATMENT", 90, 107], ["measurement formats", "TEST", 112, 131], ["sample preparation-free protocols", "TREATMENT", 167, 200]]], ["As a result, biosensors for food and water safety applications should facilitate pathogen detection at various stages of the processing operation.", [["water safety applications", "TREATMENT", 37, 62], ["pathogen detection", "TEST", 81, 99], ["the processing operation", "TREATMENT", 121, 145]]], ["Recent advances in electrochemical biosensors for food and water safety applications have established new low-cost biosensor designs, portable measurement formats, and flexible form-factors and are discussed further in the following sections.Environmental monitoring and infection control applications ::: Applications to pathogen detectionIn addition to foodborne and waterborne pathogens, the detection of environmental pathogens is also an important aspect of healthcare.", [["sections", "ANATOMY", 233, 241], ["infection", "DISEASE", 271, 280], ["foodborne and waterborne pathogens", "DISEASE", 355, 389], ["electrochemical biosensors", "TREATMENT", 19, 45], ["water safety applications", "TREATMENT", 59, 84], ["new low-cost biosensor designs", "TREATMENT", 102, 132], ["portable measurement formats", "TEST", 134, 162], ["Environmental monitoring", "TEST", 242, 266], ["pathogen detection", "TEST", 322, 340], ["foodborne", "PROBLEM", 355, 364], ["waterborne pathogens", "PROBLEM", 369, 389], ["environmental pathogens", "PROBLEM", 408, 431]]], ["For example, diseases associated with environmental pathogens are one of the leading causes of death in low-income economies (WHO, 2018a).", [["death", "DISEASE", 95, 100], ["diseases", "PROBLEM", 13, 21], ["environmental pathogens", "PROBLEM", 38, 61], ["death", "PROBLEM", 95, 100], ["diseases", "OBSERVATION", 13, 21], ["environmental", "OBSERVATION_MODIFIER", 38, 51], ["pathogens", "OBSERVATION", 52, 61], ["low", "OBSERVATION_MODIFIER", 104, 107]]], ["For example, malaria was reported to cause an estimated 435,000 deaths in 2017 (WHO, 2018b).", [["malaria", "DISEASE", 13, 20], ["deaths", "DISEASE", 64, 70], ["malaria", "PROBLEM", 13, 20], ["malaria", "OBSERVATION", 13, 20]]], ["Environmental pathogens are microorganisms that typically spend a substantial part of their lifecycle outside human hosts, but when introduced to humans through contact or inhalation cause disease with measurable frequency.", [["human", "ORGANISM", 110, 115], ["humans", "ORGANISM", 146, 152], ["human", "SPECIES", 110, 115], ["humans", "SPECIES", 146, 152], ["human", "SPECIES", 110, 115], ["humans", "SPECIES", 146, 152], ["Environmental pathogens", "PROBLEM", 0, 23], ["microorganisms", "PROBLEM", 28, 42], ["disease", "PROBLEM", 189, 196]]], ["However, here, we choose to distinguish environmental monitoring applications, which require pathogen detection in the environment (e.g., in air or on surfaces), from medical diagnostics applications, which require detection in body fluids.", [["body fluids", "ANATOMY", 228, 239], ["body", "ORGANISM_SUBDIVISION", 228, 232], ["fluids", "ORGANISM_SUBSTANCE", 233, 239], ["environmental monitoring applications", "TREATMENT", 40, 77], ["pathogen detection", "TEST", 93, 111], ["detection in body fluids", "TREATMENT", 215, 239]]], ["Thus, the distinction is based on the matrix in which the pathogen is present.", [["matrix", "CELLULAR_COMPONENT", 38, 44], ["pathogen", "OBSERVATION", 58, 66]]], ["Similar to food and water safety applications, which require biosensors capable of analyzing pathogen-containing complex matrices, such as a water or food matrix, environmental pathogens are present in multiple types of matrices.", [["water safety applications", "TREATMENT", 20, 45], ["biosensors", "TREATMENT", 61, 71], ["analyzing pathogen", "PROBLEM", 83, 101], ["complex matrices", "TREATMENT", 113, 129], ["a water or food matrix", "TREATMENT", 139, 161], ["environmental pathogens", "PROBLEM", 163, 186]]], ["While environmental pathogens can enter the body through direct physical contact, they can also be transmitted through aerosols or interaction with organisms that serve as vectors for the infectious agent, such as mosquitos in the case of Plasmodium falciparum (the infectious agent associated with malaria).", [["body", "ANATOMY", 44, 48], ["Plasmodium falciparum", "DISEASE", 239, 260], ["malaria", "DISEASE", 299, 306], ["body", "ORGANISM_SUBDIVISION", 44, 48], ["Plasmodium falciparum", "ORGANISM", 239, 260], ["Plasmodium falciparum", "SPECIES", 239, 260], ["Plasmodium falciparum", "SPECIES", 239, 260], ["organisms", "PROBLEM", 148, 157], ["the infectious agent", "TREATMENT", 184, 204], ["Plasmodium falciparum", "PROBLEM", 239, 260], ["malaria", "PROBLEM", 299, 306]]], ["Thus, the detection of environmental pathogens often requires analysis of matrices, such as air, and objects, such as the surfaces of biomedical devices or objects within healthcare facilities, that are present in the human environment (Lai et al. 2009).Environmental monitoring and infection control applications ::: Applications to pathogen detectionSeveral comprehensive reviews have been provided on the detection of environmental pathogens (Baeumner, 2003; Justino et al. 2017).", [["infection", "DISEASE", 283, 292], ["human", "ORGANISM", 218, 223], ["human", "SPECIES", 218, 223], ["human", "SPECIES", 218, 223], ["environmental pathogens", "PROBLEM", 23, 46], ["biomedical devices", "TREATMENT", 134, 152], ["Environmental monitoring", "TEST", 254, 278]]], ["Here, we describe the most common environmental pathogens found both in and outside of clinical settings.", [["the most common environmental pathogens", "PROBLEM", 18, 57], ["pathogens", "OBSERVATION", 48, 57]]], ["Common environmental pathogens in a non-clinical setting include Legionella spp., which cause Legionnellosis, Mycobacterium tuberculosis, which causes tuberculosis, and Naegleria fowleri, which causes amoebic meningitis.", [["Legionella spp.", "DISEASE", 65, 80], ["Legionnellosis", "DISEASE", 94, 108], ["Mycobacterium tuberculosis", "DISEASE", 110, 136], ["tuberculosis", "DISEASE", 151, 163], ["Naegleria fowleri", "DISEASE", 169, 186], ["amoebic meningitis", "DISEASE", 201, 219], ["Legionella spp.", "ORGANISM", 65, 80], ["Mycobacterium tuberculosis", "ORGANISM", 110, 136], ["Naegleria fowleri", "ORGANISM", 169, 186], ["Legionella spp.", "SPECIES", 65, 80], ["Mycobacterium tuberculosis", "SPECIES", 110, 136], ["Naegleria fowleri", "SPECIES", 169, 186], ["Legionella spp.", "SPECIES", 65, 80], ["Mycobacterium tuberculosis", "SPECIES", 110, 136], ["Naegleria fowleri", "SPECIES", 169, 186], ["Common environmental pathogens", "PROBLEM", 0, 30], ["Legionella spp.", "PROBLEM", 65, 80], ["Legionnellosis", "PROBLEM", 94, 108], ["Mycobacterium tuberculosis", "PROBLEM", 110, 136], ["tuberculosis", "PROBLEM", 151, 163], ["Naegleria fowleri", "PROBLEM", 169, 186], ["amoebic meningitis", "PROBLEM", 201, 219], ["pathogens", "OBSERVATION", 21, 30], ["Mycobacterium tuberculosis", "OBSERVATION", 110, 136], ["tuberculosis", "OBSERVATION", 151, 163], ["Naegleria fowleri", "OBSERVATION", 169, 186], ["amoebic", "OBSERVATION_MODIFIER", 201, 208], ["meningitis", "OBSERVATION", 209, 219]]], ["In addition to bacteria and protozoa, fungi, nematodes, and insects are also environmental pathogens.", [["bacteria", "PROBLEM", 15, 23], ["protozoa", "PROBLEM", 28, 36], ["fungi", "PROBLEM", 38, 43], ["nematodes", "PROBLEM", 45, 54], ["environmental pathogens", "PROBLEM", 77, 100], ["bacteria", "OBSERVATION", 15, 23], ["protozoa", "OBSERVATION", 28, 36]]], ["Common environmental pathogens in clinical settings associated with healthcare-acquired infections include drug-resistant and multi-drug resistant (MDR) pathogens, such as Clostridium difficile (CD) (Hookman and Barkin, 2009), which causes CD-associated diarrhea and antibiotic-induced colitis, and methicillin-resistant S. aureus (MRSA), which causes severe infections in various parts of the body, including the urinary tract (Gordon and Lowy, 2008).Environmental monitoring and infection control applications ::: Applications to pathogen detectionThe infectious dose of environmental pathogens also varies by orders of magnitude depending on the pathogen as well as age and health of the individual.", [["body", "ANATOMY", 394, 398], ["urinary tract", "ANATOMY", 414, 427], ["infections", "DISEASE", 88, 98], ["drug-resistant and multi-drug resistant (MDR) pathogens", "DISEASE", 107, 162], ["Clostridium difficile", "DISEASE", 172, 193], ["CD", "DISEASE", 195, 197], ["CD", "DISEASE", 240, 242], ["diarrhea", "DISEASE", 254, 262], ["colitis", "DISEASE", 286, 293], ["methicillin", "CHEMICAL", 299, 310], ["MRSA", "DISEASE", 332, 336], ["infections", "DISEASE", 359, 369], ["infection", "DISEASE", 481, 490], ["methicillin", "CHEMICAL", 299, 310], ["Clostridium difficile", "ORGANISM", 172, 193], ["colitis", "PATHOLOGICAL_FORMATION", 286, 293], ["methicillin-resistant S. aureus", "ORGANISM", 299, 330], ["MRSA", "ORGANISM", 332, 336], ["body", "ORGANISM_SUBDIVISION", 394, 398], ["urinary tract", "ORGANISM_SUBDIVISION", 414, 427], ["Clostridium difficile", "SPECIES", 172, 193], ["S. aureus", "SPECIES", 321, 330], ["MRSA", "SPECIES", 332, 336], ["Clostridium difficile", "SPECIES", 172, 193], ["S. aureus", "SPECIES", 321, 330], ["MRSA", "SPECIES", 332, 336], ["Common environmental pathogens", "PROBLEM", 0, 30], ["healthcare-acquired infections", "PROBLEM", 68, 98], ["drug-resistant and multi-drug resistant (MDR) pathogens", "PROBLEM", 107, 162], ["Clostridium difficile", "PROBLEM", 172, 193], ["CD", "PROBLEM", 240, 242], ["associated diarrhea", "PROBLEM", 243, 262], ["antibiotic", "TREATMENT", 267, 277], ["induced colitis", "PROBLEM", 278, 293], ["methicillin-resistant S. aureus", "PROBLEM", 299, 330], ["MRSA", "PROBLEM", 332, 336], ["severe infections in various parts of the body", "PROBLEM", 352, 398], ["Environmental monitoring", "TEST", 452, 476], ["pathogen detection", "TEST", 532, 550], ["environmental pathogens", "PROBLEM", 573, 596], ["the pathogen", "PROBLEM", 645, 657], ["pathogens", "OBSERVATION", 21, 30], ["multi-drug resistant", "OBSERVATION_MODIFIER", 126, 146], ["diarrhea", "OBSERVATION", 254, 262], ["colitis", "OBSERVATION", 286, 293], ["aureus", "OBSERVATION", 324, 330], ["MRSA", "OBSERVATION", 332, 336], ["severe", "OBSERVATION_MODIFIER", 352, 358], ["infections", "OBSERVATION", 359, 369], ["body", "ANATOMY_MODIFIER", 394, 398], ["urinary tract", "ANATOMY", 414, 427], ["infectious", "OBSERVATION_MODIFIER", 554, 564]]], ["For example, the infectious dose of CD is less than 10 spores, while that of MRSA is greater than 100,000 organisms (Schmid-Hempel and Frank, 2007).", [["CD", "DISEASE", 36, 38], ["MRSA", "CHEMICAL", 77, 81], ["MRSA", "SPECIES", 77, 81], ["the infectious dose of CD", "PROBLEM", 13, 38], ["MRSA", "PROBLEM", 77, 81], ["Schmid", "TEST", 117, 123], ["infectious", "OBSERVATION_MODIFIER", 17, 27], ["MRSA", "OBSERVATION", 77, 81]]], ["While it is possible to obtain antibodies for foodborne and waterborne pathogens, it can be challenging to obtain antibodies for various environmental pathogens, including protozoa and nematodes.", [["foodborne and waterborne pathogens", "DISEASE", 46, 80], ["antibodies", "PROTEIN", 31, 41], ["antibodies", "PROTEIN", 114, 124], ["foodborne", "PROBLEM", 46, 55], ["waterborne pathogens", "PROBLEM", 60, 80], ["antibodies", "TREATMENT", 114, 124], ["various environmental pathogens", "PROBLEM", 129, 160], ["protozoa", "PROBLEM", 172, 180]]], ["Thus, traditional bioanalytical techniques, such as PCR, are often utilized for the detection of environmental pathogens.Environmental monitoring and infection control applications ::: Applications to pathogen detectionSimilar to food and water safety applications, biosensor-based assays for environmental pathogen detection applications also utilize measurement formats that facilitate the analysis of liquids.", [["infection", "DISEASE", 150, 159], ["traditional bioanalytical techniques", "TREATMENT", 6, 42], ["PCR", "TEST", 52, 55], ["environmental pathogens", "PROBLEM", 97, 120], ["Environmental monitoring", "TEST", 121, 145], ["pathogen detectionSimilar", "TREATMENT", 201, 226], ["water safety applications", "TREATMENT", 239, 264], ["biosensor", "TREATMENT", 266, 275], ["environmental pathogen detection applications", "TREATMENT", 293, 338], ["measurement formats", "TEST", 352, 371]]], ["However, they also require measurement formats for the detection of aerosolized pathogens.", [["measurement formats", "TEST", 27, 46], ["the detection", "TEST", 51, 64], ["aerosolized pathogens", "PROBLEM", 68, 89], ["aerosolized pathogens", "OBSERVATION", 68, 89]]], ["In addition to airborne transmission, environmental pathogens are transmitted by direct surface contact (similar to many foodborne pathogens), which is a significant mode of transmission in healthcare settings (e.g., of healthcare-acquired infections).", [["surface", "ANATOMY", 88, 95], ["foodborne pathogens", "DISEASE", 121, 140], ["infections", "DISEASE", 240, 250], ["environmental pathogens", "PROBLEM", 38, 61], ["acquired infections", "PROBLEM", 231, 250]]], ["Standardized guidelines for disinfecting and sterilizing the surfaces of medical equipment, assistive technologies, counters, and doors, among other surfaces, have emerged as an important aspect of infection control in modern healthcare facilities (Fraise et al. 2008).", [["infection", "DISEASE", 198, 207], ["Standardized guidelines", "TREATMENT", 0, 23], ["disinfecting", "TREATMENT", 28, 40], ["medical equipment", "TREATMENT", 73, 90], ["infection control", "TREATMENT", 198, 215], ["infection", "OBSERVATION", 198, 207]]], ["Thus, the detection of pathogens on the surfaces of biomedical devices and objects present in healthcare facilities is an important research area (Kramer et al. 2006; Weber et al. 2010).", [["pathogens", "PROBLEM", 23, 32], ["biomedical devices", "TREATMENT", 52, 70], ["pathogens", "OBSERVATION", 23, 32]]], ["For example, bacterial contamination of inanimate surfaces and equipment has been examined as a source of intensive care unit-acquired infections, a global healthcare challenge, especially when caused by MDR pathogens (Russotto et al. 2015).", [["infections", "DISEASE", 135, 145], ["bacterial contamination of inanimate surfaces", "PROBLEM", 13, 58], ["acquired infections", "PROBLEM", 126, 145], ["MDR pathogens", "PROBLEM", 204, 217], ["bacterial", "OBSERVATION_MODIFIER", 13, 22], ["contamination", "OBSERVATION", 23, 36], ["infections", "OBSERVATION", 135, 145]]], ["Hospital-acquired infections are prevalent causes of morbidity in patients (Orsi et al. 2002).", [["infections", "DISEASE", 18, 28], ["patients", "ORGANISM", 66, 74], ["patients", "SPECIES", 66, 74], ["acquired infections", "PROBLEM", 9, 28], ["morbidity", "PROBLEM", 53, 62], ["infections", "OBSERVATION", 18, 28], ["morbidity", "OBSERVATION", 53, 62]]], ["This problem has only been exasperated by the rise of MDR CD, as well as drug-resistant strains of Campylobacter, Enterococcus, Salmonella, S. aureus, and S. dysenteriae (Ventola, 2015).", [["CD", "DISEASE", 58, 60], ["Campylobacter, Enterococcus, Salmonella, S. aureus", "DISEASE", 99, 149], ["Campylobacter", "ORGANISM", 99, 112], ["Enterococcus, Salmonella", "ORGANISM", 114, 138], ["S. aureus", "ORGANISM", 140, 149], ["S. dysenteriae", "ORGANISM", 155, 169], ["S. aureus", "SPECIES", 140, 149], ["S. dysenteriae", "SPECIES", 155, 169], ["S. aureus", "SPECIES", 140, 149], ["S. dysenteriae", "SPECIES", 155, 169], ["MDR CD", "PROBLEM", 54, 60], ["drug-resistant strains", "PROBLEM", 73, 95], ["Campylobacter", "PROBLEM", 99, 112], ["Enterococcus", "PROBLEM", 114, 126], ["Salmonella", "PROBLEM", 128, 138], ["S. aureus", "PROBLEM", 140, 149], ["S. dysenteriae", "PROBLEM", 155, 169], ["rise", "OBSERVATION_MODIFIER", 46, 50], ["MDR CD", "OBSERVATION", 54, 60], ["Campylobacter", "OBSERVATION", 99, 112], ["aureus", "OBSERVATION", 143, 149], ["dysenteriae", "OBSERVATION_MODIFIER", 158, 169]]], ["In addition to clinical pathogens, it is also of interest to detect pathogens in non-clinical settings (Faucher and Charette, 2015).", [["clinical pathogens", "PROBLEM", 15, 33], ["pathogens", "PROBLEM", 68, 77]]], ["Toxin-producing algae, such as cyanobacteria and sulphate-reducing bacteria, are also important targets for electrochemical biosensors associated with the prevention of water-based diseases.Medical diagnostic applications ::: Applications to pathogen detectionThe field of medical diagnostics heavily relies on the identification and quantification of pathogens found in body fluids, including whole blood, stool, urine, mucus, saliva, or sputum.", [["body fluids", "ANATOMY", 371, 382], ["whole blood", "ANATOMY", 394, 405], ["stool", "ANATOMY", 407, 412], ["urine", "ANATOMY", 414, 419], ["mucus", "ANATOMY", 421, 426], ["saliva", "ANATOMY", 428, 434], ["sputum", "ANATOMY", 439, 445], ["Toxin", "CHEMICAL", 0, 5], ["sulphate", "CHEMICAL", 49, 57], ["sulphate", "CHEMICAL", 49, 57], ["Toxin", "GENE_OR_GENE_PRODUCT", 0, 5], ["sulphate", "SIMPLE_CHEMICAL", 49, 57], ["body fluids", "ORGANISM_SUBSTANCE", 371, 382], ["blood", "ORGANISM_SUBSTANCE", 400, 405], ["stool", "ORGANISM_SUBSTANCE", 407, 412], ["urine", "ORGANISM_SUBSTANCE", 414, 419], ["mucus", "ORGANISM_SUBSTANCE", 421, 426], ["saliva", "ORGANISM_SUBSTANCE", 428, 434], ["Toxin", "TEST", 0, 5], ["algae", "PROBLEM", 16, 21], ["cyanobacteria", "PROBLEM", 31, 44], ["sulphate-reducing bacteria", "PROBLEM", 49, 75], ["electrochemical biosensors", "PROBLEM", 108, 134], ["water-based diseases", "PROBLEM", 169, 189], ["pathogen detection", "TEST", 242, 260], ["the identification", "TEST", 311, 329], ["pathogens", "PROBLEM", 352, 361], ["body fluids", "TEST", 371, 382], ["whole blood, stool, urine, mucus, saliva", "TEST", 394, 434], ["sputum", "PROBLEM", 439, 445], ["diseases", "OBSERVATION", 181, 189], ["mucus", "ANATOMY", 421, 426]]], ["Diagnostic assays based on traditional bioanalytical techniques for detection of pathogens in body fluids are the gold standard and serve an essential role in healthcare by enabling the diagnosis and treatment of various diseases.", [["body fluids", "ANATOMY", 94, 105], ["body", "ORGANISM_SUBDIVISION", 94, 98], ["Diagnostic assays", "TEST", 0, 17], ["traditional bioanalytical techniques", "TEST", 27, 63], ["pathogens in body fluids", "PROBLEM", 81, 105], ["treatment", "TREATMENT", 200, 209], ["various diseases", "PROBLEM", 213, 229], ["pathogens", "OBSERVATION", 81, 90], ["various", "OBSERVATION_MODIFIER", 213, 220], ["diseases", "OBSERVATION", 221, 229]]], ["Biosensors offer a complementary diagnostic platform that enable rapid and cost-effective measurements, high sensitivity, and the ability to make measurements in complex matrices that pose challenges to traditional bioanalytical techniques.", [["traditional bioanalytical techniques", "TREATMENT", 203, 239]]], ["Studies suggest that rapid diagnostic testing can potentially reduce the chance of hospitalization, duration of hospitalization and antimicrobial use, and mortality rates (Barenfanger et al. 2000; Beekmann et al. 2003; Dierkes et al. 2009; Rappo et al. 2016).", [["rapid diagnostic testing", "TEST", 21, 45], ["antimicrobial use", "TREATMENT", 132, 149]]], ["For example, repeated rapid screening programs for human immunodeficiency virus (HIV) detection is recommended as a means of increasing quality-adjusted life years of health for citizens in the United States (Paltiel et al. 2006).", [["human immunodeficiency virus (HIV) detection", "DISEASE", 51, 95], ["human immunodeficiency virus", "ORGANISM", 51, 79], ["HIV", "ORGANISM", 81, 84], ["human", "SPECIES", 51, 56], ["immunodeficiency virus", "SPECIES", 57, 79], ["human immunodeficiency virus", "SPECIES", 51, 79], ["HIV", "SPECIES", 81, 84], ["repeated rapid screening programs", "TEST", 13, 46], ["human immunodeficiency virus", "PROBLEM", 51, 79]]], ["Additionally, the need for rapid antibody screening has been identified as an important aspect of mitigating the ongoing COVID-19 pandemic.Medical diagnostic applications ::: Applications to pathogen detectionSeveral comprehensive reviews have been published on traditional bioanalytical assays and biosensor-based assays for pathogen detection in medical diagnostics applications (Ahmed et al., 2014; da Silva et al., 2017; Singh et al., 2014).", [["rapid antibody screening", "TEST", 27, 51], ["the ongoing COVID", "TEST", 109, 126], ["pandemic", "PROBLEM", 130, 138], ["traditional bioanalytical assays", "TEST", 262, 294], ["pathogen detection", "TEST", 326, 344]]], ["Common pathogens include the aforementioned foodborne, waterborne, and environmental pathogens (e.g., Mycobacterium and Plasmodium spp.), as well as additional airborne and bloodborne pathogens.", [["foodborne, waterborne, and environmental pathogens", "DISEASE", 44, 94], ["Mycobacterium and Plasmodium spp.", "DISEASE", 102, 135], ["Plasmodium spp.", "ORGANISM", 120, 135], ["Plasmodium spp.", "SPECIES", 120, 135], ["Plasmodium spp.", "SPECIES", 120, 135], ["Common pathogens", "PROBLEM", 0, 16], ["environmental pathogens", "PROBLEM", 71, 94], ["Mycobacterium", "PROBLEM", 102, 115], ["Plasmodium spp.", "TEST", 120, 135], ["bloodborne pathogens", "PROBLEM", 173, 193], ["foodborne", "OBSERVATION", 44, 53], ["bloodborne pathogens", "OBSERVATION", 173, 193]]], ["Pathogens such as Mycobacterium, HIV, and Plasmodium falciparum, represent some of the top causes of death from infectious diseases worldwide (WHO, 2018a).", [["Mycobacterium, HIV, and Plasmodium falciparum", "DISEASE", 18, 63], ["death", "DISEASE", 101, 106], ["infectious diseases", "DISEASE", 112, 131], ["Mycobacterium, HIV", "ORGANISM", 18, 36], ["Plasmodium falciparum", "ORGANISM", 42, 63], ["HIV", "SPECIES", 33, 36], ["Plasmodium falciparum", "SPECIES", 42, 63], ["HIV", "SPECIES", 33, 36], ["Plasmodium falciparum", "SPECIES", 42, 63], ["Pathogens", "PROBLEM", 0, 9], ["Mycobacterium", "PROBLEM", 18, 31], ["HIV", "PROBLEM", 33, 36], ["Plasmodium falciparum", "PROBLEM", 42, 63], ["death", "PROBLEM", 101, 106], ["Mycobacterium", "OBSERVATION", 18, 31], ["Plasmodium falciparum", "OBSERVATION", 42, 63], ["infectious", "OBSERVATION_MODIFIER", 112, 122]]], ["Other common pathogens associated with medical diagnostics applications include those that cause respiratory infections, urinary tract infections, and diarrheal diseases, such as CD and MRSA, which can be life-threatening to the children, elderly and individuals with compromised immune systems.", [["respiratory", "ANATOMY", 97, 108], ["urinary tract", "ANATOMY", 121, 134], ["respiratory infections", "DISEASE", 97, 119], ["urinary tract infections", "DISEASE", 121, 145], ["diarrheal diseases", "DISEASE", 151, 169], ["CD", "DISEASE", 179, 181], ["MRSA", "DISEASE", 186, 190], ["urinary tract", "ORGANISM_SUBDIVISION", 121, 134], ["children", "ORGANISM", 229, 237], ["MRSA", "SPECIES", 186, 190], ["children", "SPECIES", 229, 237], ["MRSA", "SPECIES", 186, 190], ["Other common pathogens", "PROBLEM", 0, 22], ["medical diagnostics applications", "TREATMENT", 39, 71], ["respiratory infections", "PROBLEM", 97, 119], ["urinary tract infections", "PROBLEM", 121, 145], ["diarrheal diseases", "PROBLEM", 151, 169], ["CD", "PROBLEM", 179, 181], ["MRSA", "PROBLEM", 186, 190], ["compromised immune systems", "PROBLEM", 268, 294], ["respiratory", "ANATOMY", 97, 108], ["infections", "OBSERVATION", 109, 119], ["urinary tract", "ANATOMY", 121, 134], ["infections", "OBSERVATION", 135, 145], ["diarrheal diseases", "OBSERVATION", 151, 169], ["MRSA", "OBSERVATION", 186, 190]]], ["Other airborne and bloodborne pathogens of interest include the influenza virus, COVID-19, hepatitis virus, rabies virus, and bacteria such as Mycoplasma pneumonia and Bordetella pertussis.Medical diagnostic applications ::: Applications to pathogen detectionThe infectious dose of airborne and bloodborne pathogens also varies by orders of magnitude depending on the pathogen, the method of contraction, and the age and health of the individual.", [["influenza virus", "DISEASE", 64, 79], ["COVID-19,", "CHEMICAL", 81, 90], ["hepatitis virus", "DISEASE", 91, 106], ["rabies virus", "DISEASE", 108, 120], ["Mycoplasma pneumonia", "DISEASE", 143, 163], ["Bordetella pertussis", "DISEASE", 168, 188], ["influenza virus", "ORGANISM", 64, 79], ["COVID-19", "ORGANISM", 81, 89], ["hepatitis virus", "ORGANISM", 91, 106], ["rabies virus", "ORGANISM", 108, 120], ["Mycoplasma pneumonia", "ORGANISM", 143, 163], ["Bordetella pertussis", "ORGANISM", 168, 188], ["influenza virus", "SPECIES", 64, 79], ["hepatitis virus", "SPECIES", 91, 106], ["rabies virus", "SPECIES", 108, 120], ["Mycoplasma pneumonia", "SPECIES", 143, 163], ["Bordetella pertussis", "SPECIES", 168, 188], ["influenza virus", "SPECIES", 64, 79], ["COVID-19", "SPECIES", 81, 89], ["hepatitis virus", "SPECIES", 91, 106], ["rabies virus", "SPECIES", 108, 120], ["Mycoplasma pneumonia", "SPECIES", 143, 163], ["Bordetella pertussis", "SPECIES", 168, 188], ["Other airborne and bloodborne pathogens", "PROBLEM", 0, 39], ["the influenza virus", "PROBLEM", 60, 79], ["COVID", "TEST", 81, 86], ["hepatitis virus", "PROBLEM", 91, 106], ["rabies virus", "PROBLEM", 108, 120], ["bacteria", "PROBLEM", 126, 134], ["Mycoplasma pneumonia", "PROBLEM", 143, 163], ["Bordetella pertussis", "PROBLEM", 168, 188], ["pathogen detection", "TEST", 241, 259], ["bloodborne pathogens", "PROBLEM", 295, 315], ["the pathogen", "PROBLEM", 364, 376], ["Mycoplasma pneumonia", "OBSERVATION", 143, 163], ["infectious", "OBSERVATION_MODIFIER", 263, 273]]], ["For example, the infectious dose of influenza is between 100\u20131000 particles (G\u00fcrtler, 2006), while the median infectious dose of HIV can vary, for example, from two RNA copies to 65,000 depending on the strain and source (Reid and Juma, 2009).Medical diagnostic applications ::: Applications to pathogen detectionThe diagnostically-relevant concentration of pathogens in each type of matrix must be considered when designing a biosensor for pathogen detection.", [["matrix", "ANATOMY", 384, 390], ["influenza", "DISEASE", 36, 45], ["HIV", "ORGANISM", 129, 132], ["matrix", "CELLULAR_COMPONENT", 384, 390], ["HIV", "SPECIES", 129, 132], ["influenza", "PROBLEM", 36, 45], ["HIV", "PROBLEM", 129, 132], ["RNA copies", "TEST", 165, 175], ["pathogen detection", "TEST", 295, 313], ["pathogens", "PROBLEM", 358, 367], ["pathogen detection", "TEST", 441, 459], ["infectious", "OBSERVATION_MODIFIER", 17, 27], ["concentration", "OBSERVATION_MODIFIER", 341, 354], ["pathogens", "OBSERVATION", 358, 367]]], ["For example, the detection of bacteria in blood versus urine exhibit different diagnostic thresholds (Kelley, 2017).", [["blood", "ANATOMY", 42, 47], ["urine", "ANATOMY", 55, 60], ["blood", "ORGANISM_SUBSTANCE", 42, 47], ["urine", "ORGANISM_SUBSTANCE", 55, 60], ["bacteria in blood versus urine", "PROBLEM", 30, 60], ["bacteria", "OBSERVATION", 30, 38]]], ["Such knowledge can inform the need for sample preparation steps.Biological defense and bio-threat applications ::: Applications to pathogen detectionThe potential for the weaponization of pathogens drives the need for rapid and sensitive biosensors for biological defense applications.", [["sample preparation steps", "TREATMENT", 39, 63], ["pathogen detection", "TEST", 131, 149], ["pathogens", "PROBLEM", 188, 197], ["rapid and sensitive biosensors", "TREATMENT", 218, 248], ["biological defense applications", "TREATMENT", 253, 284]]], ["Biosensor applications to biological defense and bio-threat are related to the aforementioned applications in food and water safety, environmental monitoring, and medical diagnostics but consider weaponized pathogens.", [["Biosensor applications", "TREATMENT", 0, 22], ["environmental monitoring", "TEST", 133, 157], ["medical diagnostics", "TEST", 163, 182], ["weaponized pathogens", "PROBLEM", 196, 216]]], ["However, while pathogens found in environmental monitoring applications are often native and endogenous agents, pathogens found in biological defense and bio-threat applications are often exogenous agents, which may have been weaponized and intentionally dispersed.", [["pathogens", "PROBLEM", 15, 24], ["environmental monitoring applications", "TREATMENT", 34, 71], ["endogenous agents", "TREATMENT", 93, 110], ["pathogens", "PROBLEM", 112, 121], ["bio-threat applications", "TREATMENT", 154, 177], ["exogenous agents", "TREATMENT", 188, 204]]], ["For example, pathogen-based bio-threat situations typically involve the overt or covert introduction of an exogenous pathogen into either the food or water supply or environments which with humans closely interact (Cirino et al. 2004; Mirski et al. 2014; Shah and Wilkins, 2003).Biological defense and bio-threat applications ::: Applications to pathogen detectionThe reader is directed to various comprehensive reviews on biosensor-based assays for the detection of biowarfare agents (Christopher et al. 1997; Shah and Wilkins, 2003).", [["humans", "ORGANISM", 190, 196], ["humans", "SPECIES", 190, 196], ["humans", "SPECIES", 190, 196], ["pathogen", "PROBLEM", 13, 21], ["pathogen detection", "TEST", 346, 364], ["biowarfare agents", "TREATMENT", 467, 484]]], ["Common targets include the aforementioned airborne pathogens.", [["the aforementioned airborne pathogens", "PROBLEM", 23, 60], ["airborne pathogens", "OBSERVATION", 42, 60]]], ["In addition to the aforementioned naturally-occurring pathogens, pathogens for bio-threat may include engineered pathogens, such as genetically-modified viruses that can be transmitted via airborne pathways.", [["pathogens", "PROBLEM", 54, 63], ["pathogens", "PROBLEM", 65, 74], ["engineered pathogens", "PROBLEM", 102, 122], ["modified viruses", "PROBLEM", 144, 160], ["pathogens", "OBSERVATION", 113, 122]]], ["B. anthracis (Anthrax), yersinia pestis (plague), and vaccinia virus are among several pathogens that have been utilized or suggested as biowarfare agents (Christopher et al. 1997; Shah and Wilkins, 2003).Biological defense and bio-threat applications ::: Applications to pathogen detectionWhile pathogen-based bio-threats may be introduced to the water and food supply, the detection of pathogen-based bio-threats in air is particularly critical to biowarfare defense, as they may be introduced into the battlefield in the form of aerosols.", [["yersinia pestis", "DISEASE", 24, 39], ["vaccinia virus", "DISEASE", 54, 68], ["B. anthracis", "ORGANISM", 0, 12], ["Anthrax)", "ORGANISM", 14, 22], ["yersinia pestis", "ORGANISM", 24, 39], ["vaccinia virus", "ORGANISM", 54, 68], ["B. anthracis", "SPECIES", 0, 12], ["yersinia pestis", "SPECIES", 24, 39], ["vaccinia virus", "SPECIES", 54, 68], ["B. anthracis", "SPECIES", 0, 12], ["yersinia pestis", "SPECIES", 24, 39], ["vaccinia virus", "SPECIES", 54, 68], ["yersinia pestis", "PROBLEM", 24, 39], ["vaccinia virus", "PROBLEM", 54, 68], ["several pathogens", "PROBLEM", 79, 96], ["pathogen detectionWhile pathogen", "PROBLEM", 272, 304], ["pathogen", "PROBLEM", 388, 396], ["air", "OBSERVATION", 418, 421], ["aerosols", "OBSERVATION", 532, 540]]], ["Further, the dispersal of pathogen-based bio-threats by air in facilities (e.g., via air-handling systems) represents a significant domestic bioterrorism concern.", [["a significant domestic bioterrorism concern", "PROBLEM", 118, 161], ["dispersal", "OBSERVATION_MODIFIER", 13, 22], ["air", "OBSERVATION", 56, 59], ["significant", "OBSERVATION_MODIFIER", 120, 131], ["domestic", "OBSERVATION_MODIFIER", 132, 140], ["bioterrorism", "OBSERVATION", 141, 153]]], ["Thus, biosensor-based assays for bio-threat applications should be low-cost and portable to enable integration with existing physical systems (e.g., facilities) and movement with the warfighter or drones on the battlefield.", [["biosensor", "TEST", 6, 15], ["bio-threat applications", "TREATMENT", 33, 56]]], ["Having discussed transduction elements, biorecognition elements, electrochemical methods, measurement formats, and pathogen detection applications, we next discuss the present challenges and future directions in the field of electrochemical biosensor-based pathogen detection.Emerging electrode materials, fabrication processes, and form factors ::: Present challenges and future directions for pathogen detection using electrochemical biosensorsThe ability to create robust, low-cost biosensors for pathogen detection is a significant challenge in the field.", [["transduction elements", "DNA", 17, 38], ["biorecognition elements", "DNA", 40, 63], ["electrochemical methods", "TEST", 65, 88], ["measurement formats", "TEST", 90, 109], ["pathogen detection applications", "TEST", 115, 146], ["electrochemical biosensor", "TEST", 225, 250], ["Emerging electrode materials", "TREATMENT", 276, 304], ["pathogen detection", "TEST", 395, 413], ["electrochemical biosensors", "TEST", 420, 446], ["pathogen detection", "TEST", 500, 518], ["electrode materials", "OBSERVATION", 285, 304]]], ["One of the primary methods of reducing cost is decreasing the material cost per device.", [["reducing cost", "TREATMENT", 30, 43], ["primary", "OBSERVATION_MODIFIER", 11, 18], ["reducing", "OBSERVATION_MODIFIER", 30, 38], ["cost", "OBSERVATION", 39, 43], ["decreasing", "OBSERVATION_MODIFIER", 47, 57]]], ["Carbon-based electrodes (e.g., graphite, graphene, CNTs), such as those shown in Fig. 7a (Afonso et al. 2016) and 7b (Wang et al. 2013), are now being examined as potential alternatives to relatively more expensive metallic or ceramic electrodes.", [["graphene", "CHEMICAL", 41, 49], ["Carbon", "CHEMICAL", 0, 6], ["graphite", "CHEMICAL", 31, 39], ["graphene", "CHEMICAL", 41, 49], ["graphene", "SIMPLE_CHEMICAL", 41, 49], ["Carbon-based electrodes (e.g., graphite, graphene, CNTs", "TREATMENT", 0, 55], ["expensive metallic or ceramic electrodes", "TREATMENT", 205, 245], ["ceramic electrodes", "OBSERVATION", 227, 245]]], ["Many of these carbon-based materials are also nanoscale in structure, and thus offer advantages regarding nanostructuring.", [["carbon", "CHEMICAL", 14, 20], ["carbon", "SIMPLE_CHEMICAL", 14, 20], ["these carbon-based materials", "TREATMENT", 8, 36], ["carbon", "OBSERVATION_MODIFIER", 14, 20], ["nanoscale", "OBSERVATION_MODIFIER", 46, 55]]], ["Similarly, polymer-based electrodes have also been examined as low-cost alternatives to metal electrodes as described in Section 2.1.3.", [["polymer-based electrodes", "TREATMENT", 11, 35], ["metal electrodes", "TREATMENT", 88, 104], ["metal electrodes", "OBSERVATION", 88, 104]]], ["For example, Afonso et al. used a home craft cutter printer as a highly accessible means of fabricating high quantities of disposable carbon-based sensors (Afonso et al. 2016).Emerging electrode materials, fabrication processes, and form factors ::: Present challenges and future directions for pathogen detection using electrochemical biosensorsIn addition to reducing the material cost per device, efforts to reduce the manufacturing cost of biosensors have also been examined.", [["carbon", "CHEMICAL", 134, 140], ["a home craft cutter printer", "TREATMENT", 32, 59], ["disposable carbon-based sensors", "TREATMENT", 123, 154], ["Emerging electrode materials", "TREATMENT", 176, 204], ["pathogen detection", "TEST", 295, 313], ["electrochemical biosensors", "TEST", 320, 346], ["the material cost per device", "TREATMENT", 370, 398], ["the manufacturing cost of biosensors", "TREATMENT", 418, 454], ["electrode materials", "OBSERVATION", 185, 204], ["fabrication processes", "OBSERVATION", 206, 227]]], ["3D printing processes have emerged as popular methods for biosensor fabrication.", [["3D printing processes", "TREATMENT", 0, 21], ["biosensor fabrication", "TREATMENT", 58, 79]]], ["For example, 3D printing is compatible with flexible and curved substrates.", [["flexible and curved substrates", "TREATMENT", 44, 74], ["compatible with", "UNCERTAINTY", 28, 43], ["flexible", "OBSERVATION", 44, 52]]], ["3D printing has also been used for the fabrication of various components of electrochemical biosensors, such as electrodes, substrates, fluid handling components, or device packaging.", [["fluid", "ANATOMY", 136, 141], ["3D printing", "TREATMENT", 0, 11], ["the fabrication", "TREATMENT", 35, 50], ["electrochemical biosensors", "TREATMENT", 76, 102], ["fluid handling components", "TREATMENT", 136, 161], ["device packaging", "TREATMENT", 166, 182], ["fluid handling", "OBSERVATION", 136, 150]]], ["For example, to date, 3D printing has enabled the fabrication of electrode-integrated microfluidics (Erkal et al. 2014), 3D microfluidics, organ-conforming microfluidics (Singh et al. 2017a), and transducer-integrated microfluidics (Cesewski et al. 2018).", [["organ", "ANATOMY", 139, 144], ["organ", "ORGAN", 139, 144], ["the fabrication of electrode", "TREATMENT", 46, 74], ["3D microfluidics", "TEST", 121, 137], ["organ", "ANATOMY", 139, 144]]], ["Thus, 3D printing may serve as an important fabrication platform for the creation of wearable microfluidic-based electrochemical biosensors for pathogen detection.Emerging electrode materials, fabrication processes, and form factors ::: Present challenges and future directions for pathogen detection using electrochemical biosensorsThe ability to quantify the level of pathogens on the surfaces of objects (e.g., skin, food, and medical equipment) remains a present challenge in the biosensing field.", [["skin", "ANATOMY", 414, 418], ["skin", "ORGAN", 414, 418], ["pathogen detection", "TEST", 144, 162], ["Emerging electrode materials", "TREATMENT", 163, 191], ["pathogen detection", "TEST", 282, 300], ["electrochemical biosensors", "TEST", 307, 333], ["electrode materials", "OBSERVATION", 172, 191], ["fabrication processes", "OBSERVATION", 193, 214], ["skin", "ANATOMY", 414, 418]]], ["Wearable biomedical devices have emerged as promising tools for point-of-care (POC) diagnostics and health monitoring.", [["Wearable biomedical devices", "TREATMENT", 0, 27], ["health monitoring", "TEST", 100, 117]]], ["The application constraints of wearable devices require them to be lightweight and simple to operate.", [["wearable devices", "TREATMENT", 31, 47]]], ["Wearable devices can provide continuous monitoring of body fluids, such as blood and sweat, allowing patients to obtain real-time bioanalytical information without the inconvenience of facility-based screening.", [["body fluids", "ANATOMY", 54, 65], ["blood", "ANATOMY", 75, 80], ["sweat", "ANATOMY", 85, 90], ["body", "ORGANISM_SUBDIVISION", 54, 58], ["fluids", "ORGANISM_SUBSTANCE", 59, 65], ["blood", "ORGANISM_SUBSTANCE", 75, 80], ["sweat", "ORGANISM_SUBDIVISION", 85, 90], ["patients", "ORGANISM", 101, 109], ["patients", "SPECIES", 101, 109], ["Wearable devices", "TREATMENT", 0, 16], ["continuous monitoring of body fluids", "TREATMENT", 29, 65], ["based screening", "TEST", 194, 209]]], ["To date, biosensors have been incorporated into a variety of wearable devices, including contact lenses, clothing, bandages, rings, and tattoos (Bandodkar and Wang, 2014).", [["wearable devices", "TREATMENT", 61, 77], ["contact lenses", "TREATMENT", 89, 103], ["bandages", "TREATMENT", 115, 123], ["contact lenses", "OBSERVATION", 89, 103]]], ["This is a rapidly emerging area linked to smartphone technology for biosensor actuation and monitoring.", [["biosensor actuation", "TREATMENT", 68, 87], ["monitoring", "TEST", 92, 102]]], ["The rise of flexible electronics has also contributed to the success of incorporating electrochemical biosensors into flexible textiles, which has enhanced their wearability (Rim et al. 2016).", [["flexible electronics", "TREATMENT", 12, 32], ["incorporating electrochemical biosensors into flexible textiles", "PROBLEM", 72, 135], ["rise", "OBSERVATION_MODIFIER", 4, 8], ["flexible electronics", "OBSERVATION", 12, 32], ["flexible textiles", "OBSERVATION", 118, 135]]], ["Although most wearable electrochemical biosensors are used to detect small molecules, such as lactate, glucose, or electrolytes, there is increasing interest in their application to pathogen detection.", [["lactate", "CHEMICAL", 94, 101], ["glucose", "CHEMICAL", 103, 110], ["lactate", "CHEMICAL", 94, 101], ["glucose", "CHEMICAL", 103, 110], ["lactate", "SIMPLE_CHEMICAL", 94, 101], ["glucose", "SIMPLE_CHEMICAL", 103, 110], ["most wearable electrochemical biosensors", "PROBLEM", 9, 49], ["small molecules", "PROBLEM", 69, 84], ["lactate, glucose", "TEST", 94, 110], ["electrolytes", "TEST", 115, 127], ["pathogen detection", "TEST", 182, 200], ["small molecules", "OBSERVATION", 69, 84]]], ["Challenges include biocompatibility (e.g., reduction of skin irritation), device power consumption, and biosensor-tissue mechanical and geometric matching.", [["skin", "ANATOMY", 56, 60], ["tissue", "ANATOMY", 114, 120], ["skin", "ORGAN", 56, 60], ["tissue", "TISSUE", 114, 120], ["biocompatibility", "TREATMENT", 19, 35], ["skin irritation", "PROBLEM", 56, 71], ["device power consumption", "TREATMENT", 74, 98], ["biosensor-tissue mechanical and geometric matching", "TREATMENT", 104, 154], ["biocompatibility", "OBSERVATION_MODIFIER", 19, 35], ["skin", "ANATOMY", 56, 60], ["irritation", "OBSERVATION", 61, 71]]], ["Because of the small sample size of body fluid secretions and the need to transport the sample to the electrode surface, microfluidic formats are now emerging for wearable bioanalytical systems (Singh et al. 2017a).Detection of protozoa ::: Present challenges and future directions for pathogen detection using electrochemical biosensorsImportantly, the size of the pathogen may have a significant impact on a given electrochemical biosensor's performance based on the type of electrochemical method used.", [["body fluid secretions", "ANATOMY", 36, 57], ["electrode surface", "ANATOMY", 102, 119], ["body", "ORGANISM_SUBDIVISION", 36, 40], ["fluid secretions", "ORGANISM_SUBSTANCE", 41, 57], ["body fluid secretions", "PROBLEM", 36, 57], ["pathogen detection", "TEST", 286, 304], ["electrochemical biosensors", "TEST", 311, 337], ["electrochemical method", "TREATMENT", 477, 499], ["small", "OBSERVATION_MODIFIER", 15, 20], ["sample", "OBSERVATION_MODIFIER", 21, 27], ["size", "OBSERVATION_MODIFIER", 28, 32], ["body", "OBSERVATION_MODIFIER", 36, 40], ["fluid secretions", "OBSERVATION", 41, 57], ["protozoa", "OBSERVATION", 228, 236], ["size", "OBSERVATION_MODIFIER", 354, 358], ["pathogen", "OBSERVATION", 366, 374], ["significant", "OBSERVATION_MODIFIER", 386, 397], ["impact", "OBSERVATION_MODIFIER", 398, 404]]], ["For example, pathogens can range greater than three orders of magnitude in size.", [["pathogens", "PROBLEM", 13, 22], ["orders of magnitude", "OBSERVATION_MODIFIER", 52, 71], ["size", "OBSERVATION_MODIFIER", 75, 79]]], ["For example, the diameter of norovirus was estimated at 27 nm (Robilotti et al. 2015), while the diameter of G. lamblia oocysts is ~14 \u03bcm (Adam, 2001).", [["norovirus", "DISEASE", 29, 38], ["norovirus", "ORGANISM", 29, 38], ["lamblia", "ORGANISM", 112, 119], ["G. lamblia", "SPECIES", 109, 119], ["G. lamblia", "SPECIES", 109, 119], ["norovirus", "PROBLEM", 29, 38], ["G. lamblia oocysts", "PROBLEM", 109, 127], ["diameter", "OBSERVATION_MODIFIER", 17, 25], ["norovirus", "OBSERVATION", 29, 38], ["27 nm", "OBSERVATION_MODIFIER", 56, 61], ["diameter", "OBSERVATION_MODIFIER", 97, 105], ["lamblia oocysts", "OBSERVATION", 112, 127]]], ["Electrochemical biosensors for the detection of protozoa-based pathogens is an area requiring further attention.", [["Electrochemical biosensors", "TEST", 0, 26], ["the detection", "TEST", 31, 44], ["protozoa", "PROBLEM", 48, 56], ["based pathogens", "PROBLEM", 57, 72], ["protozoa", "OBSERVATION", 48, 56], ["pathogens", "OBSERVATION", 63, 72]]], ["Protozoa, as large pathogens, achieve relatively less coverage of the electrode than small pathogens, thereby having a relatively smaller effect on charge transfer at the electrode-electrolyte interface.", [["Protozoa", "PROBLEM", 0, 8], ["large pathogens", "PROBLEM", 13, 28], ["small pathogens", "PROBLEM", 85, 100], ["large", "OBSERVATION_MODIFIER", 13, 18], ["pathogens", "OBSERVATION", 19, 28], ["pathogens", "OBSERVATION", 91, 100], ["relatively", "OBSERVATION_MODIFIER", 119, 129], ["smaller", "OBSERVATION_MODIFIER", 130, 137], ["effect", "OBSERVATION_MODIFIER", 138, 144], ["electrolyte interface", "OBSERVATION", 181, 202]]], ["C. parvum is at present the most commonly detected protozoa using electrochemical biosensors (see Table 1) (Iqbal et al. 2015) (Luka et al. 2019).Detection of plant pathogens ::: Present challenges and future directions for pathogen detection using electrochemical biosensorsWhile the majority of infectious agents detected using electrochemical biosensors are human pathogens, emerging agricultural applications of electrochemical biosensors, such as in smart agriculture, suggest the need for biosensors capable of detecting plant pathogens (Khater et al., 2017).", [["C. parvum", "ORGANISM", 0, 9], ["human", "ORGANISM", 361, 366], ["C. parvum", "SPECIES", 0, 9], ["human", "SPECIES", 361, 366], ["C. parvum", "SPECIES", 0, 9], ["human", "SPECIES", 361, 366], ["C. parvum", "PROBLEM", 0, 9], ["electrochemical biosensors", "TEST", 66, 92], ["plant pathogens", "PROBLEM", 159, 174], ["pathogen detection", "TEST", 224, 242], ["electrochemical biosensors", "TEST", 249, 275], ["infectious agents", "TREATMENT", 297, 314], ["electrochemical biosensors", "TREATMENT", 330, 356], ["human pathogens", "PROBLEM", 361, 376], ["electrochemical biosensors", "TREATMENT", 416, 442], ["biosensors", "TREATMENT", 495, 505], ["plant pathogens", "PROBLEM", 527, 542], ["parvum", "OBSERVATION", 3, 9], ["plant pathogens", "OBSERVATION", 159, 174], ["infectious", "OBSERVATION", 297, 307]]], ["For example, crop yield losses associated with plant pathogens range from 8.1 to 41.1% based on global production of wheat, rice, maize, potato, and soybean (Savary et al., 2019).", [["wheat, rice, maize, potato", "CHEMICAL", 117, 143], ["wheat", "ORGANISM_SUBDIVISION", 117, 122], ["rice", "ORGANISM_SUBDIVISION", 124, 128], ["maize", "ORGANISM_SUBDIVISION", 130, 135], ["potato", "ORGANISM_SUBDIVISION", 137, 143], ["soybean", "ORGANISM_SUBDIVISION", 149, 156], ["wheat", "SPECIES", 117, 122], ["rice", "SPECIES", 124, 128], ["maize", "SPECIES", 130, 135], ["potato", "SPECIES", 137, 143], ["soybean", "SPECIES", 149, 156], ["wheat", "SPECIES", 117, 122], ["rice", "SPECIES", 124, 128], ["maize", "SPECIES", 130, 135], ["potato", "SPECIES", 137, 143], ["soybean", "SPECIES", 149, 156], ["crop yield losses", "PROBLEM", 13, 30], ["plant pathogens", "TEST", 47, 62], ["pathogens", "OBSERVATION_MODIFIER", 53, 62]]], ["Common plant pathogens include viruses, viroids, bacteria, fungi, and oomycetes.", [["Common plant pathogens", "PROBLEM", 0, 22], ["viruses", "PROBLEM", 31, 38], ["viroids", "TREATMENT", 40, 47], ["bacteria", "PROBLEM", 49, 57], ["fungi", "PROBLEM", 59, 64], ["oomycetes", "PROBLEM", 70, 79], ["pathogens", "OBSERVATION", 13, 22], ["viruses", "OBSERVATION", 31, 38], ["bacteria", "OBSERVATION_MODIFIER", 49, 57]]], ["Chartuprayoon et al. recently established a polypyrrole nanoribbon-based chemiresistive immunosensor for detection of viral plant pathogens (Chartuprayoon et al., 2013).Multiplexed detection ::: Present challenges and future directions for pathogen detection using electrochemical biosensorsMultiplexed detection of pathogens has emerged as a technique for phenotype identification and identification of multiple pathogenic threats.", [["polypyrrole nanoribbon", "CHEMICAL", 44, 66], ["polypyrrole", "CHEMICAL", 44, 55], ["a polypyrrole nanoribbon", "TREATMENT", 42, 66], ["viral plant pathogens", "PROBLEM", 118, 139], ["Multiplexed detection", "TEST", 169, 190], ["pathogen detection", "TEST", 240, 258], ["electrochemical biosensors", "TEST", 265, 291], ["pathogens", "PROBLEM", 316, 325], ["a technique", "TEST", 341, 352], ["phenotype identification", "TEST", 357, 381], ["multiple pathogenic threats", "PROBLEM", 404, 431], ["multiple", "OBSERVATION_MODIFIER", 404, 412], ["pathogenic", "OBSERVATION", 413, 423]]], ["Multiplexing can be achieved via various approaches, but typically involves the use of multiple transducers that exhibit different biorecognition elements.", [["biorecognition elements", "DNA", 131, 154], ["multiple transducers", "TREATMENT", 87, 107], ["biorecognition elements", "OBSERVATION", 131, 154]]], ["For example, a strategy for multiplexed bacterial detection by Li et al. via immobilization of anti-E. coli and anti-V. cholerae on AuNPs is shown in Fig. 4b (Li et al. 2017).", [["Li", "CHEMICAL", 63, 65], ["AuNPs", "CHEMICAL", 132, 137], ["anti-E. coli", "ORGANISM", 95, 107], ["anti-V. cholerae", "ORGANISM", 112, 128], ["AuNPs", "SIMPLE_CHEMICAL", 132, 137], ["anti-E. coli", "SPECIES", 95, 107], ["anti-V. cholerae", "SPECIES", 112, 128], ["anti-E. coli", "SPECIES", 95, 107], ["anti-V. cholerae", "SPECIES", 112, 128], ["multiplexed bacterial detection", "TEST", 28, 59], ["immobilization of anti-E. coli", "TREATMENT", 77, 107], ["anti-V. cholerae on AuNPs", "TREATMENT", 112, 137]]], ["Spatially-distributed biorecognition elements on a single electrode or multiple electrodes can also provide multiplexing capability.", [["biorecognition elements", "DNA", 22, 45], ["a single electrode or multiple electrodes", "TREATMENT", 49, 90], ["distributed", "OBSERVATION_MODIFIER", 10, 21], ["biorecognition elements", "OBSERVATION", 22, 45]]], ["For example, a strategy based on the immobilization of anti-E. coli and anti-S. aureus within a microfluidic chamber created by Tian et al. is shown in Fig. 4c (Tian et al. 2016).Saturation-free continuous monitoring formats ::: Present challenges and future directions for pathogen detection using electrochemical biosensorsThe inability to regenerate biosensors is a major hindrance to biosensor-based process monitoring and control applications.", [["anti-E. coli", "ORGANISM", 55, 67], ["anti-S. aureus", "ORGANISM", 72, 86], ["anti-E. coli", "SPECIES", 55, 67], ["anti-S. aureus", "SPECIES", 72, 86], ["anti-E. coli", "SPECIES", 55, 67], ["anti-S. aureus", "SPECIES", 72, 86], ["a strategy", "TREATMENT", 13, 23], ["the immobilization of anti-E. coli", "TREATMENT", 33, 67], ["anti-S. aureus", "PROBLEM", 72, 86], ["a microfluidic chamber", "TREATMENT", 94, 116], ["Saturation", "TEST", 179, 189], ["pathogen detection", "TEST", 274, 292], ["electrochemical biosensors", "TEST", 299, 325], ["aureus", "OBSERVATION", 80, 86], ["microfluidic chamber", "OBSERVATION", 96, 116], ["Fig", "OBSERVATION", 152, 155]]], ["While various biosensors must be disposed of after a single use, the regeneration of biosensor surfaces using chemical approaches has been leveraged as an approach for creating multiple-use biosensors.", [["the regeneration of biosensor surfaces", "TREATMENT", 65, 103], ["chemical approaches", "TREATMENT", 110, 129]]], ["Biosensor regeneration approaches typically involve chemically-mediated dissociation of the target from the immobilized biorecognition element or removal of the biorecognition element altogether.", [["immobilized biorecognition element", "DNA", 108, 142], ["biorecognition element", "DNA", 161, 183], ["Biosensor regeneration approaches", "TREATMENT", 0, 33], ["the immobilized biorecognition element", "TREATMENT", 104, 142], ["removal", "TREATMENT", 146, 153], ["the biorecognition element", "TREATMENT", 157, 183], ["dissociation", "OBSERVATION", 72, 84], ["biorecognition element", "OBSERVATION", 161, 183]]], ["This can be accomplished through acid-base mediated regeneration, detergents, glycine, and urea as well as achieved by thermal regeneration, plasma cleaning, or even direct electrochemical desorption (Goode et al. 2015; Huang et al. 2010; Zelada-Guillen et al. 2010).", [["plasma", "ANATOMY", 141, 147], ["glycine", "CHEMICAL", 78, 85], ["urea", "CHEMICAL", 91, 95], ["glycine", "CHEMICAL", 78, 85], ["urea", "CHEMICAL", 91, 95], ["glycine", "SIMPLE_CHEMICAL", 78, 85], ["urea", "SIMPLE_CHEMICAL", 91, 95], ["plasma", "ORGANISM_SUBSTANCE", 141, 147], ["acid-base mediated regeneration", "TREATMENT", 33, 64], ["glycine", "TREATMENT", 78, 85], ["urea", "TREATMENT", 91, 95], ["thermal regeneration", "TREATMENT", 119, 139], ["plasma cleaning", "TREATMENT", 141, 156], ["Zelada", "TREATMENT", 239, 245], ["regeneration", "OBSERVATION_MODIFIER", 52, 64]]], ["For example, Dweik et al. used a combination of organic (acetone) and plasma cleaning protocols to regenerate an Au interdigitated microelectrode array after detection of E. coli to use devices five times each (Dweik et al. 2012).", [["plasma", "ANATOMY", 70, 76], ["Au", "CHEMICAL", 113, 115], ["acetone", "CHEMICAL", 57, 64], ["Au", "CHEMICAL", 113, 115], ["acetone", "SIMPLE_CHEMICAL", 57, 64], ["plasma", "ORGANISM_SUBSTANCE", 70, 76], ["E. coli", "ORGANISM", 171, 178], ["E. coli", "SPECIES", 171, 178], ["E. coli", "SPECIES", 171, 178], ["organic (acetone)", "TREATMENT", 48, 65], ["plasma cleaning protocols", "TREATMENT", 70, 95], ["an Au interdigitated microelectrode array", "TREATMENT", 110, 151], ["E. coli", "PROBLEM", 171, 178], ["devices", "TREATMENT", 186, 193], ["E. coli", "OBSERVATION", 171, 178]]], ["Johnson and Mutharasan used a liquid-phase hydrogen peroxide-mediated UV-photooxidation process for regeneration of biosensor surfaces as an alternative to aggressive chemical treatments, such as those based on the use of high- or low-pH solutions (Johnson and Mutharasan, 2013b).", [["Mutharasan", "CHEMICAL", 12, 22], ["hydrogen peroxide", "CHEMICAL", 43, 60], ["hydrogen peroxide", "SIMPLE_CHEMICAL", 43, 60], ["Mutharasan", "TREATMENT", 12, 22], ["a liquid-phase hydrogen peroxide", "TREATMENT", 28, 60], ["UV-photooxidation process", "TREATMENT", 70, 95], ["regeneration of biosensor surfaces", "TREATMENT", 100, 134], ["aggressive chemical treatments", "TREATMENT", 156, 186], ["high- or low-pH solutions", "TREATMENT", 222, 247]]], ["We note that an ideal biosensor regeneration (i.e., cleaning) approach for process monitoring applications would remove the captured target in situ using a chemical-free approach and preserve the biorecognition layer for subsequent measurements.Low-cost, single-use portable biosensors ::: Present challenges and future directions for pathogen detection using electrochemical biosensorsThe creation of environmentally-friendly disposable substrates is a present challenge for low-cost single-use biosensors.", [["an ideal biosensor regeneration", "PROBLEM", 13, 44], ["process monitoring applications", "TREATMENT", 75, 106], ["a chemical-free approach", "TREATMENT", 154, 178], ["subsequent measurements", "TEST", 221, 244], ["pathogen detection", "TEST", 335, 353], ["electrochemical biosensors", "TEST", 360, 386], ["biosensors", "TREATMENT", 496, 506]]], ["Paper-based substrates have recently emerged as attractive alternatives to costlier ceramic substrates (Martinez et al. 2009).", [["costlier ceramic substrates", "TREATMENT", 75, 102]]], ["Paper-based substrates can also eliminate the need for supporting fluid handling components through capillary effects.", [["fluid", "ANATOMY", 66, 71], ["capillary", "ANATOMY", 100, 109], ["capillary", "TISSUE", 100, 109], ["supporting fluid handling components", "TREATMENT", 55, 91], ["capillary effects", "OBSERVATION", 100, 117]]], ["For example, paper substrates can be patterned with hydrophobic and hydrophilic regions to direct fluid flow (Carrilho et al. 2009).", [["fluid", "ANATOMY", 98, 103], ["hydrophobic and hydrophilic regions", "PROBLEM", 52, 87], ["fluid flow", "TEST", 98, 108], ["fluid flow", "OBSERVATION", 98, 108]]], ["Paper-based devices are also relatively environmentally friendly in terms of material sourcing, disposal, and degradation.", [["Paper-based devices", "TREATMENT", 0, 19]]], ["However, the potential toxicity of materials that may have been deposited on paper substrates, such as nanomaterials, should still be considered when assessing the environmental impact of a disposable single-use biosensing platform.", [["toxicity", "DISEASE", 23, 31], ["the potential toxicity of materials", "PROBLEM", 9, 44], ["biosensing platform", "TREATMENT", 212, 231]]], ["For example, the long-term environmental and health impacts of nanomaterials remain active areas of research (Colvin, 2003; Klaine et al. 2008; Lead et al. 2018).", [["long-term", "OBSERVATION_MODIFIER", 17, 26], ["active", "OBSERVATION_MODIFIER", 84, 90], ["areas", "OBSERVATION_MODIFIER", 91, 96]]], ["Although paper-based devices have historically been most commonly used with colorimetric sensing techniques, they have been increasingly investigated for electrochemical biosensing (Ahmed et al. 2016; Meredith et al. 2016).", [["paper-based devices", "TREATMENT", 9, 28], ["colorimetric sensing techniques", "TREATMENT", 76, 107]]], ["A highlight of paper-based substrates is provided in Fig. 7c.Low-cost, single-use portable biosensors ::: Present challenges and future directions for pathogen detection using electrochemical biosensorsThe need for water safety and medical diagnostics in remote and under-developed regions has led to the demand for low-cost portable biosensing platforms.", [["pathogen detection", "TEST", 151, 169], ["electrochemical biosensors", "TEST", 176, 202], ["water safety", "TREATMENT", 215, 227], ["medical diagnostics", "TEST", 232, 251]]], ["One of the major challenges in creating portable biosensors for field use is the need to establish sample preparation-free protocols (Johnson and Mutharasan, 2012) and miniaturize components for actuation, data acquisition, and readout.", [["creating portable biosensors", "TEST", 31, 59], ["actuation, data acquisition", "TEST", 195, 222], ["major", "OBSERVATION_MODIFIER", 11, 16]]], ["However, device miniaturization also presents measurement challenges, such as increasing the biosensor signal-to-noise ratio (Wei et al. 2009).", [["device miniaturization", "TREATMENT", 9, 31], ["the biosensor signal", "TEST", 89, 109]]], ["Further, portable biosensing platforms should exhibit biorecognition elements that remain stable for extended periods and at a variety of temperatures and humidity levels.", [["biorecognition elements", "DNA", 54, 77], ["portable biosensing platforms", "TEST", 9, 38], ["humidity levels", "TEST", 155, 170], ["stable", "OBSERVATION_MODIFIER", 90, 96]]], ["The measurement robustness associated with the analysis of small sample volumes also requires further attention with the use of emerging low-cost materials, fabrication approaches, and transduction methods (Kumar et al. 2013; Luppa et al. 2016; Narayan, 2016; Wan et al. 2013).Low-cost, single-use portable biosensors ::: Present challenges and future directions for pathogen detection using electrochemical biosensorsThe elimination of sample preparation steps from biosensor-based assays represents a significant advantage relative to traditional bioanalytical techniques (Johnson and Mutharasan, 2012) and is an important advantage and consideration for single-use biosensors and remote biosensing applications based on portable low-cost platforms.", [["sample", "ANATOMY", 437, 443], ["The measurement robustness", "TEST", 0, 26], ["the analysis", "TEST", 43, 55], ["small sample volumes", "PROBLEM", 59, 79], ["emerging low-cost materials", "TREATMENT", 128, 155], ["fabrication approaches", "TREATMENT", 157, 179], ["pathogen detection", "TEST", 367, 385], ["electrochemical biosensors", "TEST", 392, 418], ["sample preparation steps", "TEST", 437, 461], ["biosensor-based assays", "TEST", 467, 489], ["biosensors", "TREATMENT", 668, 678], ["remote biosensing applications", "TREATMENT", 683, 713], ["small", "OBSERVATION_MODIFIER", 59, 64]]], ["Sample preparation-free protocols can improve measurement confidence, repeatability, and reduce TTR, which are important aspects of healthcare decision-making.", [["TTR", "GENE_OR_GENE_PRODUCT", 96, 99], ["TTR", "PROTEIN", 96, 99], ["Sample preparation", "TEST", 0, 18], ["TTR", "PROBLEM", 96, 99]]], ["For example, it has been shown that a reduction in turnaround time for diagnostic assays could have a positive effect on clinical treatment outcomes (Davenport et al. 2017; Sin et al. 2014).", [["diagnostic assays", "TEST", 71, 88], ["clinical treatment outcomes", "TREATMENT", 121, 148], ["reduction", "OBSERVATION_MODIFIER", 38, 47], ["positive effect", "OBSERVATION_MODIFIER", 102, 117]]], ["When sample preparation is required, integrated alternatives to manual techniques, such as microfluidic processes, may provide a new path toward achieving rapid and robust pathogen detection.", [["sample", "ANATOMY", 5, 11], ["manual techniques", "TREATMENT", 64, 81]]], ["For example, separation and pre-concentration steps have been increasingly examined for integration with microfluidic-based biosensor platforms to reduce the number of steps, materials needed, and required technical personnel, and thus TTR (Bunyakul and Baeumner, 2014).Wireless transduction approaches ::: Present challenges and future directions for pathogen detection using electrochemical biosensorsThe examination of wireless transduction and monitoring approaches has an important role in creating portable and wearable biosensing platforms for pathogen detection and distributed sensing systems for infection control and process monitoring (Ghafar-Zadeh, 2015).", [["infection", "DISEASE", 606, 615], ["TTR", "GENE_OR_GENE_PRODUCT", 236, 239], ["TTR", "PROTEIN", 236, 239], ["microfluidic-based biosensor platforms", "TREATMENT", 105, 143], ["pathogen detection", "TEST", 352, 370], ["electrochemical biosensors", "TEST", 377, 403], ["The examination", "TEST", 403, 418], ["wireless transduction", "TEST", 422, 443], ["monitoring approaches", "TEST", 448, 469], ["pathogen detection", "TEST", 551, 569], ["infection control", "TREATMENT", 606, 623], ["process monitoring", "TEST", 628, 646]]], ["Wireless biosensing platforms are also essential to the creation of implantable and integrated biosensors for pathogen detection, including those for medical diagnostics.", [["Wireless biosensing platforms", "TEST", 0, 29], ["pathogen detection", "TEST", 110, 128], ["medical diagnostics", "TEST", 150, 169]]], ["For example, as previously referenced, Mannoor et al. fabricated a conformal biosensor for bacteria detection on tooth enamel based on a radiofrequency (RF) link approach (Mannoor et al. 2012) (see Fig. 7d).", [["tooth enamel", "ANATOMY", 113, 125], ["tooth enamel", "MULTI-TISSUE_STRUCTURE", 113, 125], ["a conformal biosensor", "TREATMENT", 65, 86], ["bacteria detection", "TEST", 91, 109], ["tooth enamel", "PROBLEM", 113, 125], ["a radiofrequency (RF) link approach", "TREATMENT", 135, 170]]], ["Wireless transduction approaches remains an emerging area for pathogen detection.", [["Wireless transduction approaches", "TREATMENT", 0, 32], ["pathogen detection", "TEST", 62, 80], ["pathogen", "OBSERVATION", 62, 70]]], ["An example of smartphone-enabled wireless signal processing for detection of E. coli can be found in Fig. 7e (Jiang et al. 2014).ConclusionsHere, we provided a critical review of electrochemical biosensors for pathogen detection.", [["E. coli", "ORGANISM", 77, 84], ["E. coli", "SPECIES", 77, 84], ["E. coli", "SPECIES", 77, 84], ["smartphone", "TEST", 14, 24], ["E. coli", "PROBLEM", 77, 84], ["electrochemical biosensors", "TEST", 179, 205], ["pathogen detection", "TEST", 210, 228], ["E. coli", "OBSERVATION", 77, 84]]], ["Biosensor transduction elements and biorecognition elements for electrochemical pathogen detection were reviewed.", [["Biosensor transduction elements", "DNA", 0, 31], ["biorecognition elements", "DNA", 36, 59], ["Biosensor transduction elements", "TREATMENT", 0, 31], ["electrochemical pathogen detection", "TEST", 64, 98]]], ["Bacteria remain the most commonly detected pathogens using electrochemical biosensors, though the detection of viruses and protozoa have been increasingly examined over the past five years.", [["Bacteria", "CELL", 0, 8], ["Bacteria", "PROBLEM", 0, 8], ["electrochemical biosensors", "TEST", 59, 85], ["viruses", "PROBLEM", 111, 118], ["protozoa", "PROBLEM", 123, 131], ["most commonly", "OBSERVATION_MODIFIER", 20, 33], ["viruses", "OBSERVATION", 111, 118]]], ["Electrochemical biosensors now exhibit LODs as low as a single plaque-forming unit (PFU)/mL and colony-forming unit (CFU)/mL and dynamic ranges that span multiple orders of magnitude.", [["Electrochemical biosensors", "TEST", 0, 26], ["LODs", "TEST", 39, 43]]], ["While planar Au electrodes remain the most commonly utilized working electrode, nanostructured electrodes derived from a variety of engineering materials, including polymers and composites, have been increasingly examined.", [["Au", "CHEMICAL", 13, 15], ["Au", "CHEMICAL", 13, 15], ["planar Au electrodes", "TREATMENT", 6, 26], ["nanostructured electrodes", "TREATMENT", 80, 105], ["engineering materials", "TREATMENT", 132, 153], ["polymers and composites", "TREATMENT", 165, 188], ["variety", "OBSERVATION_MODIFIER", 121, 128]]], ["Present challenges and future directions in the field were discussed, including a need for further low-cost, reusable, and wearable biosensors.", [["further low-cost, reusable", "TREATMENT", 91, 117], ["wearable biosensors", "TREATMENT", 123, 142]]], ["Electrochemical biosensors offer great potential as resources for improving global healthcare, such as preventing the spread of highly contagious diseases.Declaration of competing interestThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.", [["Electrochemical biosensors", "TREATMENT", 0, 26], ["highly contagious diseases", "PROBLEM", 128, 154], ["highly", "OBSERVATION_MODIFIER", 128, 134], ["contagious", "OBSERVATION", 135, 145]]]], "758d365d79d74aee483623c5abeab0c682bf1ad3": [["B cells are central players in initiating a rapid antiviral immune response.", [["B cells", "ANATOMY", 0, 7], ["B cells", "CELL", 0, 7], ["B cells", "CELL_TYPE", 0, 7], ["a rapid antiviral immune response", "TREATMENT", 42, 75], ["cells", "ANATOMY", 2, 7], ["central", "OBSERVATION_MODIFIER", 12, 19]]], ["Their main functions are producing virus-specific antibodies, presenting antigen and participating in building the splenic architecture [1] [2] [3] [4] .", [["splenic", "ANATOMY", 115, 122], ["[1] [2] [3] [4]", "SIMPLE_CHEMICAL", 136, 151], ["virus-specific antibodies", "PROTEIN", 35, 60], ["producing virus-specific antibodies", "PROBLEM", 25, 60], ["splenic", "ANATOMY", 115, 122]]], ["Three subsets of B cells are important contributors to immune responses against pathogens: B1, marginal zone (MZ) and follicular B cells 5, 6 .", [["B cells", "ANATOMY", 17, 24], ["marginal zone", "ANATOMY", 95, 108], ["MZ", "ANATOMY", 110, 112], ["follicular B cells", "ANATOMY", 118, 136], ["B cells", "CELL", 17, 24], ["B1", "CELL", 91, 93], ["marginal zone", "CELL", 95, 108], ["MZ", "CELL", 110, 112], ["follicular B cells", "CELL", 118, 136], ["B cells", "CELL_TYPE", 17, 24], ["B1", "PROTEIN", 91, 93], ["follicular B cells", "CELL_TYPE", 118, 136], ["B cells", "TREATMENT", 17, 24], ["immune responses", "TEST", 55, 71], ["follicular B cells", "TEST", 118, 136], ["B cells", "OBSERVATION", 17, 24]]], ["B1 B cells usually seed the peritoneal and pleural cavities and develop T-cell-independent antibody responses against bacterial antigens 7 .", [["B cells", "ANATOMY", 3, 10], ["peritoneal", "ANATOMY", 28, 38], ["pleural cavities", "ANATOMY", 43, 59], ["T-cell", "ANATOMY", 72, 78], ["B1 B cells", "CELL", 0, 10], ["peritoneal", "MULTI-TISSUE_STRUCTURE", 28, 38], ["pleural cavities", "PATHOLOGICAL_FORMATION", 43, 59], ["T-cell", "CELL", 72, 78], ["B1 B cells", "CELL_TYPE", 0, 10], ["bacterial antigens 7", "PROTEIN", 118, 138], ["B1 B cells", "TEST", 0, 10], ["the peritoneal and pleural cavities", "PROBLEM", 24, 59], ["bacterial antigens", "PROBLEM", 118, 136], ["peritoneal", "ANATOMY", 28, 38], ["pleural", "ANATOMY", 43, 50], ["cavities", "ANATOMY_MODIFIER", 51, 59], ["-cell", "OBSERVATION_MODIFIER", 73, 78]]], ["B1 B cells are also responsible for generating the socalled natural antibodies that are detectable in na\u00efve mice that have not experienced antigen 7 .", [["B cells", "ANATOMY", 3, 10], ["B1 B cells", "CELL", 0, 10], ["mice", "ORGANISM", 108, 112], ["B1 B cells", "CELL_TYPE", 0, 10], ["socalled natural antibodies", "PROTEIN", 51, 78], ["antigen 7", "PROTEIN", 139, 148], ["mice", "SPECIES", 108, 112], ["mice", "SPECIES", 108, 112], ["B1 B cells", "PROBLEM", 0, 10], ["the socalled natural antibodies", "PROBLEM", 47, 78], ["cells", "OBSERVATION", 5, 10]]], ["MZ B cells are located in the splenic MZ, where they have direct contact with blood-borne pathogens.", [["B cells", "ANATOMY", 3, 10], ["splenic MZ", "ANATOMY", 30, 40], ["blood", "ANATOMY", 78, 83], ["MZ", "CHEMICAL", 0, 2], ["MZ", "CHEMICAL", 38, 40], ["B cells", "CELL", 3, 10], ["splenic MZ", "MULTI-TISSUE_STRUCTURE", 30, 40], ["blood", "ORGANISM_SUBSTANCE", 78, 83], ["B cells", "CELL_TYPE", 3, 10], ["B cells", "PROBLEM", 3, 10], ["blood-borne pathogens", "PROBLEM", 78, 99], ["cells", "OBSERVATION", 5, 10], ["splenic", "ANATOMY", 30, 37], ["MZ", "ANATOMY_MODIFIER", 38, 40]]], ["Therefore, antigen-activated MZ B cells usually respond hours after infection and build the specific antibody response early after infection 5 .", [["MZ B cells", "ANATOMY", 29, 39], ["infection", "DISEASE", 68, 77], ["infection", "DISEASE", 131, 140], ["antigen", "GENE_OR_GENE_PRODUCT", 11, 18], ["MZ B cells", "CELL", 29, 39], ["MZ B cells", "CELL_TYPE", 29, 39], ["antigen", "TEST", 11, 18], ["activated MZ B cells", "TREATMENT", 19, 39], ["infection", "PROBLEM", 68, 77], ["infection", "PROBLEM", 131, 140]]], ["Antigen-activated follicular B cells move to germinal centres, where the antibody's affinity matures, and switch classes by recombining to mount long-lasting highaffinity immunoglobulin G (IgG) antibody responses against pathogens 5 .", [["follicular B cells", "ANATOMY", 18, 36], ["germinal centres", "ANATOMY", 45, 61], ["follicular B cells", "CELL", 18, 36], ["germinal centres", "MULTI-TISSUE_STRUCTURE", 45, 61], ["immunoglobulin G", "GENE_OR_GENE_PRODUCT", 171, 187], ["IgG", "GENE_OR_GENE_PRODUCT", 189, 192], ["Antigen-activated follicular B cells", "CELL_TYPE", 0, 36], ["highaffinity immunoglobulin G", "PROTEIN", 158, 187], ["IgG", "PROTEIN", 189, 192], ["Antigen", "TEST", 0, 7], ["activated follicular B cells", "TREATMENT", 8, 36], ["the antibody's affinity", "TEST", 69, 92], ["immunoglobulin G (IgG) antibody responses", "TEST", 171, 212], ["pathogens", "PROBLEM", 221, 230]]]], "PMC7350772": []}